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Summary  i 
Three-level synthesis of single-subject experimental data: Further extensions, empirical 
validation and applications. 
Dra. Mariola Moeyaert 
Supervisor: Prof. dr. Wim Van den Noortgate, 
Co-supervisor: Prof. dr. John. M. Ferron, and Prof. dr. Patrick Onghena. 
During the last decade, there is a growing interest in using single-subject experimental designs (SSED) 
in a variety of different research fields in education as a means to investigate the effectiveness of one 
or multiple treatments (Barlow, Nock, & Hersen, 2009; Morgan & Morgan, 2001). In an SSED study, 
one or a few subject(s) (or another entity) is the focus of interest and is measured repeatedly during 
successive conditions, usually a baseline condition (in which no treatment is present) and a treatment 
condition (Barlow et al., 2009; Kazdin, 2011; Onghena, 2005). By comparing scores from both kinds 
of conditions, a single-case researcher can assess the functional relationship between the condition and 
the outcome scores on the dependent variable (e.g., the score on a statistical test). Although SSEDs are 
growing in popularity and are valued, the external validity is often questioned because of the small 
number of subjects under investigation in one SSED study. In order to establish an evidence base for 
treatment effects, several SSED studies can be combined and a three-level data structure becomes 
visible, namely measurement occasions are nested within subjects and subjects in turn are nested 
within studies. The synthesis of the studies can inform research, practice and policy and important 
decisions can be made based on the synthesis results. In this dissertation, we focus on one specific 
flexible methodological framework that takes this hierarchical data structure into account and that can 
be used to summarize SSED data across subjects and across studies, namely three-level modeling. 
This multilevel approach is promising and enables estimating treatment effects across cases and across 
studies in addition to study-specific and subject-specific treatment effects. Furthermore, variation in 
these treatment effects between studies and between subjects can be estimated, multiple predictors can 
be added, autocorrelation and heterogeneous variance can be modeled, etc. This dissertation is 
comprised of two large parts; a methodological part which is the product of four methodological 
papers and an applied part in which three applied papers are presented. As a consequence, the purpose 
of this dissertation is twofold; (1) empirically validate the methodology of multilevel modeling, and 
(2) enhancing the understanding of this flexible way of synthesizing SSED data and promoting the use 
of multilevel models by giving practical illustrations. In this way, the dissertation is of interest to the 
methodologist, the single-subject meta-analyst, and the applied single-subject researcher. The 
methodologist will be challenged to examine suggestions for further research, the meta-analyst will be 
encouraged to use the multilevel model as it provides a flexible way to model a variety of different 
SSEDs, and the practical implications will guide applied single-subject researchers in setting up SSED 
studies, doing the analysis and interpreting and reporting their results. After a general introduction 
(Chapter 1), we focus in Part 1 on intensive Monte Carlo simulation methods to validate the basic 
three-level model and some extensions. We start with the empirical validation of the basic multilevel 
model (Chapter 2). A commonly encountered issue when synthesizing SSED studies is 
standardization which will be the focus of interest in Chapter 3. SSEDs are vulnerable to several 
threats to internal validity. We suggest one way to take external event effects into account (Chapter 4). 
In the last chapter of the first part (Chapter 5), we evaluate the consequences of misspecifying the 
covariance matrix at the second and third level of the multilevel model. This allows examination of the 
robustness of the three-level model. In the second part (Part 2) of this dissertation, we aim to provide a 
broad understanding of the options, the flexibility and the use of the multilevel modeling framework 
by giving empirical illustrations using different empirical datasets. In Chapter 6, the design matrix 
specification is elaborated and illustrated using graphical presentations and real datasets. We explain 
in detail the process from single-level analysis to multilevel analysis of SSED data in Chapter 7. In the 
last chapter (Chapter 8), we illustrate how to combine several types of SSEDs such as simple AB 
designs, multiple-baseline designs, ABAB reversal designs and alternating treatment designs using 
one multilevel modeling framework on a real dataset. A third part (Part 3) of this dissertation is 
comprised of two chapters. In Chapter 9, a summary of the main findings is given, and 
methodological issues and implications for further research are discussed. We end this dissertation by 
giving suggestions for further research (Chapter10). 
  
  
Nederlandstalige samenvatting  iii 
Drie-niveau synthese van single-subject experimentele data: Verdere uitbreidingen, empirische 
validatie en toepassingen. 
Dra. Mariola Moeyaert 
Promotor: Prof. dr. Wim Van den Noortgate, 
Copromotor: Prof. dr. John. M. Ferron, and Prof. dr. Patrick Onghena 
Gedurende het laatste decennium is er een groeiende interesse om single-subject experimentele 
designs (SSED) in verschillende onderzoeksdomeinen in educatie toe te passen om de effectiviteit van 
één of meerdere behandelingen te onderzoeken (Barlow et al., 2009; Morgan & Morgan, 2001). De 
interesse van de SSED onderzoeker gaat uit naar één of meerdere individuen (of een entiteit zoals een 
school) dat geobserveerd en gekwantificeerd wordt gedurende opeenvolgende meetmomenten. Een 
SSED wordt gekenmerkt door een baseline conditie (waarin men geen behandeling toedient), gevolgd 
door een behandelingsconditie (Barlow et al., 2009; Kazdin, 2011; Onghena, 2005). Door het 
vergelijken van baseline- en behandelingsobservaties, kunnen SSED onderzoekers nagaan of er al dan 
niet een functioneel verband bestaat tussen de conditie en de geobserveerde score (bijvoorbeeld de 
behaalde score op een statistische test). Niettegenstaande de groeiende populariteit en waardering voor 
SSEDs, rijzen er vragen betreffende de externe validiteit van de onderzoeksresultaten aangezien 
slechts een beperkt aantal personen deel uitmaken van de SSED studie. Het drieniveau model kan 
gebruikt worden om SSED studies samen te vatten wat resulteert in meer extern valide uitspraken met 
betrekking tot het effect van een behandeling. De synthese van SSED data over subjecten en over 
studies heen kan onderzoek, praktijk en beleid inspireren en informeren en belangrijke beslissingen 
kunnen genomen worden op basis van deze resultaten. De drieniveau benadering is veelbelovend en 
maakt het mogelijk om behandelingseffecten over subjecten en over studies te schatten bovenop 
studie-specifieke en subject-specifieke behandelingseffecten. Bovendien kan variantie in 
behandelingseffecten tussen subjecten en tussen studies geschat worden, predictoren kunnen 
toegevoegd worden, autocorrelatie en heterogene variantie kunnen gemodelleerd worden, enz. Dit 
proefschrift bestaat uit twee grote delen: een methodologisch en een toegepast gedeelte. In het 
methodologisch deel wordt het basis drieniveau model en verschillende uitbreidingen gevalideerd 
resulterende in vier methodologische manuscripten. Het toegepaste gedeelte bestaat uit drie 
manuscripten waarin toepassingen van het drie-niveau model verhelderd en geïllustreerd worden met 
behulp van empirische illustraties. Het doel van dit proefschrift is dan ook tweevoudig, enerzijds het 
empirisch valideren van de multiniveau methodologie, en anderzijds het geven van praktische 
toepassingen. Op deze manier is dit proefschrift informatief voor zowel de methodoloog, statisticus, 
meta-analist als de toegepaste onderzoeker. De methodoloog zal uitgedaagd worden om verder op 
zoek te gaan naar antwoorden op onopgeloste vragen en kan de suggesties voor verder onderzoek 
onder de loep nemen. De statisticus en meta-analist worden verder op weg geholpen om inferenties te 
maken betreffende behandelingseffecten. De praktische toepassingen van het tweede gedeelte zetten 
toegepaste SSED onderzoekers op weg bij het opzetten van een studie, het uitvoeren van de analyse en 
het interpreteren en rapporteren van de resultaten. Na een algemene inleiding (Hoofdstuk 1), focussen 
we in het eerste gedeelte op computer-intensieve simulatiestudies om het basis drieniveau model en 
verschillende uitbreidingen van dit model te onderzoeken. We starten met de empirische validatie van 
het basis drieniveau model (Hoofdstuk 2). Een vaak voorkomend probleem bij het combineren van 
SSED studies is standaardisatie wat de onderzoek focus is in Hoofdstuk 3. SSEDs zijn gevoelig voor 
verschillende bedreigingen aan interne validiteit en daarom stellen we een mogelijkheid voor om 
externe factoren in rekening te houden (Hoofdstuk 4). In Hoofdstuk 5 evalueren we de robuustheid van 
het drieniveau model. Het doel van het tweede gedeelte van dit proefschrift is het verstrekken van de 
nodige informatie en richtlijnen om SSED data samen te vatten gebruik makende van het drieniveau 
model. In Hoofdstuk 6 leggen we de nadruk op de specificatie van de SSED matrix. In een volgend 
hoofdstuk, Hoofdstuk 7, leggen we stap per stap het proces uit om van een single-niveau analyse over 
te gaan naar een multiniveau analyse. In het laatste hoofdstuk van het tweede deel, Hoofdstuk 8, 
illustreren we hoe verschillende SSED types (AB-fase designs, multiple-baseline designs, reversal 
designs, and alternating treatment designs) gecombineerd kunnen worden gebruik makende van één 
multiniveau analyse. Tot slot geven we in een derde gedeelte een samenvatting van de belangrijkste 
onderzoeksresultaten, presenteren we beperkingen en geven we implicaties (Hoofdstuk 9). 
Verschillende suggesties voor verder onderzoek worden gepresenteerd in Hoofdstuk 10.  
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General Introduction 
Background: Funding, Additional Publications and International Collaborations 
This doctoral dissertation is funded by the Flemish Foundation (FWO, Grant number 
ZKC6624). and is part of a larger research project funded by the Institute of Educational 
Sciences (IES, Grant number R305D110024). The IES project is embedded in an international 
context and is the result of a strong collaboration between the KU Leuven, the University of 
South Florida (USF) and the University of Texas (UT). The topic of the IES grant is similar to 
the topic of this dissertation and investigates extensions to the multilevel modeling of single-
subjects. I worked closely together with Maaike Ugille (KU Leuven), who focused in her 
study on combining effect sizes instead of raw data using the multilevel modeling framework 
(Ugille, Moeyaert, Beretvas, Ferron, & Van den Noortgate, 2012; Ugille, Moeyaert, Beretvas, 
Ferron, & Van den Noortgate, 2013, Ugille, Moeyaert, Beretvas, Ferron, & Van den 
Noortgate, 2014). The second year of my PhD, I spent six months at USF, to work more 
closely together with John Ferron, one of my co-supervisors. This international stay resulted 
in two publications as second author, which are not included in this doctoral dissertation. The 
first paper deals with explaining the basics of multilevel modeling to an applied audience 
(Baek, Moeyaert, Petit-Bois, Beretvas, Van den Noortgate, & Ferron, 2013). The second 
paper is more challenging and presents and validates a between-subject estimator in context of 
multiple-baseline designs which is resistant against threats to internal validity (e.g., external 
event effect, Ferron, Moeyaert, Beretvas, & Van den Noortgate, 2014). This latter study is 
closely related to the study reported in Chapter 4 entitled ‘Modeling external event effects in 
the three-level analysis of multiple-baseline across participants design’. After staying six 
months at USF, I spent one month at UT to collaborate with the other research team involved 
in the IES research grant. Together with Tasha Beretvas and one of her PhD students, 
Rommel Bunuan, I worked on a paper concerning dependent effect sizes in contexts of 
alternating treatment designs (Moeyaert, Bunuan, & Beretvas, 2014), which we will present at 
the annual meeting of the American Educational Research Association (2014).   
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General Introduction: Single-Subject Experimental Designs and Multilevel Modeling 
Over the past decade, evidence-based practices and policy explicitly rely on scientific 
research (National Research Council, 2002, Shadish & Rindskopf, 2007). This resulted in 
developments such as the What Works Clearinghouse (WWC), which main focus is on 
evaluating the quality of published research and determining the effectiveness of specific 
practices in educational contexts. Single-subject experimental design (SSED) studies have 
provided scientifically sound evaluations of treatment effects in a variety of different research 
fields such as in biomedical research, school effectiveness, behavior modification, school 
psychology, and special education for more than 50 years (Gast, 2010; Kennedy, 2005, 
Kratochwill, 1978; Tawney & Gast, 1984; Busse, Kratochwill, & Elliott, 1995; Chorpita, 
Albano, Heimberg, & Barlow, 1996; Barlow & Hersen, 1984; Kratochwill & Levin, 1992), 
and are included in the WWC single-case design technical documentation guidelines 
(Kratochwill et al., 2010). In the writing of the WWC documentation, a panel of experts in 
SSED and analysis of SSEDs were gathered to describe SSED studies as scientific evidence 
available for quantitative synthesis. In addition, increased attention has been placed on SSEDs 
as the IES has included this type of design as a rigorous research design within its research 
grant framework. Many researchers recognize the valuable contributions SSED methods have 
made to educational research (e.g., National Research Council, 2002; Odom, Brantlinger, 
Gersten, Horner, Thompson, & Harris, 2005). A search of the Social Science Citation Index 
(SSCI) within the Web of Science using the key terms “single-case” or “single-subject” shows 
an increase in the number of published items over the last decades (see Figure 1.1).  
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Figure 1.1. Graphical display showing the increase in the number of published items for the keywords “single-
case” or “single-subject” between 1970 and 2013 using the Social Science Citation Index within the Web of 
Sciences. 
Because of the popularity of SSEDs within and across a variety of different research 
fields, a large number of SSEDs is available for quantitative synthesis (Shadish & Rindskopf, 
2007). In the remainder of this chapter, we give a brief introduction into SSEDs (i.e., 
definition, characteristics, and types), describe how an SSED can be analyzed and how the 
SSED study research findings can be synthesized across SSED studies using the multilevel 
modeling framework in order to contribute to evidence based research, to inform policy and 
research, and to improve practice (Shadish & Rindskopf, 2007). 
1.1 Single-Subject Experimental Design 
1.1.1 Definition 
According to the WWC standards, an SSED study is identified by three important 
characteristics: (1) data are gathered, analyzed and interpreted for one entity (this entity can 
be one participant or a group of participants e.g., a classroom, a school or an organisation), (2) 
the participant(s) is (are) observed repeatedly during baseline(s) and treatment(s) phase(s), 
and (3) outcomes during and after the treatment are compared with outcomes prior to 
treatment (Barlow & Hersen, 1984; Kazdin, 2011 ; Kratochwill et al., 2010; Onghena, 2005). 
Despite what might be expected from the name “single-subject experimental design study”, 
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experimental study. The main focus of this design lies in assessing whether there is a causal 
relation between the introduction of a treatment and the change in a dependent variable 
(Levin, O'Donnell, & Kratochwill, 2003; Onghena, 2005). This implies that in an SSED 
study, a case is observed longitudinally under several experimental conditions or phases (at 
least one baseline condition in which no treatment is given and one treatment or intervention 
condition). SSED studies provide detailed information about variations in the treatment effect 
related to specific subjects under investigation. This tends to be lost in group-comparison 
designs because they only provide averages and effect sizes for the entire group (Barlow & 
Hersen, 1984). In addition to individual variation, this type of design also allows the 
individual to be measured at various points in time, thereby allowing the treatment effect to be 
evaluated with more than a single observation, which allows researchers to see how the 
treatment effect changes over time (i.e., identifying trends). Due to the fact that in one SSED 
study only a small number of individuals is needed, researchers are able to study populations 
of people that have a low prevalence rate (e.g., children with special needs). Another 
advantage is that these designs reduce the gap between research and practice by allowing 
practitioners to implement SSEDs in their natural settings (Morgan & Morgan, 2001). Within 
the SSED, the subject provides its own control for purposes of comparison (Kratochwill et al., 
2010; Perone, 1999). For example, the subject’s series of outcome variable values prior to the 
intervention is compared with the series of outcome variable values during (and after) the 
intervention. In literature, single-subject experimental designs (Guralnick, 1978; McReynolds, 
& Thompson, 1986) have taken on a variety of different names, such as single-case design 
(Gingerich, 1984), intrasubject replication design (Gentile, Roden, & Klein, 1972), reversal 
design (Gentile et al., 1972), individual organism research (Michael, 1974), intrasubject 
design (Center, Skiba, & Casey, 1985-1986), intrasubject experimental design (White, Rusch, 
Kazdin, & Hartmann, 1989), N = 1 design (Strube, Gardner, & Hartmann, 1985), N of 1 
design (Gorsuch, 1983), one-subject experiment (Edgington, 1980), interrupted time series 
(Michielutte, Shelton, Paskett, Tatum, & Velez, 2000), and small-n design because some 
single-case studies investigate more than one subject (Kratochwill & Levin, 1992). In this 
doctoral dissertation we will use the terms single-case experimental design and single-subject 
experimental design interchangeably. 
The three main characteristics of an SSED study (focus on one entity, repeated 
measures across time, and experimental control) can be used to situate single-subject research 
designs in a broader research context, which might help understanding how these designs 
differ from closely related designs. Similar to group-comparison designs, also in the area of 
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SSEDs a distinction can be made between experimental and quasi-experimental SSED 
studies. In experimental studies random assignment of measurement occasions to treatments 
is feasible (e.g., Bulté & Onghena, 2009; Edgington & Onghena, 2007; Koehler & Levin, 
2000; Manolov & Solanas, 2009), whereas this is not the case in quasi-experimental studies. 
The major difference between a typical SSED study and group-comparison design study is 
that these latter type of designs focus on average treatment effect estimates, whereas SSED 
studies focus on a limited number of preselected individuals and subject-specific treatment 
effect estimates are obtained. In SSEDs, an entity is measured repeatedly across time, whereas 
group-comparison designs usually incorporate one measurement per subject. This implies that 
in group-comparison designs, often no within-subject trends can be identified. An SSED 
should not be confounded with a (qualitative) case study or observational case study research. 
In a typical case study, a single entity is involved but there is not a purposeful manipulation of 
an independent variable nor are there necessarily repeated measures. Most case studies are 
reported in a narrative way while results of SSEDs are presented numerically or graphically. 
In observational time series research there are also repeated measures but there is an absence 
of a designed treatment. SSEDs are experimental or quasi-experimental designs (in case there 
is no random assignment), because they are characterized by the active manipulation of the 
independent variable by the researcher. SSEDs and longitudinal designs have in common that 
subjects are measured repeatedly across time allowing identifying trends. In longitudinal 
designs, subjects are measured across a long period (which can be years or decades), whereas 
in SSEDs, measurement occasions tend to be closer together in time so that the SSED can be 
completed in weeks or months. In an SSED, one or multiple subject(s) can be involved, 
whereas in longitudinal designs, multiple subjects are observed simultaneously across time 
(Verbeke & Molenberghs, 2009). In this doctoral dissertation, we focus on SSEDs as a means 
to build further on an evidence base for intervention effects.  
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1.1.2 Types of single-subject experimental designs 
1.1.2.1 Basic single-subject experimental designs 
There are several types of SSEDs. The most basic type is an AB, or interrupted time 
series design (i.e., data are collected repeatedly over time, but the baseline condition is 
interrupted by a treatment, see Figure 1.2). A basic SSED is characterized by an A-phase (i.e., 
baseline condition) followed by a B-phase (i.e., treatment or intervention condition). In SSED 
research there has been a tradition to graphically display the data, such as in Figure 1.2 
(Barlow & Hersen, 1984, Kartochwill et al., 2010; Kazdin, 2011). In Figure 1.2, relatively 
stable outcome scores during a baseline phase are obtained, an increase in outcome scores due 
to the treatment is observed, and during the treatment the outcome scores gradually decrease 
across time. 
 
Figure 1.2. Graphical display of the basic AB design. 
This basic AB design type is not without criticism. For instance, when using this type of 
SSED it is difficult to attribute a change in the data to the treatment and not to some other 
event which could have occurred at the same time (Shadish, Cook, & Campbell, 2002). This 
limitation can be addressed by utilizing more complex SSED studies, such as multiple-
baseline designs, reversal designs, and alternating designs (Barlow et al., 2009). Shadish and 
Sullivan (2011) conducted a systematic review of 809 published SSEDs in the field of 
psychology and educational sciences in 2008 and found that more than a half of the SSEDs 
are characterized by a multiple-baseline design (54.3%). The reversal and alternating 
treatment designs are the other two most popular SSEDs (8.2% and 8% respectively). 
Multiple-baseline designs, reversal designs, and alternating treatment designs involve phase 
repetition and as a result handle major threats towards internal validity including for instance 
history and maturation (Shadish, et al., 2002). 
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1.1.2.2 Complex single-subject experimental designs 
1.1.2.2.1 Multiple baseline design 
A first possible extension of the basic AB phase design, is the multiple-baseline design. 
In multiple-baseline designs (MBD), an AB phase design (with one baseline phase, A, and 
one treatment phase, B) is implemented simultaneously to different subjects, behaviors, or 
settings (Ferron & Scott, 2005; Onghena, 2005; Onghena & Edgington, 2005). The 
introduction of the treatment is staggered across the subjects, behaviors or settings, which 
imply baseline phases of different lengths. The general form of an MBD across three subjects 
with 14 measurement occasions is illustrated in Figure 1.3. MBDs are popular amongst 
SSEDs (Shadish & Sullivan, 2011) thanks to the sequential introduction of the intervention 
over the cases (or settings or behaviors). It entails the advantage that researchers can more 
easily disentangle effects of the intervention and effects of some external events, such as a 
defective measurement instrument, which leads to more internally valid results (Baer, Wolf, 
& Risley, 1968; Barlow & Hersen, 1984; Kinugasa, Cerin, & Hooper, 2004; Koehler & 
Levin, 2000). In Figure 1.3, a decrease in outcome score for the three subjects is observed 
when the treatment is introduced, independent of the moment in time at which the treatment is 
administered. The subject’s baselines serve as a means of control: the SSED researcher 
investigates whether a change in outcome scores occurs only for the subject at which the 
intervention is given and not for the other subjects. Therefore it is more likely that the 
treatment causes the change in outcome score and not some external factor. Moreover, 
because the SSED is repeated to several subjects (or behaviors or settings), the external 
validity of the effectiveness of a treatment can be examined. If the treatment is found to be 
effective for a group of subjects (or behaviors or settings), a more external (generalizable) 
treatment effect estimate can be obtained. It can also be the case that the treatment is not 
effective across the subjects (or behaviors or settings), which gives a motivation to search for 
moderator variables. In order to examine external validity and moderator variables, typically 
more than three subjects are needed. 
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Figure 1.3. Graphical display of the multiple-baseline across three subjects design. 
1.1.2.2.2 Reversal designs 
The introduction and withdrawal of the treatment is typical for the reversal design (e.g., 
ABABAB design, see Figure 1.4). In these kinds of designs, there is more than one transition 
from one phase to another within one subject. If a change in outcome scores after the 
introduction of the treatment is observed during each AB pair, one can be more confident that 
a change in outcome scores is due to the treatment and not to some external event effect. The 
reversal designs provide a high degree of experimental control and are straightforward to 
implement. But, a drawback is that these designs involve the assumption that the outcome is 
reversible, which is not always the case. For instance, when the purpose is to learn a new 
behavior, you cannot unlearn it, and so this type of design gives rise to ethical questions. 
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Figure 1.4. Graphical display of the ABABAB reversal design. 
A lot of variations of reversal designs are possible in which AB-patterns are replicated (e.g., 
A-B-A-B-A-B-A-B design), separate treatment variables are evaluated (e.g., A-B-A-C-A 
design), interaction effects are studied (e.g., A-B-A-B-BC-B-BC design), variations of the 
same treatment variable are incorporated, (e.g., A-B-A-B-B1-B2-BN design), etc.  
1.1.2.2.3 Alternating treatment designs 
In many cases however, researchers are not only interested in whether one treatment 
works but also whether one treatment works better in comparison to another. In an alternating 
treatment design (ATD), two or more treatments are rapidly alternated (Barlow & Hayes, 
1979). In a typical ATD, data collection starts with a baseline phase, but during the treatment 
phase, two or more treatments are alternated (see Figure 1.5). 
 
Figure 1.5. Graphical display of the alternating design. 
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Multiple comparisons of treatments are made in relatively few sessions. Because the 
dependent variable is exposed to each of the independent variables, carryover effects might 
occur and it can be questioned whether the treatments per se have an effect. Therefore, a final 
phase can be included in the design where the selected treatment is implemented alone to 
ensure that this treatment remains effective. The ATDs entail the advantage that the 
treatments do not have to be removed, a baseline phase is not needed, and the phases are 
possibly very short which allows for more quick comparisons. However, this type of design is 
only appropriate if frequent alternation of the treatments is possible and is therefore a less 
popular SSED type. 
1.2 To Randomize or not to Randomize 
An important consideration in designing an SSED is whether or not to incorporate 
randomization. SSED researchers designing their study could for instance choose to randomly 
assign measurement occasions to conditions (i.e., for alternating treatment designs) or to 
randomly choose when the start of a condition occurs (for AB phase designs or reversal 
designs). As stated by Onghena (2005), the randomization provides statistical control over 
both known and unknown confounding variables that are time-related (e.g., history and 
maturation). In this way, randomization can improve the internal validity of an SSED. 
However, SSEDs are usually nonrandomized experiments, because the random assignment of 
measurements to conditions or the random start of a condition is practically unfeasible. 
Therefore caution has to be paid when attributing outcome changes to treatment changes 
instead of to some external event effect. Advantages of including randomization in the design 
are described in several textbooks and research articles (e.g., Barlow et al. 2009, Edgington & 
Onghena, 2007; Kazdin, 2011; Kratochwill & Levin, 1992, 2010). We acknowledge the 
importance of incorporating randomization in SSEDs to eliminate threats towards internal 
validity, but we do not limit the work in this dissertation to randomized single case designs.  
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1.3 The Analysis of a Single-Subject Experimental Design 
1.3.1 Visual analysis 
Visual analysis of graphed data has been and continues to be the traditional method for 
evaluating treatment effects in SSED research (Ferron & Jones, 2006; Horner, Swaminathan, 
Sugar & Stokowski, 2012; Kratochwill et al., 2010), but is by itself less suitable for 
synthesizing literature in an objective way (Manolov & Solanas, 2013), because it does not 
provide an effect size measure. Visual analysis methods aim at reaching a judgment about the 
reliability and consistency of treatment effects by visually examining graphed data. In the 
WWC technical documentation, clear guidelines are reported about which criteria single-case 
analysts should use to evaluate intervention effects, namely changes in level, variability in 
outcome scores, trend, the latency of change evident across phases, and whether the changes 
are consistent with the requirements of the particular design (Kazdin, 2011). When the 
changes in level, and/or variability are in the desired direction and when they are immediate, 
readily discernible, and maintained over time, it is concluded that the changes in behavior 
across phases result from the implemented treatment and are indicative of improvement 
(Busse et al., 1995). A recent study indicates that visual analyses can lead to consistent results 
concerning the effectiveness of a treatment only if visual analysts are well trained (Kahn, 
Chung, Gut shall, Pitts, Kao, & Girolami, 2010). Others have claimed that visual analysis 
procedures may have Type I error rates that are quite high (Gibson & Ottenbacher, 1988, 
Greenwood & Matyas, 1990, Matyas & Greenwood, 1990), but the Type I error rate can be 
controlled in randomized SSEDs by structuring the visual analysis (Ferron & Jones, 2006). 
1.3.2 Quantitative analysis 
Quantitative analysis methods are still being developed in the domain of SSED research 
(Kratochwill et al., 2010) and statistical challenges of producing an accepted measure of 
treatment effect remain (Beretvas & Chung, 2008; Horner, Carr, Halle, McGee, Odom, & 
Wolery, 2005; Shadish & Rindskopf, 2007). 
1.3.2.1 Randomization tests 
The use of randomization tests in the area of SSED has been suggested to increase both 
statistical and internal validity (Bulté & Onghena, 2009; Edgington & Onghena, 2007; 
Kratochwill & Levin, 2010; Manolov & Solanas, 2009; Onghena, & Edgington, 2005). To 
conduct a randomization test, researchers have to record all possible random assignments 
before the start of the SSED study. In alternating treatment designs, measurements are 
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randomly assigned to phases, or randomly assigned to phases under some restrictions 
(Onghena & Edgington, 1994). In AB phase or reversal designs the start of a condition is 
introduced in a random way (Edgington, 1967; Onghena, 1992). In multiple-baseline designs 
participants can be randomly assigned to baseline lengths (Wampold & Worsham, 1986) or 
interventions start points can be randomly chosen for each participant subject to some 
constraints (Koehler & Levin, 1998). One of the possible assignments is chosen and this 
forms the actual SSED. Then the researcher chooses an appropriate test statistic (e.g., 
difference in mean outcome between treatment and baseline conditions), collects the data, and 
calculates the test statistic based on the collected data. Once this is accomplished, the test 
statistic is calculated for each of the possible alternative random assignments that were 
recorded at the beginning of the experiment using the collected SSED data. All the test 
statistic values are sorted and based on this, the statistical significance of the SSED test 
statistic can be calculated by looking where the obtained test statistic falls within the 
distribution of possible test statistic values. The p-value of the randomized SSED is calculated 
as the proportion of possible test statistic values that is as extreme as or even more extreme 
than the value of the test statistic based on the SSED. The use of randomization tests in the 
context of SSEDs is rather limited because random assignment is not always feasible. Another 
drawback of these analyses is that the magnitude of a treatment effect cannot be estimated, 
but one can only decide if the treatment was effective. This can be dealt with by calculating 
effect size estimates. 
1.3.2.2 Effect sizes 
In the past, single-case analysts have relied on parametric and nonparametric effect 
sizes (Maggin, Swami Nathan, Rogers, O’Keeffe, Sugar, & Horner, 2011; Mastropieri & 
Scruggs, 1985; Methe, Kilgus, Nieman, & Riley-Tillman, 2012). Nonparametric effect sizes 
such as percentage of non-overlapping data, percentage of all non-overlapping data, or 
percentage exceeding the median are not affected by distributional assumptions but have been 
criticized for the inability to (1) account for data trends, (2) discriminate between large 
treatment effects due to ceiling effects (Wolery, Busick, Reichow, & Barton, 2010), or (3) 
produce a known sampling distribution (Lenz, 2013; Parker & Vannest, 2008). Parametric 
effect sizes deal with these critiques and over the last years, several parametric effect sizes 
have been proposed to enhance the analysis of SSED data including regression estimates (e.g., 
Maggin, et al., 2011; Parker, Vannest, & Davis, 2011). Amongst others, these methods allow 
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modeling trends, including predictors, and modeling autocorrelation (Shadish, Rindskopf, 
Hedges, & Sullivan, 2012).  
1.4 The Multilevel Modeling of Single-Subject Experimental Design Data 
In the past, little attention is given to the synthesis of SSED results, partly because the 
fact that the literature about meta-analysis has focused on combining the results of group-
comparison studies (Kratochwill et al., 2010). In contrast to SSED studies, in group-
comparison studies, there is widespread agreement about how these effect sizes should be 
expressed, what the statistical properties of the estimators are (e.g., distribution theory, 
conditional variance), and how to translate from one measure (e.g., a correlation) to another 
(e.g., Hedges’ g). However, individual client responses are lost in the group averaging process 
and important findings are obscured. Inferences about causes of changes (when they can be 
made) are made at the level of the group, which neglect effects of the intervention on any 
individual subject. This severely limits the applicability of results to specific clients (Barlow 
& Hersen, 1984). Group-comparison methods generally involve only one (posttest only) or 
two (pretest-posttest) measurements of subject response. Important information on the 
dynamic nature of subject response to treatment is thereby missed. 
Therefore, during the last decades, there is a growing interest in synthesizing SSED data 
across subjects and across studies. A primary search of published meta-analyses of SSED 
studies using the social sciences citation index within the Web of Sciences using the 
keywords ‘single-case’ or ‘single-subject’ or ‘multiple-baseline’ in combination with ‘meta-
analysis’ resulted in 2,242 results. Especially during 2012 and 2013, a lot of meta-analyses of 
SSEDs are reported, see Figure 1.6. 
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Figure 1.6. Graphical display showing the increase in the number of published items for the keywords “single-
case” or “single-subject” or “multiple-baseline” in combination with “meta-analysis”. 
As the number of published syntheses of SSEDs is increasing, there is a need to 
optimize the statistical techniques to quantify the research findings in an objective way. When 
using data from multiple subjects and multiple studies, a three-level structure becomes visible: 
measurement occasions are nested within subjects and subjects in turn are nested within 
studies. In SSED studies, data are commonly graphically presented, which allows retrieving 
the raw data from the primary studies using a statistical software program (e.g., Ungraph, 
Biosoft, 2004; Shadish, et al., 2009). Afterwards the raw data can be synthesized using a 
multilevel model which is an extension of the regression approach (Nugent, 1996; Nagler, 
Rindskopf, & Shadish, 2008; Rindskopf & Ferron, in press; Shadish & Rindskopf, 2007; 
Shadish, Kyse, & Rindskopf, 2013; Van den Noortgate & Onghena, 2003a, 2003b, 2007, 
2008). If the SSED data are not graphically presented in the primary studies, a multilevel 
analysis can still be conducted based on effect sizes instead of raw data. If effect sizes are 
combined instead of raw data, we will use the label ‘multilevel meta-analysis’ instead of 
‘multilevel analysis’ in the remaining of this dissertation.  
The multilevel modeling method based on the regression approach is the most flexible 
approach given its ability to model complexities such as autocorrelation, predictors at the 
different levels (e.g., age, gender, SES, school type, study quality), heterogeneous within-
subject, between-subject and between-study (co)variance, and it allows estimating average 
treatment effects across studies in addition to subject-specific and study-specific treatment 
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By conducting a multilevel analysis, important research questions can be addressed (which 
cannot be answered by single-level analysis of SSED data) such as: (1) What is the magnitude 
of the average treatment effect across cases and across studies? (2) What is the magnitude and 
direction of the case-specific intervention effect? (3) How much does the treatment effect vary 
within cases, across cases and/or across studies? and (4) Does a (case and/or study level) 
predictor influence the treatment’s effect? The two-level model (Ferron, Bell, Hess, Rendina-
Giobioff, & Hibard, 2009; Ferron, Farmer, and Owens, 2010; Van den Noortgate & Onghena, 
2003a) and the three-level model (Owens & Ferron, 2010; Moeyaert, Ugille, Ferron, Beretvas, 
& Van den Noortgate, 2013a) have been validated in previous research using extensive 
simulation studies. Extensions to the three-level model have been proposed, such as the 
modeling of non-linear trajectories during treatment phase (Beretvas, Hembry, Van den 
Noortgate, & Ferron, 2013), the modeling of autocorrelation (Baek & Ferron, 2013), 
standardizing SSED data (Moeyaert, Ugille, Ferron, Beretvas, & Van den Noortgate, 2013b), 
dealing with external event effects (Moeyaert, Ugille, Ferron, Beretvas, & Van den Noortgate, 
2013c), estimating treatment effect estimates across different types of SSEDs (i.e., multiple-
baseline designs, ABAB reversal designs, and alternating treatment designs; Moeyaert, 
Ugille, Ferron, Beretvas, & Van den Noortgate, 2014c), modeling count data as outcome 
scores (Beretvas & Chu, 2013; Shadish et al., 2013; Shadish & Rindskopf, 2007), etc. 
Ignoring the multilayered nature can have a substantial impact on the conclusions of a 
multilevel analysis (Hox, 2002; Van den Noortgate, Opdenakker, & Onghena, 2005) as 
standard error estimates will be too small resulting in an inflated number of Type I errors 
when used in statistical tests (i.e., the statistical test indicates a treatment effect, whereas in 
reality there is no). Therefore it is important to take the hierarchical structure into account.  
1.5 Research Objectives and Structure of this Dissertation 
1.5.1 Research objectives 
With this doctoral dissertation, we want to contribute to the development of the 
methodology for combining the results of SSED studies. We suggest, examine, and further 
extend the multilevel modeling approach to quantitatively integrate SSED data across subjects 
and across studies. Multilevel modeling of SSEDs allows for a quantitative summary of a 
large body of literature, which results in externally valid results, more accurate estimates, and 
valuable information that can inform policy and can improve practice. The intent of this 
dissertation is twofold. On the one hand, we empirically validate the basic three-level model 
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and several extensions to it using large simulation studies and giving empirical illustrations. 
On the other hand, we want to inform applied SSED researchers about the value of multilevel 
modeling of SSEDs and how to use these models. As a consequence, this dissertation is 
informative for methodologists, research analysts and synthesists, but also for applied SSED 
researchers. 
1.5.2 Structure of this dissertation 
The structure of this dissertation is presented in Figure 1.7. 
Chapter 1: General Introduction 
Part 1 
Three-level modeling: Further developments and methodological issues 
Chapter 2: Three-Level Analysis of Unstandardized Single-Subject Data 
Chapter 3: Three-Level Analysis of Standardized Single-Subject Data 
Chapter 4: Modeling External Event Effects in the Three-Level Modeling of Single-Subject Data 




Chapter 6: The Influence of the Design Matrix on Treatment Effect Estimates in the 
Quantitative Analyses of Single-Subject Data 
Chapter 7: From a Single-Level to a Multilevel Analysis of Single-Subject Experimental Data 
Chapter 8: Estimating Intervention Effects across Different Types of Single-Subject Designs 
Part 3 
Discussion, conclusion and future research 
Chapter 9: General Discussion 
Chapter 10: The future of Multilevel Modeling to Synthesize Single-Subject Experimental Data 
Figure 1.7. Overview and structure of this dissertation. 
The first part (Part 1) of the dissertation is composed of four computer intensive Monte 
Carlo simulation studies and is especially informative for statisticians, methodologists and 
SSED research analysts and synthesists. In these simulation studies, we look at the bias of the 
average treatment effect estimate, which is the difference between the expected effect 
estimate and the true population effect, at the mean squared error (defined as the mean 
squared difference between the estimates and the population value), at the standard error 
estimates, and at the coverage proportion of the 95% confidence intervals for the treatment 
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effects, which refers to the number of times the 95% confidence interval contains the 
population value. Furthermore, we examine the power, an important practical consideration 
when determining the conditions under which the three-level model can be recommended. We 
also look at the bias of the point estimates of the variance components. For the simulations we 
use the infrastructure of the Flemish Supercomputer Center, financed by the Department of 
Economy, Science and Innovation – Flemish Government and the Hercules Foundation. In 
Chapter 2, we evaluate whether the basic three-level model is appropriate to combine raw, 
unstandardized SSED data across cases and across studies. Chapter 3 involves the evaluation 
of a standardizing method in order to combine SSED data over cases and over studies. 
Standardizing the raw SSED data is needed because dependent variables in a set of SSED 
studies are not always measured the same way and on the same scale. For instance, 
challenging behavior in class in one study is measured on a scale from one to ten, whereas 
another researcher indicates the challenging behavior on a scale from one to five. 
Standardization allows immediate comparison and fair interpretations of scores on 
challenging behavior across different studies. In the third simulation study, we focus on the 
strength of multiple-baseline designs to disentangle treatment and event effects. Chapter 4 
presents a method to adjust the three-level model for external events and evaluates the 
appropriateness of the modified model. The last chapter of the first part, Chapter 5, examines 
the robustness of the three-level model. The focus of this simulation study is to evaluate the 
consequences of a violation of independence of the residuals at level two or level three. A 
major advantage of the multilevel approach is that covariance between the residuals can be 
modeled by specifying a specific structure for the variances and covariances at either level. 
We investigate the influence of covariance misspecification on the treatment effect estimates. 
The purpose of Part 1 is evaluating the basic three-level model and several extensions to it to 
synthesize SSED results.  
The second part of this dissertation (Part 2) consists of three applied studies. In the first 
chapter of Part 2 (Chapter 6), the influence of the design matrix specification on the 
interpretation of the regression coefficients of interest is discussed. Different design matrices 
are presented that can be used for the most common SSEDs, namely, the multiple-baseline 
designs, reversal designs, and alternating treatment designs. The purpose of this article is to 
guide data analysts interested in analyzing and meta-analyzing SSED data. Chapter 7 goes 
one step further and explains the process from single-level analysis to multilevel analysis of 
SSEDs. We advise readers not familiar with multilevel modeling to first read Chapter 7 
because the basics of multilevel modeling are explained in detail. In addition to the basic 
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multilevel models, several plausible alternative models are elaborated and empirical 
illustrations are given. Also, a sensitivity analysis is conducted by investigating to what extent 
the estimated treatment effect is dependent on the modeling specifications and the underlying 
assumptions. By considering a range of plausible models and assumptions, researchers can 
determine the degree to which the effect estimates and conclusions are sensitive to the 
specific assumptions made. If the same conclusions are reached across a range of plausible 
assumptions, confidence in the conclusions can be enhanced. We end Part 2 with Chapter 8 
in which we illustrate with the aid of an empirical illustration how SSEDs of several types, 
including AB phase designs, multiple-baseline designs, ABAB reversal designs, and 
alternating treatment designs can be combined using the three-level meta-analytic model. The 
univariate and multivariate three-level meta-analytic models are presented and discussed. If 
the same conclusion is based on a synthesis of results from different types of SSED designs, 
then there is more confidence that the results are due to the intervention and not to some 
outside experimental factors. Combining data from different designs can enhance the external 
validity of the synthesis’ findings because they are based on more diverse data. If several 
SSED studies’ results are combined, then data from multiple studies including one or multiple 
cases are used thereby providing more information and resulting in more precise treatment 
effect estimates (i.e., smaller standard errors and narrower confidence intervals). 
 In the first chapter of the third part (Part 3), Chapter 9, we give an overview of the 
main findings and we highlight some strengths of this dissertation, but simultaneously 
acknowledge that there are a number of limitations. We briefly elaborate implications for 
applied single-case researchers, research synthesists (meta-analysts) and methodologists, and 
end Chapter 9 with a global conclusion. We end this dissertation with Chapter 10 in which 
we discuss the future of multilevel modeling to summarize SSED data. In this chapter, we aim 
to make the reader aware that there is still a lot of work to be accomplished to optimize the 
multilevel modeling framework, to further extend the multilevel model and to deal with issues 
highlighted in previous chapters. This chapter can be considered as the beginning of a new 
research proposal and we hope to stimulate and encourage methodologists, SSED data 
synthesists, and applied SSED researchers to further study SSEDs and multilevel modeling. In 
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 Chapter 2|





One approach for combining single-case data within and across studies is multilevel 
modeling. Although the multilevel approach and its flexibility are appealing, there is much 
about single-case experimental data and design that is not fully understood. In this article we 
want to inform research synthesists under which realistic conditions the basic three-level 
model works to synthesize single-case data. We use an extensive Monte Carlo simulation 
study to explore the appropriateness of the multilevel modeling inferences. Therefore we 
choose to vary the value of the immediate treatment effect and the treatment effect on a time 
trend, the number of studies, the number of cases, the number of measurements per case and 
the between-case and between-study variance. The simulation study shows that the three-level 
approach results in unbiased estimates of both kinds of treatment effects. Further, in order to 
have a reasonable power for testing the treatment effects ( .80 or higher), we recommend 
researchers to use strict inclusion criteria, resulting in a homogeneous set of studies, and to 
involve a minimum of 30 studies in their three-level analysis of single-case results. The 
number of measurements and cases is less of importance. 
Keywords: single-case study, three-level multilevel analysis, Monte Carlo simulation 
study 
  
                                                 
1
 This chapter has been published as Moeyaert, M., Ugille, M., Ferron, J., Beretvas, S.N., & 
Van den Noortgate, W. (2013a). Three-level analysis of single-case experimental data: 
Empirical validation. Journal of Experimental Education, 82, 1-21. doi: 
10.1080/00220973.2012.745470 
24  Chapter 2 | Unstandardized single-case data 
2.1 Introduction 
2.1.1 Single-case experimental design 
A single-case experimental study is “…a designed experiment in which one case is 
observed repeatedly during a certain period under different levels (‘treatments’) of at least one 
independent variable.” (Onghena & Edgington, 2005). In the simplest design, an interrupted 
time series design, a participant or case is repeatedly observed under a baseline condition and 
a condition during or after a specific treatment. Results are typically graphically displayed, as 
in Figure 2.1.  
 
Figure 2.1. Graphical display of the basic single-case experimental design. 
The major purpose of this design is to evaluate the effect of the condition on a 
dependent variable. In the literature, single-case studies have been given a variety of different 
names, including single-case, N = 1, small-n, intra-subject, single-subject experimental 
design, interrupted time-series design, among others. 
Nowadays there is a growing interest in single-case designs because they have several 
advantages in comparison to other designs like group comparison designs. This type of 
research allows researchers to focus on the case-specific treatment effect, which have a 
tendency to be lost in group comparison designs where the focus is on the average treatment 
effect across individuals (Barlow & Hersen, 1984). In addition, because the case is measured 
at various points in time, this type of design also allows researchers to investigate how the 
treatment effect will change over time. Due to the fact that only one case is needed, 
researchers are able to study populations that have a low prevalence rate (e.g., children with 
special needs). Furthermore, because data are collected at multiple points, the researcher can 
optimize the treatment during the experiment, based on preliminary results. Finally, these 
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designs reduce the gap between research and practice by allowing practitioners to implement 
research in their current settings (Morgan & Morgan, 2001).  
Although single-case studies are growing in popularity and are valued, they have their 
limitations. The validity of inferences from basic single-case experimental designs (see Figure 
2.1) can be questioned, because a shift in the time series may be the results of something other 
than the treatment (e.g., an event that happened to occur around the time of the treatment; 
Shadish et al., 2002). In an effort to reduce the plausibility of alternative explanations for 
shifts in time series data, single-case researchers often turn to more complex interrupted time-
series designs, such as the reversal design and the multiple-baseline design (see Figure 2.2). 
The reversal design increases the number of phases by withdrawing and reintroducing a 
treatment, whereas the multiple-baseline design includes interrupted time-series data from 
multiple participants (or behaviors or settings), where for each participant the treatment 
begins at a different point in time. The result is that the baselines for the multiple participants 
are of different lengths. If in a reversal design the performance of the case returns to the 
baseline level if the treatment is stopped, or if in a multiple-baseline design the change in each 
time series closely follows the treatment start time, it is not likely that these changes are due 
to something other than the treatment (Shadish et al., 2002). 
 
 
Figure 2.2. Graphical display of the reversal design (left) and the multiple-baseline design (right). 
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Another limitation of single-case designs is the difficulty of generalizing their results to 
other cases, because of the small number of cases that are investigated (Kennedy, 1979). To 
enhance generalizability, researchers replicate across cases, either within studies, such as in a 
multiple-baseline design, or across studies. As more replications emerge and the evidence 
base accumulates so does the need for statistical methods designed to synthesize single-case 
experimental design studies’ results and to explore sources of systematic variability in single-
cases results by employing moderator analyses.  
One approach for combining single-case data within and across studies is multilevel 
modeling. In a single-case design, the same case is measured repeatedly within and across 
different conditions or phases (e.g. usually a baseline condition and a treatment condition). 
Therefore, there are multiple measurements within a case which makes it possible to identify 
trends in the different conditions. If we than pool together the observations from all cases 
within one multiple-baseline study, we deal with a two-level structure; measurement 
occasions at the first level are grouped within cases at the second level. An advantage of using 
the multilevel approach to synthesize data from multiple cases is that all the measurements 
within a case are taken into account instead of focusing on the average measure. Therefore the 
multilevel approach can handle autocorrelation, which means that measurements closer in 
time are more related to each other than measurements further in time, time trends (e.g. linear 
or non-linear trends) within each phase of the design and heterogeneous variances (within 
cases, across cases and across studies). Moreover, we can assess the variation both in the 
immediate treatment effect and the time trends across cases and across studies. This 
multilevel approach to single-case data has already been proposed and used in several studies 
(Ferron et al., 2009; Ferron et al., 2010; Nugent, 1996; Shadish & Rindskopf, 2007; Van den 
Noortgate & Onghena, 2003a, 2003b, 2008). To explore the appropriateness of three-level 
synthesis of single-case data, an initial Monte Carlo study was conducted focusing on the 
most basic interrupted time series model, one in which there were no trends in either phase 
(Owens & Ferron, 2012). These studies demonstrate that the fixed effect estimates are 
unbiased in correctly specified mixed linear models under relatively general conditions when 
restricted maximum likelihood estimation is used (Kackar & Harville, 1984). In this research 
we present a more extensive three-level simulation study examining a wider range of 
conditions than Owens and Ferron (2012) and include trends in both baseline and treatment 
phases. We also expect unbiased estimates of the treatment effects. Furthermore, we examine 
the power, an important practical consideration when determining the conditions under which 
the three-level model can be recommended, which was not examined by Owens and Ferron 
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(2012). The purpose is to inform applied researchers about the minimal requirements to use 
three-level modeling for combining the results of single-case data. 
In the following sections we present successively the three-level model, the Monte 
Carlo simulation study and the results from this study, to end with a discussion. 
2.1.2 Multilevel analysis of single-case experimental designs 
Multilevel structures are ubiquitous in various research areas, for instance in social and 
behavioral sciences. In educational effectiveness research, a multistage sampling procedure 
might be used such that in a first stage schools are sampled from a population of schools, next 
classes from the selected schools and in a third step, students from the selected classes. The 
students included in the study therefore can be grouped according to the classes and schools 
they belong to. This structure can induce dependence in the data: students from the same class 
and the same school are in general more alike than students from different classes and 
different schools. Therefore, the class and the school membership have to be taken into 
account when performing statistical analyses. Multilevel models were developed to deal with 
such grouped data (Raudenbush & Bryk, 2002). 
Single-case data from multiple cases also have a hierarchical structure: measurements 
are grouped in cases. If we have several single-case studies, with more than one case in some 
studies, three hierarchical levels can be distinguished: measurements are grouped in cases and 
cases are in turn grouped in studies. The hierarchical structure is illustrated in Figure 2.3. 
Studies  
 
Study 1  Study 2 … Study k 
Cases 
 
C1 C2 C1  C1 C2 C3 
Measurement 
occasions 
m … m m … m m … m  m … m m … m m … m 
Figure 2.3. The three-level hierarchical structure for single-case experimental design studies. 
A multilevel model that can be used to combine single-case data is an extension of the 
model of Center et al. (1985-1986). More specifically, Van den Noortgate and Onghena 
(2003a, 2008) suggest to use a hierarchical model in which individual measurements are 
regressed on a time indicator, T, which is centered around the first observation of the 
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treatment phase, D, a dummy variable for the treatment phase, and an interaction term of 
these variables: 
                                                        (    
 ), (2.1) 
and i standing for the measurement occasion (i = 0, 1,…I), j for the case (j = 0, 1,…J) and k 
for the study (k = 0,1,…K). The equation shows that in the baseline phase the expected score 
for the j
th
 case in study k, this is  ̂   , equals              , while it is (         )  
(         )     in the treatment phase (see Figure 2.4). 
 
Figure 2.4. Regression model to analyze data from single-case AB phase design. 
     therefore indicates the expected baseline level at the start of the treatment phase 
(when T = 0), and      the linear time trend in the baseline scores. The coefficient      can 
then be interpreted as the immediate effect of the treatment on the outcome, whereas      
gives an indication of the effect of the treatment on the time trend.  
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(2.2) 
The first equation indicates that the baseline performance for case j from study k equals an 
average baseline performance for study k, plus a random deviation from this mean; the 
subsequent equations describe the variation over cases from the same study of the time effect 
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in the baseline condition, the immediate treatment effect, and the treatment effect on the linear 
trend, respectively. 
At the third level, the variation of the study-specific regression coefficients from the 
second level equations is described: 
{
              
              
              
              
       [
    
    
    
    
]  (    )   
(2.3) 
Residuals at all three levels are assumed to be multivariate normally distributed. 
It is often the case that the studies use different dependent variables. The three-level 
model can easily be extended by including characteristics of the dependent variable as 
covariates. This permits a three-level synthesis of single-cases across a set of varying 
dependent variables, investigating whether the size of the treatment effects depends on the 
kind of dependent variable. Another way to deal with data measured on different scales is to 
standardize the data per case by dividing them by the estimated root mean squared error that 
is found when using the Center et al. (1985-1986) regression model on the data for that case. 
This method was proposed by Van den Noortgate and Onghena (2003b, 2008). 
Parameters of interest are typically primarily the  ’s, in multilevel literature called fixed 
effects, in this case referring to the mean regression coefficients, as well as the (co)variation 
in the regression coefficients over cases or studies, in multilevel literature called the variance 
components. This multilevel approach makes it possible to separate sampling variation, 
between-case variation and between-study variation, and to estimate the treatment effects.  
In the current study we are especially interested in the conditions under which the three-
level model works acceptably well, which leads us to evaluate the following for the fixed 
effects: the bias, the mean squared error, the standard error estimates, the coverage proportion 
for confidence interval estimates, and the power. In addition, we will evaluate bias in the 
variance component estimates.  
2.2 Simulation Study 
In order to evaluate in a systematic way the three-level modeling approach, we 
simulated a number of studies using a multiple-baseline across participants design, based on 
Equations 2.1 through 2.3. The restricted maximum likelihood procedure in SAS PROC 
MIXED was used to estimate the three-level model parameters (Littell, Milliken, Stroup, 
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Wolfinger, & Schabenberger, 2006). The Satterthwaite approach to estimate the degrees of 
freedom method was used (Satterthwaite, 1941) because this method provides accurate 
confidence intervals for estimates of the average treatment effect for two level-analyses of 
multiple-baseline data (Ferron et al., 2009). The procedure used in SAS is a generalization of 
the Satterthwaite methods described by Giesbrecht and Burns (1985), McLean, Sanders, and 
Stroup (1988) and Fai and Cornelius (1996). The degrees of freedom are estimated as a 
function of the covariance matrix of the fixed effects, which is approximated using the 
covariance matrix of Y along with the design matrix of the fixed effects. Furthermore, the 
following seven design conditions were varied.  
The number of simulated participants per study is equal to 3, 4 or 7 (J = 3, 4 or 7). 
These numbers were selected based on the recommendation that multiple-baseline studies 
have at least 3 (Barlow & Hersen, 1984) or 4 baselines (Kazdin & Kopel, 1975), on a survey 
of multiple-baseline studies (Ferron et al., 2010) which showed studies having from 3 to 10 
baselines with a median of 4, on the survey of single-case studies of Shadish and Sullivan 
(2011), where the number of cases per study ranged from 1 to 13 with median 3, and on a 
review of Farmer, Owens, Ferron and Allsopp (2010), where 93% of the average number of 
cases per study fell at or below 7. 
 The simulated series lengths consist of 10, 20, or 40 measurement occasions (I = 10, 20 or 
40). These values were selected based on multiple considerations. A survey of multiple-
baseline studies (Ferron et al., 2010) found average series lengths that ranged from 7 to 58 
with a median of 24, and a meta-analysis of 85 single-case studies (Swanson & Sachse-Lee, 
2000) found that 25 studies had fewer than 11 treatment sessions, 37 studies had between 11 
and 29 treatment sessions, and 23 studies had more than 29 treatment sessions. In the survey 
of Shadish and Sullivan (2011), the number of data points per case ranged from 2 to 160, with 
median and mode equal to 20, and 90.6% of the cases having 49 or fewer data points. 
Furthermore, we choose to simulate a number of studies using a multiple-baseline across 
participants design, therefore we stagger the time of the treatment across cases within studies. 
The moment at which the treatment starts differs according to the number of cases (J) and the 
number of measurements (I) within cases (see Table 2.1). For instance, when there are four 
cases (J = 4) and the number of measurements equals 20 (I = 20), then for the second case the 
treatment starts on the tenth measurement occasion and lasts until the twentieth measurement 
occasion. 
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Table 2.1 
The Number of the Measurement Occasion at which the Treatment Started 
J Case I = 10 I = 20 I = 40 
3 1 4 7 11 
 2 6 11 21 
 3 8 15 31 
4 1 4 7 11 
 2 5 10 18 
 3 7 12 24 
 4 8 15 31 
7 1 4 7 11 
 2 5 9 15 
 3 5 9 15 
 4 6 11 21 
 5 7 13 27 
 6 7 13 27 
 7 8 15 31 
The number of simulated studies is 10 or 30 (K = 10 or 30). A review of social science 
single-case meta-analysis (Farmer et al., 2010) showed that the number of studies included in 
a meta-analysis ranged from 3 to 117, with 60% of the meta-analysis including less than 30 
studies. We chose to include only lower limits for the number of studies (K = 10 or 30) to test 
if the model works appropriate in these conditions. 
The within person variance, is set to 1.0. In this way, the values chosen for the 
regression coefficients can also be regarded as the expected coefficients standardized by 
dividing by the residual within case standard deviation. 
The immediate effect of the treatment on the outcome,     , was generated to have 
values of 0 (no effect) or 2. In re-analyses of meta-analyses (Alen, Grietens, & Van den 
Noorgate, 2009; Denis, Van den Noortgate, & Maes, 2011; Kokina & Kern, 2010; Shogren, 
Fagella-Luby, Bae, & Wehmeyer, 2004; Wang, Cui, & Parrila, 2011), we found similar 
values for standardized regression coefficients. The effect of the treatment on the trend, 
defined by     , was varied to have values equal to 0 (representing no effect) or 0.2, based on 
our analyses of real data sets (Alen et al., 2009; Denis et al., 2011; Kokina & Kern, 2010; 
Shogren et al., 2004; Wang et al., 2011). The regression coefficients of the baseline      and 
     were not varied (and are set at 0), because the focus of the current study is on treatment 
effects. 
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The between-case covariance matrix   , was manipulated to have conditions with 
relatively small and relatively large amounts of between-case variance. Covariances between 
regression coefficients were set to zero at the subject and study level. Therefore,    is a 
diagonal matrix,        (    
     
     
     
 ). A review of several re-analyses showed that 
the variance between participants is sometimes less than the within-person variance (Ferron, 
et al., 2009; Van den Noortgate & Onghena, 2003b) and sometimes greater than the within-
person variance (Van den Noortgate & Onghena, 2008). Therefore we vary the four diagonal 
elements of     (the variances in the baseline intercept, the baseline slope, the immediate 
treatment effect and the treatment effect on the time trend respectively) as follow:    
    (    
     
     
     
 ) =     (            ), representing a relatively large amount of 
between-case variability (compared to the within-person variance of one) and     
    (    
     
     
     
 ) =     (                  ) to represent a relatively small amount of 
between-case variability. Re-analyses of real data sets (Denis et al., 2011; Kokina & Kern, 
2010; Shogren et al., 2004) indicated that the variance of the effect of      is sometimes much 
larger than the variance of the effect of     . Therefore, we also choose to set    
    (    
     
     
     
 ) =     (              ).  
Again based on re-analyses of meta-analyses (Alen et al., 2009; Denis et al., 2011; 
Kokina & Kern, 2010; Shogren et al., 2004; Wang et al., 2011), we have chosen the same sets 
of values for the four diagonal elements of the between-study 
variance:        (    
     
     
     
 ) =     (            ), or         (    
     
     
     
 ) 
=     (                  ), or         (    
     
     
     
 ) =     (              ).  
In total we therefore have 3x3x2x2x2x3x3 = 648 combinations. For each combination, 
we simulated 2,000 datasets, 1,296,000 in total. Each dataset was analyzed using the three-
level model used to generate the data (Equations 2.1 - 2.3). 
2.3 Results of the Simulation Study 
We will present the results in two sections. The first section presents the bias of the 
point estimate, the mean squared error, the estimation of the standard error, the coverage 
proportion of the confidence interval, and the power for the estimates of the average effects. 
The second section presents the bias of the point estimates of the variance components.  
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2.3.1 Average treatment effects 
2.3.1.1 Bias and mean squared error 
 Figure 2.5 and Figure 2.6 show the distribution of the deviations of the estimated immediate 
treatment effect from its population value (    ) and the treatment effect on the time trend 
from its population value (    ).  
 
Figure 2.5. Distribution of the deviations of the estimated immediate treatment effect from its populations value 
(    ). 
 
Figure 2.6. Distribution of the deviations of the estimated effect of treatment on the time trend from its 
populations value (    ). 
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We investigated the absolute bias and the relative bias for the estimates of the treatment 
effects,      and     . The absolute bias is the difference between the expected effect estimate 
and the true population effect. The relative bias is the absolute bias divided by the population 
parameter value. We expected both absolute bias and relative bias to be zero, which is what 
was found. When      and      equal 0, the estimated absolute bias was respectively 0.00065 
and -0.0000036 and when      = 2 and      = 0.2, the relative bias was respectively 0.00017 
and 0.00060. 
The Mean Squared Error (MSE) of the average effect estimates, defined as the mean 
squared difference between the estimates and the population value, gives important 
information about both bias and variance of the estimates. The smaller the MSE, the better the 
estimate. Table 2.2 provides the MSE for the immediate effect of the treatment (    ) for a 
subset of the conditions, specifically for those in which      = 2 and      = 0.2. Similar 
patterns were seen for the other combinations of fixed effect values (and the full set of results 
is available from the first author).  
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Table 2.2 
Mean Squared Error of      for      = 2 and      = 0.2 Conditions 
    K = 10  K = 30 
I J    
      
  = 0.5    
  = 2    
  = 8     
  = 0.5    
  = 2    
  = 8 
10 3 0.5  0.05 0.13 0.43  0.02 0.04 0.13 
  2  0.08 0.16 0.40  0.03 0.05 0.15 
  8  0.16 0.22 0.48  0.06 0.09 0.17 
 4 0.5  0.05 0.11 0.37  0.01 0.04 0.13 
  2  0.06 0.13 0.43  0.02 0.04 0.13 
  8  0.13 0.20 0.46  0.04 0.07 0.15 
 7 0.5  0.04 0.11 0.39  0.01 0.04 0.13 
  2  0.05 0.13 0.38  0.02 0.04 0.13 
  8  0.09 0.16 0.44  0.03 0.06 0.14 
20 3 0.5  0.04 0.11 0.35  0.02 0.04 0.13 
  2  0.07 0.13 0.43  0.02 0.05 0.14 
  8  0.17 0.24 0.47  0.05 0.07 0.17 
 4 0.5  0.04 0.11 0.38  0.01 0.04 0.13 
  2  0.06 0.13 0.41  0.02 0.04 0.14 
  8  0.13 0.18 0.46  0.04 0.06 0.15 
 7 0.5  0.03 0.11 0.35  0.01 0.03 0.12 
  2  0.04 0.11 0.38  0.01 0.03 0.13 
  8  0.09 0.15 0.40  0.03 0.05 0.15 
40 3 0.5  0.04 0.10 0.35  0.01 0.04 0.12 
  2  0.06 0.14 0.42  0.02 0.04 0.13 
  8  0.15 0.22 0.49  0.05 0.08 0.16 
 4 0.5  0.03 0.10 0.34  0.01 0.03 0.12 
  2  0.05 0.11 0.42  0.02 0.04 0.14 
  8  0.12 0.20 0.45  0.04 0.06 0.16 
 7 0.5  0.03 0.10 0.34  0.01 0.03 0.12 
  2  0.04 0.11 0.39  0.01 0.04 0.12 
  8  0.08 0.12 0.43  0.03 0.05 0.14 
An important finding is that the MSE for the treatment effects,      and     , became 
about three times smaller if the number of studies increased from 10 to 30. For instance, if the 
number of studies was set on 10, the MSE equaled 0.13 when I = 10, J = 3,    
  = 2 and    
  = 
0.5, whereas it was 0.04 when the number of studies was set on 30. If the analysis involved 
only 10 studies instead of 30, the MSE was affected by the number of cases. A remarkable 
finding was that if we only have 10 studies, the MSE was reduced if studies consisted of 4 
cases rather than 3, but that it was hardly reduced further by increasing the number of cases 
per study to 7. For instance, if the number of cases was set on 3, the MSE for the condition 
where K = 10, I = 10,    
  = 2,    
  = 2, equaled 0.16, whereas the MSE equaled 0.13 for 4 and 
7 cases. Yet, when the analysis involved 30 studies instead of 10, the number of cases hardly 
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influenced the MSE at all. To illustrate, if K = 30, I = 10,    
  = 2 and    
  = 2, the MSE for 3, 
4 and 7 cases equaled respectively 0.05, 0.04 and 0.04. This finding is very important in 
practice. If we have enough studies, the size of the study hardly matters. The MSE further is 
affected by the size of the between-study and the between-case variance (see Table 2.2). The 
larger the between-case and especially the between-study variance, the larger was the MSE. 
The patterns were very similar for the estimates of     , only the MSE is about 10 times 
smaller. 
2.3.1.2 Estimates of the standard errors of the average effects  
In order to construct confidence intervals around the estimated effects,      and     , the 
standard error for these effect estimates can be estimated. By definition, the standard error 
equals the standard deviation of the sampling distribution of the effect estimator. In this study, 
we simulated for each condition 2,000 data sets, which resulted in 2,000 estimates of the 
effects and 2,000 estimates of the corresponding standard error. Because of this relatively 
large number of estimates, the standard deviation of these effect estimates can be regarded as 
a good estimate of the standard deviation of the sampling distribution, and can therefore be 
used as a criterion to evaluate the estimated standard errors. 
Figure 2.7 shows that the median of the standard error estimates for      is almost equal 
to the standard deviation of the estimates of the effect for different values of the number of 
studies (K) and the between-study covariance matrix (  ). When the number of studies 
increased (K = 30 versus 10) and the between-study variance decreased (   
 = 0.5 versus 8), 
the standard error decreased (SE = 0.20 versus 0.90).  
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Figure 2.7. Median of standard error compared to standard deviation of the estimates of the effect of      , for 
     = 2,      = 0.2, J = 4, I = 20 and    
 = 2 conditions. 
The patterns were similar for the estimates of the standard error of      (see Figure 2.8), 
but the values of the standard errors were much smaller.  
 
Figure 2.8. Median of standard error compared to standard deviation of the estimates of the effect of      , for 
     = 2,      = 0.2, J = 4, I = 20 and    
 = 0,2 conditions. 
2.3.1.3 Coverage proportion  
Another way to evaluate the interval estimates of the estimated effects      and      and 
their standard error estimates is to estimate the coverage proportion of the confidence 
intervals that are calculated using these standard errors and the Satterthwaite estimated 
degrees of freedom. More specifically, we calculated the proportion of 95% confidence 
intervals around the effect estimates that contain the population values of      and     . 
The estimated coverage proportion for both      and      ranged from .93 to .97 with a 
median of .95 and a standard deviation of 0.0055 and 0.005 respectively. These deviations 
from the nominal value of .95 can be explained by chance (the standard deviation of the 
proportions is not larger than the standard error for proportions calculated on 2,000 
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observations. If the population proportion is equal to .95: SE = √(         )       = 
0.005). 
2.3.1.4 Power 
The probability of rejecting the null hypothesis when in fact a certain alternative 
parameter value is true, is called the power of a significance test (Cohen, 1988). When the 
null hypothesis is true (     = 0) and α equals .05, we expect the power (i.e., the Type I error 
rate) to be equal to .05. We found that the actual Type I error rate was close to .05 in all 
conditions.  
When the null hypothesis is false (     = 2) and α equals .05, we want the power as 
high as possible. A power equal to or higher than .80 is often regarded as an acceptable 
degree of power (Cohen, 1988). For decisions about the research design it is useful to 
estimate which conditions are needed to achieve this specific power. In Table 2.3, conditions 
in which this power level of .80 was reached are marked in bold. When the number of studies 
equals 30, the power was equal to or larger than .88 for all conditions. This did not apply 
when only 10 studies were involved. When there were 10 studies included, the power 
estimates did not reach the threshold of .80 when the between-study variance was large (   
 = 
80) and number of measurements was large (I = 40), independent of the number of cases and 
the between-case variance. In these conditions the power had values between .39 and .54. 
When there were 10 studies included, the power reached the threshold of .80 in contexts 
where the studies are quite homogeneous (   
     ). When there were 10 studies and the 
between-study variance equaled 2, power sometimes reached the threshold of .80, but tended 
to be lower in conditions with a large between-case variance (   
 = 8). In these conditions the 
power had values between .41 and .93. So the number of studies and the between-study 
variance appear to be of particular importance for achieving a power of .80.  
The actual Type I error rate for      was close to its nominal value of .05. In the 
contexts where the null hypothesis was false (     = 0.2) and the number of studies was 10, 
the power estimates had values between .17 and .66. This means that the threshold of .80 was 
not reached in any of the conditions (see Table 2.4). The power estimates lay between .75 and 
.99 when 30 studies were involved and the number of measurements was 20 or 40 in 
combination with homogeneous studies (   
  = 0.05 or 0.08). This suggests the importance of 
including enough studies in the multilevel modeling of single-case studies. 











































Note. Values   .80 are in boldface. 
 
   J = 3  J = 4  J = 7 
K I    
     
  = 0.5    
  = 2    
  = 8     
  = 0.5    
  = 2    
  = 8     
  = 0.5    
  = 2    
  = 8 
10 10 0.5 1.00 .93 1.00  .95 .47 1.00  .96 .48 .48 
    2 .99 .88 1.00  .91 .50 1.00  .94 .49 .49 
    8 .84 .69 .91  .77 .41 0.99  .88 .47 .47 
 20 0.5 1.00 .94 .52  1.00 .96 1.00  .96 .51 .51 
    2 1.00 .92 .47  1.00 .94 1.00  .94 .50 .50 
    8 .85 .70 .40  .92 .80 .99  .87 .46 .46 
 40 0.5 .00 .96 .51  1.00 .97 .54  1.00 .97 .50 
    2 1.00 .92 .47  1.00 .94 .49  1.00 .96 .51 
    8 .87 .73 .39  .94 .79 .41  .99 .88 .47 
30 10 0.5 1.00 1.00 .95  1.00 1.00 .95  1.00 1.00 .96 
    2 1.00 1.00 .94  1.00 1.00 .95  1.00 1.00 .95 
    8 1.00 1.00 .88  1.00 1.00 .91  1.00 1.00 .95 
 20 0.5 1.00 1.00 .96  1.00 1.00 .96  1.00 1.00 .96 
    2 1.00 1.00 .93  1.00 1.00 .94  1.00 1.00 .96 
    8 1.00 1.00 .89  1.00 1.00 .91  1.00 1.00 .94 
 40 0.5 1.00 1.00 .96  1.00 1.00 .96  1.00 .97 .96 
    2 1.00 1.00 .95  1.00 1.00 .96  1.00 .96 .95 
    8 1.00 1.00 .90  1.00 1.00 .91  .99 .88 .94 

























Power of      for     =0.2 and      = 2 Conditions 
   J = 3  J = 4  J = 7 
K I    
     
  = 0.05    
  = 0.08    
  = 0.2     
  = 0.05    
  = 0.08    
  = 0.2     
  = 0.05    
  = 0.08    
  = 0.2 
10 10 0.05 .33 .28 .21  .39 .32 .20  .47 .36 .22 
  0.08 .30 .25 .17  .36 .30 .20  .44 .36 .21 
   0.2 .23 .20 .17  .29 .25 .17  .38 .33 .20 
 20 0.05 .53 .40 .21  .58 .41 .23  .63 .45 .24 
  0.08 .47 .38 .21  .51 .39 .22  .60 .45 .24 
   0.2 .35 .28 .19  .38 .31 .19  .49 .39 .23 
 40 0.05 .58 .43 .24  .59 .47 .20  .66 .48 .24 
  0.08 .52 .41 .24  .55 .44 .22  .60 .46 .26 
   0.2 .36 .30 .20  .41 .36 .20  .50 .41 .21 
30 10 0.05 .81 .72 .50  .87 .79 .53  .95 .86 .57 
  0.08 .75 .69 .46  .84 .75 .52  .93 .84 .56 
   0.2 .65 .57 .41  .73 .66 .47  .88 .80 .54 
 20 0.05 .96 .89 .59  .98 .91 .61  .99 .94 .62 
  0.08 .95 .87 .58  .97 .90 .60  .99 .92 .63 
   0.2 .83 .75 .52  .89 .81 .55  .95 .88 .58 
 40 0.05 .98 .93 .62  .99 .93 .62  .99 .95 .64 
  0.08 .96 .89 .61  .98 .92 .62  .99 .94 .65 
   0.2 .87 .79 .55  .92 .84 .59  .97 .89 .60 
Note. Values   .80 are in boldface. 
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2.3.2 Variance components 
In the three-level analyses, the between-study and between-case variances were 
estimated for both the effect of the treatment on the intercept and the trend. 
In some conditions convergence was not reached and the last variance estimates were 
unrealistically large. Therefore we deleted the variance estimates larger than 100 (this was the 
case in 7.10
-5
 % of the datasets). The variance estimates were still positively skewed after 
deletion of the extreme values (skewness = 2.38) partly due to truncation of negative 
estimates to zero. Because variance estimates are still expected to be positively skewed, due 
to truncation of negative estimates to zero, we calculated the median (relative) deviation of 
the estimates from the population value, rather than the mean (relative) deviation, to evaluate 
the (relative) bias in the estimates.  
Table 2.5 shows that there is negative relative bias in the estimated between-study 
variance (   
  ) and the estimated between-case variance (   
  ) of the immediate effect and 
that this bias was worse when there are only 10 studies involved, the between-study variance 
is small (   
  = 0.5), and the between-case variance is large (   
  = 8). In these conditions, the 
estimated between-study variance had relative bias values between -0.21 and -0.50. Although 
variance estimates larger than 100 were not included in the calculation, substantially large 
bias values were obtained when estimating the between-study variance with bias as large as 
50% in the condition where K = 10, I = 20, J = 3,    
 = 8 and    
 = 0.5. This is an extremely 
high relative bias and can be explained by the positively skewed distribution of the estimated 
variance components. When estimating the between-case variance of the immediate effect, 
similar conclusions can be made, but the relative bias was smaller, with a maximum of 10%. 
The estimate of the between-study and the between-case variance of the effect on the time 
trend lead to similar conclusions, except that there is a positive instead of negative relative 
bias. 


























Median of Relative Deviation of the Variance Estimates of     , for      = 2 and      = 0.2 Conditions 
     ̂  
    ̂  
  
    K = 10  K = 30  K =10 K = 30 
I J    
      
  = 0.5    
  = 0.2    
  = 8     
  = 0.5    
  = 0.2    
  = 8     
  = 0.5    
  = 0.2    
  = 8    
  = 0.5    
  = 0.2    
  = 8 
10 3 0.5  -0.16 -0.09 -0.08  -0.02 -0.03 -0.03  -0.10 -0.08 -0.07 -0.05 -0.04 -0.04 
    2  -0.23 -0.07 -0.10  -0.04 -0.01 -0.03  -0.08 -0.08 -0.05 -0.02 0.00 0.00 
    8  -0.42 -0.17 -0.08  -0.22 -0.05 -0.02  -0.09 -0.06 -0.03 -0.03 -0.01 -0.01 
 4 0.5  -0.15 -0.08 -0.08  -0.03 -0.02 -0.04  -0.08 -0.04 -0.08 -0.03 -0.03 -0.03 
    2  -0.22 -0.06 -0.09  -0.03 -0.02 -0.03  -0.04 -0.06 -0.05 -0.02 -0.01 -0.01 
    8  -0.27 -0.12 -0.10  -0.09 -0.07 -0.03  -0.05 -0.04 -0.03 -0.02 -0.00 -0.00 
 7 0.5  -0.10 -0.09 -0.07  -0.04 -0.02 -0.02  -0.06 -0.04 -0.06 0.00 -0.01 -0.01 
    2  -0.09 -0.10 -0.07  -0.02 -0.01 -0.01  -0.01 -0.01 -0.04 -0.01 -0.01 -0.01 
    8  -0.21 -0.14 -0.07  -0.04 -0.02 -0.02  -0.03 -0.02 -0.01 -0.01 -0.01 -0.01 
20 3 0.5  -0.11 -0.10 -0.08  -0.05 -0.03 -0.02  -0.07 -0.07 -0.07 -0.03 -0.01 -0.01 
    2  -0.17 -0.11 -0.09  -0.03 -0.02 0.00  -0.08 -0.05 -0.04 -0.01 -0.00 -0.00 
    8  -0.50 -0.11 -0.08  -0.09 -0.04 -0.02  -0.09 -0.06 -0.04 -0.04 -0.01 -0.01 
 4 0.5  -0.12 -0.09 -0.09  -0.04 -0.02 -0.03  -0.03 -0.07 -0.03 -0.01 -0.00 -0.00 
    2  -0.16 -0.12 -0.11  -0.07 -0.01 -0.03  -0.07 -0.03 -0.03 -0.00 -0.01 -0.02 
    8  -0.27 -0.16 -0.08  -0.11 -0.05 -0.03  -0.06 -0.04 -0.03 -0.02 -0.01 -0.01 
 7 0.5  -0.07 -0.08 -0.08  -0.03 -0.03 -0.04  -0.02 -0.02 -0.00 -0.01 -0.01 -0.01 
    2  -0.16 -0.06 -0.08  -0.04 -0.03 -0.02  -0.02 -0.02 -0.01 -0.00 -0.00 -0.00 
    8  -0.24 -0.12 -0.09  -0.13 -0.04 -0.03  -0.03 -0.01 -0.02 -0.00 -0.00 -0.00 
40 3 0.5  -0.13 -0.09 -0.09  -0.03 -0.03 -0.03  -0.08 -0.04 -0.06 -0.03 -0.01 -0.01 
    2  -0.16 -0.12 -0.06  -0.05 -0.03 -0.01  -0.04 -0.04 -0.05 -0.03 -0.01 -0.01 
    8  -0.49 -0.18 -0.11  -0.10 -0.03 -0.03  -0.09 -0.07 -0.02 -0.03 -0.02 -0.02 
 4 0.5  -0.05 -0.11 -0.09  -0.03 -0.02 -0.01  -0.03 -0.04 -0.04 -0.00 -0.01 -0.01 
    2  -0.13 -0.09 -0.09  -0.05 -0.03 -0.01  -0.04 -0.02 -0.03 -0.01 -0.00 -0.00 
  8  -0.42 -0.09 -0.10  -0.11 -0.05 -0.05  -0.06 -0.04 -0.02 -0.01 -0.01 -0.01 
 7 0.5  -0.10 -0.09 -0.07  -0.03 -0.03 -0.02  -0.03 -0.02 -0.01 -0.01 -0.01 -0.01 
    2  -0.11 -0.06 -0.08  -0.05 -0.03 -0.02  -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 
    8  -0.28 -0.11 -0.09  -0.11 -0.03 -0.02  -0.02 -0.01 -0.01 -0.01 -0.00 -0.00 
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2.4 Discussion 
2.4.1 General conclusion 
The purpose of this simulation study was to examine the recovery of parameter and 
standard error estimates for the three-level model used with single-case data as proposed by 
Van den Noortgate and Onghena (2008). The study examined estimation of the fixed effects 
(i.e., the average immediate effect at the start of the treatment and the average effect on the 
time trend) and the variance components (i.e., the between-cases within-study variance and 
the between-study variance in the immediate effect and in the treatment effect on the time 
trend). 
The results indicated that regardless of the condition, the fixed effect estimates are 
unbiased. This finding was theoretically expected (Kackar & Harville, 1984) and is consistent 
with previous research regarding estimation of fixed effects in two level models (Ferron et al., 
2009; Raudenbush & Bryk, 2002). Further, the medians of the standard errors of      and 
     are almost equal to the standard deviations of the estimates of the effects for different 
values of the number of studies and the between-study variance. The standard error decreases 
when the number of studies increases and when the between-study variance is more 
homogeneous. In all conditions the coverage proportion has values between 93% and 97% for 
both the estimation of the effect on the intercept and the effect on the trend. These findings 
correspond to previous research concerning the two-level analysis of single-case data (Ferron 
et al., 2009) and concerning multilevel synthesis of more traditional longitudinal designs 
(Fouladi & Shieh, 2004; Gomez, Schaalje, & Fellingham, 2005; Kowalchuk, Keselman, 
Algina, & Wolfinger 1997). An important finding is that the MSE becomes more than two 
times smaller if the number of studies increases from 10 to 30. If the multilevel analysis 
involves only 10 studies, the MSE is reduced when there are more cases and measurements 
per case. If the analysis involves 30 studies, the number of cases and the number of 
measurements hardly influence the MSE. This finding is very important in practice: if we 
want to combine small single-case studies (which is very realistic), the multilevel approach 
will give us good results if the number of studies is large enough. This finding corresponds to 
the theoretical expectation and numerical examples of the two-level analysis of group-
comparison data (Snijders & Bosker, 1993). But, in some realistic conditions it is infeasible to 
combine single-case data from 30 studies. We explored conditions where only 10 studies were 
involved and we found unbiased estimates of the average treatment effects. The MSE is small, 
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the standard error is well estimated, the coverage proportion is close to the nominal value of 
.95 and the power is large when the studies and the cases are homogeneous (   
  = 0.5 and    
  
= 0.5 or    
  = 2 ). However, the power for the estimate of the treatment effect on the time 
trend does not reach the threshold of .80 in any condition. The power can be increased by 
including homogeneous cases, homogeneous studies and including a large number of cases (J 
= 7). Regarding the power when testing the treatment effects, we found that for the effect 
sizes we tested, which are typical in single-case research, the minimum requirements to obtain 
a power of .80 for the test of the effect on the time trend were at least 30 studies and 
homogeneity among the studies (i.e., a small amount of between-study variance). This 
confirms the theoretical expectation and numerical examples of Snijders and Bosker (1993) 
who state that the top-level units are of fundamental importance for optimizing power. Fewer 
studies or more heterogeneity among studies could be tolerated if the interest was just on the 
test of the immediate effect, or if the true effect size was larger than what we considered.  
As with any multilevel model, implausibly large variance components estimates can be 
obtained. From the estimates of the variance components, we deduce that there are biases 
when estimating the between-case variance of the immediate treatment effect and the effect 
on the time trend. These biased variance estimates are consistent with previous empirical 
research about the three-level analysis of single-case data (Owens and Ferron, 2012) and 
previous research from a broader methodological domain, for instance growth curve models 
(Kwok, West, & Green, 2007; Murphy & Pituch, 2009). The bias is more substantial when 
estimating the between-study variance of the immediate treatment effect and the effect on the 
time trend. In these contexts we recommend the inclusion of 30 or more studies, and even 
then researchers should anticipate some bias, particularly when the between-case variance is 
large compared to the between-study variance. If large variance components estimates are 
obtained, we advise researchers to respecify the random part of the multilevel model. 
In this study, we used a multiple-baseline across participants design, regarded as strong 
single-case designs because the staggering of the timing of the intervention makes it less 
plausible to attribute changes in the data to other extraneous events rather than the treatment 
thereby strengthening the design’s internal validity (Shadish et al., 2002). Still, it is 
recommended to identify the quality of the initial studies before combining them in a three-
level analysis, because this quality will immediately affect the quality of the meta-analytic 
results. To score single-case studies on quality, different instruments can be used, for instance 
the Single-case Experimental Design (SCED) Scale developed by Tate et al. (2008). The 
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SCED Scale is characterized by high levels of inter-rater reliability. Dependent on the score 
on quality, researchers can decide to include or not include the study in the three-level 
analysis or to give a weight to a study’s results before including them. 
2.4.2 Recommendations for single-subject analysts  
The study shows that the average treatment effects are generally well estimated if the 
between study-variability is small and if a minimum of 30 studies are involved. The number 
of measurements and cases is of less importance. Researchers can try to measure outcome 
variables in a consistent way across subjects and even across studies measuring the same 
constructs. Besides the importance of systematically varying characteristics of studies in order 
to investigate moderator effects, it also might be advantageous to replicate previous studies, 
resulting in homogeneous study results. Of course the methodology and instruments have to 
remain appropriate for the subject in a certain context. 
2.4.3  Limitations and suggestions for future research 
Although the three-level analysis of single-case experimental studies is promising, some 
limitations remain. A first limitation is that we can only use a three-level analysis of single-
case data, when the raw data are available and on the same scale. Otherwise we depend on 
standardized effect size estimates and associated meta-analytic procedures. Usually single-
case data are presented graphically in the primary studies, which allow us to retrieve the raw 
data. 
 The Monte Carlo method used in this study provided control of specific factors (the 
effect on intercept, the effect on trend, the number of studies, the number of cases, the number 
of measurements, the between-study variance and the between-case variance) to investigate 
the appropriateness of inferences made from a three-level single-case model in specific 
situations. Despite the large number of conditions and the choice of realistic values for the 
parameters, we still have to be careful with the generalization to conditions that were not 
simulated. 
When estimating the variance components, in some conditions convergence was not 
reached and the final variance estimates were very large. Therefore we deleted the variance 
estimates larger than 100 (this was the case in 7.10
-5
 % of the datasets). The variance 
estimates are still positively skewed after deletion of the extreme values (skewness = 2.38 ) 
due to truncation of negative estimates to zero.  
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In this study, we used a multiple-baseline across participants design in which we 
staggered the timing of the treatment. Staggering in multiple-baseline designs is often done to 
enhance the internal validity: if for the participant the scores change at the start of the 
treatment, it is unlikely that this is due to an external event (Ferron & Onghena, 1996; Ferron 
& Sentovich, 2002). A limitation of our simulation study is that in simulating the data, we did 
not account for potential confounding events that could have had a simultaneous effect on all 
participants. 
Despite the strengths of the simulation study, there are several aspects that need further 
exploration. First, in the three-level analyses, it is assumed that residuals are independent 
across measurement occasions. However, this assumption of independence may be violated 
because of autocorrelation (Beretvas & Chung, 2008; Kratochwill et al., 1974). In single-case 
data, random context variables that influence the score at a certain moment can also influence 
scores on one or more succeeding occasions which lead to similarity among errors that are 
close to each other in time (Kromrey & Foster-Johnson, 1996). On the one hand, the issue of 
autocorrelation cannot be ignored (Ferron et al., 2009; Huitema & McKean, 1994; McKnight, 
McKean, & Huitema, 2000). Previous research indicates that not modeling existing 
autocorrelation in a two-level analysis of single-cases results in biased parameter estimates 
(Ferron et al., 2009). However on the other hand, Shadish and Sullivan (2011) indicated that 
the size of autocorrelation in SSED studies varies tremendously, with an average of about 
zero. In this study, we assumed that the repeated measures within a case are independent 
because we only wanted to evaluate the basic three-level model. In the three-level model we 
proposed, we modeled the level-one errors as    , but there are many other covariance 
structures possible, of which the first-order autoregressive type is often used to model 
autocorrelation (Ferron et al., 2009; McKnight et al., 2000). The current study should be 
extended, for example, by generating a first-order autoregressive structure. 
Secondly, we simulated data assuming (multivariate) normal distributions of the 
residuals at each level. Further research is needed to investigate the performance of the 
approach if the normality assumption that is made in the multilevel approach is violated, for 
instance if the dependent variable is composed of count data.  
Third, we used a multiple-baseline across participants design, but there are other designs 
like alternating treatment designs and reversal designs that need further exploration. Another 
extension that would be worthwhile to investigate is how a model that ignores a linear or 
nonlinear time trend would perform if there is a linear or nonlinear trend in the data?  
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A challenging question is what to do when the obtained data are measured on different 
scales. Van den Noortgate and Onghena (2003b, 2008) propose as a first possible solution to 
standardize the data per case by dividing the data by the estimated root mean squared error 
that is found when using the Center et al. (1985-1986) regression model on the data for that 
case. Moeyaert et al. (2013b) conducted recently a three-level analysis on standardized single-
case data and found that this way of standardizing is appropriate for the estimation of the 
treatment effects, especially when many studies (30 or more) and a lot of measurements 
occasions within subjects (20 or more) are included and when the studies are rather 
homogeneous (with a small between-study variance). The estimates of the variance 
components are less accurate. A second possible solution is extending the three-level model 
by including characteristics of the dependent variable as predictors.  
This research shows that the three-level synthesis of single-cases works relatively well 
under a variety of realistic conditions, and especially when the number of studies is large and 
the studies are homogeneous, but further research is needed to give further answers on the 
unresolved questions listed above. 
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Previous research indicates that three-level modeling is a valid statistical method to 
make inferences from unstandardized data from a set of single-subject experimental studies, 
especially when a homogeneous set of at least 30 studies are included (Moeyaert et al., 
2013a). When single-subject data from multiple studies are combined, however, it often 
occurs that the dependent variable is measured on a different scale, requiring standardization 
of the data before combining them over studies. One approach is to divide the dependent 
variable by the residual standard deviation. In this study we use Monte Carlo methods to 
evaluate this approach. We examine how well the fixed effects (i.e., immediate treatment 
effect and treatment effect on the time trend) and the variance components (i.e., the between 
and within-subject variance) are estimated under a number of realistic conditions. The three-
level synthesis of standardized single-subject data is found appropriate for the estimation of 
the treatment effects, especially when many studies (30 or more) and many measurement 
occasions within subjects (20 or more) are included and when the studies are rather 
homogeneous (with small between-study variance). The estimates of the variance components 
are less accurate. 
Keywords: single-subject experimental data, three-level analysis, Monte Carlo 
simulation study, standardized single-subject data 
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3.1 Introduction 
In a single-subject experimental design (SSED), the outcome variable of one subject is 
measured repeatedly within and across different conditions or phases (e.g. baseline phase or 
A-phase, treatment phase or B-phase). Although the use of SSEDs has grown, systematic 
reviews and meta-analyses of treatment effects often include only studies using group-
comparison studies to estimate changes between different conditions under investigation (Van 
den Noortgate & Onghena, 2008). The exclusion of SSEDs from these reviews is a matter of 
concern because information about the variation between subjects in the magnitude of 
treatment effects tends to be lost in group-comparison designs, which provide averages and 
effect sizes only for the entire group.  
 A limitation of single-subject designs is that the corresponding results are subject- 
specific and therefore not generalizable to other subjects. In order to address this problem, 
researchers can replicate single-subject experiments within studies (e.g. multiple-baseline 
designs). Among single-subject designs, these multiple-baseline designs are preferred 
(Shadish & Sullivan, 2011), because the staggering of the treatment across subjects makes it 
possible to disentangle real treatment effects from extraneous factors like maturation or 
history. As a result, these designs are increasingly popular, as shown in Figure 3.1. 
 
Figure 3.1. Graphical display showing the increase in the number of citation for the keyword “multiple-baseline” 
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Another way to address the problem of generalizability is the replication of SSED across 
studies. Combining data of replicated SSEDs can for instance be accomplished by using a 
meta-analysis of effect sizes (Busk & Serlin, 1992; Shadish et al., 2012; Rindskopf et al., 
2012; Maggin et al., 2011). A problem is that there is no consensus in the literature about the 
effect size metric to be used. A number of nonparametric effect size metrics have been 
proposed to analyze single-case designs (e.g., percentage of non-overlapping data, percentage 
of all non-overlapping data, or percent exceeding the median). Although these nonparametric 
effect size measures for single-case research can be used without making distributional 
assumptions, they entail at least three weaknesses. First, such measures may be influenced by 
outliers in the baseline phase (Allison & Gorman, 1993; Salzberg, Strain, & Baer, 1987). A 
second drawback is their insensitivity to data trends and variability in the data (White, 1987; 
Wolery et al., 2010), and third, the sampling distributions of these metrics are unknown, 
which limits the validity of statistical tests such as moderator analyses that are often 
conducted in meta-analytic work (Beretvas & Chung, 2008). Other effect size measures are 
based on regression models (Beretvas & Chung, 2008; Van den Noortgate & Onghena, 
2003b). Treatment effects in single-case studies are further sometimes tested using 
nonparametric randomization tests. Randomization tests can also be used to test the existence 
of a treatment effect in a set of single-case studies (Edgington & Onghena, 2007). Up to now, 
the most common way to analyze single-case data is by using visual analyses (Barlow & 
Hersen, 1984; Kazdin, 1982; Kennedy, 2005; Kratochwill, 1978; Kratochwill & Levin, 1992; 
Tawney & Gast, 1984). Although visual analysis might do justice to the richness of single-
case data, this method tends to result in too many Type I errors (Fisch, 2001; Normand & 
Bailey, 2006) and Type II errors (Jones, Weinrott, & Vaught, 1978).  
In this article we focus on a parametric statistical method to summarize single-case 
results over cases and over studies, namely the three-level modeling of the raw data. Previous 
studies indicate that the three-level modeling is a valid statistical method to combine data 
(Ferron et al., 2010; Moeyaert et al., 2013a; Owens & Ferron, 2012; Shadish & Rindskopf, 
2007; Van den Noortgate & Onghena, 2003b, 2008). 
A complexity when single-subject data from multiple studies are combined is that the 
dependent variable often is not measured on a common scale, requiring a standardization of 
the data before combining them over studies. Given the importance of standardization, we 
discuss and evaluate in this study one specific standardization method, used before combining 
the data by means of a three-level model. In the following paragraphs, we first present the 
three-level model to aggregate single-subject data. Then, we describe the method to 
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standardize single-subject data. Next, we present the setup and results of a Monte Carlo 
simulation study evaluating the analysis of the three-level modeling of standardized single-
subject data.  
3.1.1 Three-level modeling  
Hierarchical structures occur naturally: for instance, patients are clustered, nested, or 
grouped within clinics within health authorities, voters are nested within polling districts 
within constituencies, and citizens are grouped within cities within countries. Kreft and De 
Leeuw (1998) expressed this as follow: “Once you know that hierarchies exist you see them 
everywhere” (p. 1). Also data in social and behavioral sciences are usually characterized by a 
hierarchical structure and therefore require statistical analysis methods that account for this 
structure. Schooling systems present an obvious example of a hierarchical structure: students 
are grouped within classes which themselves are grouped within schools. We refer to a 
hierarchy as consisting of units grouped at different levels. In this example, students are the 
level-1 units, classes the level-2 units, and the schools the level-3 units in a three-level 
structure. A different example of hierarchically structured data occurs when the same case or 
subject is measured repeatedly within and across different conditions or phases (e.g., a 
baseline phase and a treatment phase), such as in SSEDs. If we have a set of studies in which 
one or a few subjects are investigated, we can see a three-level structure: measurement 
occasions at the first level are grouped within cases or subjects at the second level, which in 
turn are grouped in studies at the third level (see Figure 3.2).  
 
Figure 3.2. The three-level hierarchical structure for the synthesis of single-subject experimental data. 
  
Chapter 3 | Standardized single-case data  53 
 
A three-level model can be used to analyze such a data structure. An advantage of the 
use of a three-level model is that it allows one to estimate within-subject, between-subject, 
and between-study variance. Moreover, ignoring the study level would imply that we do not 
take into account that subjects from the same study are more alike than subjects from different 
studies. Van den Noortgate, Opdenakker, and Onghena (2005) showed that ignoring a top (or 
intermediate) level has significant effects on the results of a multilevel analysis using 
hierarchical linear models.  
At the first level of this three-level model, a regression equation describes the within-
subject variability (Equation 3.1).      describes the score on the dependent variable on 
measurement occasion i (i = 1, 2, …, I), for subject j (j = 1, 2, …, J) in study k (k = 1, 2, …, 
K) as a linear function of two predictors and their interaction, more specifically a time 
indicator (    ), for instance the session number, and a dummy coded variable (    ) 
indicating whether the measurement occasion i from the j
th 
subject in study k belongs to the 
baseline phase (     = 0) or the treatment phase (     = 1).  
                                                        (    
 ) (3.1) 
If the time indicator is coded such that it equals zero at the start of the treatment phase,      
indicates the expected baseline level at the start of the treatment phase (when      = 0),      is 
the linear time trend in the baseline scores, the coefficient      is then the immediate effect of 
the treatment on the outcome, and      refers to the effect of the intervention on the trend. 
The regression coefficients have indexes j and k, meaning that they are subject- and study-
specific. 
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(3.2) 
These equations indicate that the   coefficients from Equation 3.1 equal an average study-
specific performance, the   coefficients, plus a random variation from these means. 
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At the third level, the variation of the study-specific regression coefficients from the 
second level equations is described: 
 
{
              
              
              
              
     [
    
    
    
    
]  (    )  
(3.3) 
Researchers typically are interested in the regression coefficients at the third level (the  ’s in 
Equation 3.3, called fixed effects), especially in      and      because they represent the 
average treatment effects (i.e. the immediate treatment effect and the treatment effect on the 
time trend), as well as in the variance components at each level.  
The functioning of the three-level synthesis of unstandardized SSED data was already 
evaluated by the simulation study of Owens and Ferron (2012) focusing on the most basic 
multiple-baseline designs, in which there were no trends in either phase. Recently, Moeyaert 
et al. (2013a) simulated three-level data including time trends. The simulation studies show 
that the three-level approach results in unbiased estimates of both kinds of treatment effects.  
3.1.2 Standardized single-subject experimental data 
Dependent variables in a set of SSED-studies are not always measured the same way 
and on the same scale. For instance, challenging behavior in class in one study is measured on 
a scale from one to ten, whereas another researcher indicates the challenging behavior on a 
scale from one to five. Therefore standardization is needed to allow immediate comparison 
and fair interpretations of scores on challenging behaviour across different studies. In order to 
standardize raw single-case data, Z-scores could also be used by subtracting the mean from 
each outcome score, and dividing this difference by the standard deviation. But, in this case 
we lose important information about the baseline level of the case. When combining the 
results of multiple cases, we therefore will also not obtain information about the mean 
baseline level and differences in baseline level between cases. A second option is to divide the 
outcome score by the standard deviation of the dependent variable (i.e. Z-scores), but this 
latter depends not only on the scale of the dependent variable, but also on the value of the 
treatment effects. We do not recommend this method, because the treatment effects (i.e., 
immediate treatment effect and treatment effect on level) can differ from case to case, and 
therefore dividing our scores by the standard deviation of the outcome scores could even 
make effects measured on the same scale not comparable anymore.  
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Van den Noortgate and Onghena (2008) proposed a method to standardize individual 
level raw data that addresses all these limitations. They proposed to perform an ordinary least 
squares (OLS) regression for each subject from one study separately (for instance using 
Equation 3.1) in order to estimate the residual within-subject standard deviation ( ̂   ). 
Thereafter the individual scores (      ) are divided by the estimated residual within-subject 
standard deviation ( ̂   ): 
      
    
 ̂   
 
(3.4) 
The rationale behind this method is that in many situations, the scale of the dependent variable 
in one study likely differs from the scale used in another study, for instance in a scenario 
where behavior in one study is rated using a 5-point scale rather than on a 7-point scale as in 
another study. This means that results will be on different scales too. The residual within-
subject standard deviation reflects these kinds of differences in how the dependent variable is 
measured, and thus dividing the original raw scores in a study by this variability provides a 
method of standardizing the scores. At the same time, it is not impacted by the size of the 
treatment effect, and thus is not expected to bias the treatment effect estimates. We attached 
an empirical illustration of this standardizing method in Addendum A1 (step 1 through step 
4). Thereafter, the standardized data can be combined over subjects and over studies using 
Equations 3.1 through 3.3. The aim of this simulation study is to evaluate whether the three-
level model approach is still appropriate if single-subject data are standardized using Equation 
3.4. 
3.2 Simulation Study 
Simulation studies allow us to control the population values and to assess the validity, 
accuracy and power of statistical procedures in realistic but generic situations. First, we 
simulated raw single-subject data using Equation 3.1 to 3.3. Next, we estimated for each 
subject the unstandardized regression coefficients of Equation 3.1, using OLS estimation. In a 
following step, we used Equation 3.4 to obtain standardized outcome scores. More 
specifically, for each subject we divided the outcome scores (i.e.,     ’s), by the residual 
within-phase standard deviation (Equation 3.4). Finally, the standardized data (i.e.,      ’s) 
were analyzed using the three-level approach and results were compared to the parameter 
values used to generate data. To estimate the three-level model parameters, the restricted 
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maximum likelihood procedure in SAS 9.3 PROC MIXED was used (Littell et al., 2006). To 
estimate the degrees of freedom, we used the Satterthwaite approach because this method 
seems to provide accurate confidence intervals for the estimates of the average treatment 
effect for two-level analysis of single-subject data (Ferron et al., 2009). 
To evaluate the three-level approach for standardized data, we calculated the bias and 
mean squared error of the effect parameter estimates, the corresponding standard error 
estimates, and the coverage proportion of the 95% confidence intervals for the fixed effects. 
Moreover, we focused on the power for testing treatment effects. Next, we calculated the 
relative bias of the variance components. 
Furthermore, the following seven parameters were varied: The number of simulated 
measurements within subjects, the number of subjects per study, the number of studies, the 
immediate treatment effect, the treatment effect on the time trend, the between-subjects 
variance, and the between-study variance. A description of the levels chosen for each of these 
factors is provided below, along with justification for the levels selected for study. 
The total number of simulated measurements within a subject was equal to 10, 20, or 40 
(I = 10, 20 or 40). We chose to keep I constant for all subjects within and across studies. The 
values for the measurements were selected based on a survey of multiple-baseline studies 
(Ferron et al., 2010), which found average measurement occasions with a median of 24, and 
based on a meta-analysis of 85 single-subject studies (Swanson & Sachse-Lee, 2000), which 
found that 25 studies had fewer than 11 treatment measurements, 37 studies had between 11 
and 29 treatment measurements, and 23 studies had more than 29 treatment measurements. 
Shadish and Sullivan (2011) found a median number of measurements of 20, and identified 
that 90.6% of the subjects had 49 or fewer measurement occasions. 
The number of subjects per study equaled 3, 4 or 7 (J = 3, 4 or 7). These values were 
chosen based on a survey of multiple-baseline studies (Ferron et al., 2010), which included 
multiple-baseline studies having a median of 4 subjects, based on recommendations of Barlow 
and Hersen (1984) to include three subjects and Kazdin and Kopel (1975) to include four 
baselines. Moreover Shadish and Sullivan (2011) reported the characteristics of 809 single-
subject studies and found that the number of subjects per study ranged from 1 to 13 with a 
median of 3. Farmer et al. (2010) reported in their review that 93% of the average number of 
subject per study was equal to or less than 7. 
 The number of simulated studies was 10 or 30 (K = 10 or 30). A review of social 
science single-subject meta-analysis (Farmer et al., 2010) showed that the number of studies 
included in a meta-analysis ranged from 3 to 117, with 60% of the meta-analysis including 
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less than 30 studies. We chose to include only lower limits for the number of studies (K = 10 
or 30) to test if the model works appropriately in these conditions. 
The immediate treatment effect,     , had values of 0 (no effect) or 2, and the treatment 
effect on the time trend,       equaled 0 (no effect) or 0.2. This is based on several re-analyses 
of meta-analyses (Alen et al., 2009; Denis et al., 2011; Kokina & Kern, 2010; Shogren et al., 
2004; Wang et al., 2011). The regression coefficients of the baseline      and      were not 
varied (and are set at 0), because the focus of the current study is on treatment effects. 
The between-subject variance,      had conditions with relatively large and small 
amount of between-subject variance and sometimes greater than the within-person variance 
(Alen et al., 2009; Denis et al., 2011; Kokina & Kern, 2010; Shogren et al., 2004; Wang et al., 
2011):          (    
     
     
     
 ) = diag( 2, 0.2, 2, 0.2), diag( 0.5, 0.05, 0.5, 0.05), and 
diag( 8, 0.08, 8, 0.08). Again based on re-analyses of meta-analyses (Alen et al., 2009; Denis 
et al., 2011; Kokina & Kern, 2010; Shogren et al., 2004; Wang et al., 2011), we have chosen 
the same sets of values for the four diagonal elements of the between-study variance:    
    (    
     
     
     
 ) =     (            ),        (    
     
     
     
 ) = 
    (                  ), and         (    
     
     
     
 ) =     (              ).  
We choose to keep the within-subject variability (standard deviation) constant across 
subjects, meaning that the simulated data are on the same scale for each subject and study. If 
we had simulated data using different scales, this effect would be compensated by the 
standardization (e.g., if for a specific subject we had multiplied each score by three, the 
estimated residual standard deviations would be 3 times larger, so the estimated standardized 
scores would remain unchanged). By simulating data on the same scale, it is possible to 
evaluate at the same time the multilevel approach for SSED analysis without standardization 
and the approach with standardization. 
Because we simulated data using a multiple-baseline across participants design, we 
staggered the introduction of the intervention across subjects within studies. The staggering 
depended on the total number of measurement occasions and the number of subjects (see 
Table 3.1). 
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Table 3.1 
Starting Moment of the Intervention as a Function of the Number of Subjects (J) and the Number of 
Measurements (I) 
J  I = 10 I = 20 I = 40 
3 Subject 1 4 7 11 
 Subject 2 6 11 21 
 Subject 3 8 15 31 
 4 Subject 1 4 7 11 
 Subject 2 5 10 18 
 Subject 3 7 12 24 
 Subject 4 8 15 31 
7 Subject 1 4 7 11 
 Subject 2 5 9 15 
 Subject 3 5 9 15 
 Subject 4 6 11 21 
 Subject 5 7 13 27 
 Subject 6 7 13 27 
 Subject 7 8 15 31 
Crossing the levels of the seven varying factors, leads to a 3x3x2x2x2x3x3 factorial 
design including 648 experimental conditions. For each condition, we simulated 2,000 
replications resulting in a total of 1,296,000 datasets. In order to analyze the variation between 
the experimental conditions for both treatment effects and the variance components, we used 
the procedure PROC GLM in SAS 9.3. The dependent variables were: the deviations of the 
estimated average treatment effects from the true population values, the squared deviation, the 
difference between the estimated standard error and the standard deviation of the treatment 
effects, the coverage proportion of the 95% confidence interval, the power, and the deviations 
of the variance estimates from their true population values. The experimental conditions that 
have a statistically significant (p < .001) effect on the above listed dependent variables were 
further explored. This procedure was only used as a preliminary investigation to discover the 
conditions that can play a significant role in the three-level synthesis of single-subject data. 
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3.3 Results of the Simulation Study 
The estimated average treatment effects (i.e., the immediate treatment effect and the 
treatment effect on the time trend) are discussed in the first section. In the second section we 
present the relative bias of the point estimates of the variance components (i.e., the between-
subject within study variance and the between-study variance). The full dataset is available 
from the first author. 
3.3.1 Average treatment effect 
3.3.1.1 Bias and mean squared error  
Previous simulation studies evaluating the three-level analysis of unstandardized single-
subject data indicate that the estimated relative bias for both estimated treatment effects was 
close to zero (Moeyaert et al., 2013a; Owens & Ferron, 2012). We also expected this in 
current study, which was confirmed. When      and      equal 0, the bias was respectively 
0.00079 and -0.000027 and when      = 2 and      = 0.2, the relative biases were 
respectively 0.074 and 0.075. The number of measurements had a substantial influence on the 
relative bias. Especially if the number of measurements is small (I = 10), the relative bias is 
substantial if      = 2. The relative bias for 10 measurements is .15 whereas the relative bias 
for 20 measurements equals .05 (see Figure 3.3). The bias is further reduced by adding more 
measurements. When      = 0, the bias is close to zero, independent of the number of 
measurements. These conclusions are similar for the relative bias of the estimated treatment 
effect on the slope. 
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Figure 3.3. Influence of the number of measurements on the relative bias of the estimated immediate treatment 
effect and estimated treatment effect on time trend; for       2,       0.2, K = 10, J = 4,    
 = 2 and    
 = 2 
conditions. 
Furthermore, we sorted all conditions by their relative bias for the estimate of both 
treatment effects. When estimating the immediate treatment effect, the relative bias is largest 
(3.11) in the condition with:      = 2,      = 0, K = 10, J = 3; I = 10,    
  = 8 and    
  = 8. 
This is comparable to the condition in which the bias when estimating the treatment effect on 
the time was largest (4.53):      = 0,      = 0.2, K = 10, J = 3; I = 10,    
  = 0.2 and    
  = 
0.05 . The relative bias in these conditions can significantly be reduced by including at least 
20 measurement occasions per subject: when going from 10 to 20 measurement per subject, 
the mean relative bias of the immediate treatment effect and the treatment effect on the time 
trend are respectively: 0.048 and 0.062. 
We estimated the Mean Squared Error (MSE) of both estimated treatment effects 
because it gives information about their bias and variance around the population effect. Table 
3.2 provides the MSE for the immediate effect of the treatment (    ) where      = 2 and      
= 0.2. Similar patterns are seen for the other combinations of treatment effect values.  
As expected, the MSE for both treatment effects,      and      becomes smaller when the 
number of studies increases from 10 to 30. The MSE is further affected by the size of the 
between-study and the between-subject variance (see Table 3.2). The larger the between-
subject and especially the between-study variance, the larger the MSE. The MSE is influenced 
to a much smaller degree by the number of subjects. The MSE in this study is also only 
decreasing slightly with an increasing number of measurements. This influence is mostly 
visible when only 10 studies are involved. If the values in Table 3.2 are compared to the MSE 
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values from the unstandardized data (available in Moeyaert et al., 2013a), it can be seen that 
the MSE for standardized and unstandardized data are comparable if there are at least 20 
measurements within a subject, but the MSE for standardized data remains slightly higher. 
The conclusions are very similar for the estimates of     . 
Table 3.2 
Mean Squared Error of the Estimated Immediate Treatment Effect; for      = 2 and      = 0.2 Conditions 
     K = 10   K = 30 
I J    
       
  = 0.5    
  = 2    
  = 8      
  = 0.5    
  = 2    
  = 8 
10 3  0.5   0.12 0.24 0.63   0.09 0.12 0.21 
  2   0.17 0.25 0.61   0.09 0.12 0.26 
  8   0.28 0.35 0.75   0.14 0.18 0.28 
 4  0.5   0.13 0.20 0.52   0.10 0.11 0.22 
  2   0.15 0.22 0.64   0.09 0.11 0.24 
  8   0.24 0.33 0.64   0.13 0.14 0.28 
 7  0.5   0.11 0.18 0.50   0.09 0.11 0.23 
  2   0.12 0.21 0.55   0.09 0.11 0.24 
  8   0.19 0.28 0.64   0.10 0.12 0.23 
20 3  0.5   0.05 0.12 0.41   0.02 0.05 0.15 
  2   0.08 0.14 0.49   0.03 0.06 0.16 
  8   0.19 0.26 0.51   0.06 0.09 0.20 
 4  0.5   0.05 0.13 0.44   0.02 0.05 0.16 
  2   0.07 0.15 0.46   0.03 0.05 0.16 
  8   0.16 0.21 0.53   0.05 0.07 0.17 
 7  0.5   0.04 0.12 0.42   0.02 0.04 0.15 
  2   0.05 0.13 0.44   0.02 0.04 0.15 
  8   0.10 0.16 0.48   0.03 0.06 0.17 
40 3  0.5   0.04 0.11 0.37   0.01 0.04 0.13 
  2   0.07 0.15 0.43   0.02 0.05 0.14 
  8   0.15 0.23 0.54   0.05 0.08 0.17 
 4  0.5   0.04 0.11 0.35   0.01 0.03 0.12 
  2   0.05 0.12 0.45   0.02 0.04 0.14 
  8   0.14 0.21 0.48   0.04 0.06 0.17 
 7  0.5   0.03 0.11 0.35   0.01 0.03 0.12 
  2   0.04 0.11 0.41   0.02 0.04 0.13 
  8   0.09 0.14 0.45   0.03 0.05 0.15 
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3.3.1.2 Estimates of standard errors of the average treatment effects 
In this section, we evaluate the estimate of the standard errors that can be used to 
construct confidence intervals. Standard errors are per definition equal to the standard 
deviation of the sampling distribution. Therefore, we can use the standard deviation of the 
treatment effect estimates in a specific condition as an approximation of the true standard 
errors, and use this standard deviation as a criterion to evaluate the estimated standard errors. 
The larger the number of estimates of the effects, the better the standard deviation of the 
estimates is expected to correspond to the true standard error. 
The relative difference between the median standard error estimates and the standard 
deviation of the estimates of the fixed effects was obtained by dividing the difference by the 
standard deviation of the estimates. The relative difference tends to be negative (see Table 
3.3), which indicates that the standard errors are underestimated, however none of the bias  
values found in the scenarios examined here exceeded Hoogland and Boomsma’s (1998) 
criterion value of 10% (1,000 out of 10,000). Because some of the values approached the 
cutoff, we still examined which factors affected the relative standard error bias. The 
measurement occasions, F(2,645) = 15.74, p < .001, the number of studies, F(1,646) = 
302.85, p < .001, and the between-subject variance , F(2,645) = 15.92, p < .001, were found to 
have a significant impact on the gap between the standard error estimates and the standard 
deviation of the estimates (see Table 3.3). To reduce the gap, one can increase the number of 
measurements and increase the number of studies. For example, increasing the number of 
studies to 30 results in a better estimate of the standard error of the immediate treatment 
effect. Similar results were found for the synthesis of unstandardized data, except that the 
number of measurements does not matter for unstandardized data. When we estimate the 
treatment effect on the time trend,     , the same conclusions can be made. 
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Table 3.3 
Relative Difference (*10,000) between the Median of the Standard Error Estimates and the Standard Deviation 
of the Estimated Immediate Treatment; for      = 2 and      = 0.2 Conditions 
    K = 10   K = 30 
I J    
      
   0.5    
  = 2    
  = 8      
   0.5    
  = 2    
  = 8 
10 3 0.5  -777 -668 -641   -580 -405 32 
  2  -497 -787 -650   -353 -166 -291 
  8  -69 -531 -446   104 -318 -145 
 4 0.5  -826 -619 -404   -252 -241 -377 
  2  -565 -198 -558   -256 -129 -99 
  8  -141 -213 -398   -195 24 -267 
 7 0.5  -498 -491 -365   -74 -198 -215 
  2  -407 -698 -274   -91 -15 -66 
  8  -409 -615 -495   -218 -195 41 
20 3 0.5  -433 -601 -281   -233 -261 29 
  2  -159 -288 -564   62 -83 -221 
  8  -82 -308 -150   -83 -380 -103 
 4 0.5  -285 -502 -424   57 -181 -210 
  2  -581 -231 -581   -186 459 -311 
  8  -239 -42 -151   -54 105 92 
 7 0.5  -200 -418 -370   -140 -508 -145 
  2  -264 -461 -479   -179 101 -24 
  8  -171 -229 -610   17 -256 -324 
40 3 0.5  -493 -526 -355   -216 47 -261 
  2  -491 -479 -430   -148 -105 -116 
  8  31 -520 -538   131 -201 -228 
 4 0.5  -153 -439 -277   189 132 128 
  2  -384 -131 -346   -16 -197 -43 
  8  -19 -272 -639   9 -123 -87 
 7 0.5  -187 -552 29   -173 174 7 
  2  -482 -355 -484   40 -259 -104 
  8  -445 -234 -465   11 16 -24 
3.3.1.3 Coverage proportion  
We calculated 95% interval estimates of the fixed effects, based on the point estimates, 
the standard error estimates, and the Satterthwaite estimated degrees of freedom. We 
evaluated these interval estimates by estimating their coverage proportion. An estimated 
coverage proportion of 95% means that in 95% of the confidence intervals calculated for a 
specific condition, the population value is included in the confidence interval. Because we 
simulated 2,000 datasets for each condition, the coverage proportions are expected to be close 
to the nominal value of .95: the standard error is only 0.005 (i.e., √(         )      ). The 
lower and upper limits of the confidence intervals around the population effect (     and     ) 
are constructed by multiplying the estimated standard error with the critical value of the t-
distribution, and subtracting from and adding this product to the estimated value of the effect. 
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In this study, the maximum value for the coverage proportion of the estimates of the 
average immediate treatment effect (    ) did not exceed .97, but the coverage proportion 
went down to problematically small values (e.g., .69). For the estimation of     , the smallest 
value for the coverage proportion is .92.      and      both have a median coverage 
proportion of .95 with a standard deviation over conditions of respectively .029 and .0065. 
Therefore the deviations of the coverage proportion from the nominal value of .95 for the 
estimation of      can not simply be explained by chance in contrast to the analysis on 
unstandardized data (Moeyaert et al., 2013a). 
Table 3.4 presents the coverage proportion for the estimate of     , for      = 2 and 
        . Similar results are obtained for the combination of the other values for the 
treatment effects. The coverage proportions are especially small when there are 30 studies 
with only 10 measurement occasions within a subject. An explanation is that if only 10 
measurements per subject are made, the effect is underestimated. This will especially be 
visible if we have a large number of studies, because in this case the standard error and 
therefore the confidence interval is smallest. 
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Table 3.4 
Coverage Proportion for the Estimated Immediate Treatment Effect; for      = 2 and      = 0.2 Conditions 
    K = 10  K = 30 
I J    
      
 = 0.5    
 = 2    
  = 8     
 = 0.5    
 = 2    
  = 8 
10 3 0.5  .92 .93 .95  .79 .88 .94 
  2  .93 .93 .94  .84 .90 .94 
  8  .95 .95 .94  .93 .92 .94 
 4 0.5  .90 .93 .94  .75 .87 .91 
  2  .92 .95 .94  .81 .89 .93 
  8  .95 .94 .94  .89 .92 .94 
 7 0.5  .89 .93 .94  .69 .86 .92 
  2  .90 .93 .95  .75 .87 .93 
  8  .93 .93 .95  .85 .90 .93 
20 3 0.5  .94 .95 .96  .92 .94 .95 
  2  .95 .95 .95  .94 .94 .94 
  8  .96 .96 .96  .95 .94 .94 
 4 0.5  .95 .94 .95  .92 .94 .94 
  2  .94 .95 .95  .92 .95 .95 
  8  .96 .95 .95  .95 .94 .96 
 7 0.5  .95 .94 .95  .91 .92 .94 
  2  .94 .95 .95  .92 .94 .95 
  8  .96 .95 .94  .94 .94 .94 
40 3 0.5  .94 .95 .95  .94 .95 .94 
  2  .95 .95 .95  .95 .95 .95 
  8  .96 .95 .95  .96 .95 .95 
 4 0.5  .95 .96 .95  .95 .95 .96 
  2  .95 .95 .95  .94 .95 .95 
  8  .96 .95 .95  .96 .95 .95 
 7 0.5  .95 .95 .95  .94 .95 .95 
  2  .95 .95 .95  .95 .94 .95 
  8  .95 .95 .94  .95 .95 .96 
Note. Coverage proportions between .93 and .96 are in boldface. 
3.3.1.4 Power  
The probability of rejecting the null hypothesis when in fact a certain alternative 
parameter value is true, is called the power of a significance test (Cohen, 1988). Power 
calculations can give researchers important information about the minimum required number 
of units to include in the research design. 
We want the power as high as possible when the null hypothesis is false (Cohen, 1988), 
i.e., when      is 2 rather than 0. For the multilevel analysis of standardized single-subject 
data, the conditions in which the power level is reasonably large (at least .80; Cohen, 1988) 
are marked in bold (see Table 3.5). 
66  Chapter 3 | Standardized single-case data 
 
A striking finding is that the power for the estimated immediate treatment effect is 
always too small when only 10 heterogeneous (e.g.    
  = 8) studies are involved in the three-
level analysis. Moreover, when 30 studies are included, the power is above .85 for all 
conditions. This conclusion is similar for unstandardized data (Moeyaert et al., 2013a).  
The results for the power of the estimated treatment effect on the trend,     , are also 
comparable for unstandardized and standardized data (see Table 3.5). The power is too small 
in all conditions when only 10 studies are involved. When including 30 studies, the power 
becomes larger, but stays too small if there are a small number of measurements (I = 10) and a 
small number of subjects (J = 3). When the number of subjects is 4 or 7, the power remains 
too small if the studies are heterogeneous (   
 = 0.2). When the number of measurements 
becomes larger (I = 20 or I = 40) the power level of .80 is reached in all conditions for rather 
homogeneous studies (   
 = 0.05 or    


























Power for the Estimated Immediate Treatment Effect and the Estimated Treatment Effect on the Slope; for     =2 and      = 0.2 Conditions 
     ̂       ̂    
    K = 10  K = 30  K = 10  K = 30 
       
   0.5    
  = 2    
   8     
   0.5    
  = 2    
   8     
  = 0.05    
  = 0.08    
  = 0.2     
  = 0.05    
  = 0.08    
  = 0.2 
I J    
             
          
10 3 0.5  1.00 .92 .46  1.00 1.00 .94 0.05 .31 .27 .19   .77 .68 .47 
  2  .98 .86 .47  1.00 1.00 .92 0.08 .28 .23 .17   .72 .66 .45 
  8  .80 .65 .37  1.00 .99 .85 0.2 .22 .19 .16   .61 .54 .39 
 4 0.5  1.00 .94 .47  1.00 1.00 .95 0.05 .37 .28 .18   .84 .75 .50 
  2  .99 .90 .49  1.00 1.00 .94 0.08 .34 .29 .18   .81 .71 .48 
  8  .88 .74 .40  1.00 1.00 .89 0.2 .26 .24 .17   .70 .62 .45 
 7 0.5  1.00 .96 .47  1.00 1.00 .96 0.05 .45 .34 .21   .93 .84 .55 
  2  1.00 .93 .49  1.00 1.00 .95 0.08 .42 .35 .20   .92 .82 .55 
  8  .98 .85 .45  1.00 1.00 .94 0.2 .36 .31 .19   .86 .77 .52 
20 3 0.5  1.00 .93 .51  1.00 1.00 .96 0.05 .52 .39 .20   .96 .88 .58 
  2  1.00 .91 .46  1.00 1.00 .93 0.08 .46 .37 .21   .95 .87 .58 
  8  0.84 .70 .39  1.00 1.00 .89 0.2 .35 .29 .19   .81 .73 .52 
 4 0.5  1.00 .96 .51  1.00 1.00 .96 0.05 .57 .40 .22   .98 .91 .60 
  2  1.00 .94 .49  1.00 1.00 .95 0.08 .50 .39 .21   .96 .89 .60 
  8  .92 .79 .41  1.00 1.00 .91 0.2 .37 .30 .20   .89 .81 .55 
 7 0.5  1.00 .97 .50  1.00 1.00 .96 0.05 .62 .44 .23   .99 .93 .63 
  2  1.00 .94 .50  1.00 1.00 .96 0.08 .59 .45 .24   .99 .92 .63 
  8  .99 .86 .46  1.00 1.00 .94 0.2 .49 .38 .23   .95 .88 .59 
40 3 0.5  1.00 .95 .50  1.00 1.00 .96 0.05 .58 .42 .24   .98 .93 .62 
  2  1.00 .92 .46  1.00 1.00 .95 0.08 .52 .41 .24   .96 .88 .61 
  8  .86 .73 .39  1.00 1.00 .90 0.2 .36 .30 .20   .86 .79 .55 
 4 0.5  1.00 .96 .53  1.00 1.00 .96 0.05 .59 .47 .21   .99 .93 .61 
  2  1.00 .93 .49  1.00 1.00 .96 0.08 .55 .43 .22   .98 .91 .62 
  8  .93 .79 .41  1.00 1.00 .91 0.2 .41 .35 .20   .92 .84 .58 
 7 0.5  1.00 .97 .50  1.00 1.00 .96 0.05 .66 .49 .24   .99 .95 .64 
  2  1.00 .96 .51  1.00 1.00 .95 0.08 .60 .46 .26   .99 .94 .65 
  8  .99 .88 .47  1.00 1.00 .94 0.2 .50 .41 .21   .97 .89 .60 
Note. Values   .80 are in boldface. 
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3.3.2 Variance components 
In addition to the estimation of the fixed effects, we estimated the variance components 
(i.e., the between-study and the between-subject variances) for both treatment effects (i.e., the 
immediate treatment effect and the treatment effect on the time trend). We examined the 
relative bias which is the absolute bias divided by the population parameter. Because the 
population values for the variance components differ from zero, it is possible to calculate the 
relative bias in all conditions. 
The distribution of the estimated variance components is positively skewed due to 
transformation of negative estimates to zero. Therefore, we calculated the median relative 
deviation of the estimates from the population value, rather than the mean relative deviation, 
to evaluate the relative bias in the estimates. 
There is a substantial mean relative bias for the estimate of the between-study variance, 
0.24, and the between-subject variance, 0.71, for the immediate treatment effect. Table 3.6 
provides the relative bias estimates of the between-case variance and the between-study 
variance of the immediate treatment effect per condition for      = 2 and      = 0. 
Similar conclusions can be made when estimating the between-study and the between-
subject variance for the effect on the trend, except that the relative biases are smaller. The 
condition representing the maximum relative bias (0.35) for the estimation of the between-
study variance is: K = 30, J = 3, I = 10,    
 = 0.05 and    
 = 0.02. The condition with the 
maximum relative bias (2.19) for the estimation of the between-subject variance is K = 30, J = 
3, I = 10,    
  = 0.08 and    


























Median of Relative Deviation of the Variance Estimates of     ; for     =2 and     =0.2 Conditions 
     ̂  
     ̂  
  
    K = 10  K = 30  K =10  K = 30 
       
  = 0.5    
   2    
   8     
  = 0.5    
   2    
   8     
  = 0.5    
   2    
   8  
   
  = 
0.5 
   
   2    
   8 
I J    
          
   
  
       
10 3 0,5  0.10 0.20 0.20  0.29 0.31 0.27 0.05 1.92 1.65 3.69 2.26 1.75 4.50 
  2  0.09 0.20 0.18  0.30 0.28 0.29 0.08 0.79 0.78 1.36 0.97 1.09 1.58 
  8  -0.26 0.08 0.20  0.07 0.25 0.30 0.2 0.41 0.44 0.65 0.57 0.61 0.72 
 4 0,5  0.13 0.20 0.20  0.32 0.29 0.27 0.05 2.03 2.45 3.93  2.34 2.88 4.46 
  2  0.05 0.21 0.18  0.25 0.30 0.28 0.08 0.85 0.99 1.33  1.02 1.13 1.56 
  8  -0.21 0.16 0.16  0.26 0.22 0.27 0.2 0.49 0.54 0.66  0.58 0.63 0.72 
 7 0,5  0.22 0.23 0.24  0.31 0.31 0.30 0.05 2.18 2.63 4.24  2.49 2.94 4.85 
  2  0.19 0.20 0.22  0.30 0.30 0.31 0.08 0.98 1.06 1.51  1.04 1.15 1.69 
  8  -0.06 0.09 0.21  0.26 0.28 0.29 0.2 0.55 0.60 0.71  0.61 0.66 0.77 
20 3 0,5  -0.04 -0.02 0.01  0.05 0.06 0.08 0.05 0.50 0.55 0.97  0.58 0.67 1.16 
  2  -0.07 -0.04 -0.01  0.07 0.08 0.10 0.08 0.15 0.21 0.32  0.26 0.27 0.41 
  8  -0.37 -0.07 -0.01  0.04 0.05 0.07 0.2 0.05 0.10 0.15  0.12 0.16 0.19 
 4 0,5  -0.03 0.00 0.01  0.07 0.08 0.07 0.05 0.52 0.64 1.06  0.60 0.73 1.17 
  2  -0.09 -0.02 -0.02  0.03 0.09 0.07 0.08 0.21 0.26 0.35  0.26 0.28 0.40 
  8  -0.24 -0.05 0.02  -0.04 0.03 0.07 0.2 0.10 0.13 0.16  0.15 0.17 0.20 
 7 0,5  0.03 0.01 0.02  0.07 0.07 0.06 0.05 0.57 0.70 1.12  0.61 0.74 1.20 
  2  -0.06 0.03 0.01  0.05 0.07 0.08 0.08 0.24 0.28 0.38  0.27 0.30 0.42 
  8  -0.15 -0.03 0.00  0.00 0.06 0.06 0.2 0.14 0.15 0.20  0.17 0.18 0.20 
40 3 0,5  -0.07 -0.05 -0.04  0.01 0.02 0.01 0.05 0.14 0.23 0.34  0.19 0.24 0.41 
  2  -0.14 -0.10 -0.04  0.00 0.01 0.02 0.08 0.05 0.07 0.11  0.08 0.11 0.15 
  8  -0.43 -0.17 -0.08  -0.07 0.02 0.00 0.2 -0.02 0.01 0.06  0.04 0.06 0.06 
 4 0,5  0.00 -0.07 -0.05  0.03 0.01 0.03 0.05 0.17 0.21 0.36  0.23 0.28 0.44 
  2  -0.10 -0.06 -0.04  0.00 0.00 0.03 0.08 0.06 0.09 0.12  0.10 0.11 0.16 
  8  -0.37 -0.07 -0.07  -0.08 0.00 0.00 0.2 0.01 0.03 0.05  0.06 0.07 0.08 
 7 0,5  -0.5 -0.05 -0.02  0.01 0.01 0.02 0.05 0.19 0.24 0.42  0.22 0.27 0.45 
  2  -0.08 -0.03 -0.03  0.00 0.02 0.02 0.08 0.07 0.09 0.13  0.09 0.11 0.16 
  8  -0.23 -0.07 -0.05  -0.06 0.01 0.02 0.2 0.04 0.06 0.08  0.06 0.07 0.08 
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3.4 Empirical Illustration 
In this section, we give an empirical illustration of the comparison of the three-level 
analysis of unstandardized single-subject data and the three-level analysis of standardized 
single-subject data. Therefore, we selected studies using a multiple-baseline across 
participants design from the meta-analyses of single-case studies by Heyvaert, Saenen, Maes, 
and Onghena (2012) in which restraint interventions for challenging behavior among persons 
with intellectual disabilities was investigated. In total, we retrieved the raw data of 8 studies 
having 2 to 4 subjects. We combined the studies of Lindberg, Iwata and Kahng (1999); 
Roscoe, Iwata and Goh (1998); Thompson, Iwata, Conners, and Roscoe (1999); Roane, 
Piazza, Sgro, Volkert, and Anderson (2001); McCord, Grosser, Iwata, and Powers (2005); 
Rolider, Williams, Cummings, and Van Houten (1991); Hanley, Iwata, Thompson, and 
Lindberg (2000); and Zhou, Goff, and Iwata (2000). The SAS codes used for the estimation of 
the treatment effects over subjects and over studies are described in Addendum A1. 
The average immediate treatment effect was -31.24, t(7) = -3.29, p = .01 and the 
average treatment effect on the time trend was -0.51, t(7) = -0.52, p = .19 when we used 
unstandardized data. When first standardizing the raw data using Equation 3.4 before 
estimating the effects over subjects and over studies, the immediate treatment effect was -5.14 
t(7) = -3.16, p = .01 and the treatment effect on the time trend was -0.06, t(7) = -2.92, p = .02. 
These results indicate that there is a large difference between unstandardized and standardized 
data with regard to the estimated treatment effect on the time trend. This difference is not 
surprising because in one study the challenging behavior is counted in intervals that are six 
times smaller in a study than in another study. For instance, in the study of Roane et al. 
(2001), the dependent variable is the number of challenging behavior in 10 seconds, whereas 
in the study of Roscoe et al. (1998), the same challenging behavior is measured as the number 
of responses per minute. If we standardize the data, outcome scores within phases across 
studies are closer to each other, resulting in a smaller estimated standard error of the treatment 
effect on the time trend,   ( ̂   ). A smaller estimated standard error results in a larger t 
value (i.e., t = 
 ̂   
  ( ̂   )
) and therefore a significant treatment effect on the time trend across 
studies is obtained. This means that a significant treatment effect on the time trend would not 
have been identified if unstandardized data were used. There is also a large difference in the 
estimated between-subject and between-study variance for both estimated treatment effects. 
The between-subject variance for the estimated immediate treatment effect equals 445.14 for 
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unstandardized data while it is 26.87 for standardized data. The between-subject-variance for 
the estimated treatment effect on the time trend equals 0.29 for unstandardized data and 
0.0011 for standardized data. Similar conclusions are obtained for the estimated between-
study variances. The empirical illustration indicates that there is a large difference in 
estimated treatment effects, depending on whether standardized single-case data or 
unstandardized data are used. Because not standardizing data not measured on the same scale 
will flaw the results, while standardizing data that are measured on the same scale is not 
expected to have a systematic effect, we recommend standardizing single-case data before 
combining them over cases and over studies. 
3.5 Conclusion and Discussion 
3.5.1 General conclusion 
The purpose of this study was to evaluate the standardization method proposed by Van 
den Noortgate and Onghena (2008). We first standardized the SSED data using this method 
before combining them using the three-level model. 
The study indicates that the standardizing factor works reasonably well, except when a 
study includes a small amount of measurement observations within a subject (10 or less). In 
this condition, the estimate of the average treatment effects and the standard errors are 
underestimated which result in flawed coverage proportions. 
Despite this, the results are encouraging for researchers interested in the average 
immediate treatment effect and the average treatment effect on the time trend, especially 
when including many studies (30 or more), at least 20 measurement occasions within a 
subject and when the studies are homogeneous (i.e., a small between-study variance). In these 
conditions, the average treatment effects are not biased, the mean squared error is reasonably 
close to zero, the coverage proportion of the .95 confidence intervals is close to the nominal 
level of .95. Moreover, the power of the treatment effects we tested attain the threshold level 
of .80 if a large number of studies (30 or more) are involved. For the treatment effect on the 
time trend, not only a large number of studies, but also a large number of measurements (20 
or more) and homogeneous studies and cases are needed. It is important that researchers 
combining standardized single-subject data are aware that for other conditions substantial 
problems occurred. 
Researchers who are interested in the variation in treatment effects over subjects and 
over studies should interpret the results with care. We found that estimates of the between-
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subject variance are often biased, except when there are at least 40 measurement occasions 
within a subject. The estimation of the between-study variance is less biased, but the relative 
bias remains substantial if 30 studies with only 10 measurement occasions within a subject are 
combined. For both estimated variance components, the number of measurements has a large 
effect on the bias. We have to be careful with the interpretation of the bias because the value 
representing a substantial bias depends on the research domain and the content of the study. 
The empirical illustration indicates that it is important that we standardize the data if 
subjects are not measured on the same scale. The estimated treatment effects differed when 
we use the standardized method in comparison with using the unstandardized data. 
A requirement for obtaining more accurate estimated treatment effects over subjects and 
over studies is to use at least 20 measurement occasions per subject. Thus, we encourage 
single-subjects researchers to observe and measure their subjects at least 20 times. 
3.5.2 Limitations and suggestions for future research 
Although we tried to simulate realistic data to explore the appropriateness of the three-
level model, the simulation study has the same limitation as other simulation studies, in that 
the conclusions are difficult to generalize to other conditions. Therefore we included 
conditions that are representative for the three-level analyses of single-subjects (Alen et al., 
2009; Denis et al., 2011; Kokina & Kern, 2010; Shogren et al., 2004; Wang et al., 2011). If a 
researcher is interested in the power when including other values for the different conditions, 
several tools are available. For instance, Cools, Van den Noortgate, and Onghena (2008) 
developed a user-friendly tool, MultiLevel Design Efficiency Using Simulation (MLdeS), that 
can be used for calculating the number of units needed at each level to obtain a power larger 
than .80. The user has to specify the model of interest (e.g. the number of levels, the number 
of variables at each level, the covariance structures and the parameter values) and the number 
of sample sizes at each level for which data will be generated, and will receive power and 
accuracy estimates for the parameters of interest. 
Another limitation is that we assumed linear trajectories in the treatment phase, but 
again this is a simplification for the reality. There might be non-linear trends, and this should 
be a topic for future research. 
There are concerns regarding the assumption that the errors in the statistical model are 
independent. When repeated observations are made on the same subject, there is a likelihood 
that the errors of the measurement associated with a score at one data point may be predictive 
of errors at other points in the series that follow. Subsequent measurements are more similar 
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than measurements farther in time: “Everything is related to everything else, but near things 
are more related than distant things.” (Tobler, 1970, p. 236). We did not account for this 
autocorrelation. Another assumption we made is that the residuals at each level are 
(multivariate) normally distributed. Further research is needed to investigate the performance 
of the approach if the normality assumption that is made in the multilevel approach is 
violated. A possible way to investigate this is by generating the second and third level errors 
from a non-normal distribution, for instance a distribution with heavier tails such as the t-
distribution with a small degrees of freedom or a skewed distribution such as a   - 
distribution. Further research is needed to investigate the consequences on the estimated 
treatment effect and variance components. We also assumed that residuals at each level are 
identically distributed, which may also not be the case. Currently, Moeyaert, Ugille, Ferron, 
Beretvas, and Van den Noortgate (2014a) are busy with misspecification issues in order to 
evaluate the robustness of the three-level approach. 
To simplify the simulation model, we did not account for a possible dependence 
between different regression coefficients, that can be accounted for in a multilevel analysis by 
estimating the covariances at the various levels. For instance, it seems plausible that the 
treatment effects,      and     , are smaller for subjects with an already high baseline level, 
    . Further research is needed to explore level-2 and level-3 covariance matrix 
misspecification. 
We used a multiple-baseline across participants design but we did not take into account 
confounding extraneous events that could have a simultaneous effect on all participants. In 
current research, we developed a method to model these extraneous events (Moeyaert et al., 
2013c). Beside this, there are other designs like alternating designs and reversal designs that 
need further exploration. 
Finally, parameters were estimated and tested using REML, which is based on large 
sample theory. The results indicate that the variance components at all levels were biased. We 
are currently doing more research, evaluating the approach in more complex conditions, 
exploring alternative methods for estimating the parameters and evaluating ways to avoid 
biased parameter and corresponding standard error estimates for the analysis of standardized 
SSED data. 
This research indicates that the three-level approach is appropriate to combine 
standardized single-subject data as long as the studies are quite homogeneous, there are a lot 
of measurements per subject and a lot of studies are combined. 
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 Chapter 4|
Modeling External Events in the Three-





In this study, we focus on a three-level meta-analysis for combining data from studies 
using multiple-baseline across participants designs. A complicating factor in such designs is 
that results might be biased if the dependent variable is affected by not explicitly modeled 
external events, such as the illness of a teacher, an exciting class activity, or the presence of a 
foreign observer. In multiple-baseline designs, external effects can become apparent if they 
simultaneously have an effect on the outcome score(s) of the participants within a study. This 
study presents a method to adjust the three-level model for external events and evaluates the 
appropriateness of the modified model. Therefore we use a simulation study, and we illustrate 
the new approach with real datasets. 
The results indicate that ignoring an external event effect results in biased estimates of 
the treatment effects, especially when there is only a small number of studies and 
measurement occasions involved. The mean squared error, as well as the standard error and 
coverage proportion of the effect estimates are improved with the modified model. Moreover, 
the adjusted model results in less biased variance estimates. If there is no external event 
effect, we find no differences in results between the modified and unmodified models. 
Keywords: multiple-baseline across participants, three-level meta-analysis, effect sizes, 
external event effect 
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 This chapter has been published as Moeyaert, M., Ugille, M., Ferron, J., Beretvas, S.N.,& 
Van den Noortgate, W. (2013c). Modeling external events in the three-level analysis of 
multiple-baseline across participants designs: A simulation study. Behavior Research 
Methods, 45, 547-559. doi: 10.1080/00273171.2013.816621 
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4.1 Introduction 
4.1.1 Multiple-baseline design 
A multiple-baseline design (MBD) is one of the variants of Single-Subject 
Experimental Designs (SSEDs). SSED researchers observe and measure a participant or case 
repeatedly over time. Observations are obtained during at least one baseline phase (when no 
intervention is present) and at least one treatment phase (when an intervention is present). By 
comparing scores from both kinds of phases, SSED researchers can assess whether the 
outcome scores on the dependent variable changed for instance in level or in slope when the 
treatment was present (Onghena & Edgington, 2005). 
In an MBD, an AB phase design (with one baseline phase, A, and one treatment phase, 
B) is implemented simultaneously to different participants, behaviors or settings (Barlow & 
Hersen, 1984; Ferron & Scott, 2005; Onghena, 2005; Onghena & Edgington, 2005). MBDs 
are popular amongst the SSEDs (Shadish & Sullivan, 2011) because the intervention is 
introduced sequentially over the participants (or settings or behaviors), which entails the 
advantage that researchers can more easily disentangle effects of the intervention and effects 
of some external events, such as the illness of a teacher, an exciting class activity, the 
presence of a foreign observer, and a teacher intern (Baer et al., 1968; Barlow & Hersen, 
1984; Kinugasa et al., 2004; Koehler & Levin, 2000). This is because if an external event 
occurs at certain points in time, then the outcome scores for all participants in that study 
might be simultaneously influenced. Figure 4.1 gives a graphical presentation of possible 
consequences for the occurrence of an external event in a multiple-baseline across 
participants design. In Figure 4.1a, the external event has a constant effect on the dependent 
variable on subsequent measurements, for instance the teacher is ill during subsequent days, 
or there is a foreign observer during some measurement occasions. Figure 4.1b illustrates a 
gradually fading away external event effect. For instance, the influence of a teacher intern on 
the behavior of the students may be reduced over time. 
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Figure 4.1. Graphical display of a constant external event effect (a) and a gradually fading away external event 
effect (b) affecting the score on 4 subsequent moments (day 17, day 19, day 21 and day 23) for a MBD across 
three participants with the treatment starting on day 6, day 16 and day 24 respectively. 
4.1.2 Multilevel meta-analysis 
Van den Noortgate and Onghena (2003b) proposed the use of multilevel models to 
synthesize data from multiple SSED studies, allowing investigation of the generalizability of 
the results, and exploration of potential moderating effects. In previous research evaluating 
this multilevel meta-analysis of MBD data (Ferron et al., 2009; Ferron et al., 2010; Moeyaert 
et al., 2013a, 2013b; Owens & Ferron, 2012), the data were typically simulated with a 
treatment effect and random noise only. Potential confounding events that could have a 
simultaneous effect on all participants within a study were not taken into account. In this 
study we evaluate the performance of the basic three-level model when there are effects of 
external events, as well as of an extension of the model that tries to account for potential 
event effects. In the following, we first present the basic model and a possible extension to 
account for external events. Next, we evaluate the performance of both models, by means of a 
simulation study and an analysis of real data.  
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A meta-analysis combines the results of several studies addressing the same research 
question (Cooper, 2010; Glass, 1976). Study results are typically first converted to a common 
standardized effect size before meta-analyzing them. The effect sizes may be reported in the 
primary studies or can be calculated afterwards, using reported summary and/or test statistics. 
One possible way to calculate effect sizes when using SSEDs, is to analyze the data 
using regression models, and to use the regression coefficients as effect sizes. A regression 
model of interest here is the one proposed by Center et al. (1985-1986): 
                                   (    
 ) (4.1) 
The score of the dependent variable on measurement occasion i (Yi ) depends on a 
dummy coded variable (  ) indicating whether the measurement occasion i belongs to the 
baseline phase (   = 0) or the treatment phase (   = 1), a time-related variable   , that equals 
1 on the first measurement occasion of the baseline phase, and an interaction term between 
the centered time-indicator and the dummy variable,      , where     is centered such that 
    equals 0 on the first measurement occasion of the treatment phase.    indicates the 
expected baseline level,    is the linear trend during the baseline,    refers to the immediate 
treatment effect and    to the effect of the treatment on the time trend. 
Van den Noortgate and Onghena (2003b) proposed using the ordinary least squares 
estimates for    and    from Equation 4.1 as effect sizes in the three-level meta-analysis. At 
the first level the estimated effect sizes of the immediate treatment effect,     , and the 
treatment effect on the time trend,     , for participant j from study k are equal to the 
unknown population effects sizes,      and      respectively, plus random deviation       
and     , that are assumed to be normally distributed with a mean of zero: 
                with        (       
 ) 
                with        (       
 ) 
(4.2) 
The sampling variances of the observed effects,      
 and      
  are the squared standard 
errors that are typically reported by default when performing a regression analysis. These 
variances depend to a large extent on the number of observations and the variance of these 
observations, and therefore can be participant- and study-specific.  
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At the second level, the population effect sizes      and      from Equation 4.2 can be 
modeled as varying over participants around the study-specific mean effect,      and      
(Equation 4.3).  
                with       (       
 ) 
                with       (       
 ) 
(4.3) 
The population effects for studies can vary between studies (third level, Equation 4.4). 
               with       (       
 ) 
               with       (       
 ) 
(4.4) 
The model parameters that we are typically interested in when using a multilevel model 
are the fixed effects regression coefficients (i.e.,     , referring to the average immediate 
treatment effect over participants and studies and     , referring to the average treatment 
effect on the linear trend over participants and studies in Equations 4.4), the variances (i.e., 
     
 , referring to the between-study variance for the estimated immediate treatment effect, 
     
 , indicating the between-study variance for the estimated treatment effect on the time 
trend,      
 , the between-case variance for the estimated immediate treatment effect and 
     
 , referring to the between-case variance of the estimated treatment effect on the time 
trend). 
4.1.3 Correcting effect sizes for external events 
External events in a multiple-baseline across participants design, can have an effect on 
the outcome score(s) of all participants within a study. These external event effects are 
common in SSEDs, because practitioners often implement these designs in their everyday 
setting (for example in the home, - school, - etc.), where they cannot control for outside 
experimental factors (Christ, 2007; Kratochwill et al., 2010; Shadish et al., 2002). If we do 
not model these external events, the results might be biased. For instance, suppose a 
researcher is interested in a change in challenging behavior and staggered the beginning of 
the treatment across three participants. The three participants receive the treatment at day 6, 
day 16 and day 24, respectively (see Figure 4.1) and are observed every 2 days. On day 17, 
19, 21 and 23, the teacher is ill and as a consequence a substitute teacher takes their place and 
the participants exhibit more challenging behavior. In this situation, the estimated treatment 
effect for participant 1 and 2 will be smaller and the estimated treatment effect for participant 
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3 will be larger, and therefore differences between participants in the treatment effects are 
also likely to be overestimated, unless we correct the effect sizes for possible external events. 
A possible way to calculate effect sizes corrected for an external event in an SSED is 
by estimating effect sizes for participants per study, by performing a regression analysis with 
a model including possible event effects, and assuming that external events simultaneously 
affect all participants in a study. Thereafter, the corrected effect sizes can be combined over 
studies in the three-level meta-analysis.  
For the first step, we propose to use an extension of the Center et al. (1985-1986) 
model, including dummy variables for measurement occasions:  
                                 ∑  (   )   
   
   
              (    
 ) (4.5) 
The score on the dependent variable Y on measurement occasion i (=1, 2, …, I) from 
participant j (=1, 2, …, J) is modeled as a linear function of the dummy coded variable (   ) 
indicating whether the measurement occasion i from participant j belongs to the baseline 
phase (    = 0) or the treatment phase (    = 1), a time-related variable    , that equals 1 at 
the start of the baseline phase, an interaction term between the dummy variable indicating the 
phase and the time-indicator centered around its value at the start of the treatment phase, 
       , and finally dummy coded variables indicating the moment (Mmi = 1 if m = i, zero 
otherwise). By including the effects of individual moments, coefficients     and     can be 
interpreted as the treatment effects, corrected for possible external events.  
We do not include a dummy variable for one measurement moment in the baseline 
phase and one measurement moment in the treatment phase. This is to ensure that the model 
is identified: if we would include these parameters as well, an increase in the effects for each 
moment in the baseline phase, could be compensated by a decrease of the intercept, 
illustrating that without constraining these parameters, there would be an infinite number of 
equivalent solutions. For our study we select the first and last moment as the times to set the 
moment effects to zero, but different moments could be chosen if we suspected a moment 
effect during one of these times.  
While the baseline level and slope (    and    ) and both treatment effects (    and 
   ) are participant-specific, the moment effects are assumed to be the same for all 
participants from the same study, and therefore have to be estimated for each study using all 
data from that study. To this end, we propose to extend Equation 4.5 by including a set of 
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dummy participant indicators. For two participants, using dummy participant indicators P1 
and P2  respectively, this results in Equation 4.6:  
                                                         
        
 
             
 
      ∑  (   )   
   
   
     
          (    
 ) 
(4.6) 
After using Equation 4.6 for each study to estimate the corrected effect sizes (    and 
   ) for each participant, we can use the three-level meta-analysis (see Equation 4.2 - 4.4) to 
combine the corrected effect size estimates from multiple participants. In principle we could 
also use a two-level model per study to estimate the participant-specific effects, but given the 
typically very small number of participants per study, using a multilevel model might not be 
recommended.  
4.2 A Simulation Study 
4.2.1 Simulating three-level data 
To evaluate the performance of the basic model and its extension, we performed a 
simulation study. We simulated raw data using a three-level model. At level one, we used the 
following model: 
                                                          (    
 ) (4.7) 





               
              
              
              
 with [
    
    
    
    
]  (    ) 
 
(4.8) 
The participants are in turn clustered within studies at the third level: 
{
              
              
              
              
  with [
    
    
    
    
]   (    ) (4.9) 
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4.2.3 Varying parameter 
Based on a thorough overview of 809 SSED studies, Shadish and Sullivan (2011) 
enumerated some parameters that characterize SSEDs. Based on their results and our re-
analyses of meta-analyses of SSEDs (Alen et al., 2009; Denis et al., 2011; Ferron et al., 2010; 
Kokina & Kern, 2010; Shadish & Sullivan, 2011; Shogren et al., 2004; Wang et al., 2011), 
we decided to vary the following parameters that can have a significant influence on the 
quality of model estimation:  
     , represents the immediate treatment effect on the outcome and had values 0 (no 
effect) or 2.  
 The treatment effect on the time trend, defined by     , was varied to have values 0 
(no effect) or 0.2. 
 The regression coefficients of the baseline,      and     , did not vary and were set at 
0, because the interest is in the average treatment effects (i.e. the immediate treatment 
effect and the treatment effect on the time trend). 
 The number of simulated participants, J, equaled 4 or 7. 
 The number of measurements within a participant, I, was 15 or 30. We chose to keep I 
constant for all participants within the same study. 
 The number of studies, K, was 10 or 30. 
 The between case-covariance matrix: covariances between pairs of regression 
coefficients were set to zero. Therefore,    is a diagonal matrix. 
        (    
     
     
     
 ) =     (            ) or         (    
     
     
     
 ) 
=     (                  ). 
 The between study-covariance matrix: covariances between pairs of regression 
coefficients were set to zero. Therefore,    is a diagonal matrix. 
        (    
     
    
     
 ) =     (            ) or         (    
     
     
     
 ) = 
    (                  ). 
 The moment of introducing a treatment effect was staggered across participants 
within a study (see Table 4.1), depending on the number of measurements.  
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Table 4.1 
Time of Introducing the Treatment 
 

















15 5 6 7 8 9 11 13 
30 5 8 11 14 17 20 23 
In a first scenario, a constant external event was added to influence four subsequent 
scores of all the participants within a study (as in Figure 4.1a). The moment was randomly 
generated from a uniform distribution for each study separately. Because we did not include a 
moment effect for the first and the last moment to make the model identified, the external 
event effect did not occur on these moments. The external event effect was 0 or 2, 
representing a null and a large external event effect, respectively. 
In a second scenario, the effect of the external event effect was added that fades away 
gradually (see Figure 4.1b) for all the participants within a study. The effect across four time 
points was respectively 3.5, 2.5, 1.5, 0.5. or 0, so that on average the average effect was the 
same as in the first scenario. The start of the event effect was generated completely at random 
from a uniform distribution for each study separately, so that the external event effect did not 
occur on the first or last measurement occasion. Data were generated using SAS 9.3. 
4.2.4 Analysis 
We had a total of 2
9
 (= 512) experimental conditions. We simulated 400 replications of 
each condition, resulting in 204,800 datasets to analyze. We analyzed the data twice, and 
compared the results. First we combined the uncorrected effect sizes in the three-level meta-
analysis. Next, we analyzed the three-level data by estimating the corrected effect sizes,     
and    , using the regression analysis per study (see Equation 4.6) before combining them in 
the three-level meta-analysis (see Equation 4.2 - 4.4). 
In the two approaches we used the SAS PROC MIXED (Littell et al., 2006) procedure 
to estimate the participant-specific effect sizes,      and     . In the first approach the effect 
sizes were uncorrected for the external event effect, whereas the effect sizes in the second 
approach were corrected. 
  
84   Chapter 4 | External event effects 
 
SAS PROC MIXED was also used for the three-level meta-analysis. The Satterthwaite 
approach to estimate the degrees of freedom method was applied because this method 
provides more accurate confidence intervals for estimates of the average treatment effect for 
two-level analyses of multiple-baseline data (Ferron et al., 2009).  
In order to evaluate the appropriateness of both models, uncorrected and corrected for 
external events, we calculated the deviations of the estimated immediate treatment effect, 
 ̂   , from its population value,     , and the deviations of the estimated treatment effect on 
the time trend,  ̂   , from its population value,     . The mean deviation gives us an idea of 
the bias. Next, we calculated the mean squared deviation (the Mean Squared Error, MSE) 
which gives information about the variance of both estimated treatment effects ( ̂    and 
 ̂   ) around the corresponding population effect (     and     ). Furthermore we discuss the 
standard error and the 95% confidence interval coverage proportion (CP) of the estimated 
immediate treatment effect and the treatment effect on the time trend. We also evaluate the 
bias of the point estimates of the between-study and between-case variance.  
We used ANOVAs to evaluate whether there were significant effects (α = .01) of each 
model type (e.g. model using effect sizes corrected versus uncorrected for external event 
effects) and of the simulation design parameters (    ,     , K, I, J,    
 ,    
 ) on the bias, 
MSE, the standard error and the CP. 
4.3 Results of the Simulation Study 
We present the results in two sections. In the first section we discuss the constant 
external effect over four subsequent measurement occasions. The second section considers 
the case where the external effect gradually fades away over four subsequent measurements. 
Each section presents the results of the three-level analysis of uncorrected and corrected 
effect sizes.  
When there is no external event effect, the results of the three-level meta-analysis (i.e., 
bias in the fixed effects, MSE of the fixed effects, estimated standard errors of the fixed 
effects, CP for the fixed effects, and bias in the variance components) were found to be 
independent of the model type (corrected or not corrected for external events).  
We found no significant bias for  ̂    and  ̂    when using the corrected or uncorrected 
model. Therefore we only discuss the results of the analyses of the data including external 
event effects conditions.  
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4.3.1 Constant external event over four subsequent measurement occasions 
4.3.1.1 Average treatment effect 
4.3.1.1.1 Bias and mean squared error 
When we estimate      and the effect sizes are uncorrected, the estimated treatment 
effect is on average significantly larger than the population value (     = 0 or 2). Over all 
conditions, the bias equals 0.032, t(51199) = 17.32, p < .0001, whereas there is no significant 
bias for the corrected effect sizes; -0.0015, t(51199) = -0.96, p = .34. Table 4.2 presents the 
bias estimates for  ̂   , when     = 2 and      = 0.2.  
Similar results are obtained for  ̂   . The bias is significantly negative for the uncorrected 
effect sizes and equals -0.20, t(51199) = -255.27, p < .0001, whereas the bias is not 
significant for the corrected effect sizes, t(51199) = -0.00020, p = .79. Moreover, an analysis 
of variance on the deviations reveals a significant difference between the two different 
models, both for  ̂    and  ̂   . F(1, 102398) = 192.06, p < .0001 for  ̂    and F(1, 102398) 
= 33695.1, p < .0001 for  ̂     The differences are largest when there is a small number of 
measurement occasions (I   15) and studies (K   10). In the following condition the largest 
difference was identified:      = 2,      = 0, K = 10, I = 15, J = 4,    
  = 0.5 and    
  = 2 
(with a difference of 0.23). 
Table 4.2 
The Bias of  ̂   ; for      = 2 and      = 0.2 Conditions for the Constant External Event Effect over 4 
Subsequent Measurement Occasions 
   Corrected  Unorrected 
   I = 15  I = 30  I = 15  I = 30 
K J    
     
  = 0.5    
  = 2     
  = 0.5    
  = 2     
  = 0.5    
  = 2     
  = 0.5    
  = 2 
10 4 0.5 -0.003 0.007  0.025 -0.036  0.213 0.208  -0.027 0.027 
    2 0.015 0.002  -0.017 0.014  0.129 0.196  0.012 0.035 
 7 0.5 -0.026 -0.057  0.024 0.005  -0.093 -0.058  -0.019 -0.074 
    2 -0.028 -0.015  -0.011 -0.003  -0.099 -0.060  -0.016 -0.026 
30 4 0.5 0.009 0.028  0.004 -0.005  0.219 0.185  -0.008 0.013 
    2 0.018 0.021  0.004 -0.011  0.210 0.222  0.008 0.035 
 7 0.5 0.023 0.005  0.002 -0.009  -0.075 -0.105  -0.004 -0.016 
    2 0.001 0.026  -0.006 -0.012  -0.077 -0.088  -0.003 0.006 
Note. Corrected and Uncorrected refer respectively to corrected effect size and uncorrected effect size for 
external event effects. 
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Similar to the bias, the Mean Squared Error (MSE) of the estimated treatment effect 
depends significantly on the model type; using an analysis of variance on the squared 
deviations, F(1, 102398) = 882.77, p < .0001 for  ̂    and F(1, 102398) = 7076.91, p < .0001 
for  ̂   . When using the corrected model, the MSE for respectively  ̂    and  ̂    equals: 
0.12 and 0.028, whereas it is 0.18 and 0.070, respectively, for the uncorrected effect sizes. 
Differences between both models are larger if the number of observations and the number of 
studies are small (see Table 4.3 for  ̂   , similar results are obtained for  ̂   ). So especially 
in these conditions the modified model is recommended. 
Table 4.3 
The MSE of  ̂   ; for      = 2 and      = 0.2 Conditions for the Constant External Event Effect over 4 
Subsequent Measurement Occasions 
Note. Corrected and Uncorrected refer respectively to corrected effect size and uncorrected effect size for 
external event effects. 
4.3.1.1.2 Estimates of the standard errors 
In order to evaluate inferences regarding the treatment effects, we constructed 
confidence intervals around the estimated treatment effects,  ̂    and  ̂   . Therefore we 
needed to estimate the standard errors of the estimated treatment effects. Because we 
obtained 400 estimates of the effects in each condition, the standard deviations of the effect 
estimates can be regarded as a relatively good estimate of the standard deviation of the 
sampling distribution, and can therefore be used as a criterion to evaluate the standard error. 
We looked at the relative standard error biases which are the differences between the median 
standard error estimates and the standard deviation of the estimates of the effect divided by 
the standard deviation of the estimates of  ̂    and  ̂   . The relative differences are negative 
for  ̂    which means that the median standard error estimates are smaller than expected. For 
 ̂   , these differences are positive, referring to median standard error estimates larger than 
expected. The relative standard error biases for both  ̂    and  ̂    are on average larger 
   Corrected  Unorrected 
   I = 15  I = 30  I = 15  I = 30 
K J    
     
  = 0.5    
  = 2     
  = 0.5    
  = 2     
  = 0.5    
  = 2     
  = 0.5    
  = 2 
10 4 0.5 0.17 0.28  0.11 0.26  0.32 0.43  0.14 0.25 
  2 0.20 0.32  0.14 0.28  0.31 0.49  0.16 0.36 
 7 0.5 0.09 0.24  0.07 0.23  0.18 0.31  0.09 0.22 
  2 0.11 0.26  0.09 0.24  0.20 0.31  0.09 0.28 
30 4 0.5 0.06 0.10  0.04 0.09  0.14 0.19  0.04 0.10 
  2 0.06 0.11  0.04 0.09  0.15 0.20  0.05 0.12 
 7 0.5 0.03 0.07  0.03 0.08  0.06 0.10  0.03 0.09 
  2 0.04 0.08  0.03 0.08  0.07 0.10  0.04 0.08 
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across the conditions for the uncorrected effect sizes in comparison with the corrected effect 
sizes. For  ̂   , the average relative standard error biases equal -1.8% and -2.0% for the 
corrected and uncorrected model respectively. The average relative standard error biases 
difference for  ̂    for the uncorrected model is 2% whereas it is substantial (more than 10%; 
Hoogland & Boomsma; 1998) for the uncorrected model; 25.7%. So the difference between 
the model type becomes more apparent when estimating     , F(1, 254) = 38.9, p < .0001. 
The conditions with the largest relative standard error bias when using the uncorrected model 
for  ̂    tended to coincidence with the conditions where 30 studies, an immediate treatment 
effect of 2 and a treatment effect on the time trend of 0.2 were involve with the bias mounting 
to 107% in the condition where     = 2,      = 0.2, K = 30, J = 7, I = 30,    
 = 0.5 and    
 = 
0.5.  
4.3.1.1.3 Coverage proportion  
We estimated the coverage proportion (CP) of the 95% confidence intervals which 
allows us to evaluate the interval estimates of  ̂    and  ̂   . The confidence intervals were 
estimated by using the standard errors and the Satterthwaite estimated degrees of freedom. 
The CP of these confidence intervals was estimated for each of the combinations. A positive 
significant difference between the corrected model and the uncorrected model in the CP is 
found for  ̂   , F(1, 254) = 27.56, p < .0001 (see Table 4.4). Also for  ̂   , the mean CP 
depends significantly on the model type, F(1, 254) = 20.96, p < .0001 (see Table 4.4). The 
conditions with a CP less than .93 all have 15 measurements in common and occur when the 
effect sizes are uncorrected, for both  ̂    and  ̂   . Moreover, for  ̂   , the CP is not only 
too small when I = 15 and K = 30, but also too large when I = 30 (values for the CP range 
from .99 to 1.00). When the effect sizes are uncorrected, the CP is well estimated when I = 30 
for  ̂    and I = 15 and K = 10 for  ̂   . The difference in CP for  ̂    is largest when there 
are only a small number of measurements (I   15) and a large number of studies (K   30). 
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Table 4.4 
The Coverage Proportion of  ̂    and  ̂   ; for      = 2,      = 0.2 and    
  = 2 Conditions for the Constant 
External Event Effect over 4 Subsequent Measurement Occasions 
   
   ̂    
  
 ̂    
   Corrected  Uncorrected  Corrected  Uncorrected 
K J    
  I = 15 I = 30  I = 15 I = 30  I = 15 I = 30  I = 15 I = 30 
10 4 0.5 .96 .96   .96 .96   .94 1.00   .97 1.00 
  2 .95 .95  .92 .95  .96 .98  .93 1.00 
 7 0.5 .96 .95  .94 .97  .99 1.00  .97 1.00 
  2 .97 .96  .95 .95  .96 .97  .84 .99 
30 4 0.5 .97 .96  .89 .97  .97 1.00  .90 1.00 
  2 .97 .96  .91 .94  .96 .98  .49 1.00 
 7 0.5 .94 .94  .92 .96  .98 1.00  .93 1.00 
  2 .96 .95  .96 .96  .96 .97  .26 .96 
Note. Values smaller than .93 and larger than .97 appear in bold. Corrected and Uncorrected refer respectively to 
corrected effect size and uncorrected effect size for external event effects. 
4.3.1.2 Variance components 
 In the three-level analyses, the between-study and between-case variances were 
estimated for both the immediate treatment effect and the treatment effect on the trend. 
Because variance estimates are expected to be positively skewed, due to truncation of 
negative estimates to zero, we calculated the median (relative) deviation of the estimates from 
the population value, rather than the mean (relative) deviation, to evaluate the (relative) bias 
in the estimates. We only discuss the between-case variance and the between-study variance 
of the immediate treatment effect (   
  and    
 ), because similar results are obtained for the 
treatment effect on the time trend (   
  and    
  ). The bias of the estimated between-study 
variance and the estimated between-case variance of the immediate effect is larger when 
there are only 10 studies and 15 measurement occasions involved. The conditions with the 
largest relative bias all had 15 measurements, 4 participants and a small between-study 
variance (   
  = 0.5) in common. If the effect sizes are corrected and we estimate the between-
study variance of the immediate treatment effect, we find relative parameter bias values 
across conditions ranging from 17% to 55%, while the relative bias goes up to a value of 
313% when the effect sizes are uncorrected. Similar results are found for  ̂  
 , where the 
relative bias in a condition is maximum 119% for the corrected effect sizes and 326% for the 
uncorrected effect sizes (see Table 4.5). Overall, the adjusted model results in less biased 
variance estimates. 
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4.3.2 External event fades away gradually over four subsequent measurement occasions 
4.3.2.1 Average treatment effect. 
4.3.2.1.1 Bias and mean squared error 
The bias of  ̂    for uncorrected and corrected effect sizes is respectively -.0073, t(51199) = -
418, p < .001 and 0.00057, t(51199) = 38, p = .74. This means that there is a significant 
negative bias for the uncorrected effect sizes, whereas this is not the case for the corrected 
effect sizes and the models differ significantly, F(1, 102398) = 0.009, p = .77. The bias for 
 ̂    depends largely on the model type, F(1, 102398) = 30476.1, p < .0001. The bias for the 
uncorrected effect sizes is significant: -0.19, t(51199) = -246.23, p < .0001, whereas this is not 
the case for the corrected: 0.000179, t(51199) = 0.24, p = .81. For both  ̂    and  ̂   , the 
difference is largest when there are a small number of measurements (I   15) involved.  
For both estimated treatment effects, the MSE’s are larger for the uncorrected effect 
sizes in comparison to the corrected effect sizes (see Table 4.6). For both  ̂    and  ̂   , the 
model type has a significant influence on the MSE, F(1, 102398) = 724.69, p = < .0001 for 
 ̂    and for  ̂   , F(1, 102398) = 5431.15, p < .0001. For both estimated treatment effects, 
the MSE is large when the studies are heterogeneous (   
  = 2) and a small number of 
measurement occasions (I   15) and studies (K   10) are used. The difference between the 
models is largest when a small number of measurements are used. 
Table 4.6 
The MSE of  ̂   , and  ̂   ; for      = 2,      = 0.2 and    
 = 0.5 Conditions for the External Event Effect 
Fading away Gradually over 4 Subsequent Measurement Occasions 
    ̂      ̂    
   Corrected  Uncorrected  Corrected  Uncorrected 
K J    
  I = 15 I = 30  I = 15 I = 30  I = 15 I = 30  I = 15 I = 30 
10 4 0.5 0.14 0.11   0.34 0.12   0.09 0.01   0.12 0.01 
  2 0.31 0.24  0.47 0.27  0.13 0.03  0.14 0.03 
 7 0.5 0.09 0.06  0.18 0.09  0.01 0.01  0.10 0.01 
  2 0.22 0.23  0.32 0.22  0.03 0.02  0.12 0.02 
30 4 0.5 0.05 0.03  0.11 0.04  0.04 0.004  0.11 0.01 
  2 0.11 0.09  0.17 0.09  0.04 0.01  0.12 0.01 
 7 0.5 0.03 0.02  0.06 0.02  0.004 0.002  0.09 0.01 
  2 0.08 0.08   0.10 0.07   0.01 0.01   0.1 0.01 
Note. Corrected and Uncorrected refer respectively to corrected effect size and uncorrected effect size for 
external event effects. 
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4.3.2.1.2 Estimates of the standard errors 
The difference between the average relative bias in the standard errors of the 
uncorrected effect sizes equals 0.02 for both uncorrected and corrected effect sizes when 
estimating     . 
Similar to the constant external event effect results, the difference between the average 
relative bias in the standard errors of the uncorrected effect sizes (M = 39.3) and corrected 
effect sizes (M = 0.06) for  ̂    is larger and statistically significant, F(1, 254) = 129.66, p = 
.0001, see Table 4.7. The difference in results due to the model type is more obvious if there 
are a small number of studies involved (K   10).  
Table 4.7 
Difference Between the Median of the Standard Error Estimates and the Standard Deviation of  ̂   ; for      = 
2 ,      = 0.2 and    
 = 0.05 for the External Event Effect Fading away Gradually over 4 Subsequent 
Measurement Occasions 
    Corrected  Uncorrected 
K J    
   I = 15 I = 30  I = 15 I = 30 
10 4 0.05   0.01  0.037  0.076 0.103 
  0.2  -0.031 -0.002  0.029 0.05 
 7 0.05   0.004  0.035  0.069 0.068 
  0.2  -0.001 -0.007  0.01 0.012 
30 4 0.05  -0.018  0.022  0.039 0.061 
  0.2  -0.009  0.0003  0.022 0.024 
 7 0.05   0.002  0.021  0.038 0.04 
  0.2  -0.002  0.001  0.004 0.003 
Note. Corrected and Uncorrected refer respectively to corrected effect size and uncorrected effect size for 
external event effects. 
4.3.2.1.3 Coverage proportion 
Similar to the CP for the constant external event effect, the mean CP for the uncorrected 
and corrected effect sizes for the estimate of the immediate treatment effect differ 
significantly at the 5% significance level for both  ̂   , F(1, 254) = 3.92, p = .05 and  ̂   , 
F(1, 254) = 3.25, p = .007. The CP with values smaller than .93 all have 15 measurement 
occasions, a large between-study variance (   
 = 2.0) and occur when the effect sizes are 
uncorrected (for both  ̂    and  ̂   ). Similar to the constant external event effect, the CP is 
overestimated for  ̂    and when the effect sizes are uncorrected in the condition where 30 
measurement occasions are included. In the condition where I = 15 and    
 = 2.0, the 
difference between corrected and uncorrected effect sizes is largest.  
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4.3.2.2 Variance components.  
The results are similar to the results of the constant external event effect, and results are 
less biased using the adjusted model. We only discuss the estimated variances for the 
immediate treatment effect, because the results are similar for the estimated treatment effect 
on the trend. When we estimate the between-study variance and the effect sizes are 
uncorrected, the bias ranges from -0.002 to 3.41, while it ranges from 0.002 to 0.73 for the 
corrected effect sizes. So the estimated variances depend on the model type [F(1, 102398) = 
1631, p < .0001]. Similar results are obtained for the estimate of the between-case variance. 
The maximum bias for the corrected effect sizes is 1.60 while it is 3.21 for the uncorrected 
effect sizes and these estimates depend on the model type, F(1, 102398) = 5628.62, p < .0001. 
4.4 Empirical Illustration 
In this section we give empirical illustrations of the comparison of the modified three-
level model in which external events are taken into account with the uncorrected model. 
Therefore, we used a part of the meta-analytic dataset of Heyvaert et al. (2012) in which 
restraint interventions for challenging behavior among persons with intellectual disabilities 
was investigated. We give two empirical illustrations of the consequences of ignoring the 
external event effect in a multiple-baseline across participants design. We illustrate first the 
consequences of ignoring external events in a single study, and next the consequences of 
ignoring external events in a three-level meta-analysis.  
4.4.1 Ignoring external events in a single study 
To illustrate the regression analysis of a multiple-baseline across 3 participants design, 
we use the study of Thompson et al. (1999) which was included in the meta-analysis of 
Heyvaert et al. (2012). In their study the effects of benign punishment on the self-injurious 
behavior of individuals who have been diagnosed with mental retardation was investigated. 
The three participants were measured repeatedly over time during 22 measurement occasions 
and the intervention started on session 11, 13 and 20 respectively (see Figure 4.2). From this 
figure we might expect that there is an immediate reduction in challenging behavior when the 
treatment is introduced and that the effect of the treatment on the challenging behavior 
decreases over time (so there is a positive effect on the time trend during the treatment). We 
also see that the three participants’ scores on measurement occasion 4 and 10 are possibly 
influenced by an external event. 
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Figure 4.2. Graphical display of a MBD across three participants designs using data from the study of 
Thompson, Iwata, Conners, and Roscoe (1999). 
If we ignore possible external events in the regression analysis before combining the 
effect sizes in the two-level meta-analyses, the average immediate treatment effect over cases 
for that study equals -25.58 and the average treatment effect on the time trend over cases from 
that study equals: -2.58. If we take the external event into account by correcting the effect 
sizes before combining them, the immediate treatment effect equals -23.23 and the treatment 
effect on the time trend is 1.24. This means that  ̂    is 9.19% smaller when the effect sizes 
are corrected in comparison with the uncorrected effect sizes. Moreover  ̂    is positive for 
the corrected effect sizes whereas it is negative for the uncorrected which means that the 
effect of the treatment over time decreases for the corrected effect sizes, whereas it increases 
for the uncorrected.  
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4.4.2  Ignoring external events in a three-level meta-analysis 
The three-level analysis of SSED data includes summarizing the immediate treatment 
effect and the treatment effect on the time trend over participants and over studies. 
We estimate the immediate treatment effect and the treatment effect on the time trend 
across seven studies. Again, we use the meta-analysis of Heyvaert et al. (2012) to randomly 
select multiple-baseline across participants studies. We combined the multiple-baseline across 
participants study of Lindberg et al. (1999); Chung and Cannella-Malone (2010); Zhou et al. 
(2000); Thompson et al. (1999); Hanley et al. (2000); Rolider et al. (1991); and Roscoe at al. 
(1998). In all these studies the same dependent variable was measured, namely the reduction 
in self-injurious behavior. Again, we compare the three-level meta-analysis of uncorrected 
and corrected effect sizes.  
Results  
With the uncorrected effect sizes in the three-level meta-analysis, the average 
immediate treatment effect equals: -33.14, t(6.39) = -3.44, p = .012 and the average treatment 
effect on the time trend equals: -4.42, t(3.95) = -1.52, p = .19. When correcting the effect sizes 
before estimating the effects over participants, the immediate treatment effect equals: -21.07, 
t(6.88) = -1.13, p = .30, and the treatment effect on the time trend equals: -0.43, t(1) = -0.28, p 
= .83. This means that the immediate treatment effect of the corrected effect sizes is 36.42 % 
smaller compared with the uncorrected effect size and the treatment effect on the time trend 
for the corrected effect size during the treatment is 90.27% smaller. 
This is consistent with the results of the simulation study where we found that the 
estimated treatment effects are biased when the effect sizes are uncorrected before combining 
them in the three-level meta-analysis. 
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4.5 Discussion 
4.5.1 General conclusion 
External event effects are common in SSEDs because single-case researchers often 
implement these kinds of designs in everyday scenarios where they cannot control for outside 
factors (Christ, 2007; Kratochwill et al., 2010; Shadish et al., 2002;). External events are not 
always anticipated by researchers and thus they may not be measured during the conduct of 
the study. Furthermore, the size of an event effect may be small and researchers may be 
unaware of it even after the study has been completed. Whether researchers recognize an 
external event or not, the failure to account for the event in a meta-analysis can bias the 
estimate of the treatment effect. Thus, we searched for a method to model external events that 
could be applied even when the events had not been previously identified. Because we used a 
multiple-baseline across participants design, there was a need to take into account the 
interdependence of the participants. Therefore, an external event that influenced the scores of 
one participant was assumed to influence the scores of the other participants in the same 
study.  
We discussed two possible scenarios. In one scenario, the external event effect remains 
constant and influences the scores of all participants within a study on four subsequent 
moments. This occurs for example when a teacher is ill and a substitute teacher takes over the 
classroom or when a foreign observer is present on subsequent measurement occasions. In the 
second scenario the external event’s effect would likely gradually fade away over four 
subsequent moments. For instance, the influence of a teacher intern on the behavior of 
students reduces over time. Moreover, the model adjusted for external event effects takes into 
account that measurement occasions closer in time are more related than measurement 
occasions further in time. 
We evaluated this approach using a large simulation study and gave some empirical 
examples. If there is an external event effect of zero, both models (the one that corrects for 
moment effects and the one that does not) are appropriate. If the external event influences 
subsequent scores for all the participants within a study, the three-level approach for 
uncorrected effect sizes is not recommended because the estimates of both treatment effects 
(i.e., immediate effect on level and effect on time trend) are substantially biased. The MSE, 
standard error, and CP are better estimated when using the modified model, which includes 
moment effects. The difference between the corrected and uncorrected effect sizes is largest 
when there are a small number of studies and measurement occasions, so in this context we 
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advise using the adjusted model. Moreover the adjusted model results in less biased variance 
estimates.  
4.5.2 Limitations and suggestions for future research 
But of course we should be aware of some limitations. We assumed that all the 
participants within a study are influenced the same way by the external event effect. It is 
possible that different participants from the same study are at separate locations and therefore 
are not all influenced by the external event. Modeling event effects that are not common to all 
participants in a study is an important avenue for future research.  
We chose to keep the number of measurements within a study constant for all 
participants within the same study. Of course it is possible that different participants of the 
same study have different series lengths.  
Furthermore, we cannot generalize these results to other conditions not involved in this 
simulation study, but we partially addressed this by simulating a large number of conditions 
and choosing realistic values for the parameters.  
Another limitation is that we assumed linear trajectories in the treatment phase, which 
might not be true in some real situations. To simplify the simulation model, we further did not 
account for a possible dependence between regression coefficients, which can be accounted 
for in a multilevel analysis by estimating the covariance at the various levels. 
In addition, subjects in multiple-baseline designs are repeatedly measured, and 
succeeding measurements may be more related to each other than measurements further away 
in time. We did not account for this possible autocorrelation and suggest this as a useful 
extension to the current study.  
Kazdin (2010) argued that there needs to be a minimum of three measurement occasions 
between the participants in a multiple-baseline design in order to show an experimental effect. 
We did not take this into account in the condition where the number of measurement 
occasions was 15 because it was not possible to do this and provide each of seven participants 
a unique baseline. We could alter the intervention schedule to introduce the treatment for 
some participants (e.g., randomly selected pairs) at the same moment. Examining this strategy 
specifically, and alternative intervention schedules more generally, would allow further 
research to extend results to a wider range of multiple-baseline applications.  
It can be difficult to attribute simultaneously unusual outcome scores for all 
participants within a study to an external event effect. If there is no external event effect, we 
can still use the corrected model because both the corrected and uncorrected effect sizes will 
be unbiased and thus there is no need to identify before the analyses whether an external event 
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effect occurred or not. We advise single-case researchers to first use both models in the 
sensitivity analysis and then decide which model to use. If researchers are interested in the 
occurrence of external event effects, we recommend that they keep a log in order to identify 
potential outside factors that may influence the scores at certain measurement occasions and 
include dummy indicator variables at least for these moments.  
 The extension of the three-level model for multiple-baseline across participants designs 
to include modeling of potential external effects makes it even more appropriate and useful 
for the analysis of realistic SSED datasets. This study has indicated that the three-level model 
corrected for external event effects provides better results than the uncorrected model for 
combining results from multiple-baseline across participants data especially if there are only a 
small number of observations (I    ) and a small number of studies (K   10) in the 
synthesis. As was found here, even when an external event effect is small, a failure to correct 
for it can lead to biased effect sizes. Thus, applied SSED researchers are encouraged to 
consider use of the three-level model that corrects for external event effects when 









The Misspecification of the Covariance 





The impact of misspecifying covariance matrices at the second and the third levels of the 
three-level model on inferences regarding average treatment effects and (co)variances between 
treatment effects is evaluated by means of a simulation study and an empirical illustration. The 
results indicate that ignoring an existing covariance has no effect on the treatment effects 
estimates, but results in underestimation of the variances of the treatment effects and of the 
standard errors of the treatment effect estimates. If the population covariances are zero, analyses 
including or not including covariance parameters yield similar results. Single-case researchers 
are encouraged to use the three-level model including covariances between the treatment effects 
at the second and third level when synthesizing multiple-baseline design data. 
Keywords: Multilevel modeling, multiple-baseline designs, covariance misspecification, 
Monte Carlo Simulation Study 
  
                                                 
4 This chapter has been submitted as a manuscript to the Journal of Experimental Education and 
the revised version is under review: Moeyaert, M., Ugille, M., Ferron, J., Beretvas, S.N.,& Van 
den Noortgate, W. (2014a). The misspecification of the covariance structures in multilevel 
models for single-case data: A Monte Carlo simulation study. Journal of Experimental 
Education. 
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5.1 Introduction 
Single-case experimental designs make important contributions to the field of educational 
research (National Research council, 2002; Odom et al., 2005). For instance, this kind of design 
can be applied to evaluate specific interventions to reduce challenging behavior in persons with 
intellectual disabilities or to search for strategies for persons with learning disabilities. Although 
single-case designs (SCDs) are increasingly popular (Kazdin, 2011), the quantitative analysis of 
study results obtained with this kind of design is still developing (Kratochwill et al., 2010). The 
results of a SCD study investigating the effect of an intervention are especially informative for 
the specific case under investigation, but it is hard to generalize conclusions to other cases. To 
investigate generalizability of the SCD results across cases, one can collect information for 
several cases, as is done in the multiple-baseline design (MBD) across cases. In this type of 
design, an AB phase design is implemented simultaneously to different cases, while the start 
point of the treatment is staggered (as in Figure 5.1) across cases (Ferron & Scott, 2005; 
Onghena, 2005; Onghena & Edgington, 2005).  
 
Figure 5.1. Graphical display of the multiple-baseline across participants design using hypothetical data. The start of 
the intervention is staggered across the three cases. 
The MBD is growing in popularity because external events, which are random unexpected 
events influencing the outcome scores, can be disentangled from treatment effects. These 
external events might affect the outcome scores of several cases at the same time, while 
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treatment effects are expected to occur immediately after the treatment starting point which is 
case-specific (Barlow & Hersen, 1984; Kinugasa et al., 2004; Koehler & Levin, 2000). 
5.2 Multilevel Analysis of Multiple-Baseline Across Cases Design 
To combine multiple cases’ data, multilevel models can be used. Multilevel models are 
extensions of linear models and make it possible to synthesize treatment effects across cases and 
studies. When combining SCD data from several MBD studies, a three-level hierarchical 
structure can be modeled: measurement occasions (i.e., first level units) are nested within cases 
(i.e., second level units), which in turn are nested within studies (i.e., third level units). For 
example, consider K studies (k = 0, 1,…, K), with Jk cases in study k (j = 0, 1,…Jk), and Ijk 
measurements for case j from study k (i = 0, 1,…Ijk). At level one, the continuous response 
variable can be modeled, for instance, using an extension of the piecewise regression equation of 
Center et al. (1985-1986): 
                                                         (    
 ), (5.1) 
and the errors, the eijk’s, are assumed to be independently, identically, and normally distributed. 
The score on the continuous dependent variable on measurement occasion i for case j from study 
k (Yijk ) depends on a time-related predictor (    ), a binary coded treatment indicator (    ), and 
an interaction term between the time predictor and the dummy variable. The predictor      refers 
to the measurement occasion of the dependent variable and can be expressed for instance in days 
or session numbers. For case j from study k, there are      observations in phase A,      
observations in phase B, so that      +         . The second predictor,     , indicates whether 
the measurement occasion i from case j within study k belongs to the baseline phase (     = 0) or 
the treatment phase (     = 1). The last term is an interaction term between      and     . In this 
interaction term,      is centered around its value at the start of the treatment phase, such that the 
coefficient of the treatment dummy can be interpreted as the immediate effect of the treatment. 
The centered time variable in the interaction term is indicated by       and equals       (    + 
1). This means that       takes on negative values during the baseline phase and counts down 
from the first measurement occasion of the treatment phase to the first observation of the 
baseline phase. The general coding form for case 1 from study 1 is given in Table 5.1. 
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Table 5.1 
Demonstration of General Coding for Case 1 within Study 1 
                [=       (    +1 )]      
1 0 1 - (    +1 )      
2 0 2 - (    +1 )      
. . . . 
. . . . 
. . . . 
     0 -1       
     + 1 1 0  (      )   
    + 2 1 1  (      )   
     + 3 1 2  (      )   
. . . . 
. . . . 
. . . . 
    +      = I11 1    – 1          
Equation 5.1, regressing      on     ,      and           contains four coefficients:      is 
the intercept and indicates the expected baseline level at the start of the baseline phase (i.e., when 
all other predictors equal zero),      is the linear trend during the baseline phase,      refers to 
the immediate treatment effect (i.e., the difference between the estimated outcome score at time 
zero under the treatment phase and the estimated outcome score at the same point in time under 
the baseline phase) and      is the effect of the treatment on the time trend for participant j in 
study k. Single-case researchers are mainly interested in      and      because they provide 
information about the change associated with the introduction of the treatment. 
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These equations model that the   coefficients from Equation 5.1 randomly vary across cases, 
around study-specific means, the   coefficients. The coefficients along the diagonal of the 
covariance matrix,    
 ,    
 ,    
 , and    
 , indicate the between-case variance in the intercept, the 
time trend during the baseline, the immediate treatment effect and the treatment effect on the 
slope, respectively. The off-diagonal coefficients represent covariances. For instance       
indicates the covariance between the intercept and the time trend during the baseline phase.  
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At the third level, potential variability in the study-specific regression coefficients from 
the second level equations, the   coefficients, is modeled. In the fullest model, the   coefficients 
each equal an average estimate across studies, indicated by the   coefficients, and a random 
deviation from this average: 
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Multilevel modeling entails the advantage that average treatment effects can be estimated, 
as well as variation between studies and cases in the treatment effect, or study- and case-specific 
treatment effects. Another major advantage of this multilevel approach is its flexibility. For 
instance, the model can be extended by including (additional) predictors at each level. Moreover, 
a specific structure for the variances and covariances at either level can be specified. 
Previous research indicates that multilevel modeling works appropriately to combine 
unstandardized (Moeyaert et al., 2013a) and standardized (Moeyaert et al., 2013b) SCD data 
across cases and studies. Estimation of the three-level model for SCD data was investigated, by 
evaluating the estimates of the average immediate treatment effect,     , of the average 
treatment effect on the slope,     , and of the between-case and between-study variance of both 
kinds of effect. However, in these studies, the between-case residuals (    ,     ,     ,     ) 
were each assumed to be independently, identically, and normally distributed with mean zero 
and homogeneous variance, and thus a diagonal covariance structure was assumed at level-2. 
However, this might be an over-simplification of the between-case covariance structure. A non-
zero covariance between residuals at level 2 seems reasonable, for instance, when due to a 
ceiling effect the treatment effect is expected to be smaller for cases with an already high 
baseline level. In addition, these simulation studies made the same assumptions about the 
between-study residuals (    ,     ,     ,     ) but again an unstructured covariance matrix, 
which allows the level-3 residuals to covary, may be more reasonable than a diagonal covariance 
structure. To date, no research has focused on the consequences of ignoring truly non-zero 
covariances in the context of multilevel modeling of SCD data. In most multilevel modeling 
software, the default option is to estimate an unconstrained covariance matrix for the random 
effects. However, given that there are four coefficients included in the level-1 regression 
equation, a total of 21 random effects covariance parameters can be estimated, which 
complicates estimation especially in scenarios with small sample sizes and possible covariance 
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values that are close to zero. Therefore there is a need to investigate if estimation of the 
multilevel model is robust to covariance matrix misspecification. If estimation is reasonably 
robust, then modeling of a simplified covariance matrix can be recommended for future studies 
using the three-level model in the context of SCD data.  
While only a little research has examined these issues in the context of the multilevel 
model for SCD data, there is some methodological research that has focused on specification of 
the residuals’ covariance matrix contexts other than SCDs. For example, Singer and Willett 
(2003) argue that ignoring a covariance in a multilevel model in general may bias the estimation 
of the standard errors of the average regression coefficients. This will in turn lead to distorted 
Type I error rates when testing the statistical significance regression coefficients and will affect 
estimation of the confidence intervals for the effects of interest. Kwok et al. (2007) investigated 
by means of a simulation study the misspecification of the within-case covariance structure in 
multiwave longitudinal multilevel models and found that the misspecification has a substantial 
impact on the variance estimates. Work by Berkhof and Kampen (2004) examines the effect of 
omitting a random coefficient in the multilevel models in general on the estimated variance 
components and the estimated variance of the treatment effects. They found that the 
consequences depend on the between-unit variance proportions. Another study, by Van den 
Noortgate and Onghena (2005), investigated the effects of ignoring a level from a four level 
model (in the area of school effectiveness research) on the parameter estimates and standard 
errors. They found that the variance estimate of the ignored level is divided between the other 
levels and estimates of the standard errors of the fixed effects and the random components may 
change. 
Specifically for SCD data, the effects of level-1 residuals’ covariance misspecification have 
been studied before for a two-level model (Ferron et al., 2009). In SCDs, it is reasonable that an 
external variable that influences an observation at a certain moment, also affects succeeding 
observations. This means that errors from succeeding occasions can be more alike than errors of 
occasions further in time (Kromrey & Foster-Johnson, 1996). Ferron et al. (2009) found that not 
modeling autocorrelation in a two-level analysis of SCD data results in too small coverage 
proportions of the 95% confidence intervals and positively biased variance estimates. This same 
pattern of results also apply when level-1 residuals’ autocorrelation is not modeled for the three-
level model (Petit-Bois, Baek, & Ferron, 2012). Level-2 and level-3 covariance misspecification 
issues in the SCD three-level modeling framework have not yet been investigated. The main 
focus of this paper is to examine the consequences of level-2 and level-3 covariance matrix 
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misspecification which should provide a more complete understanding of misspecification issues 
in contexts of three-level modeling of SCD data. 
5.3 Simulation Study 
We conducted a simulation study to evaluate estimation of the three-level model when 
freely estimating covariances between pairs of residuals at levels two and three in the model. It 
might be possible to mathematically derive large-sample approximations of the estimated 
standard errors of the treatment effects. However, in the context of multilevel modeling of SCD 
data, researchers deal with very small sample sizes which violate asymptotic assumption upon 
which the algebraic derivations would be based. Thus, we exclusively rely on simulation studies 
to empirically examine estimation of model parameters and standard errors under the realistic 
sample size values that are typically encountered in applied SCD research in the educational and 
social sciences. 
We simulated raw data using the three-level model in Equations 5.1 through 5.3. To 
estimate the three-level model parameters, the restricted maximum likelihood procedure in SAS 
9.3 PROC MIXED was used (Littell et al., 2006). The Satterthwaite method was used to estimate 
the degrees of freedom because this method is relatively fast and accurate (Ferron et al., 2009). 
Convergence was obtained in all conditions and replications. 
The criteria used to evaluate the results of the three-level analysis included the bias, the 
mean squared error (MSE), the standard error (SE), and the coverage proportion (CP) of the 95% 
confidence intervals of the effect parameter estimates. In addition, we looked at the bias of the 
variance and covariance parameter estimates for both treatment effects. 
For this Monte Carlo study, we varied seven design conditions, namely the immediate 
treatment effect, the treatment effect on the time trend, the number of units at the three levels 
(i.e., the number of measurements at the first level, the number of cases at the second level and 
the number of studies at the third level), the between-cases, and the between-studies variability. 
In order to identify values for the seven design conditions that are authentic for data encountered 
in the area of educational research, we re-analyzed published meta-analyses of SCD studies 
(Denis et al., 2011; Heyvaert et al., 2012; Kokina & Kern, 2010; Shogren et al., 2004; Wang et 
al., 2011). Based on the review, the immediate treatment effect on the outcome score,     , was 
given a value of 0 or 2, whereas the treatment effect on the time trend was manipulated to have 
values of 0 or 0.2. The number of units at the third level (i.e., the number of studies), K, was also 
manipulated because previous simulation studies (Moeyaert et al., 2013a, 2013b; Owens & 
Ferron, 2012;) indicate that the level-3 units have a significant effect on the results. We 
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simulated conditions with 10 and 30 studies. While very typical SCD studies tend to have 3, 4 or 
7 participants per study, we chose to only investigate 4 and 7 participants per study, because 
previous simulation studies had found similar results for 3 and 4 cases. Based on our review, we 
chose to only include one value for the number of measurements within a case, namely 15. The 
reason for this was twofold. First of all, 15 observation within a case is common (e.g., Shadish & 
Sullivan, 2011, found that more than 20% of the published SCD studies in 2008 having less than 
15 data points) in SCDs and secondly, we want to evaluate the covariance misspecification 
especially in conditions that are potentially problematic (i.e., a small number of measurement 
occasions). Based on previous simulation studies (Moeyaert et al., 2013a, 2013b), two other 
factors potentially influence the estimated treatment effects and variances of these estimated 
effects, namely the between-study and the between-case variances. Also manipulation of the true 
value of the covariance between the treatment effects is an important condition. Therefore the 
covariance matrices,     and     were manipulated to have conditions in which there is zero 
covariance, a moderate covariance, and a large covariance. The covariances were simulated with 
positive and negative values. The chosen values for the variances are based on those used in the 
study of Moeyaert et al. (2013a, 2013b). 
Level-2 and level-3 errors were generated from a normal distribution using the RANNOR 
random number generator in SAS. If the between-study variance of the immediate treatment 
equaled 8 and the between-study variance of the treatment effect on the time trend equaled 0.08, 
there were five possibilities for the covariance matrix at the third level: 
    [
    
       
    
       
] or [
    
       
       
          
] or [
    
       
        
           
] or [
    
       
       
          
] 
or [
    
       
        
           
], representing no covariance, moderate positive and negative 
covariance and large positive and negative covariance between the immediate treatment effect 
and treatment effect on the time trend regression coefficients. If the between-study variance of 
the immediate treatment equaled 2 and the between-study variance of the treatment effect on the 
time trend equaled 0.2, there were five possibilities for the covariance matrix at the third level: 
    [
    
      
    
      
] or [
    
      
       
         
] or [
    
      
        
          
] or [
    
      
       
         
] or 
[
    
      
        
          
], representing no covariance, moderate positive or negative covariance and 
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large positive or negative covariance between the immediate treatment effect and treatment 
effect on the time trend regression coefficients. The same values were chosen for the between-
case covariance matrix. The within-case variance was generated with a variance of one and 
assumed to be homogeneous across phases. 
For simplicity, we matched the covariance generating values’ pattern used at level 2 with 
that used at level 3. For example, for conditions where a moderate covariance was used to 
generate level-2 residuals, the level-3 residuals were also generated using a moderate value. The 
same held for zero covariance conditions and for large covariance conditions. In addition, we 
matched the direction of the covariance between residuals for level-2 and level-3 covariances.  
As is common in MBD, we staggered the introduction of the intervention across cases 
within studies. The staggering is a function of the total number of cases (see Table 5.2). 
Table 5.2 
Staggering of the Intervention’s Start Point as a Function of the Number of Cases (J) 
J J Start of treatment 
4 1 3 
 2 6 
 3 9 
 4 12 
7 1 3 
 2 6 
 3 6 
 4 9 
 5 9 
 6 12 
 7 12 
We examined a total of 2
6
 = 64 conditions and for each condition we simulated 500 
datasets. Because the simulation was computationally very intensive, we choose to simulate 500 
replications and included a large number of conditions instead of simulating a larger number of 
replications and including a small number of conditions. There were 32,000 datasets to analyze. 
After each dataset was generated, the simulated dataset was analyzed using a three-level 
multilevel model with maximum likelihood estimation via the MIXED procedure in SAS. Each 
dataset was analyzed twice, once, assuming a model that freely estimated covariance 
components, and another time assuming a model that constrained covariances to zero. In the 
model that included the covariances, the variances of the four random effects at both of the 
higher levels were estimated together with the covariances between the treatment effects. In 
addition, the within-case variability was estimated. This means that there were a total of 11 
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random effects variance component parameters that were estimated. When the covariance 
components were not included, nine variance component parameters were estimated. 
This results in four different scenarios: A1, A2, B1, and B2, see Table 5.3. The letter (i.e., 
A and B) indicates the model used to generate the data. In situation A, a zero covariance was 
generated whereas in situations B non-zero covariance parameters were used to generate the 
data. The number (i.e., 1 and 2) refers to the analysis model. The models accompanied with 
number 1 indicate that the data were analyzed assuming zero covariance whereas number 2 
refers to an analysis model in which covariance parameters were estimated. We expect that 
situations A1, A2 and B2 will give us approximately correct estimates of the average treatment 
effects and the (co)variances in treatment effects, but are especially interested in problems due to 
model misspecification (situation B1). 
Table 5.3 






We are especially interested in potential differences in results between scenarios A1 and 
A2 and between scenarios B1 and B2. We only discuss the results for  ̂    because similar 
results were obtained for  ̂   . Moreover, we only report the results for conditions in which a 
large positive covariance was generated in scenarios B1 and B2, because the effects of ignoring a 
moderate covariance are similar. Also similar results are found independent of the sign of the 
covariance between the treatment effects. 
5.4.1 Average immediate treatment effect 
5.4.1.1 Bias and mean squared error 
We first look at the bias, which is generally defined as the mean difference between the 
estimated values and the population value. Figure 5.2 presents the deviations of the estimated 
immediate treatment effect from the population value. We can conclude that the mean deviation 
  Model Used to Generate Data 
  Without covariance With covariance 
Model to analyze 
the data 
Without covariance Scenario A1 Scenario B1 
 With Covariance Scenario A2 Scenario B2 
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is small, but that the variance of the deviations is larger when there is covariance in the generated 
data (i.e. scenario B1 and B2). The mean bias over all conditions is small and independent of the 
scenario. It equals –0.0070, –0.0022, –0.0015 and 0.0012 for scenario A1, B1, A2 and B2 
respectively. The number of studies (K), the number of cases (J), the true values of the between- 
and within study variances (   
  and    
 ) have no significant influence on the estimated bias. 
 
Figure 5.2. Distribution of the deviations of the estimated immediate treatment effect from its population value 
(    ). The length of the box represents the interquartile range. The symbol and the horizontal line in the box 
interior indicate the scenario mean and median, respectively. The whiskers issuing from the box extend to the 
scenario minimum and maximum values. 
Table 5.4 gives an overview of the estimated MSE by condition and scenario. Based on 
Figure 5.2, we expect no difference in MSE between the two scenarios in which zero covariance 
is generated and the two scenarios in which non-zero covariance is generated which is supported 
by the ANOVA results (between scenarios A1 and A2, F(1,126) = 0.00, p = 1.00 and between 
scenario B1 and B2, F(1,126) = 0.02, p = .88. This means that if the MSE of estimates of the 
immediate treatment effect is taken as a criterion, it does not matter whether the analysis model 
includes covariance parameters. As expected from Figure 5.2, the MSE is larger in scenarios B1 
and B2 compared to scenarios A1 and A2, F(1,126) = 2.89, p = 0.09. Across all conditions, the 
ANOVA also indicates that for all scenarios, a large number of studies and cases and a small 
within- and between-study variances result in a smaller MSE. 
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Table 5.4 
The MSE of  ̂   ; for      = 2,      Conditions for the Four Scenarios 
  
   J = 4  J = 7  
Scenario K    
     
  = 2    
  = 8     
  = 2    
  = 8  
A1 10 2 0.16 0.20  0.11 0.15  
  8 0.38 0.41  0.34 0.38  
 30 2 0.05 0.07  0.04 0.05  
  8 0.11 0.17  0.12 0.14  
         
A2 10 2 0.15 0.22  0.11 0.15  
  8 0.35 0.44  0.39 0.45  
 30 2 0.05 0.06  0.04 0.05  
  8 0.14 0.18  0.12 0.14  
         
B1 10 2 0.15 0.26  0.15 0.19  
  8 0.58 0.62  0.45 0.54  
 30 2 0.06 0.08  0.04 0.07  
  8 0.16 0.22  0.17 0.15  
         
B2 10 2 0.17 0.30  0.13 0.16  
  8 0.50 0.74  0.41 0.51  
 30 2 0.08 0.08  0.04 0.07  
  8 0.19 0.22  0.13 0.15  
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5.4.1.2 Estimates of standard error and coverage proportion of the 95% confidence interval 
The standard errors of the treatment effect estimates are used to construct confidence 
intervals around the estimated treatment effects,  ̂    and  ̂   . The standard deviations of the 
effect estimates in a given condition can be used as an empirical approximation of the true 
standard error and therefore as a criterion to evaluate the standard error estimates. We look at the 
relative standard error bias, which is the difference between the median standard error estimate 
and the standard deviation of the estimate of the effect divided by the standard deviation of the 
estimate of  ̂    (Hoogland & Boomsma, 1998). 
The values for the relative standard error biases are negative (see Table 5.5), which means that 
the standard error estimates are smaller than expected. There is no significant difference in the 
relative standard error bias between scenarios A1 and A2, F(1, 126) = 0.02, p = .89 and between 
scenarios B1 and B2, F(1, 126) = 3.46, p = .07, but the median relative standard error biases in 
scenarios B1 (= -0.17) and B2 (= -0.14) are considered substantial (more than 10%, Hoogland & 
Boomsma, 1998) in comparison with scenarios A1 (-0.024) and A2 (-0.023): F(1,126) = 362.21, 
p < .0001. The ANOVA also indicated that K has a substantial effect on the standard error in 
scenarios A1 and A2, whereas K, J,    
  and    
  have an effect on the standard error in scenarios 
B1 and B2. 
The difference in CP of the 95% confidence intervals between scenarios A1 and A2 is not 
significant, F(1, 126) = 0.03, p = .86, whereas the difference between scenarios B1 and B2 is 
significant, F(1, 126) = 10.51, p = .002. In scenarios A1 and A2, the mean CP equals .95 as 
expected. The mean CP in scenarios B1 and B2 equal .91 and .92, respectively. The conditions 
with too-small CPs correspond to the conditions with too-small standard error estimates (see 
Table 5.5). In general, the results are slightly better in scenario B2 in comparison to scenario B1. 
In scenario B1 and B2, respectively 84 % and 75% of the conditions have a CP smaller than .93, 
whereas this is 0% and 3% in scenarios A1 and A2. The CP in scenarios B1 and B2 is not 
influenced by the parameters, whereas the CP in the other scenarios becomes closer to the 
nominal level of .95 if more cases (J = 7) and a smaller between-case and between-study 
variance is included. 
  


























The Relative Standard Error Biases and the Coverage Proportion of the 95% Confidence Interval for  ̂   ; for      = 2 and      = 0.2 Conditions 
   Relative standard error biases  Coverage proportion 
   J = 4  J = 7  J = 4  J = 7  
Scenario K     
  = 2    
  = 8     
  = 2    
  = 8     
  = 2    
  = 8     
  = 2    
  = 8  
A1 10    
  = 2 -0.05 -0.03  -0.06 -0.02  0.95 0.94  0.95 0.95  
     
  = 8 -0.04 -0.01  0.02 0.00  0.95 0.94  0.95 0.96  
 30    
  = 2 -0.03 0.06  -0.07 -0.02  0.94 0.96  0.93 0.95  
     
  = 8 -0.04 -0.03  -0.06 0.02  0.93 0.94  0.94 0.95  
               
A2 10    
  = 2 -0.04 -0.04  -0.01 -0.08  0.95 0.97  0.95 0.94  
     
  = 8 -0.06 -0.03  -0.06 -0.08  0.95 0.93  0.94 0.93  
 30    
  = 2 -0.05 -0.03  0.01 -0.01  0.93 0.95  0.94 0.94  
     
  = 8 -0.05 -0.01  -0.05 -0.04  0.93 0.95  0.94 0.94  
               
B1 10    
  = 2 -0.17 -0.18  -0.13 -0.15  0.91 0.91  0.94 0.92  
     
  = 8 -0.22 -0.19  -0.18 -0.19  0.91 0.91  0.91 0.90  
 30    
  = 2 -0.20 -0.12  -0.15 -0.10  0.89 0.92  0.92 0.94  
     
  = 8 -0.19 -0.23  -0.14 -0.09  0.90 0.87  0.92 0.93  
               
B2 10    
  = 2 -0.22 -0.09  -0.10 -0.12  0.92 0.96  0.94 0.93  
     
  = 8 -0.22 -0.23  -0.13 -0.13  0.91 0.92  0.91 0.91  
 30    
  = 2 -0.22 -0.14  -0.08 -0.06  0.89 0.91  0.93 0.93  
     
  = 8 -0.24 -0.11  -0.15 -0.09  0.88 0.93  0.92 0.93  
Note. For the relative standard error biases, values smaller than or equal to 0.10 in magnitude appear in bold. For the CP, values  
smaller than .93 and larger than .97 appear in bold. 
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5.4.2 Variance components estimates 
The between-study and between-case variances were estimated for both the immediate 
treatment effect and the treatment effect on the trend. The results are very similar for a moderate 
and large covariance. Also similar results are found independent of the sign of the covariance 
between the treatment effects. Therefore, we only report the results of a large positive generated 
covariance in scenario B1 and B2. Because variance estimates are positively skewed (skewness 
= 1.74), due to truncation of negative estimates to zero, we calculated the median (relative) 
deviation of the estimates from the population value, rather than the mean (relative) deviation, to 
evaluate the (relative) bias in the estimates. 
5.4.2.1 Bias of between-case and between-study variance estimate for the immediate treatment 
effect  
Table 5.6 shows that there is negative relative bias in the estimated between-case variance 
(   
  ) in all the conditions and all the scenarios. This means that the estimates are smaller than 
expected. The relative bias equals -1%, 1%, -27, and -1% in scenario A1, A2, B1, and B2 
respectively. This indicates that there is a significant larger amount of relative bias (-27%) in 
scenario B1, where the covariance matrix is misspecified (see Table 5.6). The bias ranges from   
-13% to -50% in scenario B1, while the range is much smaller in the other scenarios (from 0% to 
-8%). The ANOVA indicates that no parameter has an influence on the estimated    
  in 
scenarios A1, A2 and B2, but that the estimated    
  in scenario B1 can be reduced by decreasing 
the between-case variance. Similar results are obtained for the estimated between-case variance 
of the treatment effect on the time trend. 
Also the median of relative deviations for the estimated between-study variances for the 
immediate treatment effect are negative, indicating that the estimates are smaller than expected. 
The median relative bias is also larger in scenario B1 (-9%) in comparison to the other scenarios 
(-5%). Moreover the difference in median relative bias between scenario B1 and B2 is obvious, 
F(1, 126) = 10812.5, p < .001. In scenario B1 and B2, no parameter seems to influence the 
estimated    
 . However, in scenario A1, the  ̂  
  can be further reduced by including a large 
number of cases (J = 7) and a small amount of    
  (   
  = 2). Furthermore, the  ̂  
  in scenario A2 
is smaller if a large amount of studies (K = 30) and cases (J = 7) and a small number of between-
case and between-study variance is included. Also similar results are obtained for the estimated 






























Median of Relative Deviation of the Variance Estimates of     , for      = 2 and      = 0.2 Conditions 
     ̂  
    ̂  
  
    K = 10  K = 30  K =10  K = 30 
Scenario J    
      
  = 2    
  = 8     
  = 2    
  = 8     
  = 2    
  = 8 
 
   
  = 2    
  = 8 
A1 4 2  -0.05 -0.08  -0.03 -0.02   0.01 -0.07  -0.05 -0.02 
  8  -0.04 -0.02   0.00  0.00  -0.11 -0.11  -0.03 -0.01 
 7 2  -0.03 -0.05  -0.01  0.00  -0.10 -0.07  -0.03 -0.06 
  8  0.01 0.00  -0.01  0.00  -0.08 -0.10  -0.04 -0.03 
               
A2 4 2  -0.06 -0.08   0.01 -0.04  -0.07 -0.14  -0.03 -0.02 
  8  -0.04 -0.03  -0.02 -0.01  -0.17 -0.01  -0.01 -0.01 
 7 2  -0.01 0.02  -0.02 -0.01  -0.04 -0.09  -0.02 -0.03 
  8  -0.01 -0.01   0.00 -0.01  -0.11 -0.12  -0.06 -0.02 
               
B1 4 2  -0.47 -0.50  -0.44 -0.43  -0.12 -0.15  -0.06 -0.07 
  8  -0.18 -0.18  -0.16 -0.13  -0.20 -0.18  -0.02 -0.09 
 7 2  -0.46 -0.45  -0.45 -0.43  -0.09 -0.15  -0.09 -0.06 
  8  -0.18 -0.15  -0.15 -0.15  -0.11 -0.15  -0.07 -0.06 
               
B2 4 2  -0.06 -0.03  -0.02 -0.02  -0.18 -0.06  -0.01 -0.03 
  8  -0.06 -0.03  -0.01  0.00  -0.14 -0.11  -0.04 -0.01 
 7 2  -0.03 -0.02  -0.01  0.00  -0.12 -0.13  -0.04 -0.04 
  8  -0.01 -0.01  -0.01 -0.01  -0.07 -0.11  -0.06 -0.04 
Note. Relative median deviations of the variance estimates smaller than or equal to –0.10 appear in bold. 
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The Scheffé’s test for differences between the four scenarios in relative bias indicates 
that the relative bias in scenario B1 is significantly larger than the biases in the other scenarios 
(see Table 5.7) and this for both  ̂  
  and  ̂  
 . 
Table 5.7 
Scheffé’s Test for Differences between Scenarios in relative Biases for  ̂  
  and  ̂  
  
   ̂  




Difference Simultaneous 95% 
confidence limits 
Difference Simultaneous 95% 
confidence limits 
Lower  Upper Lower  Upper 
A1 - B1 0.015 0.004  0.265 -0.039 0.028  0.051 
A1 - A2 -0.009 -0.021  0.003 -0.007 -0.019  0.005 
A1 - B2 0.002 -0.010  0.135 0.001 -0.011  0.013 
B1 - A2 -0.023 -0.035  -0.012 -0.047 -0.058  -0.035 
B1 - B2 -0.013 -0.245  -0.002 -0.039 -0.051  -0.027 
A2 - B2 0.011 -0.000  0.023 0.007 -0.041  0.020 
Note. A significant differences between the scenarios (α = .05) appear in bold 
5.4.2.2 Covariance components estimates 
Bias of covariance between    and    (     ) and    and    (     ) estimates.  
The covariance between the residuals at level 2 (     ) and level 3(      ) were 
estimated in scenario A2 en scenario B2. The covariances at level 2 and level 3 in scenario A2 
are expected to equal zero in all conditions. The mean bias for  ̂     equals 3.0*10
-6
 and for 
 ̂    , it equals 7.3*10
-4
. Also in scenario B2, the covariance estimates are close to their 
expected value (zero, (-)0.79, (-)0.48, (-)0.63 or (-)0.38). The mean bias for  ̂     equals         
-0.001 and the mean bias for  ̂     equals -0.0005. 
5.5 Empirical Illustration 
We use the meta-analysis of single-case studies conducted by Denis et al. (2011). They 
collected studies where the effectiveness of a treatment for self-injurious behavior in people 
with profound intellectual disabilities was investigated. In particular, 18 studies were 
collected where non-aversive, non-intrusive forms of reinforcement were examined. We 
analyzed the data by modeling possible covariance between the regression coefficients 
(scenario B2) and ignoring possible covariance between the regression coefficients (scenario 
B1). The SAS codes used to estimate the immediate treatment effect (i.e.,     ), the treatment 
effect on the time trend (i.e.,     ), the variance components (   
 ,    
 ,    
 ,    
 ) and 
covariance components (     
 and      
 ) are presented in Addendum A2. 
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The results indicate that, as expected, the ignorance of existent covariance has no large 
effect on the estimated treatment effects. The immediate treatment effect estimates are 
statistically significant at the .01 level and equal -2.66, t(18.4) = -4.01, p = .0008, and -3.00, 
t(18) = -4.23, p = .0005, for scenario B1 and scenario B2 respectively and the estimated 
treatment effects on the time trend are not statistically significant and equal -0.045, t(12.5) =   
-1.01, p = .33, and -0.100, t(17) = -1.92, p = .07, for scenario B1 and B2 respectively. 
However, there is a difference in terms of the estimated variance components. The estimated 
between-study variances of the immediate treatment effect are smaller in scenario B1:  ̂  
 = 
5.89, Z = 2.03, p = .02, in comparison to scenario B2:  ̂  
 = 7.65, Z = 2.13, p = .02, and none 
of them are statistically significant at the .01 significance level. Similar results are obtained 
for the estimated between-study variance on the time trend:  ̂  
 = 0.017, Z = 1.52, p = .06, in 
scenario B1 and  ̂  
 = 0.018, Z = 1.53 , p = .06, in scenario B2. This could indicate that the 
between-study variance is underestimated if we ignore covariance at level 3, a result that is in 
line with the simulation results. We also identified a difference between the estimated 
between-case variance of the immediate treatment effect, which equals 2.38, Z = 1.92, p = .02, 
in scenario B1 and 3.51, Z = 2.39, p = .008, in scenario B2. Also a difference in between-case 
variance of the treatment effect on the time trend was found:  ̂  
 = 0.00029, Z = 0.18, p = .43, 
in scenario B1 and  ̂  
  = 0.044, Z = 2.05, p = .02, in scenario B2. The estimated covariance, 
in scenario B2, between the immediate treatment effect and the treatment effect on the time 
trend equals 0.34, Z = 2.25, p = .02, and -.13, Z = -0.79, p = .43, respectively at level 2 and 
level 3. This means that a large immediate treatment effect at level 2 goes together with a 
large treatment effect on the time trend. At level 3, a large immediate treatment effect means a 
smaller treatment effect on the time trend. 
This empirical example confirms that the estimated variance components of the 
between-case and between-study variance of the immediate treatment effects depend on the 
estimated model. The model misspecification could indicate that the between-study variance 
is underestimated. 
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5.6 Discussion 
5.6.1 General conclusion 
The main purpose of this study was to evaluate the consequences of misspecifying the 
between-case and between-study covariance matrix on the estimation of the treatment effects, 
and their corresponding mean squared error, standard errors, coverage proportion of the 95% 
confidence interval and variance and covariance components. Because it is not always 
obvious how to define the covariance matrix, it is important to examine the degree to which 
the treatment effect estimates and the variance estimates are sensitive to changes in the 
specification of the covariance matrix. Therefore, we compared the condition where 
covariance is simulated, but ignored in the analysis with the scenario where covariance is 
simulated and estimated in the analysis, and compare the scenario where covariance is not 
simulated and not estimated with the scenario where covariance is not simulated, but is 
estimated in the analysis. 
As expected from previous research, the results indicate that the average treatment 
effects estimates are unbiased. The MSE is largest in scenario B1 and B2, but is smaller if the 
number of studies and cases are large and if the between-study and between-case variance is 
small. The median relative standard error biases difference in scenario B1 and B2 are 
substantial and only slightly larger in scenario B1, which confirms previous research about 
multilevel models in general. This in turn results in a too small coverage proportion of the 
95% confidence intervals. This indicates that the treatment effect estimates are relatively 
robust for ignoring covariance. As expected, causes the misspecification in the random part of 
the multilevel model biased variance estimates. In scenario B1, the estimated between-study 
variance and between-case variance has extremely large relative bias values for both 
estimated treatment effects (going up to 27%). In the other scenarios, the variance estimates 
are unbiased. If there is no covariance in the data, the results are similar for the analyses 
including covariance or ignoring variance. Thus, this study motivates to model covariance in 
the analysis model. 
5.6.2 Limitations and suggestions for future research 
As with any simulation study, one of the major potential limitations of this study is the 
generalizability of the findings. Further research is needed for the applicability of current 
findings to a broader range of conditions. We partly addressed this limitation by including 
realistic conditions based on several re-analysis of meta-analysis. The conditions are quite 
representative for the research field of single-case experiments in educational settings. 
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In current research, we only investigated the basic multiple-baseline design including 
two predictors at the first level. We excluded models with multiple predictors at level 2 and 
level 3, models using unbalanced data, non-linear models, reversal and alternating designs, 
and other complex models. 
In this study, we only included covariance at the second and third level, which means 
that we ignored possible autocorrelation at the first level. The issue of autocorrelation itself 
deserves separate research and is beyond the scope of this paper (Baek & Ferron, 2013). 
Moreover, we only generated covariance between the regression coefficients indicating 
treatment effects because the other regression coefficients were set on zero in order to make 
the estimated treatment effect estimates better interpretable. We nevertheless believe that 
exploring relative simple scenarios is a first step for a thoughtful study of more complex 
scenarios, and for a correct interpretation of the results for these more complex scenarios. 
The combination of SCD data over studies may be difficult if studies are too different. 
Studies may for instance differ in measuring the treatment effect. We can handle this by the 
inclusion of covariates indicating certain study and even case characteristics to model this 
heterogeneity. Another possibility is standardizing the data or using a multivariate three-level 
model. 
Other approaches to estimate the treatment effects and variances in these treatment 
effects when the variance structures are misspecified should be considered in future research, 
such as the sandwich estimator (i.e., cluster-robust or Huber estimators). Even when the 
covariance matrices are misspecified, the sandwich estimator is asymptotically consistent 
(Hedges, Tipton, & Johnson, 2010; Raudenbush & Bryck, 2002;). It would be a useful 
contribution to compare the standard errors and coverage proportion of the 95% confidence 
intervals constructed with the sandwich estimator to those constructed using the model-based 
estimators in the misspecified model. 
Furthermore, the misspecification of the covariance matrix is only one aspect to test the 
robustness of the three-level modeling approach. Further research is needed to evaluate other 
issues such as non-normal data and not identical distributed errors. Meanwhile, we advise 
single-case researchers to consider use of the three-level model that takes into account 
covariance when synthesizing results of multiple-baseline design data. If there is no 
covariance and we use this model, there are no problems, but if we ignore existent covariance, 
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 Chapter 6|
The Influence of the Design Matrix on 
Treatment Effect Estimates in the 





The quantitative methods for analyzing single-subject experimental data have expanded 
during the last decade, including the use of regression models to statistically analyze the data, 
but still a lot of questions remain. One question is how to specify predictors in a regression 
model in order to account for the specifics of the design and estimate the effect size of 
interest. These quantitative effect sizes are used in retrospective analyses and allow synthesis 
of single-subject experimental study results which is informative for research and policy. We 
discuss different design matrices that can be used for the most common single-subject 
experimental designs, namely, the multiple-baseline designs, reversal designs, and alternating 
treatment designs and provide empirical illustrations. The purpose of this article is to guide 
single-subject experimental data analysts interested in analyzing and meta-analyzing single-
subject experimental design data.  
Keywords: single-subject experimental design, piecewise regression equation, multiple-
baseline design, reversal design, alternating treatment design, design matrix 
                                                 
5 This chapter has been accepted for publication in Behavior Modification: Moeyaert, M., 
Ugille, M., Ferron, J., Beretvas, S.N.,& Van den Noortgate, W. (2014b). The influence of the 
design matrix on treatment effect estimates in the quantitative analyses of single-case 
experimental designs research. Behavior Modification. 
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6.1 General Introduction 
A single-subject experimental design (SSED) is identified by three important features: 
(1) data are gathered, analyzed and interpreted for one case (this case can be one participant or 
a group of participants e.g., a classroom), (2) the participant(s) is (are) observed repeatedly 
during baseline(s) and treatment(s) phase(s), and (3) outcomes during and after the treatment 
are compared with outcomes prior to treatment (Kratochwill et al., 2010). The main focus of 
this design lies in assessing whether there is a causal relation between the introduction of a 
treatment and the change in a dependent variable (Levin et al., 2003). The demonstration of 
experimental control is also very important (i.e., a change in outcome scores is due to the 
introduction of the treatment and not to some extraneous variables). An SSED researcher 
wants to investigate whether a specific treatment works for a specific subject or group of 
subjects. Because the subjects in SSEDs are observed repeatedly over time, the time variable 
plays an important role. 
Shadish and Sullivan (2011) investigated 809 SSEDs reported in 2008 in the field of 
psychology and education and characterized all SSED variants. They used the typology 
presented in the What Works Clearinghouse Standards (WWCs) for SSEDs (Kratochwill et al. 
2010) to code the types of designs used. The most popular designs were: multiple-baseline 
designs (used in 54.3% of the 809 retrieved studies), reversal design (8.2%), and alternating 
treatment designs (8%). These designs involve phase repetition and therefore handle major 
threats to internal validity including, for instance, history or maturation (Shadish et al., 2002). 
These SSEDs have become increasingly popular and are applied in a wide array of research 
fields such as education, clinical psychology, school psychology, special education, etc. 
(Franklin, Allison, & Gorman, 1997; Ittenbach & Lawhead, 1997; Wacker, Steege, & Berg, 
1988), but the methodology to statistically analyze these kinds of data remains limited. 
In the area of SSED research there has been a long tradition of visual inspection of the 
data during data collection. Visual analysis techniques have long been acknowledged as 
effective and valuable (Michael, 1974). During visual analysis of the data, the effect of the 
independent variable and extraneous variables are evaluated while the SSED is being 
conducted. This ongoing process of data evaluation allows the applied SSED researcher to be 
responsive to the needs of the subject under investigation (Barlow & Hersen, 1984; Kazdin, 
2011). For instance, the intervention can be adapted during observation or the intervention can 
be introduced only after a stable baseline pattern emerged. This is also known as response-
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guided experimentation. Another advantage of visual inspection is that the influence of 
extraneous variables can be eliminated because of experimental control. Kahn et al. (2010) 
suggest that visual inspection can lead to consistent interpretation of SSED data among well-
trained raters, and Ferron and Jones (2006) demonstrate how Type I error control can be 
ensured in visual analyses. However, visual analyses by themselves are not well suited for 
synthesizing literature, limiting the capacity to objectively evaluate an evidence base 
(DeProspero & Cohen, 1979; Ottenbacher, 1992). The summary of SSED research findings is 
timely as the number of published SSED studies is increasing at an exponential rate in 
behavior research areas (e.g., Social Science Citation Index). The regression-based approach 
discussed in this article is a flexible technique used to analyze SSED data retrospectively, and 
as a complement to visual analysis during data collection. The purpose of the regression 
analysis is to quantify the SSED data results using an effect size estimate which can be used 
to compare SSED results across studies, enhances the communication among applied SSED 
researchers, and can be used in meta-analysis to synthesize a large body of research. The 
WWC standards (Kratochwill et al. 2010) also recommend combining results from SSED 
studies because they can provide a strong basis for causal inferences (Horner et al., 2005). 
Confidence in the validity of treatment effects demonstrated within subjects is enhanced by 
replication of effects across different subjects, studies, and research groups (Horner & 
Spaulding, in press). The evidence-based movement in SSED context has emphasized the 
need for quantitative summaries of the results, especially for making them available for meta-
analytic purposes (Jenson, Clark, Kircher, & Kristjansson, 2007).This quantification is needed 
to contribute to evidence based research and to inform research and practice. By using 
statistical analysis techniques, the following research questions can be resolved: (1)What is 
the average treatment effect estimate across studies; (2) what is the magnitude of variation 
between subjects in the size of the effect?, and (3) What is the influence of a predictor on the 
treatment effect? To conduct a meta-analysis of SSED studies, researchers have relied on 
effect sizes. For an in-depth discussion, we refer to Maggin et al. (2011). Nonparametric 
effect sizes for SSED research, such as the family of non-overlap metrics (e.g., percentage of 
non-overlapping data, Scruggs, Mastropieri, & Casto, 1987, and percentage of all non-
overlapping data, Parker, Hagan-Burke, & Vannest, 2007) do not require distributional 
assumptions but have been criticized for their inability to (1) account for data trends, (2) 
discriminate between large treatment effects due to ceiling effects, and (3) lack of a known 
sampling distribution (Wolery et al., 2010). Use of parametric effect sizes addresses these 
critiques. In addition, unlike nonparametric effect sizes, parametric effect sizes allow 
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researchers to calculate interval estimates of treatment effects and to estimate the variability in 
treatment effects within and across subjects. Regression-based analyses can also be used to 
examine explanation of variance by predictors such as age, gender, SES, school type, etc. 
(Van den Noortgate & Onghena, 2003b). 
In this paper, we focus on one specific parametric effect size obtained through 
regression analysis of SSED data (Allison & Gorman, 1993; Beretvas & Chung, 2008; Center 
et al., 1985-1986; Huitema & McKean, 2000; Kratochwill & Levin, 2010; Maggin et al., 
2011). Davis, Gagné, Frederick, Alberto, Waugh, and Regine (2013) indicate that regression 
analysis can be used as an additional, statistical analysis technique allowing researchers to 
gain as much information as possible concerning the effect of a treatment on the outcome 
scores.  
6.1.1 Introduction to the regression-based approach 
The regression equation that can be used to analyze a simple AB phase design looks as 
follows and the interpretation of the coefficients is presented in Figure 6.1: 
                               (    
 ) (6.1) 
In Equation 6.1,    indicates the outcome score on the dependent variable at measurement 
occasion i (i = 0, 1,…I),            is a dummy coded variable that equals zero when 
measurement occasion i belongs to the baseline, and one otherwise. Therefore,    indicates 
the expected baseline level and the coefficient    represents the treatment effect. 
  
Figure 6.1 Graphical presentation of the coefficients from equation 6.1 for hypothetical data. 
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In SSEDs, outcome scores on some behavior are obtained across consecutive 
measurement occasions, and therefore we can add a time variable as suggested by Center et 
al. (1985-1986). In Equation 6.2,       is a time variable, which plays a crucial role in 
SSEDs, and is coded with a zero at the beginning of the baseline phase.                 is 
a variable representing the interaction between the dummy coded treatment and time variable. 
Because the SSED researcher is commonly interested in the change in level (i.e., the 
immediate treatment effect), defined as the change between the estimated value based on the 
baseline phase regression and the treatment phase regression at the first measurement 
occasion of the treatment phase, we propose centering the                 variable around 
the first measurement occasion of the treatment phase (see Figure 6.2). The centered time 
variable used in the interaction term (               ) is indicated by Time1 in Figure 6.2 
and is centered by subtracting the sum of one plus the number of measurement occasions, n1, 
in the baseline phase {i.e.,         (    ) }(Center et al., 1985-1986; Huitema & 
McKean, 2000). As a consequence, values on Time1 during the baseline phase are coded with 
negative values, counting downwards from the start of the treatment phase to the beginning of 
the baseline phase (see Figure 6.2). 
                                                (    )     
          (    
 ) 
(6.2) 
The time variable,      , can be expressed in days, session number, etc. The 
interpretation of the coefficients from Equation 6.2 is displayed in Figure 6.2. In the baseline 
phase, the expected score at measurement occasion i,   , equals           , while the 
expected score is                        in the treatment phase. Therefore,    
indicates the expected baseline level at the start of the baseline phase (when       = 0 and 
           = 0) and    is the linear trend over time in the baseline phase scores. The 
coefficient    represents the difference between the predicted value of    at the beginning of 
the treatment phase (       equal zero) under the treatment phase and the predicted value at 
the same point in time under the baseline phase (see Figure 6.2).    is the difference in slope 
between baseline and treatment phases (i.e., the change in slope due to the treatment). In 
Figure 6.2, we use    to indicate the slope during the treatment phase. Although this 
coefficient is not presented in regression Equation 6.2, we included it in the graphical 
presentation in order to indicate that    is the difference between the slope during the baseline 
phase,   , and the slope during the treatment phase,    (i.e.,    =    –   ).   
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SSED researchers are mostly interested in    and   , but if the research interest lies in 
the actual trend during the treatment it is straightforward to calculate it from    and    (i.e., 
   =   +   ).  
 
Figure 6.2. Graphical presentation of the coefficients from equation 6.2 for hypothetical data. The X-axis 
represents the variables Time and Time1. Time is coded such that Time = 0 for the first measurement occasion in 
the baseline phase. Time1 is recoded such that Time1 = 0 for the first measurement occasion in the treatment 
phase. 
When using the regression approach to analyze SSED data, a variety of different options 
for coding the Time variable are possible and the interpretation of the coefficients depends on 
this coding. In previous research, attention is given to the coding of the time variable in 
growth curve models (Anumendem, De Fraine, Onghena, & Van Damme, 2011), but in the 
area of SSED research this is still underdeveloped. In this paper, we will discuss several 
research questions that SSED data analysts may have when analyzing results from multiple-
baseline across subjects designs, reversal designs, and alternating treatment designs, because 
these are the three most popular SSEDs. For each particular SSED and associated research 
questions, we propose several design matrices and we describe and illustrate graphically how 
to interpret the associated parameters. According to the coding of the Time variable, the 
interpretation of the regression coefficients changes, an issue about which SSED data analysts 
should be aware. We illustrate each design matrix with an empirical example. The raw data 
for the empirical examples were retrieved from real studies using the statistical software 
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DataThief III (Tummers, 2005-2006). In order to assess reliability of data extraction using 
DataThief III, the extraction process was repeated twice by two independent researchers and 
the same raw data were obtained. The purpose of this manuscript is to guide SSED 
researchers and meta-analysts in the retrospective analysis of their SSED data. The 
quantitative analysis is complementary to the visual analysis and can provide additional 
information such as estimates of effect size, within-case variability, trends, and 
autocorrelation. Through meta-analysis, additional research questions can be examined such 
as: was the treatment effect consistent across subjects or is there a large difference in 
treatment effect between subjects?  
6.1.2 Assumptions underlying the regression-based approach 
When using the piecewise regression equation as presented in Equation 6.2, notice that a 
linear trend during both baseline and treatment phases is assumed. This might not be the case 
in reality and therefore there might be a need to take non-linear trajectories into account. This 
can be accomplished, for instance, by adding quadratic terms (     
 ) in Equation 6.2 when a 
quadratic trajectory is expected. It might also be a good option to simplify Equation 6.2 by 
removing the time trend if no linear time trend is expected. In addition, the errors are assumed 
to be normally, independent and identically distributed. The regression equation can be 
extended by modeling dependent errors, and predictors, among other complexities but this is 
beyond the scope of the article. For a more in depth discussion of these extensions, we refer to 
Moeyaert, Ferron, Beretvas, and Van den Noortgate (2014). In the remainder of this article, 
we will assume linear trends in the baseline and the treatment phase and that the errors are 
normally, identically, and independently distributed. The coding strategies illustrated, 
however, are general in that they could be applied with models that made different 
assumptions about the errors and they could be adapted to handle non-linear trends.  
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6.2 Analyzing Multiple-Baseline Design Data 
A multiple-baseline design is one of the variants of SSEDs in which an AB phase design 
(with one baseline phase, A, and one treatment phase, B) is delivered simultaneously to 
different participants, behaviors or settings (Barlow & Hersen, 1984; Ferron & Scott, 2005; 
Kazdin, 2011; Onghena, 2005). The staggering of the initiation of treatment across 
participants, settings or behaviors, allows researchers to disentangle a change in data due the 
introduction of the treatment and external event effects (Baer et al., 1968; Barlow & Hersen, 
1984; Kinugasa et al., 2004; Koehler & Levin, 2000). 
We can choose to analyze the data for each participant separately (in a single-level 
analysis) or to analyze the data from multiple participants simultaneously (in a two-level 
analysis, see Van den Noortgate & Onghena, 2003a). We use the multiple-baseline study of 
Laski, Charlop, and Schreibman (1988) to illustrate both approaches. In their study, the 
effects of parents training in using the natural language paradigm to increase autistic 
children’s speech were investigated for nine children. In all cases, the treatment increased the 
amount of spontaneous speech.  
6.2.1 Single-level analysis 
6.2.1.1 Design matrix 1 
For the single-level analysis, we consider the multiple-baseline design as separate AB 
phase designs. If the SSED researcher is mainly interested in the treatment effect estimates for 
each participant separately and not in an average estimate over the participants, than we can 
simply use the piecewise regression equation proposed by Center et al. (1985-1986) and 
presented in Equation 6.2. The results of this analysis are displayed in Table 6.1 and the SAS 
code is included in Addendum A3. We only present the results for the first two subjects (see 
Figure 6.3) in order to reduce size of the table. The raw data are included in Addendum B. 
  




Figure 6.3. Graphical presentation of a multiple-baseline design across two participants using the data from 
“Training Parents to use Natural Language Paradigm to increase their Autistic Children’s’ speech” by Laski, K. 
E., Charlop, M. H., and Schreibman, L., 1988, Journal of Applied Behavior Analysis, 21, p.391-400.  
The estimate of the predicted outcome score at the start of the baseline phase,  ̂ , the 
slope during the baseline  ̂ , the immediate treatment effect,  ̂ , and the change in slope due 
to the treatment,  ̂ , correspond to what we expect from the graphical presentation of the raw 
data in Figure 6.3. The outcome score at the beginning of the baseline phase differs 
significantly from zero for the second participant and equals 35.48, t(9) = 3.95, p = .003. The 
trend during the baseline is positive for both participants, but not statistically significant. For 
the Laski et al. (1988) data,  ̂  equals 16.51 ,t(9) = 0.99, p = .35, and 48.02, t(9) = 3.36, p = 
.008 for the first and the second subject, respectively. The estimated change in trend for the 
first participant is more than 18 times larger;  ̂  = -6.43, t(9) = 0.03, p = .03, than the 
estimated change in trend for the second participant;  ̂ = -0.34, t(9) = -0.28, p = .78, but 
neither estimate is statistically significant. In this example, the interpretation of the immediate 
treatment effect,  ̂ , represents the difference at the start of treatment (Time1 = 0) between the 
estimated outcome score based on the baseline phase’s regression model versus the estimated 
outcome score using the treatment phase’s regression model (see Figure 6.2).  
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Design matrix 1 can be used if the research questions of interest include: 
(a) What is the outcome score at the beginning of the baseline phase (  )? 
(b) What is the trend during the baseline phase (  )? 
(c) What is the immediate treatment effect (  )? 
(d) What is the change in trend between the baseline phase and the treatment phase (  )? 
Design matrix 1 is of particular interest because SSED researchers are typically interested in 
the immediate treatment effect (research question c) and the treatment effect on the slope 
(research question d). 
In the following paragraphs we suggest three alternative design matrixes that can be 
used for the single-level analysis of multiple-baseline design data along with a graphical 
presentation of the coefficients’ interpretation for hypothetical data. We finish with an 
empirical illustration using a real dataset. For the empirical illustration for each design matrix, 
we choose to include only the data for two participants of the study of Laski et al. (1988) 
instead of the data from all nine participants. However, the same single-level analysis could 
be conducted for the seven other participants.  
6.2.1.2 Design matrix 2 
It might be the case that the SSED analyst chooses to leave the Time variable uncentered 
in the                 interaction term in Equation 6.2 as follows: 
                                                         (    
 )  (6.3) 
This has consequences for the interpretation of the  ̂  coefficient as it no longer represents the 
change in outcome scores between baseline and treatment at the start of the treatment phase, 
see Figure 6.4. 
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Figure 6.4. Graphical presentation of the coefficients from equation 6.3 for hypothetical data. 
The interpretation of the immediate treatment effect,  ̂ , using design matrix 2 now is 
the difference at the start of the baseline phase (Time = 0) between the estimated outcome 
score based on the baseline regression model versus the estimate using the treatment phase 
regression model (see Figure 6.4). This is unlikely an interesting parameterization for an 
SSED researcher. Interpretation of the other coefficients (including predicted outcome score 
at the start of the baseline phase,  ̂ , the slope during the baseline phase,  ̂ , and the change in 
slope due to the treatment,  ̂ ) remains the same as under the first design matrix. The results 
of this analysis are displayed in Table 6.1 and the SAS code that was utilized is included in 
Addendum A3. Nevertheless, design matrix 2 can be used if the research questions of interest 
are: 
(a) What is the outcome score at the beginning of the baseline phase (  )? 
(b) What is the trend during the baseline phase (  )? 
(c) What is the change in trend between the baseline phase and the treatment phase (  )? 
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6.2.1.3 Design matrix 3 
The  ̂  coefficient in design matrix 2 is likely not of interest for a typical SSED analyst 
and even more problematic is that the change in level cannot be estimated. Because the SSED 
researcher is commonly interested in the change in the outcome’s level (i.e., the immediate 
treatment effect), defined as the change between the estimated value based on the baseline 
regression and the treatment regression at the first measurement occasion of the treatment 
phase, we propose centering the time variable used in the calculation of the interaction effect 
around the first measurement occasion of the treatment phase as proposed in design matrix 1. 
If the research interest focuses solely on the immediate treatment effect and the treatment 
effect on the slope, design matrix 1 can be simplified by using one centered time variable: 
       [i.e.,        =       (    )] instead of using two different time indicators (i.e., 
      and        in the interaction term in design matrix 1). In addition, design matrix 3 
answers another important research question: What would to outcome value have been at the 
start of the treatment phase, had the baseline phase continued? Baseline observations are used 
to document the need for an intervention and therefore it may be more interested to document 
how problematic the measured dependent variable was at the time of intervention ( ̂  from 
design matrix 3) than to know how problematic it was at some earlier point in time ( ̂  from 
design matrix 1). This results in the following: 
            (    )                                (    )       
         (    
 ) 
(6.4) 
The results of this analysis are displayed in Table 6.1 and the necessary SAS code is included 
in Addendum A3. The only difference between design matrix 1 and design matrix 3 lies in the 
interpretation of  ̂  (see Figure 6.5).  
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Figure 6.5. Graphical presentation of the coefficients from equation 6.4 for hypothetical data. The X-axis 
represents the variable Time1 which is recoded such that Time1 = 0 for the first measurement occasion in the 
treatment phase. 
Using design matrix 3,  ̂  is the estimated outcome score at the beginning of the 
treatment phase using the data from the baseline phase and equals 45.38, t(9) = 3.05, p = .014, 
and 33.31, t(9) = 2.74, p = .02, for participant 1 and 2 respectively (see Table 6.1). This means 
that  ̂  is statistically significant and its value is larger in comparison to estimates when using 
the previous proposed design matrices. Moreover, when an SSED researcher chooses to use 
design matrix 3, they should be aware that the interpretation of the intercept changes 
depending on the length of the baseline phase (which itself determines the timing of the first 
intervention measurement occasion).  
6.2.1.4 Design matrix 4  
In design matrices 1 through 3, the     coefficient indicated the difference in slope 
during the baseline versus treatment phases. An SSED researcher might not be interested in 
this change, but rather in the value of the slope during the treatment phase,    (i.e., the change 
in slopes can still be calculated as the difference in the estimated slopes in both phases as 
discussed in design matrix 1). If this is the case, we propose to set the time variable (now 
represented by Time2 in Figure 6.6) to a constant value during the treatment phase 
representing the time variable’s value at the first measurement occasion during intervention 
(here, a value of four, see the values on the X-axis in Figure 6.6). 
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Using design matrix 4, the trend during the treatment,   , is obtained directly with its standard 
error and p-value, and the interpretation of the other coefficients,   ,   , and    remains the 
same as in design matrix 2 (see Table 6.1). Equation 6.4 can be used to estimate the 
coefficients of interest: 
                                             (    )       




Figure 6.6. Graphical presentation of the coefficients from Equation 6.5 for hypothetical data. The X-axis 
represents the variable Time1 which is recoded such that Time1 = 0 for the first measurement occasion in the 
treatment phase. 
The results of this analysis are displayed in Table 6.1 and the SAS code that was used is 
included in Addendum A3. 
Using this design matrix, the following research questions can be evaluated:  
(a) What is the outcome value at the beginning of the baseline phase (  )? 
(b) What is the trend during the baseline phase (  )?  
(c) What is the immediate treatment effect (  )? 
(d) What is the trend during the treatment phase (  )? 
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Using design matrix 4, we found that the linear slope for participant 1 equals 5.86, t(9) = 
5.43, p = .31, during baseline and -0.55, t(9) = 1.57, p = .74, during treatment, this 
corresponds to a change in slope of -6.11 (-0.55 - 5.86), and equals well approximated 
estimates of    using design matrices 1 through 3;    = -6.43, t(9) = -1.14, p = .28. This was 
expected because    in design matrices 1 through 3 refers to the difference in slopes between 
the baseline and the treatment phase. A similar result was found for participant 2:  ̂   ̂  
      (     ) = -0.34 and this equals the    estimate that was found when using matrices 
1 through 3; -0.34, t(9) = 0.08, p = .94. 
6.2.1.5 Conclusion - single-level analysis of multiple baseline design 
The results of the single-level analysis using four different design matrices applied to 
the first two participants of the study of Laksi (1988) are presented in Table 6.1. Design 
matrices 1 through 3 build further upon the design matrices proposed by Huitema and 
McKean (2000). In summary, we advocate most strongly for using design matrix 1 (in which 
the Time variable in the interaction term is centered around the intervention phase’s starting 
point), because it is more likely that an SSED researcher is interested in the change in level 
(immediate treatment effect) at the first treatment phase measurement occasion and the 
change in slope due to the treatment. Design matrix 1 also entails the advantage that the 
outcome score at the beginning of the baseline phase can be estimated. If one is not interested 
in the outcome score at the beginning of the baseline phase, design matrix 3 can instead be 
used. Design matrix 4 is also of practical use if the research interest lies in the estimate of the 
slope during the treatment instead of in the change in slope due to the treatment. And note that 
the slope during the treatment can also be calculated indirectly via the estimate of the change 
in slope between baseline and treatment phase,   , and the slope during the baseline phase, 
  . A drawback of this latter approach is that the standard errors and p-values are not directly 
obtained and have to be calculated by hand. 
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Table 6.1 
Summary Results Single-Level Regression Analysis: Design Matrix 1 – Design Matrix 4 
  Matrix 1 Matrix 2 Matrix 3 Matrix 4 
Coefficient  Estimate (SE) Estimate (SE) Estimate (SE) Estimate (SE) 
Participant 1      
Score when Treatment=0  and  Time= 0  ̂ 
a
 21.84  (10.16) 21.84 (10.16) 45.38*(14.88) 21.84  (10.16) 
 Linear trend during the baseline  ̂    5.86    (5.43)  5.86 (5.43)  5.86     (5.43)   5.86    (5.43) 
 Treatment effect on level  ̂ 
b
 16.51  (16.64) 42.23*(16.64) 16.51  (16.64) 16.51  (16.64) 
 Treatment effect on slope  ̂ 
c
  -6.43    (5.65)  -6.43   (5.65)   -6.43    (5.65) -6.11     (5.65) 
Participant 2      
Score when Treatment=0  and  Time= 0  ̂ 
a
 35.48*  (8.98) 35.48*  (8.98) 33.31*(12.16) 35.48*  (8.98) 
 Linear trend during the baseline  ̂   -0.43    (3.67) -0.43    (3.67)  -0.43    (3.67) -0.43    (3.67) 
 Treatment effect on level  ̂ 
b
 48.02*(14.28) 49.72*(18.13) 48.92*(14.28) 48.02* (14.28) 
 Treatment effect on slope  ̂ 
c
  -0.34    (4.08) -0.34    (4.08)  -0.34    (4.08) -0.34     (4.08) 
Note. 
a ̂  represents the outcome score at the start of the baseline in design matrix 1, design matrix 2 and design 
matrix 4. In design matrix 3,  ̂  represents the outcome score at the start of the treatment using baseline data. 
b ̂  
indicates the immediate treatment effect in design matrix 1, design matrix 3 and design matrix 4. In design 
matrix 2,  ̂  refers to the treatment effect on the first measurement occasion in the baseline phase. 
c ̂  is the 
treatment effect on the slope in design matrix 1, design matrix 2 and design matrix 3. In design matrix 4, the 
treatment effect on the slope is calculated indirectly, using the estimated slope during the baseline,  ̂ , and the 
estimated slope during the treatment,  ̂ .  
* p < .05. 
6.2.2 Two-level analysis 
It might be time consuming to analyze data from a multiple-baseline design for each 
subject separately. There is an increased interest in using scaled-up multiple-baseline designs. 
For instance, the multiple-baseline design study of Koutsoftas, Harmon, and Gray (2009) 
included 36 participants. Therefore we propose using a two-level analysis which allows 
estimating the treatment effect across participant without losing information about the 
individual participants (Van den Noortgate & Onghena, 2003a). Moreover, this analysis takes 
into account that measurement occasions are nested within participants and it allows modeling 
of and estimating the variability in these treatment effects as well. We will illustrate the two-
level analysis using design matrix 1 (i.e., the Time variable within the interaction term is 
centered around the first measurement occasion of the treatment). Note that the analysis is 
similar if using any of the other design matrices described earlier. We chose design matrix 1, 
because this design matrix allows estimation of (1) the average outcome score at the 
beginning of the baseline phase, (2) the average trend during the baseline phase, (3) the 
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average immediate treatment effect, and (4) the average treatment effect on the trend across 
participants. Also the between-case variability in each of these four parameter estimates can 
be estimated. We can extend Equation 6.2 from the single-level analysis by adding an 
additional index, j, indicating the subject. At the first level of the two-level model, 
measurement occasions, i, are nested within participants, j. In contrast to the single-level 
model, we allow the coefficients from the first level,    ,    ,     and     to vary at the 
second (participant) level: 
Level 1: 
                                                       (    )      
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]  (    )  
 
(6.7) 
The first equation in Equation 6.7 indicates that the baseline intercept for participant j equals 
an average baseline intercept,    , plus a random deviation from this mean,    . The 
subsequent equations describe the variation across participants from the same study in the 
time effect in the baseline phase, the immediate treatment effect, and the treatment effect on 
the linear trend, respectively. SSED researchers are especially interested in the immediate 
treatment effect across participants,    , the treatment effect on the time trend across 
participants,    , the between-case variability of the immediate treatment effect,     
 , and the 
between-case variance of the treatment effect on the time trend,     
 . The results of the two-
level analysis applied to the nine participants of the study of Laski et al. (1988) are displayed 
in Table 6.2 and the SAS code that was used to estimate the parameters is included in 
Addendum A4. 
The outcome score predicted at the beginning of the baseline phase across the nine 
participants ( ̂  ) equals 37.72, t(1.23) = 4.33, p = .002, and is statistically significant. There 
is a small average downward linear time trend during the baseline phase,  ̂   = -0.15, t(34.8) 
= -0.24, p = .81, and the estimated average immediate treatment effect ( ̂  ) equals 32.10, 
t(6.88) = 5.52, p <.001. This means that the treatment has an immediate, significant positive 
effect on speech across the nine participants. The change in slope due to the treatment equals 
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0.70, t(43.7) = 0.81, p = .42. Despite obtaining an average estimate of the effects over 
participants, participant-specific effects can also be obtained using empirical Bayes estimates. 
To obtain these estimates in the output, we simply add the command: “solution” after the 
random statement in the PROC MIXED procedure detailed in Addendum A4. This two-level 
approach also allows estimation of the between-case variability of the outcome score at the 
start of the baseline phase (    
 ), the average trend during the baseline (    
 ), the average 
immediate treatment effect (    
 ), and the average treatment effect on the time trend (    
 ), 
and within-case variability (    
 ). For the dataset being analyzed, here, the following results 
were obtained: significant between-case variability in terms of the outcome score at the start 
of the baseline;     
  = 520.59, Z = 1.92, p =.027, and the within-case variability;     
  = 
148.67, Z = 7.54, p < .0001. None of the between-case variances (in the trend during the 
baseline, the immediate treatment effect and the treatment effect on the time trend) differed 
significantly from zero. 
Table 6.2 
Two- Level Analysis using Design Matrix 2 Applied to the Study of Laski et al. (1988) 
Coefficient Parameter Estimate   (SE) 
Fixed coefficient     
     Outcome score at the start of the baseline  ̂    37.72*  (8.01) 
     Trend during the baseline  ̂    -0.15 (0.64) 
     Immediate treatment effect  ̂    32.10*  (5.82) 
     Treatment effect on the slope  ̂      0.70 (0.86) 
Between-case variance    
     Outcome score at the start of the baseline  ̂  
  520.59* (271.11) 
     Trend during the baseline  ̂  
  - - 
     Immediate treatment effect  ̂  
  162.42 (105.30) 
     Treatment effect on the slope  ̂  
      0.18 (1.57) 
Residual within-case variance  ̂ 
  148.67*  (19.72) 
Note. * p < .05.  
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6.2.2.1 Conclusions - two-level analysis of multiple-baseline designs 
As with the single-level model’s parameterization, for the two-level analysis of 
multiple-baseline designs we also encourage use of the design matrix in which the Time 
variable is centered around the start of the intervention phase. This enables researchers to 
estimate the between-case variance in the immediate treatment effect and the treatment effect 
on the time trend at the first measurement occasion of the treatment phase. Moreover by only 
centering the time variable involved in the interaction term, we can estimate the between-case 
variance in the outcome score at the beginning of the baseline phase. A possible problem 
when centering the time variable and the time variable in the interaction term as in design 
matrix 3 is that if there is variation over cases in the baseline trend, the between case-variance 
depends on the measurement occasion around which the time variable is centered. As a 
consequence, if the length of the baseline varies over cases (as is common in a MBD), the 
assumption of homoscedasticity might be violated. The two-level model is more efficient and 
provides more information in comparison to the use of level-1 regression equation for each 
participant. More specifically, we can estimate the effects (e.g. immediate treatment effect 
and treatment effect on time trend) across participants which allow us to make more general 
conclusions. We can also estimate the participant-specific effects using empirical Bayes 
estimates. Using this two-level model allows estimation of within- and between-case 
variability.  
6.3 Reversal Designs 
Reversal designs, including for instance the ABAB design involve introduction and 
withdrawal of the treatment. In these kinds of designs, there is more than one baseline and 
treatment phase per participant. 
We will divide this section into two parts. In the first part, we propose a design matrix to 
use when the researcher is interested in the average outcome score in the baseline, the average 
treatment effect across the phases, and in the difference between the treatment effect estimates 
between the two AB pairs. In the second part, we are interested in the differences in outcome 
score and trends between consecutive phases and propose three different design matrices. In 
both parts, we present the regression equation(s) that can be used to analyze some 
hypothetical data, and a graphical representation to help understand the coefficients. We end 
using data from Moes’ (1998) study to provide an empirical illustration. In Moes’ study, the 
author evaluated the effects of choice making (students vs. tutor) on challenging behavior of 
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four children with autism using an ABAB design. The results indicated (based on visual 
analysis) a reduction in challenging behaviors during the treatment phase. We randomly 
selected the data for one of the students to illustrate the proposed designs matrices (see Figure 
6.7).  
 
Figure 6.7. ABAB reversal design data for one participant of the study of Moes (1998). 
6.3.1 First way to code phase and time in an ABAB reversal design 
6.3.1.1 Design matrix 5 
If a researcher wants to study change in response patterns between baseline and 
treatment phases (between the first and second AB pair), and wants to look at the difference in 
these effects between AB pairs, we can use Equation 6.8: 
                                                     
with     (    
 ) 
(6.8) 
The dummy variable            indicates if measurement i is part of the baseline phase 
(i.e., A1 or A2) or the treatment phase (i.e., B1 or B2). If the measurement occasion belongs 
to B1 or B2, then            equals one, otherwise zero. The dummy variable,        
indicates whether the measurements belong to the first or the second AB pair.       equals 1 
if the measurement occasion belongs to the second AB pair, zero otherwise. Using Equation 
6.8,    and    equal the baseline level and the immediate treatment effect, respectively, 
during the first AB pair;   +    indicates the second baseline level and   +    refers to the 
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change in level in the second AB pair. In this way,    indicates the change in outcome score 
between the second and the first baseline phase and    indicates the difference in treatment 
effect between the first AB pair and the second AB pair. The graphical presentation of these 
coefficients is presented in Figure 6.8 and the results using this coding for the one participant 
randomly selected from the study of Moes (1998) are presented in Table 6.3. 
The research questions that can be assessed using this design matrix include: 
(a) Is the outcome score during the second baseline phase different than the outcome score 
during the first baseline phase (  )? 
(b) Is the outcome score during the first treatment phase different than the outcome score 
during the first baseline phase (  )? 
(c) Is the change in outcome score during the first AB pair different than the change in 
outcome score during the second AB pair (  )? 
 
Figure 6.8. Graphical presentation of the coefficients from equation 6.8 for hypothetical data for an ABAB 
design. 
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Table 6.3 
Regression Analysis of an ABAB Design using the First Way of Coding Applied to the Dataset of Moes (1998) 
Coefficient Parameter Estimate (SE) 
Outcome at the start of the baseline  ̂  86.71* (3.31) 
Immediate treatment effect first AB pair  ̂  -30.40* (4.69) 
Difference between the outcome score during A2 and A1  ̂  3.94      (4.69) 
Difference between the immediate  treatment effect during the 
second AB pair and the first AB pair. 
 ̂  -21.08* (6.63) 
Note. * p < .05. 
From these results we can deduce that the difference in outcome during the first and the 
second baseline equals 3.94 and is not statistically significant, t(1) = -6.47, p < .0001. A 
striking and interesting result is that the immediate treatment effect during the second AB pair 
is significantly larger than the immediate treatment effect during the first AB pair: 
 ̂  = -21.08, t(1) = -3.18, p = .006.  
6.3.2 Alternative way of coding an ABAB reversal design 
In this second part, the SSED researcher is interested in the following research question: 
Is there a change in response patterns (immediate treatment effects and changes in trends) 
between the four phases? The design matrix is more complex and involves coding of multiple 
dummy coded variables indicating the phase to which a measurement occasion belongs. We 
choose the following notation to distinguish between the consecutive phases: A1 and A2 
indicate respectively the first and the second baseline phase and B1 and B2 the first and the 
second treatment phase (see Figure 6.8). 
For the ABAB phase design, three dummy variables, A1B1, B1A2 and A2B2 are coded 
(se Figure 6.9) as suggested by Shadish et al. (2013). A1B1 =1 for all the measurement 
occasions after the first baseline phase, B1A2 = 1 for all the measurement occasions after the 
first treatment phase and A2B2 equals 1 during the last treatment phase. When all three 
dummy coded variables equal zero (i.e., A1B1 = B1A2 = A2B2 = 0), then the indicated phase 
is the first baseline phase. Each dummy variable represents the jump from an earlier to its 
adjacent phase. Thus, for example, B1A2 refers to the jump from B1 to A2. Besides these 
dummy coded variables, we suggest coding multiple Time variables in order to estimate 
changes in trends. The way the Time variables are coded is dependent on the research 
question one might have.   
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Research questions in which SSED researchers are likely interested when using ABAB 
reversal designs involve but are not limited to: 
- What is the difference in trend during the first treatment phase and the second treatment 
phase and what is the difference in level if we jump from one phase to another (design matrix 
6)? 
- Has the treatment more influence on the slope during the first AB than during the second AB 
phase pairs? The researcher might also be interested in estimating the difference in level 
between consecutive phases (Design matrix 7). 
- What is the change in slope between the two baseline phases and the two treatment phases 
and what is the difference in level between consecutive phases (design matrix 8)? 
We propose three design matrices in order to directly investigate these research 
questions and will use the data from Moes’ (1998) study to illustrate them.  
6.3.2.1 Design matrix 6  
In this scenario the SSED researcher is interested in: 
(a) What is the difference in level between consecutive phases? 
 (b) What is the difference in trend between the first treatment phase and the second treatment 
phase? 
In addition to the three dummy coded variables indicating the phase, we need to code 
four time variables (see Time, Time1, Time2, and Time3 in Figure 6.9). The first time variable, 
Time, equals zero at the start of the first baseline phase (A1) and remains constant during the 
other phases. Time1 is centered around the start of the first treatment phase (B1) and remains 
constant during the second baseline phase, however, it increases again during the second 
treatment phase. The reason for this is that we want to estimate the difference in trend 
between the first and the second treatment. Time2 is centered around the first measurement 
occasion of the second baseline phase (A2) and is then held constant during the second 
treatment. Time3 is centered around the first measurement occasion of the second treatment 
(B2) phase. In Figure 6.9 the coding scheme is indicated.  
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Figure 6.9. Coding scheme for the reversal ABAB single-case design using design matrix 6. 
The extension of the Center et al. (1985-1986) equation in order to estimate the 
parameters of interest is as follows: 
   (          )  (           )      (           )     
 (           )                  (    
 ) 
(6.9) 
The coefficients from Equation 6.9 are graphically presented in Figure 6.10. Also the 
interpretation and the estimation of the coefficients of interest are given in Table 6.4. Similar 
to the graphical presentation of the change in trend in design matrix 1 to design matrix 4 in 
the discussion of the multiple-baseline designs, we add a coefficient, here   , representing the 
trend during the second treatment phase. This is to indicate that    is the change between the 
slope during the first treatment phase,   , and the slope during the second treatment phase,    
(i.e.,    =    -   ). If an SSED researcher is interested in the trend during the treatment as 
well,   , can be easily calculated by adding    to   . If we analyze the dataset of Moes 
(1998), then we obtain the results displayed in Table 6.4. Also the interpretation of the 
coefficients from Equation 6.9 is given in Table 6.4. 
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Figure 6.10. Graphical presentation of the coefficients from Equation 6.9 for hypothetical data for an ABAB 
design. The X-axis represents the variables Time, Time1, Time2, and Time3. Time is recoded such that Time = 0 
for the first measurement occasion in A1, and is kept constant in consecutive phases. Time1 is recoded such that 
Time1 = 0 at the first measurement occasion in B1, is kept constant in A2, and counts further in B2. Time2 is 
recoded such that Time2 = 0 at the first measurement occasion in A2, and is kept constant in B2. Time3 is 
recoded such that Time3 = 0 at the first measurement occasion of B2.  
6.3.2.2 Design matrix 7  
In this scenario, the SSED researcher is interested in: 
(a) What is the difference in level between consecutive phases? 
(b) Has the treatment effect had more or less influence on the slope during the first AB pair in 
comparison to the second AB pair. Again, in addition to the three dummy coded variables 
indicating the phase (A1B1, B1A2 and A2B2), we code four time variables (Time, Time1, 
Time2, and Time3 in Figure 6.11) which are slightly different than those used in design matrix 
6. Time is a time variable set to zero at the first measurement occasion in A1 and increasing 
across the phase but then remaining constant after phase B1. Time1 is centered around the 
start of phase B1 and remains constant after this phase. Time2 is centered around the start of 
phase A2 and Time3 is centered around the start of phase B2. Coding time this way makes it 
also possible to estimate whether the change in slope during the first AB pair differs from the 
change in slope during the second AB pair. The results of the analysis are graphically 
presented in Figure 6.11. If we analyze the dataset of Moes (1998), then we obtain the results 
and interpretations displayed in Table 6.4. In the previous design,   , representing the slope 
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during the second treatment was inserted. In addition to   , another coefficient is included, 
namely   , indicating the slope during the first treatment phase. This is to indicate that    is 
the change between the slope during the first baseline phase,   , and the slope during the first 
treatment phase,   .  
 
Figure 6.11. Graphical presentation of the coefficients using design matrix 7 for hypothetical data for an ABAB 
design. The X-axis represents the variables Time, Time1, Time2, and Time3. Time is recoded such that Time = 0 
for the first measurement occasion in A1, and is kept constant in A2 and B2. Time1 is recoded such that Time1 = 
0 at the first measurement occasion in B1, and is kept constant in consecutive phases. Time2 is recoded such that 
Time2 = 0 at the first measurement occasion in A2. Time3 is recoded such that Time3 = 0 at the first 
measurement occasion in B2. 
6.3.2.3 Design matrix 8 
In this scenario, the SSED researcher is interested in: 
(a) What is the difference in level between consecutive phases? 
(b) What is the difference in slope between common phases (i.e., what is the difference in the 
slope between A1 and A2? And what is the difference in the slope between B1 and B2)? 
Again we code the three dummy variables (A1B1, B1A2 and A2B2) indicating the treatment 
phase as given in Figure 6.12. In this design matrix, we code four time variables slightly 
differently than for design matrices 6 and 7 (see Time, Time1, Time2, and Time3 in Figure 
6.12). Time equals zero at the start of phase A1. During phase B1, Time remains constant. 
During the A2 phase, Time begins to increase again until the start of the B2 phase. This is 
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because we want to compare the trend during the A2 phase with the trend during A1.We use a 
similar coding scheme for Time1. Time1 is centered around the start of phase B1, remains 
constant during phase A2 and continues to increase during the B2 phase. This is because we 
want to compare the trend during B1 with the trend during B2. Time2 is centered around the 
start of the second baseline and is set constant during the second treatment. Time3 is centered 
around the start of phase A2. If we analyze the dataset of Moes (1998), then we obtain the 
results as displayed in Table 6.4. The coefficients of interest are graphically presented in 
Figure 6.12. In the previous two designs,   , representing the slope during the second 
treatment was inserted. In addition to   , another coefficient is included, namely    , 
indicating the slope during the second baseline phase. This is to indicate that    is the change 
between the slope during the first baseline phase,   , and the slope during the second baseline 
phase,    .  
 
Figure 6.12. Graphical presentation of the coefficients using design matrix 8 for hypothetical data for an ABAB 
design. The X-axis represents the variables Time, Time1, Time2, and Time3. Time is recoded such that Time = 0 
for the first measurement occasion in A1, is kept constant in B1, counts further in A2 and is kept constant in B2. 
Time1 is recoded such that Time1 = 0 at the first measurement occasion in B1, is kept constant in A2 and counts 
further in B2. Time2 is recoded such that Time2 = 0 at the first measurement occasion in A2 and is kept constant 
in B2. Time3 is recoded such that Time3 = 0 at the first measurement occasion in B2. 
  
150   Chapter 6 | Design matrix 
 
6.3.3 Conclusion - reversal designs 
Depending on the research questions of interest to the SSED researcher, we suggest two 
complementary ways of coding the design matrix for ABAB reversal designs. Under the first 
coding scheme, the research interest lies in the average treatment effect. Therefore, we 
suggest including a dummy variable, indicating whether a measurement occasion belongs to a 
baseline phase (either the first or the second one) or a treatment phase (either the first or the 
second one). On top of this, a researcher might also be interested in whether the estimated 
treatment effect is different between AB pairs by including a second dummy coded variable 
pair (indicating the AB pair).  
If the research questions focus on the change in outcome score and/or trends between 
consecutive phases, then we suggest coding three dummy variables indicating the phase 
(A1B1, B1A2, and A2B2) and four time variables (Time, Time1, Time2 and Time3). We center 
Time around the beginning of the first baseline phase, Time1 around the beginning of the first 
treatment phase, Time2 around the beginning of the second baseline phase and Time3 around 
the beginning of the second treatment phase. If a researcher is interested in whether there is a 
difference between the slope in the first baseline phase and the second baseline phase, we 
choose to keep Time constant during the first treatment phase. As illustrated in the three 
design matrices, the coding of the time predictors depends on which phase’s slopes the 
researcher wants to compare. A summary table using design matrices 6 through 8 to analyze 
the ABAB design of the first participant of Moes’ study (1998) is given in Table 6.4.  
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Table 6.4 
Summary Results ABAB Regression Analysis using the Alternative Way of Coding: Design Matrix 6 – Design 
Matrix 8 
Coefficient Parameter Estimate (SE) 
Design Matrix 6   
     Outcome score at the start of A1  ̂  73.61* (4.49) 
     Linear trend during A1  ̂  6.55* (1.83) 
     Immediate treatment effect in the first AB pair  ̂  -51.15* (4.56) 
     Linear trend during B1  ̂  0.59   (1.83) 
     Difference in outcome score when removing the treatment  ̂  29.42* (7.56) 
     Linear trend during A2  ̂  1.52   (1.83) 
     Immediate treatment effect in the second AB pair  ̂  -53.85* (-6.92) 
     Difference in trend between B1 and B2  ̂  -1.95   (-0.75) 
Design Matrix 7   
     Outcome score at the start of A1  ̂  73.61* (4.49) 
     Linear trend during A1  ̂  6.55*  (1.83) 
     Immediate treatment effect in the first AB pair  ̂  -51.15* (7.56) 
     Difference in trend between A1 and B1  ̂  -5.96*  (2.59) 
     Difference in outcome score when removing the treatment  ̂  29.42* (7.56) 
     Linear trend during A2  ̂  1.52   (1.83) 
     Immediate treatment effect in the second AB pair  ̂  -53.85* (-6.92) 
     Difference in trend between A2 and B2  ̂  -2.88   (2.59) 
Design Matrix 8   
     Outcome score at the start of A1  ̂  73.61*  (4.49) 
     Linear trend during A1  ̂  6.55*  (1.83) 
     Immediate treatment effect in the first AB pair  ̂  -51.15*  (7.56) 
     Linear trend during B1  ̂  0.59    (1.83) 
     Difference in outcome score when removing the treatment  ̂  29.42* (7.56) 
     Difference in trend between A1 and A2  ̂  -5.03     (2.59) 
     Immediate treatment effect in the second AB pair  ̂  -53.85* (-6.92) 
     Difference in trend between B1 and B2  ̂  1.95   (-0.75) 
Note. * p < .05. 
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6.4 Alternating Treatment Designs 
Thus far, we have only discussed SSEDs in which a single treatment is introduced (e.g., 
AB design, multiple-baseline designs, and ABAB reversal designs). In many cases however, 
researchers are not only interested in whether one treatment works but also whether one 
treatment works better in comparison to another. In an alternating treatment design (ATD), 
two or more treatments are rapidly alternated (Barlow & Hayes, 1979). In a typical ATD, data 
collection starts with a baseline phase, but during the treatment phase, two or more treatments 
are alternated (see Figure 6.13). Because we cannot identify distinct treatment “phases”, the 
analysis of the data of an ATD differs from those for the SSEDs previously discussed. In 
order to illustrate the design matrices necessary for analyzing ATD data, we use data from the 
study of Luiselli, Suskin, and McPhee (1981). In this study the authors investigate the effects 
of an intermittent (i.e. treatment 1; Figure 6.13) versus continuous (treatment 2; Figure 6.13) 
schedule of overcorrection for a self-injurious autistic child. 
 
Figure 6.13. Graphical presentation of an alternating treatment design. From “Continuous and intermittent 
application of overcorrection in a self-injurious autistic child: Alternating treatments design analysis” by 
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6.4.1.1 Design matrix 9  
Using design matrix 9, an SSED researcher is interested in: 
(a) What is the outcome score at the start of the baseline phase and what is the trend during 
the baseline phase? 
(b) What is the immediate treatment effect for treatment 1 and treatment 2, respectively? 
(c) What are the changes in slopes between the baseline versus the first treatment and between 
the baseline versus the second treatment, respectively? 
Again we use an extension of the Center et al. (1985-1986) regression approach by 
introducing dummy variables for each treatment. The dummy coded variables, Treatmentmis , 
indicate the treatment phase (Treatmentmi = 1 if the person is in treatment phase m on moment 
i., zero otherwise. If all the Treatmentmis are zero, then the measurement occasion belongs to 
the baseline phase). Extending Equation 6.1 for two treatments, using treatment indicators 
Treatment1i and Treatment2i results in the following: 
 
                                            
                                                      (    
 ) 
(6.10) 
The immediate treatment effect of the first treatment,    , is the difference between the 
predicted outcome score using the first treatment’s regression model and the predicted 
outcome score using the baseline regression model at the first measurement occasion of the 
first treatment.     is then the immediate treatment effect of the second treatment. Therefore 
we center the time in                   around the first measurement occasion of the first 
treatment and                   around the first measurement of the second treatment (see 
Figure 6.14). Equation 6.10 allows a comparison between the immediate treatment effect     
in the first treatment and the immediate treatment effect in the second treatment    . Also the 
treatment effect on the time trends in both treatment phases (i.e.     and    ) can be tested. 
The regression coefficients of interest in Equation 6.10 are graphically presented in Figure 
6.14. The results using this proposed analysis method using the data from Luiselli et al. 
(1981) are given in Table 6.5. An interpretation of the coefficients of interest is provided as 
well. 
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Figure 6.14. Hypothetical alternating treatment design. Graphical presentation of coefficients in design matrix 9. 
The X-axis represents the variables Time, Time1 and Time2. Time is recoded such that Time = 0 for the first 
measurement occasion in the baseline phase. Time1 is recoded such that Time1 = 0 at the start of treatment 1. 
Time 2 is recoded such that Time2 = 0 at the start of treatment 2. 
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6.4.1.2 Design Matrix 10  
The previous design matrix allows estimating the change in slope due to the first 
treatment,      and the change in slope due to the second treatment,    . In case the research 
interest lies in estimating the slopes in both treatment phases instead of the changes in slopes, 
we propose the design matrix in which the baseline phase time variable, Time, is held constant 
during the treatment phases (see Figure 6.15). A graphical presentation of the coefficients 
using design matrix 10 is given in Figure 6.15. The results using design matrix 10 applied to 
the data of Luiselli et al. (1981) are displayed in Table 6.5. An interpretation of the 
coefficients of interest is provided as well. 
 
Figure 6.15. Hypothetical alternating treatment design. Graphical presentation of coefficients in design matrix 
10. The X-axis represents the variables Time, Time1 and Time2. Time is recoded such that Time = 0 for the first 
measurement occasion in the baseline phase and is kept constant in the treatment phase. Time1 is recoded such 
that Time1 = 0 at the start of treatment 1. Time2 is recoded such that Time2 = 0 at the start of treatment 2. 
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6.4.2 Conclusion alternating treatment designs 
Alternating treatment designs are of particular interest if multiple treatments are under 
investigation. In this design, the treatments are alternatingly given to the participant(s). This 
allows estimating multiple treatment effects using one design and one participant. In order to 
analyze this type of data, we suggest to include two dummy coded variables,             
and             in order to estimate the immediate treatment effect for each treatment. 
Furthermore, three time variables are needed to estimate the linear trend or the change in 
linear trend. The coding of these time variables depends on the research interest and therefore 
we suggested two modeling options. The results of design matrix 9 and 10 are summarized in 
Table 6.5. The only difference between the matrices is the estimate of     and     
representing the change in slope between treatment and baseline in design matrix 9 versus the 
slope itself during each treatment phase. 
Table 6.5 
Summary Results Alternating Treatment Design Regression Analysis: Design Matrix 9 – Design Matrix 10 
Coefficient  Estimate (SE) 
Design Matrix 10    
    Outcome score at the start of A1  ̂   7.74* (1.96) 
     Linear trend during A1  ̂  -0.33   (0.37) 
     Immediate treatment effect of the first treatment  ̂    5.86   (3.62) 
     Immediate treatment effect of the second treatment  ̂    1.42   (3.65) 
     Difference in trend between the first treatment and the baseline  ̂   -1.07   (0.79) 
     Difference in trend between the second treatment and the baseline  ̂   -0.23   (0.68) 
Design Matrix 11   
     Outcome score at the start of A1  ̂   7.74* (1.96) 
     Linear trend during A1  ̂  -0.33   (0.37) 
     Immediate treatment effect of the first treatment  ̂    5.86   (3.62) 
     Immediate treatment effect of the second treatment  ̂    1.10   (3.42) 
     Linear trend during treatment 1  ̂   -1.39   (0.70) 
     Linear trend during treatment 2  ̂   -0.56   (0.58) 
Note. * p < .05. 
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6.5 Discussion 
6.5.1 General conclusion 
The main rationale for this article is the result of the growing interest in SSEDs as a 
means of establishing an evidence base for intervention effects. Due to the increased number 
of published SSED studies in a variety of different research fields, there is a need to 
summarize SSED data across studies in order to make generalized decisions and to inform 
research and policy. If a conclusion is reached across a large number of studies, one can be 
more confident in the study results. In order to synthesize SSED data across a large number of 
studies, statistical techniques are needed. In this article we proposed a regression model-based 
approach, which was already suggested in the 80s, as a flexible and easy way to analyze 
SSED data. The regression approach results in an effect size estimate (i.e., immediate 
treatment effect and treatment effect on the slope), and allows the modeling of 
autocorrelation, non-linear trends, predictors, etc. Despite the enormous flexibility of the 
regression technique, little is known about the interpretation of the regression coefficients and 
the consequences of misspecifying the design matrix. As a consequence, this article aims to 
provide guidance to SSED analysts about how to specify the design matrix in order to answer 
predefined research question. We illustrated that the specification of the design matrix and the 
interpretation of the regression coefficients are interdependent. We only discussed the most 
common and typical research questions per design that SSED researchers might have. Other 
researcher questions can also be resolved using a little modification of the suggested coding 
schemes. Also note that parameters of interest can be estimated indirectly. For instance, in 
design matrix 4, the slope during the treatment is estimated directly but it might be the case 
that the SSED researcher is interested in the change in slope between baseline and treatment 
rather than in the slope during the treatment. In this situation, the change in slope can be 
estimated based on the estimated slope during the baseline and the estimated slope during the 
treatment. However, we do not advise calculating parameters of interest indirectly, because 
the standard errors and p-values are not given and have to be calculated by hand. 
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6.5.2 Limitations and suggestions for future research 
Although we focused on the design matrix of the three most common SSEDs, we are 
aware that combinations of different designs are possible. For instance, an alternating 
treatments design might be implemented using the same staggering of intervention start times 
across participants. Also simplification or extensions of the presented designs are possible, 
including, for example, ABA, ABABAB designs or alternating treatment designs without a 
baseline phase. In this article we present the coding schemes for the most common design 
types, but these coding schemes can easily be modified. Because we used regression analysis, 
we have to re-emphasize the assumptions that are made, such as linear trends in baseline and 
treatment phases, and errors that are normally and independently distributed. A violation of 
one or some of these assumptions might lead to misleading results. Moreover the regression 
equation as proposed here is suitable for continuous data, when the data are counts, a 
generalized (multilevel) regression model would be more appropriate. In the current 
examples, we included only two kinds of predictors, representing the phase and time, but 
additional predictors might be included such as a quadratic time term. It is also possible that 
no time trends are expected. Although we did not cover all the possible variations of design 
matrices, the ones proposed in this article cover a substantial variety of research questions for 
the three most common SSEDs. However, our suggestion for further research is to further 
extend the regression equations proposed in this manuscript by adding complexities such as 
autocorrelation, non-linear trends, non-continuous outcome scores, heterogeneous within-case 
variance etc. Further research is needed to combine different types of SSEDs because this can 
lead to more accurate and reliable treatment effect inferences. If the same research finding is 
found across different types of SSEDs, the research findings are more reliable. In addition, 
more SSED data are available, which results in more accuracy in the average treatment effect 
estimate. 
Despite the limitations and assumptions, use of parametric statistics is preferable over 
nonparametric statistics because the latter approach cannot easily model trends in the data, 
discriminate between large treatment effects due to ceiling effects, and be associated with a 
tractable sampling distribution. The regression approach is easily conducted using standard 
statistical software packages and results in calculation of effect size estimates. The resulting 
effect size estimates can be used to summarize results from a large body of SSED studies 
thereby offering a stronger evidence base about interventions’ effects which will ultimately be 
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 Chapter 7|
From a Single-Level to a Multilevel 





Multilevel modeling provides one approach to synthesizing single-case experimental 
design data. In this study, we present the multilevel model (the two-level and the three-level 
models) for summarizing single-case results over cases, over studies, or both. In addition to 
the basic multilevel models, we elaborate on several plausible alternative models. We apply 
the proposed models to real datasets and investigate to what extent the estimated treatment 
effect is dependent on the modeling specifications and the underlying assumptions. By 
considering a range of plausible models and assumptions, researchers can determine the 
degree to which the effect estimates and conclusions are sensitive to the specific assumptions 
made. If the same conclusions are reached across a range of plausible assumptions, 
confidence in the conclusions can be enhanced. We advise researchers not to focus on one 
model but conduct multiple plausible multilevel analyses and investigate whether the results 
depend on the modeling options. 
Keywords: single-case experimental design, multilevel analysis 
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7.1 Introduction 
The use of single-case designs in a variety of different research fields in education as 
well as the suggested methods to analyze these types of designs have been expanding for 
decades. In this article, we describe and illustrate one method, namely, the use of multilevel 
modeling, which provides an appropriate method to analyze and summarize single-case data 
(Moeyaert et al., 2013a; Owens & Ferron, 2012; Van den Noortgate & Onghena, 2008). In a 
single-case study, usually multiple cases, subjects, or participants are involved and repeatedly 
measured over time (Shadish & Sullivan, 2011). Therefore, in addition to the case-specific 
estimates, it is useful to develop methods to summarize the results over cases within a 
particular study. In the first part of this article, we present the basic two-level regression 
modeling framework that can be used to estimate the treatment effect across cases within 
studies and the between-case variance of this treatment effect (Van den Noortgate & 
Onghena, 2003a). We suggest and illustrate a sensitivity analysis approach in which multiple 
alternative specifications of this basic two-level model are examined. For illustration, we use 
the dataset of Lambert, Cartledge, Heward, and Lo (2006). In order to allow further 
examination of external validity and contribute to evidence-based research (Shadish & 
Rindskopf, 2007), multiple single-case studies measuring the same outcome variable can be 
combined using the three-level model, which is a straightforward extension of the two-level 
model. Thus, the second part of this article focuses on the three-level model. We present the 
basic three-level model assuming no linear trends in which the treatment effect across cases 
and across studies can be estimated as well as the between-case and between-study variances 
of this estimate. We will discuss the flexibility of this three-level modeling framework by 
suggesting multiple alternatives to the basic three-level model. The basic three-level model 
and alternative specifications of this basic three-level model will be illustrated by 
summarizing five studies in which a multiple-baseline across participants design was used to 
investigate the effects of pivotal response training with children with autism.  
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7.2 From a Single-Level to a Two-Level Framework 
7.2.1 Two-level model 
In single-case experiments, usually more than one case is the focus of interest (Shadish 
& Sullivan, 2011), such as in the replicated ABAB reversal designs and the multiple-baseline 
across participants designs. In this first design, there are multiple baseline phases (A phases) 
and multiple treatment phases (B phases), and the same ABAB design is implemented 
simultaneously to different participants (see Figure 7.1a). In the multiple-baseline across 
participants design, an AB phase design (with one baseline phase, A, and one treatment phase, 
B) is delivered simultaneously to different participants and the start of the delivery is 
staggered across the participants (see Figure 7.1b). 
 
Figure 7.1. Graphical display of an ABAB reversal design (a) and a multiple-baseline across participants design 
(b) using hypothetical datasets. 
In order to analyze these single-case data, an autoregressive integrated moving average 
approach (Velicer & Fava, 2003), an ordinary least square regression analysis (Huitema & 
McKean, 1998), or a generalized least squares regression analysis (Maggin et al., 2011) could 
be performed for each case within the single-case study separately. These analysis procedures 
allow researchers to estimate case-specific treatment effects. However, in order to add to 
evidence-based research, researchers are not only interested in whether a specific treatment 
works for a particular case but also whether its effect can be generalized to other cases. 
Therefore, in addition to case-specific estimates, there is a need to estimate the average 
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treatment effect across cases within the same study. If there are only two cases within a study, 
a single-level analysis is reasonable to estimate the treatment effects for the two cases 
separately, compare them, and calculate the average in order to find the average treatment 
effect. However, Shadish and Sullivan’s (2011) review of 809 single-case studies published in 
2008 indicated that the number of cases within studies can range from 1 to 13 with an average 
of 3.64. Moreover, there is an increased interest in using scaled-up multiple-baseline designs. 
For instance, the study of Koutsoftas et al. (2009) included 36 participants, which makes it 
practically complex and inefficient to estimate treatment effects for each participant 
separately and to calculate the average treatment estimate and the between- and within-case 
variability of this treatment effect.  
Therefore, Van den Noortgate and Onghena (2003a, 2003b) suggested combining 
single-case data within a study using a two-level model, which is a simple extension of a 
regression equation, in which the hierarchical nature of single-case data is taken into account. 
Measurement occasions, going from 1 up to I, are nested within a case, j, and in each study 
there are J cases. At the first level, a regression equation in which the outcome score for case j 
at measurement occasion i,     (e.g., the number of correct responses at a particular moment i 
for case j) is regressed on an intercept, indicating the baseline level for case j and a dummy 
coded variable,        , indicating the condition (if         = 0, measurement occasion i 
belongs to the baseline phase, A, otherwise to the treatment phase, B). Following regression 
equation can be used:  
Level 1 (Model 1A): 
                                     (    
 ) (7.1) 
The within-case residuals, the    s, are assumed to be independent, identically, and normally 
distributed. At the second level, the case-specific coefficients from the first level,     and    , 
are modeled as varying across participants because it is unlikely that the estimated baseline 
level and the treatment effect are the same for all cases within a particular study: 
Level 2 (Model 1A): 
{
           
           
           [
   
   




   
      
        
 ]) 
(7.2) 
In Equation 7.2,     indicates the average baseline level, and     represents the 
treatment effect across the J cases. Each individual case, j, can have a baseline level and a 
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treatment effect that deviate from the average baseline level,    , and the average treatment 
effect,    , quantified by the participant-specific residuals (    and    , respectively). Level-2 
residuals are also assumed to be independent and identically, and multivariate normally 
distributed. Single-case researchers are interested in the average baseline level,    , as this 
level can be used to substantiate the need for intervention. Of primary interest, however, is the 
average treatment effect,    , because this parameter indexes the magnitude of the shift in 
behavior that tends to occur with intervention. This two-level framework can also be used to 
estimate the between-case variance in baseline level and treatment effect indicated by    
  and 
   
  respectively and the covariance between the baseline level and treatment effect, indicated 
by      . The variance component    
  would be particularly useful for a researcher interested 
in determining whether the shift in behavior associated with treatment is similar across 
participants or whether the shift in behavior differs substantially across participants and thus 
indicates that the treatment is differentially effective. Another advantage is that, in addition to 
estimating the average treatment effect and the variance in the treatment effect, researchers 
can obtain empirical Bayes estimates of case-specific treatment effects.  
By using this two-level model, we have to be aware of several assumptions. First, we 
assume that the outcome variable is continuous (e.g., the score on a math test) and that the 
errors at the different levels are independent, identically, and normally distributed. Another 
drawback is that the variance estimates (i.e., the between-case variance of the baseline level 
and the between-case variance of the treatment effect) can be biased when a limited number 
of participants are included. Ferron et al. (2009) studied restricted maximum likelihood 
estimation of this two-level model assuming no covariance between the baseline level and 
treatment effect (i.e.,       = 0) and found unbiased estimates of the average treatment effect 
but biases in the estimates of    
  and    
  with four, six, and eight participants. Furthermore, 
the model does not take trends into account whereas linear, quadratic, or nonlinear trends are 
possible. Modeling a time trend can be accomplished by adding predictors at the first level, 
for instance a continuous time variable if a linear trend is expected. Also, case-specific 
predictors, such as age or gender, can be included at the second level in order to explain the 
between-case variability. We illustrate the flexibility of the two-level model by proposing 
several modeling options in addition to the basic two-level model (see Equation 7.1). The 
basic two-level model together with several alternative models will be illustrated using the 
Lambert et al. dataset (2006). By analyzing this dataset using different models, we can also 
investigate to what extent the estimated treatment effect, which is the primary interest of the 
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single-case researcher, is sensitive to the different modeling options. If we will find similar 
results across the different models, then we can be more confident in the results. 
7.2.2 Empirical illustration of the two-level model 
As discussed in the first section, the multilevel modeling approach is very flexible which 
gives us several modeling options for analyzing the Lambert et al. (2006) dataset. In the first 
part, we illustrate the basic two-level model, which will be modified in several ways in the 
second part, representing more complex and probably more realistic modeling assumptions. 
When discussing the results, we use .05 as the alpha-level. We used SAS 9.3 to conduct the 
analysis and the SAS codes for the basic two-level model (i.e., Model 1) as well as the 
extensions to this model (Models 2 to 4) contained in Addendum A5. 
7.2.2.1 Model 1: the basic two-level model 
We use the replicated ABAB reversal design study of Lambert et al. (2006) to illustrate 
the two-level model. We indicate the first and the second baseline phases by A1 and A2, 
respectively, and the first and second treatment phases by B1 and B2, respectively (see Figure 
7.2). 
 
Figure 7.2. Graphical display of an ABAB reversal design using a hypothetical dataset. 
In the simplest scenario, the single-case researchers’ interest lies in the average 
estimated treatment effect across cases within a study and the variability of this estimated 
effect between cases. In this scenario, measurement occasions belonging to baseline phases 
(A1 or A2), are indicated by         = 0, and measurements obtained during treatment 
phases (B1 or B2) have         = 1. The average estimated baseline level,  ̂  , the average 
estimated treatment effect,  ̂  , the between-case variance of these estimates and the 
covariance between these estimates as well as the within-case variance estimate are presented 
in Table 7.1 and labeled as Model 1A. The SAS code can be found in Addendum A5 (Model 
1A).  
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Table 7.1 
Parameter and Standard Error Estimates Resulting from Estimation of Model 1A and Model 1B Using the 
Lambert et al. (2006) Dataset 
  Parameter Parameter 
estimate 
SE p 
Model 1A      Fixed coefficient     
 Average baseline level     6.78* 0.40 < .001 
 Average treatment effect     -5.40* 0.34 < .001 
  (Co)variance component    
 Baseline level    
  1.14* 0.67 .045 
 Treatment effect    
   0.43 0.49 .191 
 Covariance between baseline level and 
treatment effect 
      -0.79  0.54 .142 
      Residual variance   
  4.44* 0.40 < .001 
Model 1B  Fixed coefficient    
 Average baseline level, first AB pair     6.88* 0.34 < .001 
 Average treatment effect, first AB pair     -5.66* 0.38 < .001 
 Average change in level, from B1 to A2     5.35* 0.61 < .001 
 Average treatment effect, second AB pair     -5.08* 0.49 < .001 
  Variance component    
      Baseline level, first AB pair    
  0.52 0.41 .102 
 Treatment effect, first AB pair    
  0.00 - - 
 Change in level, from B1 to A2    
  1.93 1.51 .100 
 Treatment effect, second AB pair    
  1.07 1.02 .148 
 Residual variance   
  4.28* 0.39 < .001 
Note. * p < .05. 
In a second scenario, the single-case researcher is interested in the estimated change in 
outcome score when another phase is introduced. In order to estimate the change in outcome 
score due to the introduction or removal of a treatment, Shadish et al. (2013) suggested 
extending Equation 7.1 by adding three dummy coded predictors indicating the phase. We 
chose to name the dummy variables       ,        and       . The first dummy variable 
       equals 1 if measurement occasion i from case j is obtained after the first baseline 
phase;        equals 1 for all measurement occasions after the first treatment phase, and 
       equals 1 if the measurement occasion occurs in the last treatment phase. If       , 
      , and        equal simultaneously 0, then the measurement is taken in the first 
baseline phase.  By choosing this way of coding, the expected value during the first baseline 
phase (A1) equals     (i.e.,     +    * 0 +    * 0 +     * 0), whereas the expected value 
during the first treatment phase equals     +     (i.e.,     +    * 1 +    * 0 +     * 0).  
Therefore,     indicates the treatment effect during the first treatment phase. The expected 
value during the second baseline phase is     +     +     (i.e.,      +    * 1 +    * 1 +     * 
0), and in this way,     indicates the effect of removing the treatment on the outcome score. 
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The expected value during the second intervention is     +     +     +     (=     +    * 1 + 
   * 1 +     * 1), and therefore     is the treatment effect during the second AB pair. 
This results in Equation 7.3: 
Level 1 (Model 1B): 
                                                    (    
 ) (7.3) 
In Table 7.2, the coding scheme for the first case of the Lambert et al. (2006) study is 
demonstrated. Using these three dummy variables (i.e.,      ,      , and      ),     
indicates the change in level between phase A1 and B1,     refers to the jump from phase B1 
to phase A2, and the last coefficient,    , represents the change in expected outcome score 
from phase A2 to phase B2. The four coefficients of the first level vary at the second level, 
which makes it possible to estimate the average treatment effects across cases and the 
between-case variability in this treatment effect. The results of using this second way to 
analyze the single-case data are presented in Table 7.1 under Model 1B and the SAS code can 
be found in Addendum A5 (Model 1B). Note that for both Model 1A and Model 1B the 
covariance between the coefficients at the second level is estimated. However, we only 
presented the covariance for Model 1 A because otherwise Table 7.1 would be too extensive, 
and the main interest lies in the fixed effects and the variance estimates and not in the 
covariance estimates. 
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Table 7.2 
Demonstrating Second Way of Coding Predictors in an ABAB Reversal Design using Model 1B 
A1B1 B1A2 A2B2 Y 
0 0 0 7 
0 0 0 9 
0 0 0 8 
0 0 0 6 
0 0 0 7 
0 0 0 4 
0 0 0 5 
0 0 0 1 
1 0 0 2 
1 0 0 0 
1 0 0 1 
1 0 0 0 
1 0 0 0 
1 1 0 3 
1 1 0 8 
1 1 0 8 
1 1 0 6 
1 1 0 10 
1 1 0 10 
1 1 0 10 
1 1 0 8 
1 1 1 3 
1 1 1 4 
1 1 1 1 
1 1 1 3 
1 1 1 2 
1 1 1 4 
1 1 1 0 
1 1 1 1 
1 1 1 0 
For Model 1A, the estimated average treatment effect across phases and across cases 
was -5.40, t(16.99) = -15.96, p < .001, indicating a significant reduction in disruptive behavior 
due to the treatment. From Model 1B, the change in level during the first AB pair and the 
second AB pair are both statistically significant:  ̂   = -5.66, t(239) = -14.75, p < .001, and 
 ̂   = -5.08, t(8.91) = -10.37, p < .001. The mean of the estimated treatment effects of the first 
AB pair and the second AB pair is -5.37: [i.e., -5.66 + (-5.08)] / 2 and equals (as expected) 
approximately the average estimated treatment effect across phases and across cases using 
Model 1A ( ̂   = -5.40).  
In terms of the variance estimates, only the residual within-case variance is statistically 
significant in both Models. Note that the Wald test was used to investigate whether the 
variance components were significant. Given the small number of participants, the Wald test 
is questionable, and it might be better to consider the likelihood ratio test (Snijders & Bosker, 
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2002). Therefore, the difference in deviance score between the model with the variance 
component of interest and the model without the variance component of interest can be 
calculated. For instance, the deviance score of Model 1A without the between-case variance 
of the baseline level and with the between-case variance of the baseline level equals 1175.2 
and 1153.4 respectively. The difference in the deviance is 21.8, which can be compared to a χ² 
distribution with 2 degrees of freedom (i.e., the number of degrees of freedom is calculated as 
the difference in parameters in the models that are compared) and indicates a statistically 
significant between-case variance of the intercept (similar to what was found with the Wald 
test, see Table 7.1). In the remainder of this article, we will focus primarily on the average 
effects, but we will present the variance components for completeness and use the Wald test 
for simplicity (because it is used by default in the statistical software program we used). We 
encourage readers to view the estimates of the variance components and the inferences about 
them with more caution than the estimates of the average effects and the inferences about 
them. 
Although we estimated the average baseline level and average treatment effect across 
cases, we can also estimate the case-specific baseline level and treatment effect. Therefore, 
we simply add the command “solution” after the random statement in the model specification 
(see Addendum A5, Model 1A and Model 1B). Table 7.3 presents the results for the first three 
cases of the Lambert et al. (2006) dataset for Models 1A and 1B, respectively. Using Model 
1A,  ̂   and  ̂   refer to the estimated baseline level and the treatment effect respectively for 
the j
th
 case. Using Model 1B,  ̂   refers to the estimated baseline level during the first baseline 
for the j
th
 case and  ̂  ,  ̂  , and  ̂   refer to the changes in level between the consecutive 
phases for the j
th
 case. The estimates using Model 1B are graphically presented in Figure 7.3. 
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Table 7.3 
Results Empirical Bayes Estimation of the Case-Specific Effects for the First Three Cases of the Lambert et al. 
(2006) Dataset using the Basic Two-Level Model 
  Parameter Parameter 
estimate 
SE p 
Model 1A      
Case 1 Baseline level     6.79* 0.52 < .001 
 Treatment level     -5.23* 0.40 < .001 
       
Case 2 Baseline level     8.09* 0.54 < .001 
 Treatment level    
 
 -6.29* 0.79 < .001 
       
Case 3 Baseline level     7.80* 0.58 < .001 
 Treatment level    
 
 -5.81* 0.81 < .001 
Model 1B      
Case 1 Baseline level A1     5.73* 0.72 < .001 
 Treatment level B1     -4.79* 1.14 < .001 
 Baseline level A2    
 
 6.69* 1.14 < .001 
 Treatment level B2    
 
 -5.52* 0.98 < .001 
       
Case 2 Baseline level A1     7.22* 0.77 < .001 
 Treatment level B1     -5.58* 1.12 < .001 
 Baseline level A2     6.96* 1.08 < .001 
 Treatment level B2     -6.48* 0.98 < .001 
  
 
     
Case 3 Baseline level A1     7.56* 0.83 < .001 
 Treatment level B1     -6.76* 1.21 < .001 
 Baseline level A2     6.93* 1.17 < .001 
 Treatment level B2     -4.76* 1.04 < .001 
Note. * p < .05.  
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Figure 7.3. Graphical presentation case specific baseline level and changes in level between consecutive phases 
for the first three cases from the Lambert et al. (2006) study.  
Using Models 1A and 1B, we make several assumptions, such as (1) the outcome 
variable,    , is continuous, (2) errors at the first and second level are independent, identically, 
and multivariate normally distributed, (3) there are no time-trends, and (4) there is no 
systematic variation between the two classes from which the participants came. Because we 
make several assumptions in the basic two-level model, we suggest multiple alternatives to 
analyze the Lambert et al. (2006) dataset based on visual analysis of the graphs included in 
the original study. Similar to the first part, in the alternative models, Model A will refer to the 
first way of coding in which the research interest lies in the average treatment effect estimate 
across phases and Model B will refer to the alternative way of coding in which the treatment 
effect during the first AB pair and the second AB pair are estimated separately. 
In all these models, we discuss the average estimates across cases for the fixed effects. Case-
specific estimates can also be obtained by adding the command “solution” in the random 
specification (see Addendum A5). In addition to the fixed effect estimates (i.e., treatment 
effect estimate), the between-case variance in intercept and treatment effects is estimated. 
Also, the covariances between the regression coefficients at the second level are estimated but 
not presented in the tables for simplicity. 
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7.2.2.2 Model 2 
In a single-case design, cases are measured repeatedly over time. Therefore, it is likely 
that outcome scores that are measured closer in time are more related to each other than 
outcome scores measured further away in time. For instance, in single-case data, event effects 
that influence the score at a certain moment can also influence scores on one or more 
succeeding occasions which lead to similarity among errors that are close to each other in 
time (Kromrey & Foster-Johnson, 1996). As a consequence, the assumption of independence 
of errors may be violated because of autocorrelation (Ferron et al., 2009; Huitema & McKean, 
1994; McKnight, McKean, & Huitema, 2000). In the basic two-level model (see Equation 
7.1), we modeled the level-one errors as    , but there are many other covariance structures 
possible, of which the first-order autoregressive type is often used (Goldstein, 1995; 
Goldstein, Healey, & Rasbash, 1994; Wolfinger, 1996).  
In addition to modeling autocorrelation, we also question the assumption of 
homogeneous within-case variance across phases. From the graphical presentation of the 
single-case data (Lambert et al., 2006), we expect that there is more variability in outcome 
scores during the baseline phase in comparison to the outcome scores during the treatment 
phase. Therefore, in this model, we assume heterogeneous phase variances and this is 
indicated by   ( )
  and   ( )
  in Table 7.4 referring to the within-case variance in the baseline 
and treatment phases, respectively. Assuming first-order autoregressive autocorrelation and 
heterogeneous within-case variance, we obtain the results presented in Table 7.4.  ( ) and 
 ( ) refer to the estimated autocorrelation in the baseline and treatment phases, respectively. 
The SAS code for Models 2A and 2B is presented in Addendum A5. 
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Table 7.4 
Parameter and Standard Error Estimates Resulting from Estimation of Models 2A and 2B Using the Lambert et 
al. (2006) Dataset 
  Parameter Parameter 
estimate 
SE p 
Model 2A      Fixed coefficient     
Average baseline level     6.73* 0.43 < .001 
Average treatment effect     -5.36* 0.37 < .001 
  Variance component    
Baseline level    
        0.95 0.84 .130 
Treatment effect    
  0.20 0.64 .378 
Residual variance, baseline   ( )
  6.09* 0.91 < .001 
Residual variance, treatment   ( )
  3.14* 0.45 < .001 
Autocorrelation, baseline  ( ) 0.34* 0.10 < .001 
Autocorrelation, treatment  ( ) 0.23* 0.10  .019 
Model 2B  Fixed coefficient    
Average baseline level, first AB pair     6.95* 0.42 < .001 
Average treatment effect, first AB pair     -5.76* 0.50 < .001 
Average change in level, from B1 to A2     5.23* 0.55 < .001 
Average treatment effect, second AB pair     -4.92* 0.49 < .001 
  Variance component    
Baseline level, first AB pair    
  0.21 0.62 .362 
Treatment effect, first AB pair    
  0.00 - - 
Change in level, from B1 to A2    
  1.42 1.85 .221 
Treatment effect, second AB pair    
  0.13 1.16 .455 
Residual variance, baseline   ( )
  5.96* 0.93 < .001 
Residual variance, treatment   ( )
  3.22* 0.52 < .001 
Autocorrelation, baseline  ( ) 0.32* 0.10 .002 
Autocorrelation, treatment  ( ) 0.25* 0.11 .027 
Note. * p < .05 
The estimated variance in the treatment phase is smaller (more than twice) than the 
variance estimated for the baseline phase and both variance estimates are statistically 
significant. Furthermore, we found that the estimated autocorrelation in the baseline phase 
and the treatment phase is similar across the two models. The autocorrelation in the baseline 
and in the treatment phases using Model 2B equals 0.32, Z = 3.10, p = .002, and 0.25, Z = 
2.21, p = .027, respectively. The estimated treatment effects are similar to those estimated in 
previous models, which indicates that for this dataset, specification of autocorrelation and 
across-phase heterogeneity does not have a large influence. 
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7.2.2.3 Model 3 
The graphical presentation of the data of the students investigated in the Lambert et al. 
(2006) dataset indicates that linear trends during both baseline and treatment phase are 
possible. Therefore, we suggest including time predictors in Model B in order to investigate 
changes in slopes due to the transition from one phase to another phase. Moeyaert et al. 
(2014b) proposed including four time variables (T1, T2, T3, and T4) in addition to the dummy 
variables (A1B1, B1A2, and A2B2) to estimate changes in trends between the phases of 
interest. In this way, single-case researchers can (in addition to modeling a shift in level due 
to the introduction or removal of a treatment) investigate whether there is a difference in 
trends between pairs of adjacent phases. The coding for the time variables depends on the 
changes in trends a researcher is interested in. In this third proposed model, we discuss the 
coding scheme to investigate whether the treatment effect on the trend during the first AB pair 
is different than the treatment effect on the time trend during the second AB pair. Other 
coding schemes are also possible. For a detailed discussion of these alternative coding 
scenarios, we refer readers to Moeyaert et al. (2014b). 
We code T1, T2, T3 and T4 as follows: The first time variable, T1, equals zero at the 
start of the first baseline phase (A1) and remains constant after condition B1. T2 is centered 
around the start of the first treatment phase (B1) and remains constant after that phase is 
completed. T3 is centered around the first measurement occasion of the second baseline phase 
(A2), and T4 is centered around the first measurement occasion of the second treatment phase 
(B2). In Table 7.5, the coding scheme is displayed using one student from the study of 
Lambert et al. (2006).  
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Table 7.5 
Coding Scheme for the Reversal ABAB Single-Case Design Including Changes in Trends 
Dummy coded variable 





A1B1 B1A2 A2B2  T1 T2 T3 T4  Y 
0 0 0  0 -10 -16 -23  10 
0 0 0  1 -9 -15 -22  6 
0 0 0  2 -8 -14 -21  9 
0 0 0  3 -7 -13 -20  4 
0 0 0  4 -6 -12 -19  5 
0 0 0  5 -5 -11 -18  9 
0 0 0  6 -4 -10 -17  6 
0 0 0  7 -3 -9 -16  10 
0 0 0  8 -2 -8 -15  9 
0 0 0  9 -1 -7 -14  9 
1 0 0  10 0 -6 -13  4 
1 0 0  11 1 -5 -12  3 
1 0 0  12 2 -4 -11  4 
1 0 0  13 3 -3 -10  4 
1 0 0  14 4 -2 -9  1 
1 0 0  15 5 -1 -8  0 
1 1 0  15 6 0 -7  3 
1 1 0  15 6 1 -6  5 
1 1 0  15 6 2 -5  8 
1 1 0  15 6 3 -4  10 
1 1 0  15 6 4 -3  10 
1 1 0  15 6 5 -2  10 
1 1 0  15 6 6 -1  6 
1 1 1  15 6 7 0  3 
1 1 1  15 6 8 1  0 
1 1 1  15 6 9 2  2 
1 1 1  15 6 10 3  4 
1 1 1  15 6 11 4  1 
1 1 1  15 6 12 5  0 
1 1 1  15 6 13 6  1 
1 1 1  15 6 14 7  3 
1 1 1  15 6 15 8  0 
1 1 1  15 6 16 9  1 
1 1 1  15 6 17 10  0 
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In order to estimate the parameters of interest, the following regression equation can 
be used: 
Level 1 (Model 3): 
    (           )  (           )        (           )      
 (           )           ( )          ( )  (    
 ) 
(7.4) 
The m in the error term,    ( )  equals A or B and is used to indicate that we model 
heterogeneous within-case phase variances.    ( ) is the residual within the baseline phase and 
   ( ) indicates the residual in the treatment phase.     and     indicate the outcome score at 
the start of phase A1 and the trend during phase A1, respectively.     and     represent the 
immediate treatment effect (i.e., the shift in level at the time of the first treatment phase 
observation) and the treatment effect on the trend (i.e., the change in slope) in the first AB 
pair.     is the difference in outcome score when removing the treatment (from phase B1 to 
phase A2), and     is the trend during phase A2.     is the immediate treatment effect in the 
second AB pair and     is the difference in trend between phase A2 and phase B2. The single-
case researcher is especially interested in    ,    ,     and     because     and     represent 
the immediate treatment effect and the treatment effect on the slope, respectively, during the 
first AB pair.     and     represent the immediate treatment effect and the treatment effect on 
the slope, respectively, during the second AB pair. 
We only discuss the second way of coding (Model B) because it is reasonable that the 
slopes during similar phases differ. The SAS code is presented in Addendum A5, and the 
results are displayed in Table 7.6. The covariance between the coefficients is estimated, but 
for simplicity not included in Table 7.6. Similar to Models 1 and 2, we conclude that the 
estimated immediate treatment effect during both AB pairs is statistically significant. The 
treatment effect on the trend during both AB pairs is statistically significant. The estimated 
autocorrelation during the baseline phase is statistically significant and equals 0.37, Z = 4.05, 
p < .001, whereas the estimated autocorrelation during the treatment phase is not significant 
and equals 0.10, Z = 1.10, p = .269. 
  
178  Chapter 7 | From a single-level to a multilevel analysis 
 
Table 7.6 
Parameter and Standard Error Estimates Resulting from Estimation of Model 3 Using the Lambert et al. (2006) 
Dataset 
  Parameter Parameter 
estimate 
SE p 
Model 3  Fixed coefficient    
 Average baseline level, phase A1     7.11* 0.48 < .001 
 Average trend, phase A1          -0.04  0.07 .546 
 Average treatment effect, first AB pair     -5.10* 0.69 <.001 
 Average treatment effect on trend, first AB pair     -0.16* 0.07 .032 
 Average change in level from B1 to A2     4.61* 0.78 < .001 
 Average trend, phase A2     0.49* 0.17 .005 
 Average treatment effect, second AB pair     -5.77* 0.84 < .001 
 Average treatment effect on trend, second AB 
pair 
    -0.66* 0.17 <.001 
  Variance component    
      Baseline level, phase A1    
  0.03 0.10 0.40 
 Trend, phase A1    
  0 - - 
 Treatment effect, first AB pair    
  0 - - 
 Treatment effect on trend, first AB pair    
  0 - - 
 Change in level from B1 to A2    
  0 - - 
 Trend, phase A2   
  0 - - 
 Treatment effect, second AB pair    
  0 - - 
 Treatment effect on trend, second AB pair    
  0 - - 
 Residual variance, baseline   ( )
  6.27* 0.92 < .001 
 Residual variance, treatment   ( )
  2.66* 0.34 < .001 
 Autocorrelation, baseline  ( ) 0.37* 0.09 < .001 
 Autocorrelation, treatment  ( )       0.10 0.09 .269 
Note. * p < .05. 
7.2.2.4 Model 4  
In all previous suggested models, only level-1 predictors were included (i.e., dummy 
variables indicating the phase to which a measurement occasion belongs and time-related 
predictors). In this fourth model, we add a predictor at the second level, namely the class to 
which a participant belongs. The intent of adding a predictor at the second level is to explain 
the between-case variance. We include the predictor class in the first equation of the level-2 
equations (see Equation 7.5) in order to explain between-case variance in baseline levels. We 
expect that the initial outcome score (i.e., outcome score during phase A1) can partially be 
explained by the class to which a student belongs. We do not expect that changes in outcome 
scores due to the introduction or removal of the treatment can be explained by the class 
predictor. As a consequence, the regression equations at the second level look as follow:  
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Level 2 (Model 4): 
           (     )     
           
           
           
           
           
           











   
   
   
   
   
   
   
   























































   
                                    
        
                               
             
                          
                  
                     
                       
                
                            
           
                                 
      





















We only discuss Model B because it is reasonable that the slopes during similar phases differ, 
and therefore pooling the data from different phases together is conceptually not reasonable. 
The results of this fourth model are presented in Table 7.7. The covariance between the 
coefficients is estimated but for simplicity not presented in Table 7.7. The SAS code is 
presented in Addendum A5, Model 4 . 
The baseline level for students belonging to class A equals 7.22, t(47.1) = 15.24, p < 
.001, whereas the baseline level for students belonging to class B was estimated to be lower 
but not by a statistically significant amount:  ̂   = -0.52, t(20.1) = -1.45, p = .163. This is 
consistent with the graphical presentation of the single-case data of the study of Lambert et al. 
(2006). Note that the treatment effect estimates (immediate shifts in level and changes in 
slope) and resulting conclusions are similar whether the predictor class is added to the model 
(Table 7.7) or not (Table 7.6). 
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Table 7.7 
Parameter and Standard Error Estimates Resulting from Estimation of Model 4 Using the Lambert et al. (2006) 
Data 
  Parameter Parameter 
estimate 
SE p 
Model 4  Fixed coefficient    
 Average baseline level, first AB pair     7.22* 0.47 < .001 
 Average effect of belonging to class B during A1          -0.52 0.36 .163 
 Average trend, phase A1           0.01 0.08 .907 
 Average treatment effect, first AB pair     -5.53* 0.74 < .001 
 Average treatment effect on trend, first AB pair          -0.13 0.07 .085 
 Average change in level, from B1 to A2     4.49* 0.77 < .001 
 Average trend, phase A2           0.39* 0.18 .037 
 Average treatment effect, second AB pair     -5.60* 0.84 < .001 
 Average treatment effect on trend, second AB pair          -0.60* 0.18 <.001 
  Variance component    
      Baseline level, first AB pair    
  0.006 0.09 .472 
 Trend, phase A1    
  0.00 - - 
 Treatment effect, first AB pair    
  0.00 - - 
 Treatment effect on trend, first AB pair    
  0.00 - - 
 Change in level, from B1 to A2    
  0.00 - - 
 Trend, phase A2    
  0.00 - - 
 Treatment effect, second AB pair    
  0.00 - - 
 Treatment effect on trend, second AB pair    
  0.00 - - 
 Residual variance, baseline    
  6.08* 0.88 < .001 
 Residual variance, treatment    
  2.69* 0.35 < .001 
 Autocorrelation, baseline  ( ) 0.35* 0.09 < .001 
 Autocorrelation, treatment  ( )         0.12  0.09 .22 
Note.      indicates the expected outcome during the baseline phase for class A.     +     indicates the expected 
outcome during the baseline phase for class B.  
* p < .05. 
7.2.3 Summary of two-level analysis of single-case experimental data  
We suggested four plausible models, starting with the most basic two-level model and 
gradually making it more complex, in order to analyze the dataset of Lambert et al. (2006). By 
analyzing the data using four different models, we can investigate the extent to which the 
results are influenced by using different, increasingly complex modeling options. If different 
results are obtained across models, we recommend single-case researchers to report the 
different models and discuss the diverse results. The results of the immediate treatment effect 
estimates using the different models are summarized in Table 7.8 because the single-case 
researcher is mainly interested in these effects. We can conclude that these results are 
relatively robust against the different model choices, at least for this empirical illustration. 
Therefore, our confidence in the conclusion concerning the effectiveness of the treatment is 
increased. However, if single-case researchers are interested in the variance components 
estimates, more caution is needed in interpretation because the variance estimates are more 
sensitive to model choice. 
Chapter 7 | From a single-level to a multilevel analysis 181 
 
Table 7.8 
Summary of Treatment Effect Estimates for Model 1 through Model 4 Using the First Way or the Second Way of 
Coding the ABAB Reversal Design 
  Parameter estimates (SE) 
  Model 1 Model 2 aModel 3 aModel 4 
First way of coding Average shift -5.40* (0.39) -5.34* (0.35)   
 Fit statistics 








          AIC 1165.4 1142.7   
          BIC 1166.5 1144.5   
Second way of coding A1 to B1 -5.66* (0.38) -5.76* (0.50) -5.10* (0.69) -5.53* (0.84) 
 A2 to B2 -5.08* (0.49) -4.92* (0.49) -5.77* (0.84) -5.60* (0.84) 
 Fit statistics 









          AIC 1170.7 1151.6 1132.5 1132.5 
          BIC 1173.4 1150.0 1135.0 1135.3 
Note. Standard errors are in parentheses.  
a
Model 3A and Model 4A were not estimated, because the average trend across the two baseline phases and the 
average trend across the two treatment phases were not of interest. 
*p < .05. 
In the presentation of the four models, we choose to systematically extend the basic two-
level model to more complex models. A drawback of this approach is that some of the 
complexities that have been added may not be needed. An alternative approach, which is 
illustrated by Singer and Willlet (2003), is to use fit statistics, such as -2 times the log 
likelihood ratio (i.e., -2LL; Raudenbush & Bryk, 2002), Akaike’s information criterion (i.e., 
AIC; Akaike, 1973), and Bayesian Information Criterion (i.e., BIC; Schwarz, 1978), to choose 
which complexities to keep (or drop) as the model is being built. The fit statistics for the four 
models we examined are presented in Table 7.8 and indicate that Model 2 fits the single-case 
data better (i.e., has smaller values for the fit statistics) than Model 1, but making Model 2 
more complex (i.e., Model 3 and Model 4) does not result in better fit statistics. A drawback 
of using fit statistics to choose a single model is that, with small sample sizes, fit statistics can 
lead to selection of the incorrect model. Our preference, when working with single-case data, 
is to estimate treatment effects across a range of plausible models.  
Power for testing the treatment effect is also an important issue if small datasets are 
encountered, which is the case in the two-level analysis of single-cases. In this study, the 
effects were found to be statistically significant across each of the four models, so power was 
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adequate for the tests of the average treatment effect. Recently, Ferron et al. (accepted) 
conducted a simulation study and found that a reasonable power (.80 or higher) was reached 
when only four participants were included in the study (and the treatment effect equaled a 
shift of 2 baseline standard deviations). To compare, for 12 participants, a power that 
exceeded .80 was obtained with effect sizes of one and higher.  
In Model 1 through Model 4, continuous outcomes were assumed because the 
continuous outcome multilevel model has been more extensively studied in previous research 
(Ferron et al., 2009; Moeyaert et al., 2013a, 2013b, 2013c; Owens & Ferron, 2012; Ugille et 
al., 2012, 2013; Van den Noortgate & Onghena, 2003a, 2003b, 2008). However, in Lambert 
et al. (2006), the outcome variable is a count (i.e. per session, the participating students were 
each observed during 10 intervals, and the number of intervals in which disruptive behavior 
was observed was recorded). Therefore, we will briefly discuss a basic logistic regression 
model to show that the multilevel model can be adjusted to model count data. However, 
further research is needed to investigate how the basic logistic regression model functions for 
single-case experimental data. Equations 7.6 and 7.7 display the logistic models and  ̂   
indicates the expected proportion of trials within session i for subject j in which the behavior 
was exhibited:  ̂         .  
Level 1 (Logistic Model A): 
                      (
 ̂  
   ̂  
)                       
(7.6) 
Level 1 (Logistic Model B): 
   (
 ̂  
   ̂  
)                                    
(7.7) 
When using Equation 7.6 and Equation 7.7, the parameter estimates are expressed on a 
logit scale, which complicates interpretation. Therefore, we back-transformed the parameter 
estimates as displayed in Table 7.9:     can be calculated by solving the following equation: 
     ̂  (   ̂         
   
  
 (  
   
  
)  = 0.79. As a consequence, 
   
  
 (  
   
  
) = exp(0.82), 
and     equals 6.88, indicating the predicted number of challenging behaviors during the 
baseline phase. The expected logit during the treatment phase equals -1.93. If we back-
transform this value, we obtain an average number of challenging behaviors of 1.27 during 
the treatment phase. By back-transforming the predicted baseline level (i.e., 6.88) and the 
predicted outcome score during the treatment phase (i.e., 1.27), a treatment effect of -5.61 is 
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found  (= 6.88  1.27), which is what we expected from visual analysis. Also, the treatment 
effect during both AB pairs is statistically significant,  ̂   = -5.84, t(8) = -12.66, p = .001, and 
 ̂   = 5.39, t(8) = -10.47, p < .001. 
Table 7.9 
Parameter and Standard Error Estimates Resulting from Estimation of the Logistic Model Using the Lambert et 
al. (2006) Dataset 
 Parameter Parameter 
Estimate 
SE p Back 
Transformed 
Logistic Model A      Fixed coefficient      
     Average baseline level     0.79* 0.19 .003 6.88* 
     Average outcome score during the 
treatment                 
    -2.72* 0.22 < .001 -5.61* 
 Variance component     
     Baseline level    
    0.29 0.16 - - 
     Treatment effect    
  0.32 0.24 - - 
Logistic Model B Fixed coefficient     
     Average baseline level, first AB pair     0.82* 0.16  .001 6.94* 
     Average treatment effect, first AB pair     -2.91* 0.23 < .001 -5.84* 
     Average change in level, from B1 to A2     2.82* 0.29 < .001 5.65* 
     Average treatment effect, second AB pair     -2.58* 0.25 < .001 -5.39* 
 Variance component     
     Baseline level, first AB pair    
  0.17 0.12 - - 
     Treatment effect, first AB pair    
  0.22 0.22 - - 
     Change in level, from B1 to A2    
  0.51 0.36 - - 
     Treatment effect, second AB pair    
  0.36 0.28 - - 
Note. * p < .05.  
Note that the results for the fixed effect estimates from the analysis recognizing count 
outcomes are similar to those obtained by treating the outcomes as continuous. For some 
datasets and models the difference in results between continuous and count outcome models 
may be substantial, but for this dataset and model, the differences are small, and as a 
consequence, our confidence in the conclusion that the treatment was effective is 
strengthened. Although we presented a variety of plausible two-level models, other models 
are also possible—for instance, models including a quadratic or other nonlinear trend and 
models with more predictors We only presented a subset of modeling options that seemed 
most appropriate for this particular dataset, based on a visual analysis of the data. 
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7.3 From a Two-Level to a Three-Level Framework 
7.3.1 Three-level model 
The number of published single-case studies is growing rapidly during the last decade, 
and therefore there is an increasing interest in meta-analyzing these types of studies in order 
to estimate average treatment effects. The three-level model can be used to synthesize data 
across cases and across studies. If we pool several studies together, we can examine the 
generalizability of the results. The synthesis of the studies can inform policy and important 
decisions can be made based on these results. Van den Noortgate and Onghena (2008) 
suggested extending the two-level model to a three-level model by adding an index k in 
Equation 7.1 referring to the study. The outcome score,     , indicates the outcome score at 
measurement occasion i for the j
th
 case from study k. For a single-case design with one A-
phase and one B-phase, the regression equation at the first level looks as follow: 
Level 1:                                with        (    
 ) (7.8) 
Note that Equation 7.8 is exactly the same as Equation 7.1 with the only difference that 
Equation 7.8 has an additional index, k, indicating the study. Equation 7.8 takes the 
hierarchical structure of the data into account when combining single-case studies: 
measurement occasions, i (i = 1, 2, …I), belong to cases, and cases, j (j = 1, 2, … J), belong to 
studies, k (k = 1, 2, … K). Equation 7.8 can be used to describe continuous data assuming no 
trends, a homogeneous within-case variance, and residuals that are independent and normally 
distributed. At the second level of the three-level model, the two coefficients from the first 
level are modeled as varying across cases within studies: 
Level 2:               
              
    [
    
    




   
      
        
 ]) 
(7.9) 
These two equations represent the average baseline level and the average treatment effect 
across cases within study k. Also, the deviation of each particular case from the average 
study-specific baseline phase level (    ) and the average study-specific treatment effect 
(    ) can be estimated. When summarizing single-case results over cases within a study, 
     and    
  are of particular interest, because they represent the average treatment effect and 
the extent to which this estimated treatment effect varies across cases within the same study. 
A researcher can go a step further by meta-analyzing the single-case studies (i.e., combining 
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the single-case results across studies) in order to estimate the average baseline level and the 
average treatment effect across cases and across studies. Also, the variation in these estimates 
between studies might be of interest and can be estimated. At the third level of the model, the 
variation of the level-2 coefficients from equation 7.9 is modeled as follow:  
Level 3:               
              
       and  [
    
    




   
      
        
 ]) 
(7.10) 
The interest of the single-case researcher lies typically in      indicating the average 
estimated treatment effect and    
  referring to the deviation of study k from this average 
estimated effect.  
The three-level model is an extension of the two-level model and has the advantage that 
more general conclusions can be made and that it increases the examination of external 
validity. For instance, if a low estimate for the between-study variance of the average 
treatment effect is found, then there is more evidence that the estimated treatment effect is 
generalizable. If a large amount of between-study variance is found, predictors can be added 
to explain this variance and therefore more general conclusions regarding the average 
estimated treatment effect can be made. Moreover, in addition to average estimates across 
cases and studies, study-specific and case-specific estimates can be obtained using the 
command “solution” after the random statements. This three-level model takes the 
hierarchical structure of the data into account: measurements are nested within cases and 
cases in turn are nested in studies. Also, the between-case and between-study variance of 
these effects can be estimated. The other advantages of this three-level approach are similar to 
the two-level approach and include, amongst others, the possibility of modeling different 
types of trajectories (e.g., nonlinear trends), modeling count data, including autocorrelation, 
and adding predictors at the three levels (e.g., study quality at the third level and participant-
specific predictors such as age at the second level). Also dependent, non-normal and 
heterogeneous error variances at the three levels can be taken into account. 
There has been some work devoted to the empirical validation of the basic three-level 
models using Monte Carlo simulation studies. The three-level model used to analyze multiple-
baseline designs with only a treatment effect has been studied for unstandardized raw data 
(Owens & Ferron, 2010), and the three-level model applied to unstandardized and 
standardized multiple-baseline data modeling trends during baseline and treatment phases has 
also been studied (Moeyaert et al., 2013a, 2013b). These studies indicate that the three-level 
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model results in unbiased average treatment effect estimates (even if there are a small group 
of cases and studies included) and that the between-case and between-study variance 
estimates can be biased if there are a small number of studies (  10) and a small number of 
cases ( 3 per study) included. Furthermore, this three-level model including time trends has 
been adapted to model external event effects (Moeyaert et al., 2013c). The misspecification of 
the error variances at the first level of the three-level model has been investigated by Petit-
Bois, Baek, and Ferron (2013) as well as the misspecification of the variance matrix at the 
second and third level (Moeyaert et al., 2014a).  
7.3.2 Empirical illustration of the three-level model 
In this section, we illustrate this three-level approach in order to summarize results in 
seven studies measuring the same outcome variable, namely the effects of pivotal response 
training with children with autism (measured as the percentage of trials with appropriate 
speech). In these seven studies, a multiple-baseline across participants design is used. We are 
mainly interested in the fixed effect estimates (i.e., average baseline level and treatment effect 
across cases and studies), but we also illustrate that the between-case and the between-study 
variance can be estimated. Again, the multilevel model is very flexible, and several models 
can be investigated when analyzing single-case data. We will present four plausible three-
level models based on a visual analysis of the data, but other models are also possible. We 
propose a variety of models to illustrate several modeling options and emphasize that there is 
no single superior model that works with all three-level single-case datasets. The analysis of 
multiple-baseline design data is simpler than the analysis of reversal design data in that there 
is only one transition from the baseline to the treatment phase.  
All of the seven multiple-baseline studies we want to combine are characterized by 
multiple dependent variables (Koegel, Symon, & Koegel, 2002; Koegel, Camarata, Valdez-
Menchaca, & Koegel, 1998; Laski et al., 1988; Leblanc, Geiger, Sautter, & Sidener, 2007; 
Schreibman, Stahmber, Bartlett, & Dufek, 2009; Sherer & Schreibman, 2005; Thorp, 
Stahmer, & Schreibman, 1995). From these seven studies, we choose to only include the 
dependent variable measuring appropriate or spontaneous speech. Furthermore, the outcome 
scale of two of the seven studies was a count (Koegel, Camarata, & Koegel, 1998; Koegel, 
Symon, & Koegel, 2002) and differed from the outcome scale from the other studies, which 
was a percentage (the percent of intervals in which the desired behavior occurred). Therefore, 
we choose to reduce the dataset by only combining results from the five studies in which the 
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appropriate or spontaneous behavior was measured on the same scale (as a percentage instead 
of a count). The SAS code is included in Addendum A6. 
We start with discussing the results using the basic three-level model in which there is 
only a shift in level; there are no trends; the errors at the three levels are independent, 
identically, and normal distributed; and there are no predictors at the higher levels of the 
model. This basic three-level model will then be modified in several ways in the second part, 
representing more complex and probably more realistic modeling assumptions. When 
discussing the results, we choose .05 as the alpha-level. We used SAS 9.3 to conduct the 
analyses and the SAS code for the basic three-level model (i.e., Model 1) as well as the 
extensions to this model (Model 2 to Model 4) are contained in Addendum A5. 
7.3.2.1 Model 1: basic three-level model 
We start by presenting the results obtained by using the most basic three-level model to 
combine results from the five multiple-baseline design studies. In this basic model, we make a 
lot of assumptions: there are no time trends, there are no predictors at the second and third 
level, and the errors at the three levels are independent, identically, and normal distributed 
(see Equations 7.8 - 7.10). The average baseline level (i.e.,      ) and treatment effect (i.e., 
     ) are estimated across cases and across studies in addition to the between-case 
(co)variance and between-study (co)variance of these estimates. Results are displayed in 
Table 7.10. 
Table 7.10 
Parameter and Standard Error Estimates Resulting from Estimation of the Three-Level Analysis of Model 1  
 Parameter Parameter 
estimate 
SE p 
 Fixed coefficient    
Average baseline level      19.36* 5.75 .016 
Average treatment effect      31.07* 8.15 .016 
 (Co)variance component    
Between-study (co)variance     
     Baseline level    
  96.76 95.31 .155 
     Treatment effect    
  271.96  223.79 .112 
     Covariance between baseline level and 
     treatment effect                    
      144.26 124.38 .246 
Between-case (co)variance     
     Baseline level    
  316.15* 103.52 .001 
     Treatment effect    
  224.11* 83.56  .004 
     Covariance between baseline level and 
     treatment effect  
            -49.24 70.99 .488 
 Residual variance   
   328.72* 15.70 < .001 
Note. * p < .05.  
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From this basic three-level analysis, we conclude that there is a statistically significant 
average treatment effect that equals 31.07, t(4.38) = 3.81, p = .016. The variance in the 
estimated treatment effect between studies is not statistically significant, whereas the variance 
in this estimated treatment effect between cases is significant and equals 224.11, Z = 2.68, p = 
.004. There is also a significant within-case variance.  
We suggest three alternatives to Model 1 (i.e. the basic three-level model), based on the 
graphical presentation of the data in the primary studies, but other models are also possible 
dependent on the research interest and the specific meta-analysis you want to conduct. In 
Model 2, we make a less strong assumption by modeling dependence between the residuals at 
the first level (i.e., autocorrelation) and assuming that the within-case residuals are not 
necessarily identically distributed across the two phases. In Model 3, we suggest including a 
time trend in the treatment phase, because the visual inspection of the five primary studies 
indicates that there is no trend during the baseline but a slightly positive linear trend during 
the treatment phase. In the last model (i.e., Model 4), we will explore whether predictors at 
the higher levels of the multilevel model have a significant effect on the estimated outcome 
scores and if these predictors succeed in reducing the between-case variance, the between-
study variance, or both. 
7.3.2.2 Model 2 
In this first alternative model, we model autocorrelation because in a single-case design, 
the cases are measured repeatedly, usually with small time periods in between the consecutive 
measurement occasions. Therefore, it is likely that measurement occasions closer in time are 
more related than measurements further away in time. In this second model, we also model 
heterogeneous within-case phase variances. Looking at the primary multiple-baseline studies, 
we expect that the scores within the baseline phase are more stable in comparison to the 
scores in the treatment phase. The results of the three-level analysis taking autocorrelation 
into account and modeling heterogeneous within-case phase variances are presented in Table 
7.11. 
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Table 7.11 
Parameter and Standard Error Estimates Resulting from Estimation of the Three-Level Analysis of Model 2 
 Parameter Parameter 
estimate 
SE p 
 Fixed coefficient    
Average baseline level      18.72* 5.69 .017 
     Average treatment effect      30.50* 7.92 .016 
 (Co)variance component    
Between-study (co)variance     
     Baseline level    
            93.93  92.19 .154 
     Treatment effect    
          242.43 211.83 .126 
Covariance between baseline level and 
treatment effect 
              125.16 116.82 .284 
Between-case (co)variance     
     Baseline level    
  302.95* 100.83 .001 
     Treatment effect    
  160.79* 85.61 .030 
Covariance between baseline level and 
treatment effect 
            -11.32 72.47 .876 
Residual variance, baseline    
  167.68* 16.56 < .001 
Residual variance, treatment    
  534.84* 55.88 < .001 
Autocorrelation, baseline  ( )             0.46* 0.05 < .001 
Autocorrelation, treatment  ( ) 0.60* 0.04 < .001 
Note. * p < .05. 
Similar to the basic three-level model, we found a significant estimated treatment effect: 
 ̂    = 30.50, t(4.29) = 3.85, p = .016. For the estimated variances, we conclude that the 
between-case variance estimates are statistically significant and that the between-study 
variance estimates are smaller in comparison to the ones obtained by the basic three-level 
model and are not statistically significant. As expected, we found that the variance estimate 
within the treatment phase is larger (3.19 times) than the estimated variance within the 
baseline phase. Another important finding is that we found significant autocorrelation both in 
the baseline and the treatment phase. In the baseline phase, the autocorrelation equals 0.46, Z 
= 8.90, p < .001, and in the treatment phase, the measurements closer in time are more related 
to each other than in the baseline phase: autocorrelation = 0.60, Z = 14.47, p < .001. 
7.3.2.3 Model 3  
In this third model, we add a time predictor in the model in addition to modeling 
autocorrelation and heterogeneous within-case phase variances. For simplicity, we chose to 
not estimate covariance between regression coefficients at the second and third level. The 
visual analysis of data from the primary studies indicate relatively stable outcome scores 
during the baseline phase but slightly increasing outcome scores over time during the 
treatment phase. Therefore, we modified the level 1 equation by adding time as predictor in 
the treatment phase: 
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Level1                             
 
            
              and        (    
 ) 
 (7.11) 
We indicate in Equation 7.11 that the trend over time predictor, modeled during the 
treatment phase, is centered around the first measurement occasion of the treatment phase by 
T’ (see Figure 7.4). In this way,      represents the average outcome score for case j of study 
k during the baseline, and      and      indicate respectively the estimated immediate 
treatment effect (i.e., the shift in level at the time of the first treatment phase observation) and 
the time trend during the treatment phase, which are of particular interest. The level-1 
coefficients vary at the second level and the third level and allows us to estimate the average 
treatment effect across studies and the between-case and between-study variance as presented 
in Table 7.12.  
Table 7.12 
Parameter and Standard Error Estimates Resulting from Estimation of the Three-Level Analysis of Model 3 
Model 3 Parameter Parameter 
Estimate 
SE p 
 Fixed coefficient     
Average baseline level      17.31* 5.74 .024 
Average immediate treatment effect              25.26 10.28 .058 
Average trend during treatment      0.76* 0.15 .019 
 Variance component    
Between-study variance     
     Baseline level    
  98.48 93.24 .145 
     Immediate treatment effect    
  478.03 334.26 .073 
     Treatment effect on trend    
  0.00 - - 
Between-case variance     
     Baseline level    
  277.37* 89.47  .001 
     Immediate treatment effect    
  85.82* 42.97 .023 
     Treatment effect on trend    
  0.09 0.13 .234 
Residual variance baseline    
  170.01* 16.93 < .001 
Residual variance treatment    
  268.58* 19.19 < .001 
Autocorrelation, baseline  ( ) 0.47* 0.05 < .001 
Autocorrelation, treatment  ( ) 0.21* 0.05 < .001 
Note. * p < .05. 
Chapter 7 | From a single-level to a multilevel analysis 191 
 
 
Figure 7.4. Graphical presentation of the coefficients in Equation 7.11 based on hypothetical AB design data.  
An interesting finding is that the estimated immediate treatment effect is not statistically 
significant when a time trend during the treatment phase is modeled and equals 25.26, t(4.98) 
= 2.46, p = .058. The estimated time trend,  ̂   , equals 0.76 and is statistically significant, 
t(2.8) = 4.92, p = .019. The estimated between-case variance estimates are significant, except 
for the trend during the treatment. Also the estimated residual variances are significant. 
Notwithstanding the modeling of a time trend, the estimated autocorrelation within both the 
baseline and treatment phase remain positive and statistically significant: autocorrelation 
during the baseline and the treatment phase equal 0.47, Z = 9.05, p < .001, and 0.21, Z = 4.06, 
p < .001, respectively. However, the estimated autocorrelation during the treatment phase is 
smaller in comparison to the estimated autocorrelation modeled in Model 2. Note that we 
chose to center the time predictor around the first measurement occasion of the treatment 
phase because we wanted to estimate the difference in outcome score between the baseline 
data and the treatment data at the first measurement occasion in the treatment. A single-case 
researcher might be interested in the difference in outcome scores at another later point in 
time, for instance at the third measurement occasion in the treatment. In this case, the time 
variable has to be centered around that value. If we center time around the middle 
measurement occasion of the treatment phase, then we would obtain an estimated treatment 
effect that is more similar to the average shift in level from the previous models. 
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7.3.2.4 Model 4  
In the previous models, we only added predictors at the first level of the three-level 
model. However, when combining data over cases and over studies case-specific and study-
specific characteristics can be included in order to explain between-case and between-study 
variability in estimated effects. Age, expressed in years, is a case-specific characteristic that 
was coded in the primary studies and can be included as a second-level predictor. We expect 
that this predictor will influence the estimated baseline level and that the estimated treatment 
effect is independent of age. In order to conduct a meaningful analysis, we centered age 
around the average age, because otherwise the variation in intercept is estimated for 
participants having an age of zero. We also model autocorrelation and heterogeneous within-
case phase variances. Similar to the previous model, we chose to not estimate covariance 
between regression coefficients at the second and third level for simplicity. The level two and 
level three equations look as follow: 
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The results of the fixed effect estimates and variance components are displayed in Table 7.13.  
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Table 7.13 
Parameter and Standard Error Estimates Resulting from Estimation of the Three-Level Analysis of Model 4 
Model 4 Parameter Parameter 
estimate 
SE p 
 Fixed coefficient    
Average baseline level      17.57* 5.90 .028 
Average effect of predictor age during baseline            -0.05 0.31 .864 
Average treatment effect          25.28 10.30 .058 
Average trend during treatment           0.76* 0.15 .019 
 Variance component    
Between-study variance     
     Baseline level    
        97.56 92.40 .146 
     Treatment effect    
       488.88 335.61 .073 
     Trend during treatment    
             0.00 - - 
Between-case variance     
     Baseline level    
        277.40* 89.45 .001 
     Treatment effect    
          85.92* 43.00 .023 
     Trend during treatment    
          0.09 0.13 .234 
Residual variance baseline    
        170.00* 16.93 < .001 
Residual variance treatment    
        268.57* 19.19 < .001 
Autocorrelation, baseline  ( )           0.47* 0.05 < .001 
Autocorrelation, treatment  ( )           0.21* 0.05 < .001 
Note. * p < .05. 
The average immediate effect of treatment was estimated to be 25.28, t(4.97) = 2.46, p = 
.058. The estimated effect of the predictor age on the baseline level is not statistically 
significant and equals 0.05, t(8.71) = 0.18, p = .864. The negative value of the predictor age 
means that the older the case is, the lower the estimated baseline level. The ages of the 
participants included in this three-level analysis ranged from 2 to 57. The estimated baseline 
level for a participant with age 2 equals 17.57 + (0.05 * 2) = 17.47, whereas the estimated 
baseline level equals 17.57 + (0.05 * 57) = 14.71 for a participant with age 57. Furthermore, 
the between-case variances of the intercept and the immediate treatment effect and the within-
case variances are statistically significant matching findings from previous models. The 
autocorrelation during the baseline and the treatment phase is statistically significant and 
equals .47, Z = 9.04, p < .001 and .21, Z = 4.06, p < .001, respectively. 
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7.3.3 Summary of three-level analysis of single-case experimental data 
Table 7.14 provides a summary of the immediate treatment effect estimates for each 
proposed model (Models 1 through 4).  
Table 7.14 
Summary of Treatment Effect Estimates for Model 1 through Model 4 Using the First Way or the Second Way of 
Coding the ABAB Reversal Design 
 Parameter estimates (standard errors) 
 Model 1 Model 2 Model 3 Model 4 
Average (immediate) treatment effect 31.08* (5.75) 30.50 * (7.92) 25.26 (10.28) 25.28 (10.30) 
Fit statistics     
         -2*log likelihood 8181.0 7798.8 7678.0 7678.0 
         AIC 8199.0 7822.8 7702.0 7704.0 
         BIC 8195.5 7798.8 7678.0 7678.0 
Note. Standard errors are in parentheses.  
*p < .05 
Notwithstanding each suggested model has its own assumptions, we found similar 
results for the treatment effect estimates across Model 1 and Model 2 on the one hand and 
Model 3 and Model 4 on the other hand. The reason is that, in Model 3 and Model 4, a time 
trend during the treatment phase is modeled, which is not the case in Models 1 and 2. The 
positive estimated time trend during the treatment phase in Model 3 and 4 resulted in an 
estimated outcome score at the start of the treatment phase that was lower in comparison to 
Models 1 and 2. If single-case researchers are interested in the variance components 
estimates, more caution is needed when choosing the analysis model, because the variance 
estimates depend more on the selected model. Thus, interpretation of variance estimates from 
the models estimated here should be made with some caution. If different results are obtained 
across models, we recommend that single-case researchers report the different models and 
discuss the diverse results. Note that for all suggested models, the estimated standard errors at 
the study level are larger than the estimated standard errors at the second level which has 
consequences for the significance testing. For instance, the between-study variance of the 
immediate treatment is large but found to be not statistically significant because of the large 
estimated standard error (i.e., the estimated standard error is large in comparison to the 
parameter estimate, resulting in a small t-statistic and a large p-value), whereas the smaller 
estimated between-case variance of the immediate treatment effect estimate is found to be 
statistically significant. There are no problems concerning the power of detecting the 
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treatment effect, as a total of 27 participants (spread over 5 studies) are included in this study 
(Moeyaert et al., 2013a). Also, fit statistics (i.e., -2LL, AIC, and BIC) are presented in Table 
7.14 and indicate that Model 2 fits the SSED data better than Model 1 (i.e., has smaller values 
for the fit statistics). Model 3 and 4 fit the data better than Model 1 and 2, but the difference 
between Model 3 and 4 is negligible.  
Although we demonstrated a variety of different model extensions, other extensions are 
also possible—for instance adding quadratic or other nonlinear trends, adding more 
predictors, or adding covariance between the random effects at the different levels. We only 
presented the modeling options that are most plausible, based on visual analysis of the 
primary studies. The four models are presented in an increasing level of complexity. 
However, single-case researchers may choose another way of modeling building, such as the 
approach suggested by Singer and Willet (2003) in which nonsignificant parameters are 
removed. 
7.4 Discussion 
Using the multilevel model (either the two-level or three-level model) to summarize 
single-case results over cases, over studies, or both has multiple advantages. Multilevel 
models can provide detailed information regarding the treatment effects (e.g., estimates of 
case-specific immediate treatment effects, case-specific trend shifts, level shifts across cases 
and across studies, average trend shifts across cases and across studies, and variance in effects 
across participants and studies). The multilevel models can be adapted for different designs 
(e.g., multiple-baseline, reversal, and alternating treatments designs) and for different types of 
outcomes (e.g., continuous, binary, and count), while also taking into account trends, 
autocorrelation, heterogeneity, and nesting of cases within studies. To show the flexibility of 
the multilevel model, we suggested a variety of plausible two-level and three-level models in 
this article, and we provided empirical illustrations and interpretation of results. 
In the first part of the study, we presented the two-level analysis of single-case studies 
using two different ways of coding data based on the ABAB design. We combined the data of 
nine replicated ABAB designs using the basic two-level model and proposed several 
alternatives. The results of the fixed effects estimates were relatively robust against several 
modeling options. However, variance estimates varied, but we have to interpret their values 
with caution because previous simulation studies have indicated that variance estimates can 
be biased, especially when a small number of measurement occasions and cases are involved. 
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In this first part, there were enough measurement occasions, but the number of cases is likely 
too small for valid inferences about variance values. Ferron et al. (2009) do not encourage 
interpreting the variances if there are eight or fewer cases due to the bias that they found. The 
current study included nine cases, but combining more than eight cases has not yet been 
examined. Moreover, the study of Ferron et al. (2009) focused on multiple-baseline designs, 
whereas in this study, nine replicated ABAB designs were combined.  
In the second part of the study, we focused on three-level analyses, combining single-
case results over cases and over studies. The three-level analyses of Owens and Ferron 
(2012), estimating the treatment over cases and over studies, showed that the estimate of the 
average baseline level and average treatment effect lead to unbiased estimates; however, the 
estimates of the variance components (between-case and between-study variance) are 
questionable. Similar conclusion were obtained by Moeyaert et al. (2013a, 2013b) in which 
trends were included. So the results of the variance estimates in the second part of the current 
study have to be interpreted with some caution. 
We only presented a limited number of plausible two-level and three-level models, but 
others are also possible. For instance, in this study, we choose to model amongst others 
autocorrelation, heterogeneous within-case variance, and trends during the treatment phase. 
However, other modeling options such as trends during the baseline phase and different types 
of predictors are also possible. Estimating multiple models has two purposes. First it allows us 
to illustrate the flexibility of the multilevel model and to illustrate how convenient it is to 
adjust the model according to the assumptions one makes and according to the researcher’s 
interests. Second, it illustrates the practice of estimating multiple alternative models. Any 
model rests on a series of assumptions and the amount of data available to single-case 
researchers is often not sufficient to rigorously test and validate these assumptions. As a 
consequence, the assumptions and model can be questioned, leading to uncertainty in the 
conclusions reached. By considering a range of plausible models and assumptions, researchers 
can determine the degree to which the effect estimates and conclusions are sensitive to the 
specific assumptions made. If the same conclusions are reached across a range of plausible 
assumptions, confidence in the conclusions can be enhanced. We advise researchers not to 
focus on one model but to conduct multiple plausible multilevel analyses and investigate 
whether the results depend on the modeling choices.  
In this study, significant treatment effect estimates across cases (two-level analysis) and 
across cases and studies (three-level analysis) are found. However, this does not imply 
significant treatment effect for all cases included in the two-level or three-level analysis. The 
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multilevel analysis does not throw away information about these individual cases. On the 
contrary, it allows estimating and explaining differences between individual cases and 
obtaining case-specific treatment effect estimates by using empirical Bayes techniques. 
The parameters were estimated and tested using the maximum likelihood (ML) 
estimation in SAS. However, ML estimation of multilevel models is also included in HLM, 
MLwiN, R, SPSS, and Stata. Previous simulation studies indicate that using ML (similar to 
using restricted maximum likelihood), which is based on large sample theory, to estimate 
multilevel models for single-case data leads to biased variance estimates, especially with a 
smaller number of units at level 2 or level 3 (Ferron et al., 2009; Moeyaert et al., 2013a, 
2013b; Owens & Ferron, 2012). Alternatives, which may result in less biased variance 
estimates in small samples, are Bayesian estimation (Shadish & Rindskopf, 2007; Shadish, 
Rindskopf, & Hedges, 2008) and bootstrapping (Wang, Xie, & Fisher, 2012) procedures. 
Further research is needed assessing use of these alternative procedures. 
We illustrated the multilevel approach using the raw data, but it is also possible to 
synthesize the data at the first level using effect sizes. These effect sizes can then be combined 
over cases and over studies using a multilevel meta-analysis instead of multilevel analysis. 
Originally, Van den Noortgate and Onghena (2008) proposed regression coefficients as effect 
size estimator, and Ugille et al. (2012) conducted a simulation study to empirically validate 
the multilevel meta-analysis of this effect size estimator. Similar to the effect size estimator 
presented by Hedges, Pustejovsky, and Shadish (2012), namely the standardized mean 
difference, the effect size proposed by Van den Noortgate and Onghena (2008) can be 
converted to an effect size that can be used in meta-analysis of both single-case experimental 
data and group-comparison designs. For more details about this effect size, we refer to the 
article of Van den Noortgate and Onghena (2008). 
The studies combined in the three-level analysis were chosen on purpose to make sure 
that the outcome variable was measured on the same scale. If studies are not on the same 
scale, we advise researchers to first standardize the single-data before combining them in a 
multilevel analysis. The standardization method for continuous outcomes was introduced by 
Van den Noortgate and Onghena (2008). They proposed performing an ordinary least squares 
regression for each subject from one study separately (for instance, using Equation 7.8) in 
order to estimate the residual within-subject standard deviation ( ̂   ). Thereafter, the 
individual scores (      ) are divided by the estimated residual within-subject standard 
deviation ( ̂   ). The residual within-subject standard deviation estimate reflects the 
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differences in how the dependent variable is measured, and thus dividing the original raw 
scores in a study by this variability provides a method of standardizing the scores. The 
standardized scores can then be used in the multilevel model. This standardization method in 
contexts of the three-level modeling of continuous single-case data has been explored and 
studied. Moeyaert et al. (2013b) found that the standardization procedure resulted in more 
biased and less precise treatment effect estimates and that these problems became negligible 
as series lengths increased (i.e., larger than 20).  
In this article, we discussed several plausible multilevel models for the analysis of two-
level and three-level single-case data. Although we selected a variety of different modeling 
options based on visual inspection of the data, other options are also possible. We will never 
know what the correct underlying model is, but by showing that the results of interest are 
similar across a range of plausible models, confidence in the obtained findings can be 
increased. Applied researchers are thus encouraged to explore several multilevel models to 
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 Chapter 8|
Estimating Intervention Effects Across 
Different Types of Single-Subject 





The purpose of this study is to illustrate the multilevel meta-analysis of results from 
single-subject experimental designs of different types, including AB phase designs, multiple-
baseline designs, ABAB reversal designs, and alternating treatment designs. Current 
methodological work on the meta-analysis of single-subject experimental designs often 
focuses on combining simple AB phase designs or multiple-baseline designs. We discuss the 
estimation of the average intervention effect estimate across different types of single-subject 
experimental designs using several multilevel meta-analytic models. We illustrate the 
different models using a re-analysis of a meta-analysis of single-subject experimental designs 
(Heyvaert, Saenen, Maes, & Onghena, 2014). The intervention effect estimates using 
univariate three-level models differ from those obtained using a multivariate three-level 
model that takes the dependence between effect sizes into account. Because different results 
are obtained and the multivariate model has multiple advantages, including more information 
and smaller standard errors, we recommend researchers to use the multivariate multilevel 
model to meta-analyze studies that utilize different single-subject designs. 
Keywords: single-subject experimental design, univariate multilevel modeling, 
multivariate multilevel modeling, average intervention effect  
                                                 
7 This chapter has been published as: Moeyaert, M., Ugille, M., Ferron, J., Onghena, P., 
Heyvaert, M., Beretvas, S.N.,& Van den Noortgate, W. (2014c). Estimating intervention 
effects across different types of single-subject experimental designs: Empirical illustration. 
School Psychology Quarterly, 52 (2).  
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8.1 Introduction 
To help improve schools and the care for students within schools it is critical to 
understand the effects of interventions, the degree to which those effects vary across students 
and settings, and the characteristics of the students and settings that are associated with 
intervention effectiveness. As a consequence, it is important to not only conduct intervention 
studies that focus on individuals, but also to maximize what is collectively learned through the 
synthesis of this intervention research. In school psychology, single-subject experimental 
designs (SSEDs) are often used (Kratochwill, 1985; Wacker, Steege, & Berg, 1988) to 
evaluate the effect of the experimental manipulation of an independent variable (e.g., a 
specific intervention) on the dependent variable (e.g., outcome scores). The focus of the study 
is then on a single entity, for instance, on a single student or a single teacher-student dyad, or 
a small number of entities (e.g., McGoey & DuPaul, 2000; Briesch & Chafouleas, 2009). In 
an SSED, the independent variable is manipulated by the experimenter, and the dependent 
variable is measured repeatedly for this entity under different levels of the independent 
variable. Reasons for the popularity of SSEDs in school psychology research include the 
focus on the individual that parallels the care for the individual in applied settings and the fact 
that an SSED is one of the only eligible design options if rare or unique conditions are 
involved. Furthermore, an SSED is warranted when researchers are interested in within-
subject variability, rather than the between-subject variability. Although SSED studies are 
commonly undertaken, techniques used for the synthesis of SSED studies has not received the 
same level of attention as the synthesis of group studies. In this manuscript, we focus on 
techniques for the meta-analysis of results from multiple SSED studies, allowing for the 
exploration of the generalizability of the intervention effects and the study of moderator 
variables that might influence an intervention’s effects. Assessment and improvement of 
techniques to synthesize SSED results is of the utmost importance, as the number of published 
SSEDs is increasing at an astonishing rate (Social Science Citation Index). 
Visual analysis has been the traditional method for evaluating treatment effects in SSED 
research, but is by itself less suited for synthesizing literature in an objective way (Manolov & 
Solanas, 2013). The evidence-based movement in SSED context has emphasized the need for 
quantitative summaries of studies’ results, especially for making them available for meta-
analytic purposes (Jenson et al., 2007). Parker and Brossart (2003) state three major 
advantages of developing effect sizes. First, effect sizes express the magnitude of the 
relationship between an intervention and outcome. Second, effect sizes provide a continuous 
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(rather than categorical) evaluation of treatment success. Third, effect sizes are not 
systematically affected by sample size. Manolov and Solanas (2013) argue that statistical and 
visual analysis are complementary because of the lack of formal decision rules in visual 
analysis, the corresponding lack of objective and replicable outcomes, the idea that 
practitioners would have more confidence in treatment effectiveness when visual and 
statistical analysis inferences coincide, and the increased credibility of SSED findings for the 
scientific community given the use of statistical analysis.  
Effect sizes based on non-overlap statistics and those based on regression models have 
been considered for synthesizing single-case studies (Maggin et al., 2011; Methe et al., 2012). 
We focus on regression-based effect sizes because they have the capacity to model complex 
data patterns (Center et al., 1985-1986; Van den Noortgate & Onghena, 2003a). For instance, 
they can account for non-linear trends and dependent error structures. The regression 
approach also allows an estimate of the baseline level, the trend during the baseline, an 
immediate treatment effect and a treatment effect on slope. Also within-phase and within-case 
variability can be estimated. For a more in depth discussion of regression-based effect sizes 
and their combination across SSED cases and studies using multilevel regression models, we 
refer the reader to Van den Noortgate and Onghena (2003a, 2003b). 
Regression-based effect size estimates can be combined across cases and across studies 
using the multilevel model, which is an extension of the single-level regression model (Van 
den Noortgate & Onghena, 2003a). In recent years, much attention has been paid to the 
synthesis of simple AB phase designs and multiple-baseline designs using the two-level 
model (Ferron et al., 2009; Ferron et al., 2010; Van den Noortgate & Onghena, 2003a) or the 
three-level model (Moeyaert et al, 2013a; Owens & Ferron, 2010; Van den Noortgate & 
Onghena, 2008). In the two-level model, data are summarized across cases within a single 
study which implies a two-level structure: measurement occasions are nested within cases in 
one SSED study. The three-level analysis goes one step further and can be used to combine 
data across cases and across studies, which includes a three-level structure: the measurement 
occasions are clustered within cases and cases are clustered within studies. Using the 
multilevel modeling framework, the following research questions can be resolved: (1) What is 
the magnitude of the average treatment effect across cases and across studies?; (2) What is the 
magnitude and direction of the case-specific intervention effect?; (3) How much does the 
treatment effect vary within cases, across cases and/or across studies? and (4) Does a (case 
and/or study level) predictor influence the treatment’s effect?  
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While multilevel modeling techniques are proposed to combine data from simple AB 
phase designs and multiple-baseline designs, combining data from ABAB phase designs and 
alternating treatment designs has hardly received any attention. However, Shadish and 
Sullivan (2011) found that 70% of all published SSEDs in 2008 are characterized by a 
multiple-baseline design, an alternating treatment design or an ABAB phase design. 
Combining several types of SSEDs is therefore of importance to increase both the validity and 
credibility of the intervention effect estimates. If the same conclusion is based on a synthesis 
of results from different types of SSED designs, then there is more confidence that the results 
are due to the intervention and not to some outside experimental factors (i.e. internal validity). 
Combining data from different designs can enhance the external validity of the synthesis’ 
findings because they are based on more diverse data. If several SSED studies’ results are 
combined, then data from multiple studies including one or multiple cases are used thereby 
providing more information and resulting in more precise treatment effect estimates (i.e., 
smaller standard errors and narrower confidence intervals). Given the potential benefits of 
combining results from several types of SSEDs, it is surprising that past research focusing on 
multilevel analysis of SSEDs has not focused on this issue. The synthesis of single-case 
results across cases and across studies using the multilevel modeling framework is still in its 
infancy. Previous research focused on the validation of the basic three-level model in order to 
obtain a better understanding and assessment of the multilevel modeling framework in this 
context (Moeyaert et al., 2013a; Ugille et al., 2012). In this previous research, suggestions are 
made to gradually extend this multilevel model in order to represent more realistic situations 
such as taking different design types into account. Combining several types of SSEDs in a 
multilevel modeling framework is challenging, because choices have to be made concerning 
the coding of data from the different SSEDs and also methodological questions arise 
concerning the dependency between effect sizes. Therefore in this study, we extend the 
multilevel meta-analytic method proposed by Van den Noortgate and Onghena (2008) to 
combine several types of SSEDs We start with a review of the basic characteristics of the AB 
and ABAB phase designs, the multiple-baseline designs and the alternating treatment designs. 
We continue by presenting the multilevel modeling framework for combining these designs. 
Models are illustrated using empirical data. 
In order to make this study results comparable to the study of Heyvaert et al. (2014), we 
will assume flat baseline and treatment levels, and homogeneous within-case variance. The 
main interest lies in the average intervention effect estimate (and not in changes in slope or 
variability in outcome scores due to the intervention). Note that according to the What Works 
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Clearinghouse (WWC) standards (Kratochwill et al., 2010), a flat baseline is needed prior to 
intervening and therefore this assumption is not unreasonable. Trends and heterogeneous 
within-case variance can be modeled using the regression-based effect size estimator as 
explained and illustrated in more detail in Moeyaert et al. (2014), but these extensions of the 
basic model are beyond the scope of this manuscript. 
8.2 AB Phase Design 
An AB phase design is the simplest type of SSED and is characterized by one baseline 
phase and one treatment phase. The baseline phase is critical as it serves as the basis for 
predicting the level of performance in the near future if the intervention is not in effect. 
According to the WWC standards (Kratochwill et al., 2010), it is important to observe baseline 
performance minimally across three measurement occasions to provide a sufficient basis for 
making a prediction of future performance. Figure 8.1 illustrates how observations during the 
baseline phase are used to predict future performance. 
 
Figure 8.1. Graphical presentation of the intervention effect for an AB phase design. The solid lines refer to the 
actual outcome level and the dashed lines refer to the projected outcome level. 
In order to analyze SSED data as presented in Figure 1, we can apply the following 
basic regression equation in which the outcome score is regressed on an intercept [i.e., 
expected outcome level when the independent variable(s) equal(s) zero] and a dummy 
variable indicating the phase (i.e., the dummy variable, Intervention, equals zero if the 
measurement occasion belongs to the baseline phase, one otherwise). 
                         and     (     
 ) (8.1) 
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Using Equation 8.1,    indicates how performance is increased when going from the baseline 
to the intervention phase, and therefore can be interpreted as the intervention effect. Research 
synthesists of SSED data often assume homogeneous, normally distributed and independent 
errors, such as in Equation 8.1, to facilitate estimation and interpretation of the parameters.  
8.3 ABAB Reversal Designs 
A possible extension of the AB phase design, in which we distinguish between four 
phases (i.e., two baseline phases, A1 and A2, and two intervention phases, B1 and B2), is the 
ABAB reversal design. During each phase, the level of behavior is assessed and is projected 
to the next phase to predict the level of behavior in the near future (see Figure 8.2). Other 
variations of reversal designs are possible, but serve the same purpose (e.g., ABABAB, 
ABCBC, see Barlow et al., 2009 and Kazdin, 2011). 
 
Figure 8.2. Graphical presentation of the intervention effect in the first and the second AB pairs for an ABAB 
reversal design using hypothetical data. The solid lines refer to the actual outcome level and the dashed lines 
refer to the projected outcome level. 
We discuss the scenario in which stable outcome scores during baseline and intervention 
phases are obtained. Depending on the research interest, different parameters can be 
estimated. For instance, one could estimate the intervention effect during the second AB pair 
as a kind of control for the effect observed during the first AB pair. Single-subject researchers 
are especially interested in the intervention effect in both first and second AB pairs and more 
specifically whether the intervention effect in the second AB pair is equal to the one obtained 
in the first AB pair. Therefore, two dummy variables, namely               and       can 
be modeled as discussed in Moeyaert et al. (2014c). The dummy,              , indicates 
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whether measurement i is part of a baseline phase (i.e., A1 or A2) or an intervention phase 
(i.e., B1 or B2). If the measurement occasion belongs to B1 or B2, then               equals 
one, otherwise zero. The dummy variable,      , indicates whether the measurements belong 
to the first (Pair = 0) or the second AB pair (Pair = 1). The equation that can be used to 
analyze an ABAB reversal design, assuming no trends and homogeneous within-subject 
variance, looks as follows: 
                                                         
and     (    
 ) 
(8.2) 
Using Equation 8.2,    and    refer to the baseline level and the intervention effect, 
respectively, during the first AB pair;   +    indicates the second baseline level and   +    
refers to the change in level when the treatment starts in the second AB pair. Using Equation 
2 therefore results in two coefficients of particular interest, namely,    and   +   .    
indicates the intervention effect for the first AB pair and    indicates the difference in the 
intervention effect of the first AB pair and the second AB pair, which we label the additional 
intervention effect in Figure 8.2. Other coding options for the dummy variables in ABAB 
phase designs are also possible and provide alternative interpretation of coefficients. For a 
detailed discussion, we refer the reader to Moeyaert et al. (2014b).  
8.4 Multiple-Baseline Designs 
A multiple-baseline design (MBD) is characterized by the simultaneous 
implementation of an AB phase design to different subjects, behaviors or settings (Ferron & 
Scott, 2005; Onghena, 2005). In this study, we focus on the multiple-baseline across subjects 
design. An important feature is that the intervention is introduced to the subjects at different 
points in time. As in the AB and ABAB phase designs, treatment effects can be evaluated in 
the MBDs by comparing the level of performance during the intervention and the projected 
baseline level. Because the MBDs are comprised of simultaneously repeated AB designs 
across different subjects (as opposed to ABAB designs wherein the AB phases are replicated 
within a single participant), the MBD will be analyzed as separate AB phase designs using 
Equation 8.1 for each participant. The MBD design and the intervention effects are presented 
in Figure 8.3. 
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Figure 8.3. Graphical presentation of the intervention effect for an MBD across three subjects using hypothetical 
data. The solid lines refer to the actual outcome level and the dashed lines refer to the projected outcome levels. 
8.5 Alternating Treatment Designs 
The difference between alternating treatment designs (ATDs) and previously presented 
SSEDs is that in ATDs, two or more interventions are rapidly (sometimes randomly) 
alternated within a single subject. Because we are interested in the estimate of the intervention 
effect as the difference in outcome scores between intervention and baseline phases, we only 
discuss the ATDs characterized by multiple interventions during the intervention phase and a 
baseline phase. The following regression equation can be used in order to analyze data 
obtained by an ATD: 
                                            and   
   (    
 ) (8.3) 
The interpretation of the coefficients in Equation 8.3 is straightforward and is depicted 
in Figure 8.4.                and                are two dummy coded variables. 
               equals 1 if observation i belongs to the intervention phase, 0 otherwise. 
               equals 1 of observation i belongs to the second treatment, 0 otherwise. As a 
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consequence, if                equals 1 and                equals 0, the observation is 
made during the first intervention, and    can be interpreted as the effect of the first 
intervention on the outcome score and    as the effect of the second intervention, on top of 
the effect of the first intervention(i.e., the difference between the first and second intervention 
effect). For a detailed discussion, we refer the reader to Moeyaert et al. (2014b). 
 
Figure 8.4. Graphical presentation of the intervention effect for an ATD using hypothetical data. The solid lines 
refer to the actual outcome level and the dashed lines refer to the projected outcome levels. 
Equation 8.1 for the AB phase designs and MBDs, Equation 8.2 for the ABAB phase 
designs and Equation 8.3 for the ATDs all share in common that    refers to the intervention 
effect either for the first intervention or in the first AB pair. This is fundamental for the 
remainder of this study.    and    refer to the additional effect of a second intervention 
(ATDs) and the intervention during the second AB pair (for ABAB phase designs) 
respectively. 
8.6 Three-Level Meta-Analysis Across SSED Types 
8.6.1 Effect size 
As far back as in the mid-1970s, large numbers of studies, addressing similar underlying 
research questions, have been published at an astounding rate. Meta-analytic techniques have 
been proposed to integrate research findings across studies as a basis for examining external 
validity of treatment effects (Glass, 1976). By pooling results from several studies together, 
an average treatment effect estimate can be obtained as well as estimates of the variation in 
the treatment effect across cases and studies. Also, by pooling together results from multiple 
studies, more reliable treatment effect estimates can be obtained which can inform research 
and policy. Important advantages of using meta-analysis for SSEDs are that it overcomes the 
limitations associated with small sample sizes encountered in individual studies, enhances the 
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power to detect effects of interest, and increases the precision of treatment effect estimates. In 
addition, differences in intervention effect estimates as a function of individual and study 
characteristics can be investigated.  
In a typical meta-analysis, standardized effect sizes, based on the mean difference in 
outcome variable between treated and untreated subjects divided by the within-group standard 
deviation are summarized. In this study, we use another type of effect size, namely regression 
coefficients as suggested by Van den Noortgate and Onghena (2008). These effect sizes can 
easily be obtained by conducting an ordinary least square (OLS) regression analysis for each 
subject using Equations 8.1 to 8.3. Depending on the SSED type and the underlying 
assumptions, a regression equation is chosen and regression coefficients of interest are 
estimated (and will serve as the foundation of the effect size in the multilevel analysis). In this 
study, the intervention effect estimate is represented by    and is an estimate of the true 
intervention effect,   . For the ABAB phase designs and the ATDs, an additional effect size 
estimate is obtained, namely    or   , representing the estimate of the true deviation of the 
second from the first intervention effect in an ATD (  ) and the true deviation of the 
intervention effect in the second AB pair from the intervention effect in the first AB pair for 
ABAB phase designs (  ). 
8.6.2 Standardized and bias-corrected effect sizes  
Once the subject-specific effect sizes,   , and possibly (depending on the design)    or 
   are estimated by conducting an OLS regression analysis for each subject, the next step 
involves combining the effect estimates across subjects and across studies in order to estimate 
the average effect size. However, it is reasonable that different studies and different types of 
studies use a different scale to measure the dependent variable and therefore the effect sizes 
are not on comparable scales and cannot be combined. For instance, in one study the 
dependent variable might be measured on a scale from one to ten whereas in another study a 
scale from one to five might be used. One way to standardize SSED data is by dividing the 
estimated subject-specific effect size by the estimated residuals’ standard deviation as 
suggested by Van den Noortgate and Onghena (2008). Simulation studies (Moeyaert et al., 
2013b; Ugille et al., 2012) show that this works well if the number of observations per subject 
is larger than 10. The residuals’ standard deviation is used as a reflection of the scale used in 
the original single-subject.      with a = 1, 2 or 3 represents an effect size estimate for subject 
j from study k. In particular,      indicates the intervention effect estimate for the reference 
treatment and the first AB pair,      is the estimate of the difference in the effect of the 
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second versus the first intervention for an ATD, and      is the deviation of the intervention 
effect estimate during the second versus first AB pair for an ABAB phase design. The 
standardized effect size,      , is then obtained by dividing the estimated effect size,     , by 
the residuals’ standard deviation, √ ̂   as follows: 
      = 
    
√ ̂ 
 
  (8.4) 
For more details, we refer the reader to Van den Noortgate and Onghena (2008). 
Because SSEDs result in small data sets, Ugille et al. (2013) suggested correcting the 
standardized effect sizes (i.e.,       in Equation 8.4) for small sample bias by multiplying the 
effect size by Hedges’ bias correction factor (Hedges, 1981), which is approximately equal to 
1-[3/(4m-1)], with m indicating the degrees of freedom. In the models discussed above, m 
equals the number of measurement occasions (I) minus the number of predictors (p) in the 
regression model minus 1 (i.e., m = I – p – 1): 
     
       (   
 
  (     )   
) 
(8.5) 
where      
  represents the standardized, bias-corrected regression coefficient estimate for 
subject j from study k. Because the effect is multiplied by a constant, the variance of this 
effect size, of which the inverse is used as weight in a meta-analysis, should be corrected as 
follows: 
   
    
  (  
 





8.6.3 Multilevel meta-analysis 
Multilevel meta-analysis is one technique that can be used to combine effect sizes 
(standardized and bias-corrected regression coefficients in this study) measuring the same 
dependent variable such as the number of challenging behaviors during a specified time 
interval. The multilevel approach can be applied when synthesizing SSED studies in which at 
least some are characterized by more than one participant, because in that case, measurement 
occasions are nested within subjects and subjects in turn are nested within independent 
studies. The approach takes the hierarchical structure into account and the within-subject, 
between-subject and between-study variability in estimated intervention effect(s) can be 
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estimated. Such a multilevel analysis gives insight into the average intervention effects across 
subjects and studies, as well as variation in the effect between subjects and between studies 
and factors that explain this variation. Previous meta-analyses of single-subject studies 
ignored the different design types used in their primary studies and reduced all the designs 
into simple AB designs (e.g., Denis et al., 2011; Heyvaert et al., 2012; Heyvaert et al., 2014). 
This is unfortunate because in this way available information is not fully used. Below we re-
analyze the data of Heyvaert et al. (2014) by means of three alternative models that take the 
specificities of the designs into account. To aggregate the data of multiple SSED types across 
subjects and across studies, the (standardized and bias-corrected) OLS regression coefficients 
can be combined either using a univariate meta-analysis for each kind of coefficient (i.e., b1, 
b2, b3) or a multivariate meta-analysis of all types of coefficients together.  
8.6.3.1 Univariate three-level meta-analysis 
To combine the estimated effect sizes across subjects and across studies, three univariate 
multilevel meta-analyses can be performed, one for each kind of coefficient (i.e.,      
 ,      
 , 
and      
 ). This will be referred to as Model 1, although parameters are estimated for three 
separate univariate models– one for each coefficient type. At the first level of the multilevel 
model, these OLS estimated treatment effects equal an unknown population effect size, 
indicated by the   coefficients in Equation 8.7, plus a random deviation from this population 
parameter, indicated by the error terms: 
Level 1:       
             with         (       
 )   (8.7) 
     
             with         (       
 ) 
     
             with         (       
 ) 
The within-subject variability is set to the estimated variance from the ordinary least square 
regression analysis conducted for each subject. 
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The subject-specific population intervention effect,     , and differences between 
intervention effects,      for ATDs and      for ABAB phase designs, respectively, can vary 
from subject to subject and therefore we add a second level. 
This results in the following: 
Level 2:                  with         (       
 )   (8.8) 
                with         (       
 ) 
                with         (       
 ) 
At the subject level the population regression coefficient for the intervention 
effect,       equals an average intervention effect across subjects in the k
th
 study,       and a 
subject-specific deviation,     , from the study-specific average intervention effect. Similar 
equations can be obtained for      and     . 
At the study level, the study-specific effect sizes,     ,     , and     , are allowed to 
vary across studies: 
Level 3:                  with         (       
 )   (8.9) 
                with         (       
 ) 
                with         (       
 ) 
At level 2 and level 3, residual terms are assumed to be normally distributed. We are 
interested in     ,     , and      indicating the estimated effect sizes across subjects and 
across studies (the average intervention effect, the additional intervention effect of the second 
intervention for ATDs and the additional intervention effect during the second AB pair for the 
ABAB phase designs).  
In a second model (Model 2), we are interested in assessing differences between design 
types in the average intervention effects. The analysis model is similar to the one presented 
using Equations 8.7 through 8.9. In both Model 1 and Model 2, three univariate three-level 
meta-analyses are performed, one for each effect size. The only difference between Model 1 
and Model 2 is that the estimated intervention effect size,     , will be separated into three 
estimated intervention effects, one for each design type. This can be accomplished by adding 
a dummy variable per design type in the univariate model estimating the average intervention 
effect: one for the AB/MBDs, one for the ATDs and one for the ABAB phase designs. The 
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dummy coefficient referring to the AB/MBDs is reduced to AB for simplicity. As a 
consequence, the first line of Equation 8.7 becomes: 
       
                                              . (8.10) 
8.6.3.2 Multivariate three-level meta-analysis 
The multivariate model is of importance when the researcher wants to estimate multiple 
effect sizes simultaneously (as opposed to conducting separate analysis per type of effect size 
as presented in the univariate section), taking into account that effect sizes within a subject are 
possibly correlated, as is the case for the ABABs (between      and     ) and the ATDs 
(between      and     ). Another major advantage is that, in addition to variance estimates, 
the multivariate model allows estimation of the covariance between effect sizes at the subject 
and study level. For instance, the covariance between the average intervention effect estimate 
and the additional intervention effect estimate for the ATDs and the ABAB phase designs at 
the subject level and study level can be estimated (Van den Noortgate & Onghena, 2003b). 
The multivariate three-level meta-analysis might be preferred because of its ability to provide 
more information compared to the univariate three-level model approach as well as its 
handling of the potentially non-zero covariances between effect sizes.  
The estimation approach is a multivariate extension of the univariate approach of Model 
1. Kalaian and Raudenbush (1996) describe how such a multivariate analysis can be executed, 
using estimates of the sampling variances and covariances of the observed effect sizes (here, 
estimates obtained from the OLS regression analyses). The covariance between effect sizes at 
the second and third level will be estimated. This multivariate model is the third analysis 
model (Model 3) we discuss in the empirical illustration. 
8.7 Empirical Illustration 
Recently, Heyvaert, et al. (2014) conducted a meta-analysis of 59 SSEDs looking at 
restraint interventions for challenging behavior among persons with intellectual disabilities. 
Heyvaert et al. (2014) retrieved raw data graphically presented in the primary studies using 
the statistical software program UnGraph, recommended by Shadish, et al. (2009). In the 
study of Heyvaert et al. (2014), the previously discussed SSEDs are included (AB, ABAB 
phase designs, MBDs, and ATDs). However, they simplified their dataset by reducing all 
types of SSEDs to simple AB phase designs. In this study, we re-analyze 55 of the 59 studies 
(i.e., 4 studies were not re-coded because it was not clear which design type was used in the 
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primary study), and recoded them (taking multiple intervention phases and multiple 
interventions within a phase into account). We found that within some studies, multiple types 
of SSEDs were used. For instance the first subject can be characterized by an ABAB phase 
design and another subject by an ATD. A total of 98 subjects were recoded and a median of 1 
subject per study was found with a minimum of 1 and a maximum of 6 subjects per study. 
The median number of measurements within a subject was 51 with a minimum of 9 and a 
maximum of 237. Over one half of the subjects (52.82%) were characterized by an ABAB 
reversal design, 22.45% of the subjects were associated with simple AB phase designs, 
18.37% of the subjects are MBDs, and 6.36% are ATDs. For the ATDs, the two introduced 
treatments per subject are variants of each other. 
Table 8.1 gives an overview of the parameter estimates and standard errors when using 
the different analysis models of interest. Model 1 and 2 are composed of three univariate 
three-level meta-analyses. In Model 1, an average intervention effect is estimated across the 
SSED types (    ), and an additional intervention effect for the second AB pair was estimated 
for the ABAB phase designs (    ) and an additional intervention effect for the second 
treatment was estimated from the ATDs (    ). In Model 2, predictors indicating the design 
type are included. This results in an average intervention effect estimate per design type 
(                 and        ). Again, an additional intervention effect for the ATDs (    ) 
and the ABAB phase designs (    ) was estimated. In the third analysis model (Model 3), the 
dependency between effect sizes was modeled by using the multivariate three-level model.  
The average intervention effect estimate across SSED types was estimated in Model 1 
and Model 3 and was found to be statistically significant: -3.26, t(42) = -7.23, p < .01, and -
3.12, t(41) = -15.99, p < .01, respectively. This indicates that in general, restraint interventions 
are effective in reducing challenging behavior among persons with intellectual disabilities. 
The average intervention effect estimates per SSED type (i.e., Model 2) was found to be 
statistically significant for the AB/MBDs and the ABAB phase designs, but insignificant for 
the ATDs (see       ,         , and         in Table 8.1). The three models allow 
estimating whether the intervention effect in the second AB pair (for ABAB phase designs) 
differs significantly from the intervention effect in the first AB pair, which is not the case in 
the univariate models. In contrast to the statistically non-significant effect found in Model 1 
and Model 2, the multivariate model indicates that the additional intervention effect for the 
ABAB phase designs is statistically significant;     = -1.10, t(12) = -5.62, p < .01. The 
additional effect of the second intervention (for ATDs) is not statistically significant. 
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Heyvaert et al. (2014) also estimated the average intervention effect across subjects and 
across studies, but simplified all included SSEDs to simple AB phase designs. They found an 
average significant intervention effect estimate of -3.16, which is comparable with the one 
obtained by Model 1 and Model 3. However, Heyvaert et al. (2014) did not provide separate 
effect size estimates for each SSED type nor any information concerning additional 
intervention effect estimates. 
No statistically significant variance is found at the study level for the univariate models 
(i.e., Model 1 and Model 2), whereas significant variance estimates are found for the 
multivariate model (i.e., Model 3). At the subject level, all variances are statistically 
significant except for the additional intervention effect estimate for the ATDs. For the 
univariate models, the between-subject variance of the average intervention effect estimate is 
more than seven times larger than the between-subject variance of the additional intervention 
effect estimates, which is not the case for the multivariate model. In addition to variance 
estimates, the multivariate model allows estimation of covariance between effect sizes. We 
found a statistically significant positive covariance between the average intervention effect 
estimate and the additional intervention effect estimates both at the subject and study level. 
For instance, the covariance between the average intervention effect estimate and the 
additional intervention effect estimate for the ATDs at the subject level equals 1.03, Z = 4.95, 
p < .01. In order to interpret this value, we can calculate the correlation. The correlation 
between the two effect sizes equals the covariance of these effect sizes divided by the product 
of the standard deviation of both effect sizes. In this example, the correlation between the 
average intervention effect estimate and the additional intervention effect estimate for the 
ATDs at the subject level equals 0.65 [            (√      √    )]. This means that a large 
average intervention effect estimate goes together with a large additional intervention effect 
estimate. Note that the estimated variances in the multivariate model are smaller compared to 
the estimated variances using the univariate models, but still statistically significant because 
of the smaller estimated standard errors. The estimated variance components of the study of 
Heyvaert et al. (2014) are comparable to the ones obtained by Model 1 and 2. In their study, 
the between-study variance was not statistically significant (= 3.49), but the between-subject 
variance was significant (= 12.21). The study of Heyvaert et al. (2014) could not provide any 
information concerning the variance of additional intervention effects or the covariance 
between effect sizes. 
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Table 8.1 
Parameter and Standard Error Estimates Resulting from Estimation of the Three-Level Meta-Analysis of Model 
1 – Model 3 
Parameter  Parameter estimate (SE) 
 Model 1     Model 2     Model 3 
Fixed coefficient    
Average intervention effect  
 across SSED types,      
 per design type 
        
          


















Additional intervention effect 
 Second intervention effect in ATD,      
 second AB pair for ABAB phase designs,      
 
-1.83  (0.90) 
-0.12  (0.07) 
 
-1.83  (0.90) 
-0.12  (0.07) 
 
-0.96   (0.42) 
-1.10* (0.20) 
(co)variance component    
Between-study variance    
Average intervention effect,      
  
Average additional intervention effect 
 Second intervention effect in ATD,      
  
 Second AB pair for ABAB phase designs,      
  
Covariance intervention effect second intervention in ATD 
Covariance intervention effect second AB pair 
3.00  (2.18) 
 
0.50  (2.96) 
0.0          (-) 
3.30  (2.22) 
 
0.50  (2.96) 





  1.00         (0) 
1.14* (0.16) 
      0.99         (0) 
1.11* (0.16) 
Between-case variance    
Average intervention effect,      
  
Average additional intervention effect 
 Second intervention effect in ATD,      
  
 Second AB pair for ABAB phase designs,      
  
Covariance intervention effect second intervention in ATD 
Covariance intervention effect second AB pair 
13.12* (2.52) 
 




1.83   (1.98) 
0.17* (0.06) 
1.48 * (0.10) 
 
1.68   (0.73) 
1.42* (0.11) 
1.03* (0.21) 
        1.22*(0.09) 
Note. Standard errors are in parentheses.  
 * p < .05. 
8.8 Discussion 
The purpose of this study was to illustrate the multilevel meta-analysis of SSEDs of 
different types because current methodological work on the synthesis of SSEDs often focuses 
on combining simple AB phase designs and MBDs or simplify more complex SSEDs to 
simple AB phase designs. We focused on the average intervention effect estimate and we 
proposed three different analysis models to accomplish this and compared the results to the 
study of Heyvaert et al. (2014). We found a significant average intervention effect across 
SSED types (Model 1 and Model 3). This matches the results of the study of Heyvaert et al. 
(2014). When the average intervention effect is estimated per design type (Model 2), an 
insignificant effect is found for the ATDs, which are represented in only 6% of the studies and 
thus their effect is estimated less precisely than the effect for AB or ABAB designs. This is a 
major limitation of Model 2. The multivariate model (i.e., Model 3) gives more information in 
comparison to the univariate one because the dependency between different kinds of effect 
sizes is handled and estimated. For instance, in this study we found that the magnitude of the 
average intervention effect was strongly positively correlated with the additional 
218          Chapter 8 | Intervention effect estimate across types of single-case designs 
 
intervention’s effect. A major advantage of the multivariate model is that the average effect 
sizes can be estimated simultaneously, whereas in model 1 and 2, three univariate multilevel 
meta-analyses have to be performed.  
This study has some limitations. The focus of the current study was on synthesizing 
results from SSED studies involving different design types and investigating average effects. 
However, it is possible to also use the multilevel model demonstrated here to provide subject-
specific estimates. To extend the multilevel meta-analysis of SSEDs to incorporate multiple 
design types we chose to start with a relatively simple statistical model. We assumed that the 
within-subject variance was homogenous over phases, but in some studies the variance may 
change with intervention. We also assumed that the within-participant errors were 
independent, however, errors may be autocorrelated (Beretvas & Chung, 2008; Ferron et al., 
2009; McKnight, McKean, & Huitema, 2000). We assumed that the errors at the three-levels 
were (multivariate) normally distributed, which may not be the case with some outcomes 
(e.g., counts of behaviors). We also assumed no trend in baseline and treatment phases. 
However, in some studies a linear or non-linear trend might be more realistic. More complex 
regression and multilevel models have been proposed to handle these various data 
complexities, but we chose to start with a relatively simple statistical model. Now that we 
have developed a multilevel meta-analytic method for synthesizing results across design 
types, future research could extend the approach to more complex models that can 
accommodate these additional data complexities. Making the methods for synthesizing SSED 
studies more inclusive of varying SSED design types and varying data structures will lead to 
more precise and accurate estimates of average treatment effects, as well as more precise and 
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9.1 Introduction 
SSEDs have been used to evaluate the effect of a treatment on the outcome score of a 
dependent variable for many years (Busse et al., 1995; Chorpita et al., 1996; Kratochwill & 
Levin, 1992). However, only during the last decade, SSEDs have been acknowledged as a 
means to establish an evidence base for examining the effectiveness of treatments 
(Kratochwill et al., 2010). As a consequence, it is not surprising that especially during recent 
years the number of published SSEDs has been increasing at an astonishing rate in accordance 
with the need of appropriate techniques to analyze SSED data. In order to support an evidence 
base and make externally valid conclusions to inform research, practice and policy it is not 
only necessary to analyze SSED data but also to meta-analyze (i.e., summarize, synthesize) a 
set of similar focused SSEDs. The literature indicates that there has been made efforts to 
meta-analyze SSEDs as the number of published meta-analysis of SSED studies is increasing, 
especially during the last seven years (e.g., Social Science Citation Index within the Web of 
Sciences). However, in contrast to meta-analysis of group-comparison studies, there is still a 
lack of consensus regarding methods to quantitatively summarize SSED results. Over the past 
twenty years, suggestions have been made about how to meta-analyze these SSEDs (Center et 
al., 1985-1986; Hedges et al., 2012; Maggin et al., 2011; Mastropieri & Scruggs, 1985; Parker 
et al., 2011; Shadish et al., 2013; Shadish, et al., 2012; Swanson & Sachse-lee, 2000), but it is 
fraught with a lot of controversy (Allison & Gorman, 1993; Kratochwill et al., 2010; Shadish 
& Rindskopf, 2007). To combine SSED data within and across studies, a promising approach 
recently suggested and recommended is multilevel modeling (Nugent, 1996; Rindskopf & 
Ferron, in press; Shadish & Rindskopf, 2007; Shadish et al., 2013; Van den Noortgate & 
Onghena, 2003a, 2003b, 2007, 2008). The multilevel modeling method is a very flexible 
approach given its ability to model complexities such as autocorrelation, predictors at the 
different levels (such as age, gender, school type, study quality), heterogeneous within-
subject, between-subject and between-study covariance and allows estimating average 
treatment effects in addition to subject-specific and study-specific treatment effects (Shadish 
& Rindskopf, 2007; Van den Noortgate & Onghena, 2003b). By conducting a multilevel 
analysis, important research questions can be addressed (which cannot be answered by single-
level analysis of SSED data) such as: (1) What is the magnitude of the average treatment 
effect across subjects and across studies? (2) What is the magnitude and direction of the 
subject-specific intervention effect? (3) How much does the treatment effect vary within 
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subjects, across subjects and/or across studies? and (4) Does a (subject and/or study level) 
predictor influence the treatment’s effect? 
This dissertation is dedicated to the three-level modeling of SSEDs as little is known about its 
potentials, modeling options, performance and power. The goal of this dissertation is twofold. 
The first part (Part 1) deals with the examination of the performance of the three-level model 
to summarize SSED data across subjects and across studies and is especially interesting for 
methodologists, meta-analysts, and single-case research synthesists (Chapters 2, 3, 4, and 5). 
The second part (Part 2) focuses on modeling options and practical applications of the three-
level model and is intended for an applied audience (Chapters 6, 7, and 8). In the following 
sections, an overview is given of the main research findings from the different studies and 
their strengths and limitations are discussed (Chapter 9). Chapter 9 is of primordial 
importance as it handles implications for SSED researchers, SSED meta-analysts, and 
methodologists. Research without implications would be meaningless. We end this chapter 
with a brief summary and global conclusion. Chapter 10 is the most important chapter of the 
dissertation as it yields suggestions to continue research in the area of multilevel analysis and 
single-subjects. 
9.2 Research Overview: Summary of the Main Findings 
9.2.1 Part 1 
The first part is methodological and presents the results of four computer-intensive 
Monte Carlo simulation studies.  
In Chapter 2, the first Monte Carlo simulation study (of which three will follow) was 
conducted in order to evaluate whether the basic three-level model (including changes in 
level, changes in slopes and homogeneous variances at the three-levels) is appropriate to 
synthesize SSED data across subjects and across studies. The simulation study shows that the 
three-level approach results in unbiased estimates of the immediate treatment effect and the 
treatment effect on the slope. In order to have reasonable power (  .80) for testing the 
treatment effects, a homogeneous set of at least 30 studies should be included. If this 
condition is fulfilled, the number of measurements and subjects is of less importance. From 
the estimates of the variance components, we deduce that there is bias when estimating the 
between-case variance of the immediate treatment effect and the effect on the slope (mean 
bias equals 2% with a minimum of 0% and a maximum of 10%). These biased variance 
estimates are consistent with previous empirical research about the three-level analysis of 
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SSED data (Owens & Ferron, 2012) and previous research from a broader methodological 
domain, for instance growth curve models (Kwok et al., 2007; Murphy & Pituch, 2009). The 
bias is even larger when estimating the between-study variance of the immediate treatment 
effect and the effect on the time trend (mean relative bias equals 17% with a minimum of 0% 
and a maximum of 49%). In these contexts the inclusion of 30 or more studies is 
recommended, and even then researchers should anticipate some bias. 
In Chapter 3, the focus of interest is on one specific method, originally suggested by 
Van den Noortgate and Onghena (2008), to standardize raw single-subject data. They 
proposed performing an ordinary least squares regression for each case separately, and 
dividing the individual scores by the estimated residual within-case standard deviation. The 
issue of standardization is timely, as there is an increasing interest in combining SSED data 
across a variety of different studies, and as dependent variables in a set of SSED studies are 
not always measured the same way and on the same scale. Therefore standardization is 
needed to allow immediate comparison and fair interpretations of scores on challenging 
behavior across different studies. The three-level synthesis of standardized single-case data is 
found to be appropriate for the estimation of the treatment effects, especially when many 
studies (30 or more) and a lot of measurement occasions within cases (20 or more) are 
included, and when the studies are rather homogeneous (with a small between-study 
variance). The estimates of the variance components are less accurate. There is a significant 
mean bias for the estimate of the between-study variance (24%) and the between-case 
variance (71%) for the immediate treatment effect (similar results are obtained for the 
estimated between-study and between-case variance for the treatment effect on the slope). The 
maximum bias  for the estimation of the between-study variance is 35%: while it is 219% for 
the estimation of the between-subject variance. Especially the estimate of the between-subject 
variance is biased, except when at least 40 measurement occasions within a case are included. 
The estimation of the between-study variance is more accurate, but the bias remains 
substantial if 30 studies with only 10 measurements within a subject are included. The bias is 
especially larger when the between-study variance is large and the within-study variance is 
small. For both estimated variance components, the number of measurements has a large 
effect on the bias. 
In Chapter 4, we proposed a possible way to handle a threat towards internal validity, 
commonly encountered in SSED, namely external event effects. In multiple-baseline designs, 
external effects can become apparent if they simultaneously have an effect on the outcome 
score(s) of the cases within a study. This study presents a method to adjust the three-level 
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model for external events and evaluates the appropriateness of the modified model. The 
results of the simulation study show that if the external event influences subsequent scores for 
all the cases within a study, the three-level approach for uncorrected effect sizes is not 
recommended because the estimates of both treatment effects (i.e., immediate effect on level 
and effect on time trend) are biased. The mean squared error, standard error, and coverage 
proportion are better estimated when using the modified model, which includes moment 
effects. The difference between the corrected and uncorrected effect sizes is largest when 
there are a small number of studies (10) and measurement occasions (15), so in this context 
we advise using the adjusted model. Moreover the adjusted model results in less biased 
variance estimates. As was found here, even when an external event effect is small, a failure 
to correct for it can lead to biased effect sizes. For instance, the maximum relative bias equals 
313% for the estimated between-study variance of the immediate treatment effect for the 
uncorrected effect sizes, while it is 55% for the corrected effect sizes. Thus, single-subject 
data analysts are encouraged to consider use of the three-level model that corrects for external 
event effects when synthesizing results of multiple-baseline design data. 
In the last chapter of the first part, Chapter 5, the robustness of the multilevel model 
against misspecification of the covariance matrix at the second and third level of the three-
level model is investigated. The results confirm previous research and indicate that the 
treatment effect estimates across subjects and across studies are unbiased. However, when 
covariance is generated, the mean squared error is large, but is reduced by increasing the 
number of studies and subjects and reducing the between-subject variance. The median 
relative standard error biases is also substantial when covariance is generated and only 
slightly larger when covariance is generated and ignored in the analysis. As a consequence, 
the coverage proportion of the 95% confidence intervals is too small. This indicates that the 
treatment effect estimates across cases and across studies is relatively robust against 
misspecification of the covariance matrix. However, this is not the case for the estimates of 
the variance components (i.e., between-case and between-study variance). When covariance is 
present in the generated data but ignored in the analysis, the between-study variance and 
between-subject variance has large bias values. Thus, when researchers are interested in the 
estimate of the variance components, modeling covariance at the second and third level is 
recommended. 
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9.2.2 Part 2 
The second part of this dissertation is the applied part and contains three applications of 
the multilevel modeling method.  
In Chapter 6, representing the first applied chapter, we present and extend the piecewise 
regression analysis (Center et al., 1985-1986) to analyze SSED data. The regression-based 
approach is a flexible technique to analyze SSED data retrospectively, in addition to visual 
analysis during data collection. The purpose of the regression analysis is to quantify the SSED 
data results resulting in an effect size estimate which can be used to compare SSED results 
across studies, enhance the communication between applied SSED researchers, and can be 
used in meta-analysis to synthesize a large body of research. But, one question is how to 
specify predictors in a regression model in order to account for the specifics of the design and 
estimate the effect size of interest. In this study, we go back to basics and discuss in large 
detail what the design matrix looks like for the three most popular design matrices (i.e., 
multiple-baseline designs, reversal designs, and alternating treatment designs) to estimate the 
regression coefficients of interest. A graphical presentation of the regression coefficients is 
displayed and empirical illustrations are given. 
In Chapter 7, the extension of a single-level analysis to a three-level analysis of SSED 
data is discussed in detail. The enormous flexibility of the multilevel models is also a major 
drawback, because there are a variety of different modeling options and it is not always 
obvious in which conditions which to choose. Therefore in this article, a variety of different 
modeling options are discussed and illustrated using real datasets. We investigate to what 
extent the estimated treatment effect is dependent on the modeling specifications and the 
underlying assumptions. By considering a range of plausible models and assumptions, 
researchers can determine the degree to which the effect estimates and conclusions are 
sensitive to the specific assumptions made. If the same conclusions are reached across a range 
of plausible assumptions, confidence in the conclusions can be enhanced. We advise 
researchers not to focus on one model but to conduct multiple plausible multilevel analyses 
and investigate whether the results depend on the modeling options. 
In Chapter 8, the multilevel modeling framework is extended by giving different 
modeling options to combine several different SSED types (i.e., multiple-baseline design, 
ABAB reversal designs, and alternating treatment designs). This is timely, as in previous 
research all SSEDs are commonly reduced to simple AB phase designs, ignoring the complex 
data structures, which possibly resulted in biased treatment effect estimates. We illustrate the 
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different models using a re-analysis of a meta-analysis of single-subject experimental designs 
(Heyvaert et al., 2014). The intervention effect estimates using univariate three-level models 
differ from those obtained using a multivariate three-level model that takes the dependence 
between effect sizes into account. Because different results are obtained, and because the 
multivariate model has multiple advantages – including more information and smaller 
standard errors – we recommend researchers to use the multivariate multilevel model to meta-
analyze studies that utilize different SSED types. 
9.3 Strengths and Limitations of this Dissertation 
9.3.1 Strengths of this dissertation 
The first major strength of this dissertation lies in validating a promising flexible 
technique to summarize a large body of literature, namely multilevel modeling. The further 
development of such a technique is timely as there is a growing interest in summarizing SSED 
studies as a means to establish an evidence base for the effectiveness of treatment effects. The 
number of published SSED studies has been increasing at a spectacular rate during the last 
decade, which makes them suitable for quantitative syntheses. Moreover, it would be a waste 
of research investments to neglect this wealth of information that is already in the literature. 
The multilevel model can be used to perform SSED data synthesis and takes the hierarchical 
structure of the data into account. It is surprising that previous research did not use the 
multilevel model to synthesize SSED data, but rather focused on subject-specific analysis. A 
reason for this might be that the multilevel model methodology was not well understood and 
was not further developed; problems that are hopefully solved, at least partially, after reading 
this dissertation. 
A second major strength of this dissertation is that we focus on a heterogeneous 
audience, namely methodologists, meta-analysts, and applied single-case researchers. The 
articles included in the dissertation are published in both methodological and applied 
international peer-reviewed journals, and therefore we tried to make the multilevel modeling 
option widely-spread known. In the first part of this dissertation, methodologists are 
challenged by the extensive and computer-intensive simulation studies conducted using the 
infrastructure of the Flemish Supercomputer Center. Given the urgency, we challenge 
methodologists to investigate further developments and complexities resulted from the 
simulation studies. A lot of coding expertise and statistical knowledge is needed. Because new 
methodologies are meaningless without applications, we elaborated a second part in which 
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applied single-case researchers and meta-analysts are taken on a journey through the 
multilevel modeling process using a step-by-step approach and making the multilevel model 
gradually more complex. Different modeling options are presented and illustrated using real 
data examples. We explain in large detail why research synthesis and multilevel modeling is 
needed. 
A third strength of this dissertation is that the included conditions in the simulation 
studies represent realistic conditions, as they are based on thorough re-analysis of published 
meta-analyses of SSEDs in the field of educational research. During my first months as a 
PhD-student, raw data were retrieved from these meta-analyses of SSEDs using statistical 
software, which resulted in a dataset allowing identification of realistic conditions and 
parameter values. We also consulted recently published articles such as the Shadish and 
Sullivan (2011) paper and the WWC technical documentation (Kratochwill et al., 2010) giving 
characteristics of SSEDs. We did not only formulate conditions to be included in the basic 
three-level model, but we also formulated complexities such as external event effects, 
misspecification of the covariance matrix and the issue of standardization. All these 
extensions are discussed in detail and are validated through extensive Monte Carlo simulation 
studies. In the first two simulation studies (Chapter 2 and Chapter 3), we included 2,000 
iterations of each condition, which reduces the likelihood that the results are obtained by 
chance. For the other two simulation studies, we only included 500 (Chapter 5) or 400 
(Chapter 4) replications. Because of the model complexity, and time and money issues, we 
had to find a balance between the number of replications and the included conditions and 
parameter values in these last two simulation studies. Although we did not empirically 
validate all possible extensions to the three-level model, a major strength of this dissertation is 
that we discussed a variety of different and plausible modeling options in the applied part 
(i.e., we chose to model autocorrelations, heterogeneous within-case variance, predictors at 
the different levels, trends during the treatment phase, and different types of SSEDs designs 
such as multiple-baseline designs, reversal designs and alternating treatment designs). By 
considering a range of plausible models and assumptions, researchers can determine the 
degree to which the effect estimates and conclusions are sensitive to the specific assumptions 
made. If the same conclusions are reached across a range of plausible assumptions, 
confidence in the conclusions can be enhanced.  
Previous research aiming to summarize SSED data only focused on fixed effect 
estimates ignoring the meaningful information (co)variance components estimates can 
provide. An additional strength of this dissertation is that the (co)variances are modeled and 
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estimated, in addition to the fixed effect estimates, and the influence of the covariance 
specification on the treatment effect estimates and (co)variance components estimates is 
evaluated. For instance, the between-study variance indicates to what extent the estimated 
treatment effects of individual studies deviate from an average treatment effect estimate. We 
found that homogeneous studies have a beneficial effect on the treatment effect estimates. 
Also, the covariance between regression coefficients at the different levels should not be 
ignored, as it can give interesting information. For instance, a non-zero covariance between 
residuals at level 2 seems reasonable, as due to a ceiling effect, the estimated treatment effect 
is expected to be smaller for cases with an already high estimated baseline level. 
The traditional estimation procedure used within the multilevel modeling framework is 
the restricted maximum likelihood estimation (REML). A strength is that the REML 
estimation of multilevel models is implemented by default in a variety of commercial 
software programs such as SAS, HLM, MLwiN, SPSS, and Stata, and is even available in the 
freeware, R. This enhances the use of multilevel modeling. Although we only elaborated on 
how to conduct multilevel modeling using SAS codes, a strength of this manuscript is that a 
description of the codes is provided, enabling the researcher to make the translation to the 
preferred statistical software program. 
A last major strength of this dissertation is that it is embedded in an international 
context. This dissertation is the result of a collaboration between the Methodology of 
Educational Science Research Center of KU Leuven, Quantitative Methods, University of 
Texas, and Educational Measurement and Research, University of South Florida. As a 
consequence, the research team is composed of researchers with a different background: 
experts in multilevel modeling, SSEDs, meta-analysis, randomization tests, and applied SSED 
research. This mix of research expertise enabled the development of methodological 
innovations that are relevant for everyday SSED practice. Also because of the international 
interest, the use of the multilevel modeling technique can be spread widely. 
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9.3.2 Limitations of this dissertation 
A first problem is that the multilevel model assumes that studies and subjects are 
randomly sampled from a population of studies and subjects respectively. However in reality 
and practice, subjects are not randomly sampled, but are chosen on purpose because the 
researcher is interested in that particular subject (e.g., subjects with special needs). As a 
consequence, researchers interested in summarizing SSED studies must be careful in 
generalizing SSED results to a broader population of subjects. It is important to define the 
population, as conclusions are exclusively restricted to the population of subjects from which 
the included subjects in the multilevel analysis could be regarded as a random sample. Note 
that this is not only a limitation of SSED studies. Also in group-comparison designs, 
participants can be purposely sampled. 
Although the conditions included in the simulation studies are chosen to be 
representative for published SSED studies in the domain of education, as we conducted re-
analyses of published SSEDs in this research area, not all conditions could be included in the 
Monte Carlo simulation studies. As a consequence, we evaluated the appropriateness of 
inferences made from a three-level single-subject model in specific conditions and caution is 
warranted with generalization of the research findings to conditions that were not simulated. 
In addition, in this dissertation we focused on balanced data. We chose to keep the number of 
measurements within a study constant for all subjects within the same study. Of course it is 
possible that different participants of the same study have different series lengths. Also 
homogeneous within-subject, between-subject and between-study variance is assumed 
whereas this might not be the case. 
The number of replications (i.e., datasets) per condition in this simulation study is either 
2,000, 500 or 400 depending on the model complexity and the number of included conditions 
(i.e., if models are rather basic, 2,000 replications were feasible, otherwise 500 or 400). Of 
course, as more replications emerge, one can be more confident in the research findings. If 
money and time issues are not a matter of concern, we advise to include 2,000 replications (or 
even more). However, the chance is small that the results are obtained by coincidence if 500 
or 400 replications are included. 
Another issue in the context of multilevel analysis of SSEDs is that small sample sizes 
are an inherent characteristic of SSEDs, which limits the achievable complexity of the three-
level model. As models are getting more complex (as in the fourth simulation study where 
covariance at the second and third level is modelled), and represent more realistic models that 
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fit the data better, the estimation might fail due to small sample sizes. This might have been 
the reason why in the fourth simulation study, ignoring existing covariance did not have 
consequences on the fixed effects and variance components estimates.  
Although our research team consists of several researchers with a complementary 
background, a person with extended algebraic knowledge is missing. It might be possible to 
mathematically derive large-sample approximations of the estimated standard errors of the 
treatment effects for balanced situations. Because of the small sample sizes in the context of 
multilevel modeling of SSED data, asymptotic assumptions are violated, upon which the 
algebraic derivations would be based. However, algebraic derivations could have provided 
guidance when setting up the simulation studies or could have helped the interpretation of the 
simulation results. Thus, we exclusively rely on simulation studies to empirically examine the 
three-level modeling technique. 
In this dissertation, we only discovered the top of the iceberg and validated the three-
level model with relatively few extensions (i.e., modeling trends, standardization, external 
event effects, and covariance at the second and third level). Other extensions are plausible and 
some of them were proposed in the applied part of the dissertation, such as autocorrelation, 
heterogeneous variance, non-linear trajectories, count outcomes, etc. However, little is known 
about the performance of the three-level model if extensions and combinations of extensions 
are included. So far, the multilevel model has been promising, but caution is needed when 
stating that the multilevel model is appropriate to summarize SSED data because we did not 
focus on all possible extensions and combinations of extensions. 
We simulated data assuming that the errors at the different levels are independent, 
identical, and (multivariate) normally distributed. First, there are concerns regarding the 
assumption that the errors in the statistical model are independent. When repeated 
observations are made on the same subject, it is plausible that the errors of the measurement 
associated with a score at one data point may be predictive of errors at other points in the 
series that follow. To simplify the simulation model, we did not account for a possible 
dependence between different regression coefficients, which can be accounted for in a 
multilevel analysis by estimating the covariances at the various levels. It is likely that the 
distribution of the errors are case-and study-specific. Lastly, because of the small sample sizes 
included (especially at the second level of the multilevel model), it is hard to examine the 
normality assumption. 
A next limitation lies in the fact that we only focused on the traditional estimation 
procedure in multilevel modeling for estimating fixed effects and variance components, 
234   Chapter 9 | General conclusion 
 
namely the restricted maximum likelihood. We did not include alternative estimation 
procedures such as bootstrapping and Bayesian estimation procedures (Rindskopf, 2013; Van 
den Noortgate & Onghena, 2005). These procedures are promising as they rely on less 
restrictive assumptions but are not yet investigated in the context of three-level modeling of 
SSED data. Alternative estimation techniques might solve the biased variance component 
estimates. Despite the valuable information these variance components provide, we did not 
yet focus on possible solutions to deal with this issue. 
In this dissertation, we only focused on educational and social sciences data. However, 
the number of published SSEDs is increasing in a variety of different research fields, 
including for instance the biomedical world. We only discussed educational and social 
sciences data because they are different in nature from biomedical data. However, despite the 
particular characteristics of educational data, a lot could have been learned from other 
research fields. It is unfortunate that we did not look beyond our own research field and 
broaden our view. 
Another limitation is that we focused on the multilevel modeling of raw SSED data. 
This is only possible if raw data can be retrieved from the original SSED studies. Usually this 
will be the case as there is a tradition in SSED research to present the data graphically. 
However, retrieving raw data from single-case studies using statistical software tools (which 
is a point and click procedure) entails a large workload. Also, it might be the case that the data 
are not graphically presented and that the author of the SSED study is unable to provide the 
raw data. In that case, combining effect sizes instead of raw data is a solution as discussed by 
Ugille et al. (2012). However, it might be the case that the effect sizes are not reported in the 
original studies and additional calculations have to be conducted. 
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9.4 Implications of this Dissertation 
9.4.1 Implications for research synthesists 
The results of this dissertation are promising and encouraging for researchers interested 
in estimating fixed effect (i.e., average immediate treatment effect and treatment effect on 
slope) across subjects and across studies. Valid and reliable average treatment effect estimates 
are obtained at least if the underlying assumptions are met and if the model is correctly 
specified. The results of these syntheses establish a means of evaluating treatment effect 
estimates and contribute to evidence based practice. Valuable information is obtained in order 
to improve research and everyday practice and important policy decisions can be made based 
on the results of literature synthesis. However, we advise research meta-analysts to increase 
the number of primary studies included in the multilevel analysis whenever possible as greater 
precision and accuracy in effect size estimates can be obtained. While single-case meta-
analysts are constrained by the availability of primary studies, they could adjust their methods 
for searching (e.g., expanding their search terms) whenever possible, but are limited by what 
the field has generated. 
In contrast to the average fixed effect estimates, caution should be paid when 
interpreting the variation in treatment effects between subjects and between studies. Even 
assuming the model is correctly specified, the variance components at all levels are biased. 
Furthermore, it is not always obvious which specific SSED data characteristics and synthesis 
characteristics best fit the data and have to be modeled. Therefore, we advise the research 
synthesists to conduct a sensitivity analysis and evaluate to what extent the average treatment 
effect estimates depend on specific modeling options. If the same conclusions are reached 
across a variety of different multilevel modeling options, the researcher can be more confident 
in its research findings and more reliable estimates are obtained. 
9.4.2 Implications for applied single-case researchers 
The study shows that the average treatment effects are generally well estimated if the 
between study-variability is small and if a minimum of 30 studies are involved. The number 
of measurements and cases is of less importance. Therefore, besides the importance of 
systematically varying characteristics of studies in order to investigate moderator effects, it 
might be advantageous to replicate previous studies, resulting in homogeneous study results. 
Of course the methodology and instruments have to remain appropriate for the subject in a 
certain context. Also, single-subject researchers should pay attention to baseline variability or 
stability in an effort to decrease variability at level one. This might partly solve 
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standardization problems. Also, as the baseline trajectory is used as a means to estimate the 
treatment effect, a more justified treatment effect estimate is obtained. Another cause of 
variability is measurement error. Finding a way to eliminate measurement error might 
decrease overall variability. Therefore, we encourage single-case researchers to measure a 
dependent variable consistently at the same time of day, at the same setting and for the same 
amount of time across subjects and even across studies investigating the same underlying 
treatments. We also advise single-case researchers to pay attention to treatment fidelity 
(Kazdin, 2011), because this can result in a decrease in between-subject variability, and as a 
result in less variability in the average treatment effect estimate. For example, if a treatment 
was administered exactly like it was intended to be administered, the associated treatment 
effect would be different than a treatment effect associated with a treatment administered 
differently than intended.  
A requirement for obtaining more accurate estimated treatment effects over subjects and 
over studies if standardized SSED data are used, is to include at least 20 measurement 
occasions per subject. As standardization is desirable if SSED studies are combined, we 
encourage single-subjects researchers to observe and measure their subjects at least 20 times.  
A final recommendation to single-case researchers is to consider previous single-subject 
studies. Specifically, if single-case researchers from similar areas of interest (e.g., reading, 
math) measure their dependent variables the same across studies, then single-case meta-
analysts would have a larger number of primary studies to include in their research synthesis 
and could feel more confident in their interpretation of average treatment effect estimates. 
9.4.3 Implications for methodologists 
We encourage methodologists studying the use of multilevel modeling to summarize 
single-case data to conduct further research on modeling count outcomes, non-linear 
trajectories, etc. Furthermore, violations of assumptions (e.g., non-normality of the level-1, 
level-2, or level-3 errors, heteroscedasticity of errors at all levels) and various level-1 error 
models (e.g., high order autoregressive or moving average models) need to be investigated in 
the future. Investigation of these more complex models would allow for a better 
understanding of the applicability of the models under a variety of conditions. Future research 
on other approaches to estimate variance components would also be of interest. The results of 
this dissertation have indicated that the variance components at all levels are biased. 
Therefore, it would be interesting to investigate alternative methods for estimating variance 
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such as the Bayesian approach. More details about these suggestions and other suggestions for 
further research are given in Chapter 10. 
9.5 Global Conclusion 
From the first part of this dissertation, we conclude that the basic three-level multilevel 
model is found to be appropriate to synthesize raw unstandardized single-case experimental 
data across cases and across studies, at least if the researcher is interested in the fixed effect 
estimates (i.e., immediate treatment effect and treatment effect on slope) and if the underlying 
assumptions are not violated (independent, identically and normally distributed errors). The 
variance components estimates (i.e., the between-case and between-study) can be questioned 
and are biased, especially when estimating the between-study variance of the immediate 
treatment effect and the effect on the time trend. The bias can be reduced by including at least 
30 studies, but even then researchers should anticipate some bias. When the basic three-level 
model is extended by modeling standardized raw data instead of unstandardized raw data, the 
variance components estimates become even more biased. This dissertation has shown that 
the multilevel modeling approach can easily be extended, by for instance taking external 
event effect into account, a major threat towards internal validity in SSED research. 
Moreover, the multilevel model is relatively robust against misspecification of covariance 
components at the second and third level of the multilevel model. This first part should be 
extended in further research, by extending the basic three-level model by including 
combinations of commonly encountered complexities, such as standardization in combination 
with external event effect, autocorrelation, non-linearity, etc.  
From the second part of this dissertation, we conclude that the multilevel modeling 
framework has a lot of applications and a lot of potential. Both the two- and three-level model 
can easily be extended by taking for instance count data, autocorrelation, non-linearity, 
heterogeneous within-phase variance, etc. into account. However, caution should be paid 
when specifying the design matrix, as the interpretation of the parameters of interest is 
dependent on this. There are also different ways to combine different types of SSEDs using 
multilevel models. So its enormous flexibility is one of the major advantages of the multilevel 
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The future of Multilevel Chapter 10|
Modeling to Synthesize Single-Subject 
Experimental Design Data? 
  
240  Chapter 10 | Future research 
 
Suggestions for Further Research 
Doing research is a never-ending process and does not simply end with a global 
conclusion and implication. By writing this dissertation, I realize that I only discovered the 
top of a huge iceberg and that my research has just started. Questions about optimizing the 
research methodology rise, new problems emerge, research ideas are born, and further 
research is needed to deal with recently discovered issues in the multilevel modeling of 
SSEDs. Literally a hundred directions for further research are possible, of which we will 
discuss the most important and timely ones. 
10.1 Suggestion 1 
As a first suggestion for further research, we suggest to conduct a systematic review of 
published and unpublished meta-analyses of SSEDs. This is needed to establish the empirical 
foundation for further studies by SSED researchers, meta-analysts and methodologists. In this 
dissertation, we chose a limited number of specific conditions to investigate. We could not 
focus on all interesting conditions, because of the limited extent of this dissertation. Also, the 
choice of the included conditions are based on a limited number of re-analyses of published 
and unpublised meta-analyses of SSED studies (e.g., Alen et al., 2009; Denis et al., 2011; 
Kokina & Kern, 2010; Shogren et al., 2004; Wang et al., 2011). A clear and more extended 
overview of published and unpublished meta-analyses together with an overview of meta-
analystic and single-case data characteristics is missing in the literature. The overview can 
also report commonly encountered design complexities and combinations of complexities in 
the area of SSED research. We advise to formulate strict inclusion criteria about which meta-
analyses of SSEDs to include, because a primary search for published meta-analyses of 
SSEDs using the social sciences citation index with the keywords ‘single-case’ or ‘single-
subject’ or ‘interrupted time-series’ or ‘multiple-baseline’ in combination with ‘meta-
analysis’ or ‘synthesis’ already resulted in 367 results. By refining the inclusion criteria and 
specifying “Education and Educational Research” as research area, and by only including 
studies published over the past 20 years, 65 results remain, which is more feasible to focus on. 
In addition to simply giving an extended overview of SSED data and synthesis characteristics, 
we suggest to retrieve the raw data graphically presented in the primary studies included in 
the meta-analyses. The raw data can be digitized using the statistical software program 
UnGraph (Biosoft, 2004). This results in a large dataset with which single-case 
analysts/synthesists can conduct a secondary analysis. By doing this, important information is 
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obtained and realistic values for a number of parameters can be defined. This is of importance 
for research synthesists and methodologists interested in improving the analysis and meta-
analysis of SSEDs. The between-study variance, between-subject variance, within-subject 
variance, degree of autocorrelation, and covariance at the second and third level amongst 
other parameters can be estimated. Also trajectories during the baseline and treatment phase, 
design types, types of outcomes, number of data points per phase, phases per subject, number 
of subjects within the study, etc. can be determined. A sense of commonly encountered 
combinations of synthesis and SSED data characteristics can be obtained. Another interesting 
topic is the analysis technique used in the primary studies. We advise to keep track of the used 
analysis technique in order to identify the most commonly used analysis method (e.g., 
randomization tests, visual analysis, effect size estimates, etc.), and to investigate whether this 
is dependent on the year in which the article is published. This suggestion is timely, as in the 
past, the absence of this systematic approach resulted in not well documented conditions and 
complexities studied at the meta-analytic level of SSED studies.  
10.2 Suggestion 2 
There is a need to search for alternative estimation procedures to the maximum 
likelihood estimation in contexts of multilevel modeling of SSEDs that have the potential to 
solve the problem of biased variance estimates. In addition, estimation problems occur even 
for the fixed effects estimates when the multilevel model is getting more complex (i.e., when 
complex SSED data characteristics and synthesis characteristics are included). We suggest to 
investigate two alternative promising estimation procedures to synthesize SSED studies, 
namely Bayesian estimation paired with different prior distributions (Shadish et al., 2013) and 
parametric and nonparametric bootstrapping methods (Efron & Tibshirani, 1994; Mooney & 
Duval, 1993; Van den Noortgate & Onghena, 2005). This suggestion is timely and of crucial 
importance to solve estimation problems encountered when models get complex or when the 
research interest lies in (co-) variance estimation. Covariance estimation hardly got any 
attention in previous research, which is unfortunate because of the complementary and other 
source of information they can provide in addition to fixed effect estimates. For instance, the 
variance in estimated treatment effects (i.e., immediate treatment effect and treatment effect 
on time trend) between subjects and/or between studies can be estimated. There is a need to 
validate these alternative procedures using simulation studies, to program these procedures in 
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software packages, and to give clear guidelines in which circumstances which estimation 
procedure is advisable.  
10.3 Suggestion 3 
In this research, we focused on the validation of the basic three-level model and three 
extensions to it, namely standardizing the raw data, modeling external event effects and 
focusing on misspecification issues. However, we did not focus on extensions simultaneously 
modeled, for instance standardizing and modeling external event effects. Also, we only 
validated a limited number of extensions to the multilevel model, but suggested several 
extensions of which some are validated by simulation studies by other members of the 
research team. For instance, the modeling of non-linear trajectories is studied by Beretvas et 
al. (2013), the modeling of autocorrelation is investigated by Baek and Ferron (2013), and 
count data as outcome scores are modeled by Beretvas and Chu (2013). Ugille et al. (2012, 
2013) focused on combining effect sizes across subjects and across studies, and validated a 
bias correction factor for the fixed effect estimates. If the SSED date are not graphically 
displayed in the primary studies, raw data cannot be retrieved, and then the approach of Ugille 
et al. (2012) is recommended. In addition, treatment effects estimates are often evaluated by 
group-comparison studies, in which data are aggregated over participants per condition, 
before comparing conditions. Results from these studies only permit assessment and 
explanation of variability between studies. Combining group-comparison and  SSED data 
would result in more general treatment effect estimates, which is currently investigated by 
Ugille et al. (2014). The basic three-level model and extensions to it discussed in this 
dissertation only involved continuous outcome scales. However, the article of Shadish and 
Sullivan (2011), in which single-case characteristics of all 809 published single-case studies 
in 2008 were discussed, shows that nearly all outcome variables were some form of a count. 
Therefore, further research is needed to discuss the basic tree-level model and several 
extensions to it when the outcome scores are counts. For instance, a Poisson-distribution can 
be used. In addition, we discovered that if several studies are combined in the multilevel 
model, it might be the case that outcome scores are on different scales (e.g., interval, count, 
percentages). This influence of assuming continuous outcomes when in fact another type of 
scale is used, is an interesting research question. Also, estimating treatment and variance 
components across studies using different type of outcome scales is needed (or transferring 
outcome scales to continuous outcome scales could also be investigated). The systematic 
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review of published and unpublished meta-analyses of SSED studies (proposed as the first 
suggestion for further research) might provide some insight into which SSED data 
characteristics and synthesis characteristics are commonly encountered in the multilevel 
modeling of SSEDs. We advise to conduct a large simulation study, integrating realistic and 
complex conditions and parameter values for these conditions. These could be obtained by the 
secondary analysis of the retrieved meta-analytic SSED data (as presented in the first 
suggestion for further research). As these multilevel models are potentially getting complex, 
we advise to use alternative estimation procedures to the restricted maximum likelihood 
estimation, such as the Bayesian estimation procedure, which potentially results in less biased 
treatment and variance components estimates. 
10.4 Suggestion 4 
We recommend focusing on power in further research, as little is known about the 
power of the extended multilevel models to identify the statistical significance of treatment 
effect estimates and variance component estimates. The power is traditionally defined as the 
probability of correctly rejecting a false null hypothesis and is dependent on the sample size, 
the effect size, the probability of Type I error, and the specific experimental design (Howell, 
2005). Although the first two simulation studies in this dissertation dealt with the issue of 
power, this was not the focus of interest in the other studies, neither was it the focus of the 
simulations conducted by the other members of our research team. Therefore, further research 
is needed to investigate to what degree the power is dependent on synthesis and SSED data 
characteristics. By examining the power, conditions can be determined under which the three-
level model can be recommended. Furthermore, we suggest investigating under what 
conditions a reasonable power is obtained, and how the three-level modes can be modified 
and optimized to obtain a predefined power. 
10.5 Suggestion 5 
Standardization is of crucial importance when a researcher is interested in summarizing 
data across different studies, because it is likely that outcome scores from different studies are 
measured on different scales. In this dissertation, we proposed to standardize the SSED data 
for each subject separately before combining them across cases and across studies using the 
multilevel model. We validated the standardizing method proposed by Van den Noortgate and 
Onghena (2008), which involves dividing the subject-specific outcome scores by the 
244  Chapter 10 | Future research 
 
estimated within-case standard deviation prior to synthesis. However, the simulation study 
combining the standardized SSED data showed that the variance estimates are even more 
problematic in comparison to the three-level modeling of unstandardized raw data. We also 
discovered that the fixed effect estimates are underestimated when a large number of studies 
characterized with a small number of measurement occasions are included in the multilevel 
model. To standardize, we used the variance at the lowest level (the within-case variance), 
which is expected to be one. However, we estimated the (co)variances at the three levels and 
therefore, the estimated within-subject variance might slightly deviate from one. In the 
simulation studies, we found that the most problematic conditions are those where a lot of 
studies including a limited number of measurement occasions are included. When less 
measurement occasions are included, a less accurate within-subject variance might be 
obtained. Therefore, further research is needed to find a more optimal way of standardizing 
the SSED data. We suggest to evaluate whether analyzing standardized raw SSED data with a 
constrained level-1 variance would lead to less biased variance estimates. Another option is to 
use a fully Bayesian approach,  and the use of a bias correction factor that was proposed by 
Hedges in another context (Ugille et al., 2013). 
10.6 Suggestion 6 
When using the multilevel model, specific assumptions about the data under 
investigation are made. In this dissertation, we only discussed one assumption in greater detail 
and that is the covariance specification at the second and the third level. We were especially 
interested in the influence of ignoring existing covariance on the fixed effects and variance 
component estimates. We did not focus on the level-1 residual specification as the research 
team of Prof. dr. John Ferron is investigating this. However, a combination of level-1, level-2 
and level-3 variance misspecification issues is an interesting research line. Another 
assumption underlying the multilevel model is the assumption of normality. We assumed that 
the level-1 residuals come from a normal distribution and level-2 and level-3 residuals are 
multivariate normally distributed. However, single-case studies by definition focus on a small 
number of participants, which can negatively impact the distribution of the residuals. It would 
be interested to investigate to what degree the research results are accurate when we analyze 
non-normally distributed data. This can be accomplished by transforming the second and third 
level errors to a non-normal distribution, more specifically a distribution with heavier tails 
such as the t-distribution with small degrees of freedom, and a skewed distribution such as a 
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   distribution. Another assumption we made about the errors is that they are identically 
distributed. However, this might not be the case. For instance, in some SSED studies, it is 
obvious that the variance within the treatment phase is larger than the variance within the 
baseline phase. Also at the second level, it might be that the variance within one study is 
larger than the variance within another study. We did not take this into account. In all 
previous simulation studies investigating the multilevel modeling (Ferron et al., 2010; 
Moeyaert et al., 2013a, 2013b, 2013c, 2014b), designs were assumed to be balanced 
(homogeneous number of measurements within subjects, and subjects within studies, and 
homogeneous within- and between-subject and between-study variance). However, multilevel 
modeling data might be unbalanced. We suggest taking into account that the variance between 
subjects varies across studies, that the variance within subjects varies across subjects, and that 
the variance within studies varies between studies. We wonder whether this has a 
consequence on the fixed effects and variance components estimates. 
10.7 Suggestion 7 
Further research is needed to investigate cross-classified data in contexts of three-level 
modeling of SSED data. For instance measurements can be classified in a subject, but also in 
a setting. We already try to give some possible ways to deal with cross-classified data. One 
solution is to use a cross-classification mixed model. Another model that can be used is the 
multivariate three-level model, in which the dependent variables are the outcome scores in a 
particular setting; for instance       is the outcome score in setting h for measurement 
occasion i from subject j and study k. A third option is including the setting as a measurement 
characteristic, by including the setting as a categorical predictor in the first level equation. 
10.8 Suggestion 8 
In this dissertation, we discussed that not only the number of published SSED studies is 
increasing at an astonishing rate, but also the number of meta-analyses (see Figure 1.7). 
Therefore, we argue that it might be interesting to include a predictor indicating the meta-
analysis at the third level, but also this needs some further exploration as little is known about 
the modeling of predictors at the different levels of the multilevel model. For instance, the 
level two and level three equations can be extended by including predictors allowing us to 
investigate possible moderating effects of subject (e.g., age, gender, etc.) and study 
characteristics (e.g., study quality, publication year, etc.). We want to gain insight in how 
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many measurements, subjects and studies are required for adding a specific number of 
predictors at level two and level three to achieve a reasonable power. 
10.9 Suggestion 9 
Further work on multilevel modeling is needed to develop a practical manual about the 
multilevel modeling of SSED data in which all modeling options are discussed in detail, in 
accordance with the interpretation of the results obtained by the multilevel model. In this 
dissertation, we only discussed the possibilities of the statistical program SAS to combine 
single-case data across cases and across studies using the mixed procedure. However, the 
multilevel analysis is implemented in a variety of other statistical programs such as R, HLM, 
SPSS, and MLwiN. A translation of the SAS codes into other statistical software programs is 
needed, in accordance with their own advantages and disadvantages. In addition, developing a 
user-friendly tool in which the SSED researcher can explore their data might be helpful, as a 
number of different modeling options is possible with the multilevel model, and it might 
sometimes not be obvious which option to choose and to what degree the fixed effects and 
random effect estimates are dependent on these modeling options. In this way a quick 
sensitivity analysis could be conducted (i.e., to what extent are the results dependent on the 
modeling options). The underlying purpose of this dissertation is to guide single-case data 
analysts interested in using the multilevel model to summarize their data. 
10.10   Suggestion 10 
Previous research has focused on the coding schemes and syntheses of results from 
several types of SSEDs separately, including the multiple-baseline design, ABAB reversal 
design, ATD, and the changing criterion design (Moeyaert et al., 2014b; Shadish et al., 2013). 
However, a large proportion of actual SSEDs do not use a ‘pure’ design (such as a phase 
design or ATD), but rather a design that combines characteristics of two or more designs. 
Shadish and Sullivan (2011) found that 26% of the 809 studies they reviewed entailed 
combinations of the basic designs. As far as we know, no research has investigated coding, 
and effect size estimation for combinations of these designs. 
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10.11   Suggestion 11 
In this dissertation we did not stress the importance to take specific issues related to 
SSED studies into account. A first issue is the need of stable baseline outcome scores prior to 
intervention in order to extrapolate accurately (Kazdin, 2011; Kratochwill et al., 2010). As a 
consequence, the start of the treatment phase cannot be determined a priori. Usually, single-
case researchers apply a form of response-guided experimentation, where they continue to 
gather baseline data until an acceptable pattern emerges. Little is known about the 
consequences of response guided-experimentation on the treatment effect estimate across 
subjects and across studies. In this dissertation we were mainly interested in the immediate 
treatment effect and in the treatment effect on the slope. However, it might be the case that the 
effect of the treatment is delayed, and as a consequence, there is no linear increase in outcome 
scores during the treatment phase. Therefore, a non-significant immediate treatment effect and 
a significant change in slope can be found. It might be of more interest to identify the moment 
of intervention at which the treatment starts to have an impact on the outcome scores. Little is 
known about how to take delayed treatment effects into account and the consequences of 
ignoring this in the analysis. Another important issue that we did not elaborate on in this 
dissertation is the importance of randomization in SSEDs in order to increase the internal 
validity. Whenever it is possible, researchers should be advised to apply a form of 
randomization to eliminate alternative explanations for the change in outcome scores. 
Randomization can for instance be introduced for the start of the treatment, the assignment of 
measurement occasions to treatment phases, the number and order of phase repetitions, or the 
assignment of participants to baseline lengths. In further research, we recommend to 
implement a form of randomization in the design of the study and compare the results 
obtained by randomization tests and multilevel modeling or other methods. In contrast to the 
multilevel modeling approach suggested in this dissertation, randomization tests make no 
assumptions about the distribution of the residuals. An alternative approach to randomization 
is to include nonparametric bootstrap procedures in the multilevel modeling approach, which 
also needs further exploration.  
10.12   Suggestion 12 
In this dissertation, the focus of interest is the statistical analysis in order to summarize a 
large amount of data across subjects and across studies. However, visual analysis is also of 
importance as it can provide experimental control during the single-subject experiment. Both 
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procedures are complementary and necessary. Visual analysis techniques have long been 
acknowledged as effective and valuable (Michael, 1974). During visual analysis of the data, 
the effect of the independent variable and extraneous variables are evaluated while the SSED 
is being conducted. This ongoing process of data evaluation allows the applied SSED 
researcher to be responsive to the needs of the subject under investigation (Barlow & Hersen, 
1984; Kazdin, 2011). For instance, the intervention can be adapted during observation or the 
intervention can be introduced only after a stable baseline pattern emerged. Further research is 
needed to provide guidelines about how both procedures can be implemented and how they 
can lead to consistent results. 
10.13   Suggestion 13 
Further research is needed to examine to what extent the results found here are 
informative to other research fields than education, such as in biomedical research fields. 
There is a need to look beyond our own applied research domain (i.e., educational research) 
and to learn from other research fields in which SSEDs are prevalent. Therefore, there is a 
need for a systematic review, giving an overview of published SSED studies per research 
field, and investigating to what extent the complexities and specific SSED data characteristics 
and synthesis characteristics are also found in other research fields. There is a need to work 
more interdisciplinary because the multilevel model is a generic approach and can be applied 
to synthesize SSED data in a variety of different research fields. Also, to my opinion, we 
could have learned a lot from the modeling of longitudinal data (Verbeke & Molenberghs, 
2009), because they also deal with repeated measurements, and therefore cannot ignore the 
issue of autocorrelation. They also have to define trajectories, model different type of 
outcome scales, etc. 
The Need for Further Research 
We have plenty of other suggestions for further research, but we chose to only highlight 
the most important ones. This proves that there is still a lot of further research needed in the 
domain of single-subject designs and the multilevel modeling framework. We want to make 
clear that the research started in this dissertation is not finished and thus the dissertation 
should not be read as a closed book. We hope to inspire other researchers and motivate them 
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Addendum A: SAS codes  
Addendum A1: SAS code used to standardize single-case data in 
(Chapter 3) 
We prepare a dataset called ‘raw’ with the raw data, and then we run following codes in SAS 
9.3: 
 
 Step 1: we conduct an ordinary least square regression analysis on the raw single-case data 
in order to estimate the residual standard deviation per subject. In this example, the data 
file ‘raw’ contains the raw unstandardized data. We give the dataset containing the 
parameter estimates the name ‘uncorrected’ and the dataset containing the RMSE (= root 
mean squared error) per case the name ‘MSE’. 
PROC REG DATA=raw; 
BY study case; 
    MODEL y = t D Dt; 




 Step 2: we calculate the standard deviation of  ̂   , which is the RMSE. The new dataset 
‘MSE’ only contains the study and subject number and the subject specific RMSE. 
DATA MSE; 
 SET MSE; 
 WHERE source='Error'; 
 RMSE=sqrt(MS); 
 KEEP study case RMSE; 
RUN; 
 
 Step 3: we merge the estimated residual within-subject standard deviation (the RMSE in 
the dataset named ‘MSE’) with the raw estimated data (‘uncorrected’). 
DATA uncorrected; 
 MERGE uncorrected MSE; 
 BY study case; 
RUN; 
 
 Step 4: we calculate the standardized scores by dividing the scores (Y) by the estimated 
residual within-subject standard deviation (RMSE) 
 
DATA raw; 
 MERGE raw MSE; 
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 Step 5 (three-level analysis): we use PROC MIXED in order to estimate the treatment 
effects over cases and over studies using the standardized single-case data (yS from the 
dataset ‘raw’). We apply the PROC MIXED procedure on the dataset ‘raw’. In the second 
statement we use study and case as CLASS variables which indicates that these variables 
are categorical. In the third statement we use MODEL to indicate the fixed part. The 
variable Ys (the standardized single-case data) is the dependent variable and the variables t 
(time), D (condition), Dt (interaction between time and condition) are the independent 
variables. The model estimates by default the intercept. If you are interested in the 
estimation of the treatment effects over cases and over studies using the unstandardized 
data, then you just use Y instead of Ys in the MODEL statement. The next statement 
includes the random part of the model, using RANDOM. We define that the intercept, t, D 
and Dt can vary randomly vary across studies (SUB = study) and across cases [SUB = 
case(study)].  
PROC MIXED DATA=raw; 
CLASS study case; 
 MODEL yS=t D Dt/ SOLUTION; 
 RANDOM intercept t D Dt/ SUB=study; 
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Addendum A2: SAS code multilevel analysis of unstandardized 
single-case data modeling and ignoring covariance at level 2 and 
level 3 (Chapter 5) 
 
SAS code used for the empirical example. 
We prepared the dataset called ‘raw’ and then we ran following programs in SAS 9.3: 
 
1. Three-Level Analysis Ignoring Covariance  
Code 
We use PROC MIXED in order to estimate the treatment effects over cases and over studies. 
PROC MIXED DATA = raw; 
CLASS   study   case; 
MODEL   Y   =   t   D   Dt   /   SOLUTION DDFM = sat; 
RANDOM   intercept   t   D    Dt   /   SUB = study; 
RANDOM   intercept   t   D   Dt   /   SUB = case(study); 
ODS OUTPUT   solution = fixed1 covparms = random1; 
RUN; 
In the first statement, we call the PROC MIXED procedure. Then we use DATA= statement 
to indicate which dataset we will use. In the second statement we use study and case as 
CLASS variables. This means that we define study and case as categorical variables. In the 
third statement we use MODEL to indicate the fixed part. The variable Y is the dependent 
variable and the variables t (time), D (condition), and Dt(interaction between t, centered 
around its value at the start of the treatment phase, and D) are the independent variables. The 
model estimates by default the intercept. The statement also involves the command 
SOLUTION. This is to request the estimates, standard errors, t-values, and p-values for the 
average intercept, and effects of t, D and Dt (the fixed effects or independent variables). 
DDFM = sat indicates that the Satterthwaite method was used to estimate the degrees of 
freedom. The next statement includes the random part of the model, using RANDOM. We 
define that the intercept, and the effects of t, D and Dt can vary randomly across studies (SUB 
= study) and across cases, which are nested in studies [SUB = case(study)]. The fixed effects 





The average intercept, and the average effects of t, D and Dt across cases and across studies 
are estimated. 
  
274   Addendum A 
 
Random1 
In the first row, the estimated between-study variance of the intercept is presented. The 
second, third and fourth row represent the between-study variance of the trend during 
baseline, of the immediate treatment effect, and of the treatment effect on the time trend 
respectively. The next four rows present the between-case variance of the intercept, the trend 
during baseline, the immediate treatment effect and the treatment effect on the time trend. The 
remaining row contains the estimated within-case variance. 
 
 
2. Three-Level Analysis Modeling Covariance 
We use again the SAS PROC MIXED procedure. But now we have to specify that the 
covariance matrix has to be estimated. We can accomplish that by using the ‘TYPE’ 
statement: TYPE = un in the random part of the model. This means that we estimate the 
variances and covariance. In the simulation study, we only estimated the covariance between 
the regression coefficients of the treatment effects. This is reasonable, because we set the 
intercept and the trend during the baseline level on zero (to obtain a more clear interpretation 
of the treatment effects). Therefore we restrained some parameters to zero using the PARMS 
statement in line 5. Here you can see that parameter 2, 4, 5, 7, 8, 12, 14, 15, 17 and 18 of the 
covariance matrix are restrained to zero. This means that the covariance between the effect of 
t and the intercept UN(2,1), between the effect of D and the intercept UN(3,1), between the 
effects of D and t UN(3,2), between the interaction effect of Dt and the intercept UN(4,1), 
between the effects of Dt and t (4,2) are restrained to zero at the second level (SUB = study) 
and at the third level [SUB = case(study)]. 
 
Code 
PROC MIXED DATA = raw; 
CLASS     study     case; 
MODEL Y =   t   D   Dt   /   SOLUTION; 
RANDOM   intercept   t   D   Dt   /    SUB = study   TYPE = un; 
RANDOM   intercept   t   D   Dt   /    SUB = case(study)   TYPE=un; 
PARMS 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1   /   HOLD=2 4 5 7 8 12 14 15 17 18; 
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Addendum A3: SAS code single-level analysis (Chapter 6) 
We give a description of the SAS code that can be used to conduct a separate linear 
regression for each participant of the multiple-baseline study of Laski et al. (1988) using 
design matrix 1. The same steps are used for design matrix 2, design matrix 3 and design 
matrix 4. The only difference between the design matrices is the coding of the time variable 
and multiple time variables are used in design matrix 2 and design matrix 4. 
1. SAS Code Design Matrix 1 
In the first statement, we conduct an ordinary least square regression analysis using the 
dataset named “Laski”. In the second statement we use a “by” statement to indicate that we 
conduct the regression analysis for each case separately. In the third statement we define the 
model. The variable Y is the dependent variable and the variables Time, treatment, and 
TreatmentTime1 are the independent variables. By default, the intercept is estimated. 
PROC REG DATA=Laski; 
BY case; 
    MODEL y = Time    Treatment     TreatmentTime1; 
RUN; 
2. SAS Code Design Matrix 2 
PROC REG DATA= Laski; 
BY case; 
    MODEL y = Time    Treatment    TreatmentTime; 
RUN; 
3. SAS Code Design Matrix 3 
PROC REG DATA=Laski; 
BY case; 
    MODEL y = Time1    Treatment    TreatmentTime1; 
RUN; 
4. SAS Code Design Matrix 4 
PROC REG DATA=Laski; 
BY case; 
    MODEL y = Time2    Treatment    TreatmentTime1; 
RUN; 
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Addendum A4: SAS code two-level analysis (Chapter 6) 
We provide a description of the SAS code that can be used to conduct a two-level 
analysis for the multiple-baseline design data from Laski et al. (1988). 
In the first statement, we request a two-level analysis on the dataset named “Laski”. In the 
second statement we specify case as a CLASS variable which indicates that this variable is 
categorical. In the third statement we use MODEL to indicate the fixed effects in the model. 
The variable Y is the dependent variable and the variables Time, Treatment, and 
TreatmentTime1 are the independent variables. By default, an intercept is estimated. The next 
statement specifies the random effects in the model, using RANDOM. We specify, here, that 
the intercept, Time, Treatment, and Treatment Time1 can vary randomly across cases (SUB = 
case). By using the statement SOLUTION in the random statement, the case-specific 
regression coefficients are estimated using empirical Bayes estimation. 
PROC MIXED DATA=Laski; 
CLASS case; 
 MODEL Y= Time    Treatment    Treatment Time1/ SOLUTION ; 
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Addendum A5: SAS code two-level analysis (Chapter 7) 
1. Model 1: Basic Two-Level Model 
 
Model 1A 
PROC MIXED  COVTEST DATA=TwoLevel METHOD=ML; 
CLASS case; 
MODEL Y =  Phase /  SOLUTION DDFM=sat; 
RANDOM Intercept  Phase /  SUB=Case; 




PROC MIXED  COVTEST DATA=TwoLevel METHOD=ML; 
CLASS Case; 
MODEL Y =  A1B1 B1A2 A2B2  /  SOLUTION DDFM=sat; 
RANDOM Intercept A1B1 B1A2 A2B2 /  SUB=Case; 
ODS OUTPUT solutionF=fixed1b covparms=random1b fitstatistics=fit1b; 
RUN; 
 
In the first statement, the mixed procedure is called. The DATA = statement refers to the data 
set in which the data are stored. The METHOD = statement asks the maximum likelihood 
estimation procedure. In the second line, the variable case,  identifying the cases, is defined as 
a categorical variable. In the third line, the fixed part of the model is described. The variable 
Y is defined as the dependent variable and the variable Phase in Model A and the variables 
A1B1 B1A2 A2B2 in Model B are defined as independent variables. The model includes an 
intercept by default. The SOLUTION-option is used to request in the output the estimates, 
standard errors, t-statistics and p-values for significance testing for all fixed effects. The 
RANDOM statement is used to describe the random part of the model. We indicate that the 
intercept and phase can vary randomly across cases. If one is interested in the case-specific 
baseline levels and treatment effects, the code can be adapted by including the SOLUTION-
option in the random part. The ODS OUTPUT is used to save the fixed effect estimates ( 
solutionF), the random effect estimates (covparms), and the fit statistics (fitstatistics) in output 
files. 
 




PROC MIXED  covtest DATA=TwoLevel METHOD=ML; 
CLASS Case Phase; 
MODEL Y =  Phase /  SOLUTION DDFM=sat; 
RANDOM Intercept  Phase /  SUB=Case; 
REPEATED / SUB=case GROUP=Phase TYPE=ar(1); 
ODS OUTPUT solutionF=fixed2a covparms=random2a fitstatistics=fit2a; 
RUN; 
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Model 2b 
PROC MIXED  covtest DATA=TwoLevel METHOD=ML; 
CLASS Case Phase; 
MODEL Y =  A1B1 B1A2 A2B2  /  SOLUTION ddfm=sat; 
RANDOM Intercept  A1B1 B1A2 A2B2  /  SUB=Case; 
REPEATED / SUB=Case GROUP=Phase TYPE=ar(1); 
ODS OUTPUT solutionF=fixed2b covparms=random2b fitstatistics=fit2b; 
RUN; 
Compared with the former programs (Model 1 and Model 2) there is an additional line 
requesting the modeling of a first order autocorrelation within cases. This random part on the 
first level is modeled using the repeated statement. The option type = AR(1) requests 
modeling a first-order autocorrelation within cases. 
 
3. Model 3: Autocorrelation + Heterogeneous Within-Case Variance + Linear 
Time Trend in the Treatment Phase 
 
Model 3 
PROC MIXED  COVTEST DATA=TwoLevel METHOD=ML; 
CLASS Case Phase; 
MODEL Y = A1B1 B1A2 A2B2  T1 A1B1*T2 B1A2*T3 A2B2*T4  
/ SOLUTION DFM=sat; 
RANDOM Intercept A1B1 B1A2 A2B2 T1 A1B1*T2 B1A2*T3 A2B2*T4 
/SUB=Case; 
REPEATED / SUB=Case GROUP=Phase TYPE=ar(1); 
ODS OUTPUT solutionF=fixed3 covparms=random3 fitstatistics=fit3; 
RUN; 
Compared with Model 3, the model specification accordingly with the random part is changed 
by adding time variables. 
 
4. Model 4: Autocorrelation + Heterogeneous Within-Case Variance + Linear 
Time Trend in the Treatment Phase + Level Two Predictor 
 
Model 4 
PROC MIXED  COVTEST DATA=TwoLevel METHOD=ML; 
CLASS Case Phase Class ; 
MODEL Y =  class A1B1 B1A2 A2B2  T1 A1B1*T2 B1A2*T3 A2B2*T4/   
SOLUTION  DDFM=sat; 
RANDOM Intercept  A1B1 B1A2 A2B2  T1 A1B1*T2 B1A2*T3 A2B2*T4/   
SUB=Case  DDFM=sat; 
REPEATED / sub=Case  group=Phase type=ar(1); 
ODS OUTPUT solutionF=fixed4 covparms=random4 fitstatistics=fit4; 
RUN; 
Model 4   is similar to model 3 with the only change that a fixed predictor, Class, is added in 
the model-option. 
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5. Logistic Model 
 
Logistic Model A 
PROC GLIMMIX  DATA=TwoLevel; 
CLASS Case ; 
MODEL Y/10 =  Phase   / SOLUTION DIST=binomial LINK=logit CL; 
RANDOM Intercept Phase /SUB=Case; 
RUN; 
 
Logistic Model B 
PROC GLIMMIX  DATA=TwoLevel; 
CLASS Case ; 
MODEL Y/10 =  A1B1 B1A2 A2B2  / SOLUTION DIST=binomial LINK=logit CL; 
RANDOM Intercept A1B1 B1A2 A2B2  /SUB=Case; 
ODS OUTPUT solutionF=fixed5 covparms=random5 fitstatistics=fit5; 
RUN; 
 
For count data, the glimmix procedure is called. The other options are similar as in Model 1, 
with the only difference that the type of distribution has to be defined using the dist-option 
and the link-option. The dependent variable, Y, is divided by 10 because the outcome variable 
is a count out of ten.  
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Addendum A6: SAS code three-level analysis (Chapter 7) 
Model 1: Basic Three-Level Model 
PROC MIXED covtest DATA=ThreeLevel METHOD=ML; 
CLASS Study Case; 
MODEL Y = Phase / SOLUTION DDFM=sat; 
RANDOM Intercept  Phase / SUB=Study; 
RANDOM Intercept  Phase / SUB=Case(Study); 
RUN; 
 
The code for the three-level modeling is similar to the one used for the two-level modeling 
(see Appendix A). The only difference is an additional categorical variable, namely Study, 
defined in the class statement. We also have an additional random statement to indicate that 
the intercept and phase randomly vary across cases and across studies. The modeling of 
autocorrelation, heterogeneous within-case variance (Model 2), linear trends (Model 3) and 
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Addendum B: Raw data  
Raw data Multiple-baseline data for the first two participants of 
the study of Laski et al. (1988) (Chapter 6) 
Case Time Time1 Time2 Treatment Treatment*Time Treatment*Time1 Treatment*Time2 Y 
1 0 -4 0 0 0 0 0 27.60 
1 1 -3 1 0 0 0 0 23.96 
1 2 -2 2 0 0 0 0 23.83 
1 3 -1 3 0 0 0 0 47.26 
1 4 0 4 1 4 0 4 52.70 
1 5 1 4 1 5 1 4 60.99 
1 6 2 4 1 6 2 4 66.6 
1 7 3 4 1 7 3 4 52.50 
1 8 4 4 1 8 4 4 85.88 
1 9 5 4 1 9 5 4 47.05 
1 10 6 4 1 10 6 4 66.28 
1 11 7 4 1 11 7 4 54.05 
1 12 8 4 1 12 8 4 51.23 
2 0 -5 0 0 0 0 0 49.67 
2 1 -4 1 0 0 0 0 23.57 
2 2 -3 2 0 0 0 0 26.38 
2 3 -2 3 0 0 0 0 28.35 
2 4 -1 4 0 0 0 0 45.11 
2 5 0 5 1 5 0 5 70.67 
2 6 1 5 1 6 1 5 79.13 
2 7 2 5 1 7 2 5 84.09 
2 8 3 5 1 8 3 5 88.56 
2 9 4 5 1 9 4 5 80.90 
2 10 5 5 1 10 5 5 91.84 
2 11 6 5 1 11 6 5 63.42 
2 12 7 5 1 12 7 5 70.38 
 
